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Notes on the data
1. The data used in the report have been weighted. The weighting is described
in Chapter 14. Unweighted sample sizes are shown at the foot of each table.
The tables can all be downloaded as separate spreadsheets.
2. Where trends are presented, data from the 1993 and 2000 surveys have been
rerun on participants living in England only, to be comparable in scope with
the 2007 and 2014 surveys.
3. ‘Missing values’ occur for several reasons, including refusal or inability to
answer a particular question; refusal to complete an entire section of the
survey (such as the self-completion questionnaire); and cases where the
question is not applicable to the participant. In general, missing values
have been omitted from tables and analyses.
4. The estimated prevalence of the disorders and behaviours in this report
are presented as percentages to one decimal place, which is equivalent to
reporting rates per thousand.
5. The term ‘significant’ is used in this report to refer to statistical significance
and is not intended to imply substantive importance. Unless otherwise
stated, differences mentioned in the text have been found to be statistically
significant at the 95% confidence level. Standard errors that reflect the
complex sampling design and weighting procedures used in the survey have
been calculated and used in tests of statistical significance. Tables giving
the standard errors for and confidence intervals around key estimates are
provided in Chapter 14.
Mental health and wellbeing 
in England
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Key findings from the fourth in a series of surveys of the 
mental health of people living in England
Trends in mental illness
• One adult in six had a common mental disorder (CMD): about one woman in 
five and one man in eight. Since 2000, overall rates of CMD in England steadily 
increased in women and remained largely stable in men.
• Reported rates of self-harming increased in men and women and across age 
groups since 2007. However, much of this increase in reporting may have been 
due to greater awareness about the behaviour.
• Young women have emerged as a high-risk group, with high rates of CMD, self-
harm, and positive screens for posttraumatic stress disorder (PTSD) and bipolar 
disorder. The gap between young women and young men increased.
• Most mental disorders were more common in people living alone, in poor physical 
health, and not employed. Claimants of Employment and Support Allowance 
(ESA), a benefit aimed at those unable to work due to poor health or disability, 
experienced particularly high rates of all the disorders assessed.
Trends in treatment and service use
• One person in three with CMD reported current use of mental health treatment 
in 2014, an increase from the one in four who reported this in 2000 and 2007. 
This was driven by steep increases in reported use of psychotropic medication. 
Increased use of psychological therapies was also evident among people with 
more severe CMD symptoms.
• There were demographic inequalities in who received treatment. After controlling 
for level of need, people who were White British, female, or in mid-life (especially 
aged 35 to 54) were more likely to receive treatment. People in the Black ethnic 
group had particularly low treatment rates.
• Socioeconomic inequalities in treatment use were less evident, although people 
living in lower income households were more likely to have requested but not 
received a particular mental health treatment.
• Since 2007, people with CMD had become more likely to use community services 
and more likely to discuss their mental health with a GP.
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About the survey
Every seven years a rigorous assessment of the nation’s mental health is 
carried out. England has the longest running programme using consistent 
methods in the world.
The Adult Psychiatric Morbidity Survey (APMS) provides England’s National Statistics 
for the monitoring of mental illness and treatment access in the household 
population. The data series is unique and valuable because:
• A range of mental disorders, substance disorders and self-harm behaviours
is covered.
• High quality screening and assessment tools are used and undiagnosed conditions
identified. A two phase design is used.
• Surveys have been carried out in 1993, 2000, 2007 and 2014 using comparable
methods so trends can be examined.
• A large representative sample of the household population was interviewed,
7,500 people aged 16 or more, including those who do not access services.
As with all surveys, it should be acknowledged that prevalence rates are 
only estimates. If everyone in the population had been assessed the rate found 
may be higher or lower than the survey estimate. 95% confidence intervals (CIs) 
are given for key estimates in the individual chapters and Chapter 14 (Methods). 
For low prevalence disorders, relatively few positive cases were identified. Particular 
attention should be given to uncertainty around these estimates and to subgroup 
analysis based on these small samples. Comparisons made in the text have been 
tested and only statistically significant differences are described.
This latest survey, with fieldwork carried out in 2014 and 2015, presents the 
most reliable profile available of mental health in England. It was commissioned 
by NHS Digital, funded by the Department of Health, and carried out by NatCen 
Social Research and the University of Leicester. The survey includes data on mental 
health not available from any other source, and complements the range of statistics 
routinely published by NHS Digital. Reports on the use of Psychological Therapies 
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can be found at www.digital.nhs.uk/iaptreports. Reports on the use of specialist 
Mental Health and Learning Disability health services can be found at  
www.digital.nhs.uk/mhldsreports.
 Context 
Changes in the economy and models of mental health service delivery 
mean that the context of mental health in England has evolved since 
the last survey.
• Since the 2007, society has experienced changes in technology and media and 
the onset of recession.
• Treatment services have undergone change, including the introduction of the 
Improving Access to Psychological Therapy (IAPT) programme.
• The cross-government strategy No Health without Mental Health has sought 
to mainstream mental health and give it parity with physical health (DH 2011).
The APMS series is made up of cross-sectional surveys. While it cannot tell us 
whether these changes have impacted on mental health, it does provide us with 
a recent profile of mental health in England.
 Extent of mental illness in England
One adult in six had a CMD: one in five women and one in eight men.
The presence of CMD in the past week was assessed using the revised Clinical 
Interview Schedule (CIS-R). Disorders such as depression and generalised anxiety 
disorder (GAD) were identified, and a severity score produced. A score of 12 or 
more indicated symptoms warranting clinical recognition, a score of 18 or more is 
considered severe and requiring intervention.
One adult in six (17.0%) had a CMD. Throughout the survey series, rates have been 
higher in women than men: one woman in five had CMD (20.7%) compared with 
about one man in eight (13.2%).
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Other disorders were rarer, for example psychotic disorder and autism each affected 
about one adult in a hundred. Bipolar disorder was covered for the first time in the 
survey series in 2014, the Mood Disorder Questionnaire identified traits in about 
one adult in fifty. Signs of drug dependence were evident in one adult in thirty, with 
a similar level found for probable alcohol dependence (an AUDIT score of 16 or 
more). Both types of substance dependence were twice as likely in men as women.
 Trends in mental illness
Mental illness has increased in women, and remained largely stable in men.
The proportion of people with severe CMD symptoms (CIS-R score of 18+) did not 
change significantly between 2007 and 2014. However, the longer term trend has 
been one of steady increase (6.9% of 16 to 64 year olds in 1993, 7.9% in 2000; 
8.5% in 2007; 9.3% in 2014).1
1 Trends are based on people aged 16–64, as this age-group has been covered by every survey in the series.
Severe CMD symptoms in past week (CIS-R score 18+), 1993 to 2014
Base: adults aged 16–64
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Increases in CMD symptoms were driven by rises in women; the prevalence of 
CMD symptoms in men had remained broadly stable since 2000. Reports of self-
harming doubled in men and women and across age groups between 2007 and 
2014. This increase in reporting may be due (at least in part) to changes in reporting 
behaviour, that minor self-injury which people had not included as self-harm in 
previous surveys had started to be labelled as such. It is also likely that people felt 
more able to disclose self-harm. This might have happened if self-harming had 
become more normalised and less stigmatised. Finally, it is possible that increased 
reporting of self-harm reflects a real increase in the behaviour. A combination 
of these factors was probably at play.
CMD symptoms in past week (CIS-R score 12+ and 18+) by sex: 1993 to 2014
Base: adults aged 16–64
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Since 2000, rates of hazardous drinking (AUDIT scores 8–15) declined in men and 
remained (at a lower level) stable in women. Levels of harmful or dependent 
drinking (AUDIT 16+) had not experienced a corresponding fall.
Inequalities and high risk groups
A key objective of the No Health Without Mental Health Strategy is tackling 
inequalities in mental illness; APMS provides data for monitoring progress 
towards this.
Young women have become a key high risk group.
The gender gap in mental illness had become most pronounced in young 
people, and there is evidence that this gap has widened in recent years. Due to 
small base sizes, caution is needed with interpretation of results for age-by-sex 
Hazardous and harmful/dependent drinking (AUDIT score 8+ and 16+) 
in past year by sex: 2000, 2007 and 2014
Base: adults aged 16–74
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subgroups. However, the pattern here is consistent with other recent data sources 
(Knudsen 2016; The Children’s Society 2016; Lessof et al. 2016).
In 2014, one in five 16 to 24 year old women reported having self-harmed at 
some point in her life when asked face-to-face and one in four reported this in 
the self-completion section of the survey. Most of the young people who reported 
self-harming did not seek professional help afterwards. Individuals who start to 
self-harm when young might adopt the behaviour as a long-term strategy for 
coping; there is a risk that the behaviour will spread to others; and also that greater 
engagement with the behaviour may lead in time to a higher suicide rate.
CMD symptoms in past week (CIS-R score 12+), by age and sex
Base: all adults 
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%
0
5
10
15
20
25
30
Age
16–24 25–34 35–44 45–54 55–64 65–74 75+ 
 15 | APMS 2014  | Executive summary | © 2016, Health and Social Care Information Centre
Self-harm ever (reported face-to-face) in 16–24 year olds, by sex:
2000, 2007 and 2014 
Base: adults aged 16–24 and living in England
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Young women had high rates of screening positive for posttraumatic stress disorder 
(PTSD) (12.6% compared with 3.6% of men of the same age). 
Screening positive for posttraumatic stress disorder (PTSD), by age and sex
Base: all adults 
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While a decline in rates of harmful and probable dependent drinking since 2000 is 
clear in young men, such improvements are less evident in young women. Survey 
data on drug dependence trends in young people are likely to be incomplete, due 
to changes in the types of drugs becoming available, in particular the emergence of 
new psychoactive substances (NPS) which are challenging to research and regulate. 
Rates of mental illness increased in men and women aged 55 to 64.
Since 2007, there had been increases in CMD symptoms in late midlife men 
and women (aged 55 to 64). This continued an upward trend in CMD in midlife 
women since 1993 (the longer term trend in men is less clear). Like young people, 
those in late life had also seen a steep increase in rates of reported lifetime self-
harm. Men in this age-group have the highest rates of registered suicide, and 
have been identified as a priority group in England’s National Suicide Prevention 
Strategy (DH 2015).
Harmful/dependent drinking in past year (AUDIT score 16+) 
in 16 to 24 year olds by sex: 2000, 2007 and 2014
Base: adults aged 16–24
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CMD symptoms in past week (CIS-R score 12+) in 55 to 64 year olds 
by sex: 1993 to 2014
Base: adults aged 55–64
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In contrast with the decline in rates of probable alcohol dependence in young men 
since 2000, there was no evidence of any decline in alcohol dependence rates in 
men and women aged 55 to 64.
Harmful/dependent drinking in the past year (AUDIT score 16+) 
in 55 to 64 year olds by sex: 2000, 2007 and 2014
Base: adults aged 55–64
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 Mental illness in context
Living alone
Links between mental illness and social context are well established, for example 
rates tend to be higher in people who are single or divorced. Increasingly people live 
alone. Those that do live alone were identified in APMS 2014 as having experienced 
higher rates of most different mental disorders, including CMD, PTSD, psychotic 
disorder, personality disorder, and bipolar disorder.2
Living in socioeconomic adversity
Links between mental illness and socioeconomic context are also well-established, 
and APMS 2014 findings are consistent with this.
In the APMS 2014 data, it emerged that people in receipt of Employment and 
Support Allowance (ESA), a benefit aimed at those unable to work due to poor 
health or disability, were a particularly vulnerable group. While many will have 
2 APMS is a cross-sectional survey, capturing one moment in time, and cannot confirm whether living alone contributes to people 
having worse mental health or if people with poor mental health are more likely to choose to or end up living alone.
Psychotic disorder in the past year (2007 and 2014 combined), 
by household type and sex
Base: all adults
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received ESA primarily for a physical health reason the great majority of this group 
had very high levels of psychiatric comorbidity. People in receipt of ESA experienced 
particularly high rates of most disorders: one in eight screened positive for bipolar 
disorder, a third for attention-deficit/hyperactivity disorder (ADHD), and approaching 
half had made a suicide attempt at some point.
Comorbidity with chronic physical conditions, low mental wellbeing 
and intellectual impairment
• APMS data can be used to examine comorbidity between physical and mental
illnesses. The report focuses on five chronic physical conditions: asthma, cancer,
diabetes, epilepsy, and high blood pressure. All had some association with at least
one mental disorder. Even subthreshold levels of CMD symptoms were associated
with higher rates of chronic physical conditions.
• Mental wellbeing was assessed using the Warwick Edinburgh Mental Wellbeing
Scale (WEMWBS). Low mental wellbeing was associated with presence of chronic
physical conditions, but links with mental disorders were far stronger.
Psychotic disorder in the past year (2014), by benefit status
Base: 16–64 years (out of work benefits); all adults (housing benefit)
%
5
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• Predicted verbal IQ was estimated using the National Adult Reading Test
(NART). Those with a lower score, indicating borderline intelligence of a level
where assistance with functioning may be needed, had higher rates of most
of the mental disorders assessed on the survey.
These associations support the need for treatment and health service delivery in 
a general setting, addressing physical and mental health needs together.
Use of mental health treatment
One person in three with CMD was in receipt of treatment.
Treatment was defined as current receipt of psychotropic medication and/or 
counselling or other psychological therapy.3
3 It was not established who provided the treatment, it could have been NHS or private.
Presence of any CMD, by predicted verbal IQ score 
(based on the National Adult Reading Test) 
Base: all adults
%
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The more severe people’s current symptoms of CMD were, the more likely it was 
that they were using treatment. Treatment rates were higher for some disorders 
than others. The majority of people identified with psychotic disorder were in 
treatment, and around half of those with depression, obsessive compulsive disorder 
(OCD), phobias, GAD, a positive screen for PTSD, or signs of dependence on drugs 
other than cannabis. Very few people with autism were in receipt of mental health 
treatment, despite high levels of psychiatric comorbidity in this group.
The proportion of people with CMD using treatment increased.
People with CMD were more likely to use treatment in 2014 than at any time in 
the survey series. This was driven by steep increases in the use of psychotropic 
medication since 2007. Increased use of psychological therapies was also evident 
among people with more severe symptoms.
Current use of mental health treatment, by CIS-R score
Base: all adults
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Current use of treatment in adults with CIS-R score 12+ and 18+: 
2000, 2007, 2014 
Base: 16–74 year olds with CIS-R score of 12+/18+
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Changes in data collection methodology could have played a part in this increased 
reporting of medication. However, this is unlikely to account for all of the rise. 
Furthermore, this increase is consistent with other data sources, for example 
analyses of prescribing data (Spence et al. 2014).
Alongside increases in receipt of treatment, the use of primary and community 
care for a mental health reason also increased over time. People with CMD became 
more likely to discuss their mental health with a GP, and since 2000 there had 
been a slight – but steady – increase in the proportion of adults with CMD using 
community and day care services.
Inequalities in mental health treatment
Among people with CMD, those who were female, White British, or in 
midlife were more likely than others to receive treatment.
There were demographic inequalities in who received treatment. After accounting 
for differences in level of need between groups, people who were White British, 
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female or in mid-life (especially aged 35 to 54) were more likely to receive treatment 
than others. People in the Black/ Black British group had particularly low treatment 
rates. After an episode of self-harm, older people were more likely than younger 
people to seek professional help.
Autism was the only condition where people with the condition were no more likely 
to use treatment than the rest of the population, suggesting that this group may 
not be having their needs met by existing service provision.
One adult in ten with severe CMD symptoms (CIS-R 18+) asked for a particular 
mental health treatment in the past 12 months but did not receive it.
Among people with CMD, those who were young and those living in a low income 
household were particularly likely to have unmet treatment requests. About half of 
people with CMD and an unmet treatment request were not receiving any other 
type of treatment at the time of the interview.
Requested but not received particular mental health treatment in past 
12 months in adults with CIS-R score 12+, by equivalised household income
Base: all adults
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 Further information
Limitations
All surveys are subject to bias. Some people, for example those who live in an 
institution, could not have been selected to take part. Non-response means that 
some selected households or individuals could either not be contacted or declined 
to take part. Others may not have been well enough or lacked the cognitive 
capabilities to complete a long survey interview. Social desirability biases may 
mean some people, especially in the face-to-face section of the interview, did not 
answer fully or honestly. Survey screening and assessment tools should also not be 
considered the equivalent of an assessment conducted by a psychiatrist or other 
trained professional over a number of sessions. These limitations, while ameliorated 
to some extent with use of validated measures, self-completion data entry, 
weights, understanding of the population they relate to and how the data should 
appropriately be applied, should be acknowledged.
Coverage and data access: the survey report includes the following chapters:
1. Introduction to the survey series
2. Common mental disorders (CMD)
3. Mental health treatment and service use
4. Posttraumatic stress disorder (PTSD)
5. Psychotic disorder
6. Autism
7. Personality disorder
8. Attention-deficit/hyperactivity disorder (ADHD)
9. Bipolar disorder
10. Alcohol misuse and dependence
11. Drug misuse and dependence
12. Suicidal thoughts, suicide attempts and self-harm
13. Comorbidity in mental and physical illness
14. Methodology
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The long interview, carried out in people’s own homes, covered a wealth of other 
topics. Researchers can access the data for free from the UK Data Service. It can 
take three months from the date of report publication for the data to be released.
The full survey report can be accessed: www.digital.nhs.uk/pubs/apmsurvey14
Survey website with information about how the data has been used: 
www.mentalhealthsurveys.org.uk
In case of questions please contact: enquiries@nhsdigital.nhs.net
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1.1 Policy context
Poor mental health has enormous economic and social impact. Mental illness is 
one of the largest single causes of disability (OECD 2014) and sickness absence 
in the UK (CMH 2010), accounting for 70 million sick days in 2007 (CMH 2007). 
On average, people with mental illness die 15 to 20 years earlier than those 
without (Thornicroft 2013; DH 2015). Yet while mental illness accounts for 28% 
of the national disease burden in England, only 13% of NHS spending is on 
mental health care (DH 2013).
In recent years there has been a strong policy narrative, with cross-party support, 
calling for a ‘parity of esteem’ in health service response to physical and mental 
illness. The Chief Medical Officer’s 2013 report, Public Mental Health: Investing in 
the Evidence, states that despite a welcome policy focus on mental illness, there 
has been a real-terms fall in investment (DH 2014). Previous APMS data has tended 
to find that, at any one time, about three-quarters of people with mental illness 
are in receipt of no treatment at all.
In key aspects, such as community outreach and early intervention, the provision 
of mental health services in England has been identified as among the best in 
Europe (WHO 2008). However, the independent Mental Health Taskforce to the 
NHS has highlighted that people living with mental health problems still experience 
stigma and discrimination, many people struggle to get the right help at the right 
time, and evidence-based care is significantly underfunded (2016). There is a need 
for prevention efforts and for closer working between primary care, social and 
occupational health services (GOS 2008). Furthermore, it is also recognised that 
little is known specifically of the prevalence and effects in adulthood of disorders 
better recognised in children, including attention-deficit/hyperactivity disorder 
(ADHD) and autism.
No Health without Mental Health is a cross-government mental health outcomes 
strategy for people of all ages (DH 2011a). It was launched in 2011 and aimed 
to ‘mainstream mental health’. It highlighted six overarching objectives:
• More people will have good mental health
• More people with mental health problems will recover
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• More people with mental health problems will have good physical health
• More people will have positive experiences of care and support
• Fewer people will suffer avoidable harm
• Fewer people will experience stigma and discrimination.
The strategy highlights the role of Improving Access to Psychological Therapies 
(IAPT) (DH 2011b) in improving outcomes in mental health. It also re-states the 
Government’s commitment to removing inequalities in access to services and 
to improving the lives of people with mental illness.
1.2 Survey background
The Psychiatric Morbidity Survey series provides key context for understanding mental 
illness in England and for informing initiatives in this area. The survey series has run 
since the early 1990s and covered a range of general population groups, including:
• Adults living in private households: aged 16 to 64 in 1993 (Meltzer et al. 1995), 
aged 16 to 74 in 2000 (Singleton et al. 2001), and 16 and over in 2007 
(McManus et al. 2009)
• Residents of institutions providing care and support to people with mental health 
problems (Meltzer et al. 1996)
• Homeless adults (Gill et al. 1996; Kershaw et al. 2000)
• Adults with a psychotic disorder (Forster et al. 1996; Singleton and Lewis 2003)
• Prisoners and young offenders (Melzer et al. 2000; O’Brien et al. 2001; 
Lader et al. 2000)
• Young people in local authority care (Meltzer et al. 2004)
• Children and adolescents (Green et al. 2005; Clements et al. 2008) (with a 
new survey of children from age 2 to 19 currently being planned), and
• Carers (Singleton et al. 2002).
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The 2014 Adult Psychiatric Morbidity Survey (APMS) is the fourth survey of 
psychiatric morbidity in adults living in private households. It was carried out by 
NatCen Social Research in collaboration with the University of Leicester, and was 
commissioned by NHS Digital (formerly the Health and Social Care Information 
Centre, HSCIC). The survey series is supported by psychiatrists and epidemiologists 
working in a number of UK universities.
APMS 2014 retains the same core questionnaire content and methodological 
approach as the 1993, 2000 and 2007 surveys to enable the examination of trends. 
The latest survey also included some new topics to reflect emerging policy priorities. 
In summary, the distinguishing attributes of the most recent two household surveys 
(2007 and 2014) were that they:
• Were conducted in England only
• Had no upper age limit for participation
• Were in the field over the course of a whole year, and
• Included additional conditions (such as bipolar disorder) and risk factors
(such as experience of childhood neglect).
See Chapter 14, Methods, for details of topic coverage and a list of the differences 
across the surveys series. The full phase one questionnaire is in Appendix D.
1.3 Survey aims
The main aim of the survey series is to collect data on poor mental health among 
adults (aged 16 and over) living in private households in England. The specific 
objectives include:
• To estimate the prevalence of psychiatric morbidity according to diagnostic
category in the adult household population of England. The survey includes
assessment of common mental disorders, psychosis, autism, substance misuse
and dependency, and suicidal thoughts, attempts and self-harm.
• To screen for attention-deficit/hyperactivity disorder (ADHD), posttraumatic stress
disorder (PTSD), bipolar disorder and personality disorders.
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• To examine trends in the psychiatric disorders that were included in previous 
survey years (1993, 2000, and 2007).
• To identify the nature and extent of social disadvantage associated with 
mental illness.
• To gauge the level and nature of treatment and service use in relation to mental 
health problems, with an emphasis on primary care.
• To collect data on key current and lifetime factors that might be associated with 
mental health problems, such as the experience of stressful life events, abusive 
relationships, and work stress.
• To collect data on factors that might protect against poor mental health, 
such as social support networks and neighbourhood cohesion.
1.4 Overview of the survey design
Fieldwork was carried out between May 2014 and September 2015. As with 
the preceding surveys, a two-phase approach was used for the assessment of 
several disorders.
The first phase interviews were carried out by NatCen Social Research interviewers. 
These included structured assessments and screening instruments for mental 
disorders, as well as questions about other topics, such as general health, service 
use, risk factors and demographics. These interviews lasted about an hour 
and a half on average.
The second phase interviews were carried out by clinically-trained research 
interviewers employed by the University of Leicester. A sub-sample of phase one 
respondents were invited to take part in the second phase interview to permit 
assessment of psychotic disorder, attention-deficit/hyperactivity disorder and 
autism. The assessment of these conditions requires a more detailed and flexible 
interview than was possible at the first phase, and the use of clinical judgement 
in establishing a diagnosis.
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1.5 Summary of strengths and limitations
Details of and rationale for the sample design and methods are provided in 
Chapter 14. In summary, benefits of this study design include that:
• By sampling from the general population rather than from lists of patients, 
APMS data can be used to examine the ‘treatment gap’.
• The use of validated mental disorder screens and assessments allows for 
identification of people with sub-threshold symptoms and those with an 
undiagnosed disorder.
• The questionnaire collects details of social and economic circumstances, 
information which does not tend to be collected in a consistent or comprehensive 
way in administrative datasets.
• The use of a computer assisted self-completion module to cover the most 
sensitive topics means that the survey includes information that some participants 
may have never disclosed before.
• At the end of the survey a question is asked about permission for follow-up 
and data linkage. The study therefore presents an opportunity for longitudinal 
data collection and a sampling frame that allows a random sample of people with 
very specific experiences, who may not otherwise have been identifiable, to be 
invited for further research.
• The APMS dataset is being deposited at the UK Data Service and is designed to 
be suitable for extensive further analysis. There is only scope for a small part of 
the data collected to be covered in this report.
Surveys such as APMS, however, are subject to a number of limitations. 
These include:
• The sampling frame covers only those living in private households. Those living 
in institutional settings such as care homes, offender institutions, prisons, or 
in temporary housing or sleeping rough, would not have had a chance to be 
selected. People living in such settings are likely to have worse mental health 
than those living in private households.
 32 | APMS 2014  | Chapter 1: Introduction | Copyright © 2016, Health and Social Care Information Centre
• Some people selected could not be contacted or refused to take part. Adults 
with severe mental health problems who do live in private households may be 
less available or willing to respond to surveys.
• Some people selected were not able to take part in a long interview. These 
include those with serious physical health conditions or who were staying in 
hospital, and those whose mental capability may be impaired.
• Survey assessments of mental illness are not as reliable as a clinical interview. 
In a clinical interview, a trained psychologist or psychiatrist may take many 
sessions and clinical judgement to reach a diagnosis. In the context of a 
questionnaire administered by a lay interviewer, this is not possible. However, 
the assessments used have been validated and are among the best available 
for the purpose in hand. Rather than focus on the prevalence estimated for each 
disorder, the greater value of the survey is being able to examine how rates vary 
over time and between groups in the population.
• For low prevalence disorders, the number of positive cases in the sample is 
small which limits the scope for subgroup analysis. Confidence intervals for key 
estimates are provided in the methods chapter (Chapter 14).
1.6 Coverage of this report
Each of the main disorders and behaviours covered by APMS 2014 is discussed 
in a separate chapter. The chapters compare disorder rates by age, sex, ethnicity, 
employment and benefit status, region, household composition, and the level 
and nature of mental health treatment and service use. Where disorders were 
also covered in the 1993, 2000 and/or 2007 surveys, changes in rates are also 
considered. The tables for each chapter are provided in a separate spreadsheet. 
Further analyses of the data are planned.
Publications based on data collected in the previous surveys in the series are listed 
in Appendix A.
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1.7 Access to the data
A copy of the anonymised 2014 APMS dataset will be deposited at the UK 
Data Service, and made available for specific research projects. The dataset will be 
accompanied with guidance on its use. Information on data access is available at 
the Data Service website. A list of the derived variables used in this report can be 
found in Appendix C.
1.8 Ethical clearance
Ethical approval for APMS 2014 was obtained from the West London National 
Research Ethics Committee.1
1.9 Further information
Further information about the adult psychiatric morbidity survey series is obtainable 
from a range of websites:
• NHS Digital – www.digital.nhs.uk/pubs/apmsurvey14
• NatCen – www.natcen.ac.uk/our-research/research/adult-psychiatric-
morbidity-survey/
• UK Data Service – https://discover.ukdataservice.ac.uk/series/?sn=2000044
• Academic – https://mentalhealthsurveys.org
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Summary
• Common mental disorders (CMDs) comprise different types of depression and 
anxiety. They cause marked emotional distress and interfere with daily function, 
but do not usually affect insight or cognition. Although usually less disabling than 
major psychiatric disorders, their higher prevalence means the cumulative cost 
of CMDs to society is great.
• The revised Clinical Interview Schedule (CIS-R) has been used on each Adult 
Psychiatric Morbidity Survey (APMS) in the series to assess six types of CMD: 
depression, generalised anxiety disorder (GAD), panic disorder, phobias, obsessive 
compulsive disorder (OCD), and CMD not otherwise specified (CMD-NOS). 
Many people meet the criteria for more than one CMD. The CIS-R is also used 
to produce a score that reflects overall severity of CMD symptoms.
• Since 2000, there has been a slight but steady increase in the proportion of 
women with CMD symptoms (as indicated by a CIS-R score of 12 or more), but 
overall stability at this level among men. The increase in prevalence was evident 
mostly at the more severe end of the scale (CIS-R score 18 or more).
• Since the last survey (2007), increases in CMD have also been evident among 
late midlife men and women (aged 55 to 64), and approached significance in 
young women (aged 16 to 24).
• The gap in rates of CMD symptoms between young men and women appears 
to have grown. In 1993, 16 to 24 year old women (19.2%) were twice as likely 
as 16 to 24 year old men (8.4%) to have symptoms of CMD (CIS-R score 12 
or more). In 2014, CMD symptoms were about three times more common in 
women of that age (26.0%) than men (9.1%).
• CMDs were more prevalent in certain groups of the population. These included 
Black women, adults under the age of 60 who lived alone, women who lived 
in large households, adults not in employment, those in receipt of benefits and 
those who smoked cigarettes. These associations are in keeping with increased 
social disadvantage and poverty being associated with higher risk of CMD.
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• Most people identified by the CIS-R with a CMD also perceived themselves 
to have a CMD. This was not the case for most of the other disorders assessed 
in the APMS.
• While most of these people had been diagnosed with a mental disorder by 
a professional, the disorders they reported having been diagnosed with tended 
to be ‘depression’ or ‘panic attacks’. However, the disorder most commonly 
identified by the CIS-R was GAD. This difference may reflect the language 
and terminology used by people when discussing their mental health with 
a professional.
2.1 Introduction
Reducing the prevalence of common mental disorders such as depression and 
anxiety is a major public health challenge (Davies 2014). CMDs range in 
severity from mild to severe and are often associated with physical and social 
problems (Goldberg and Huxley 1992). They can result in physical impairment 
and problems with social and occupational functioning, and are a significant 
source of distress to individuals and those around them. Both anxiety and 
depression often remain undiagnosed (Kessler et al. 2002) and sometimes 
individuals do not seek or receive treatment. If left untreated, CMDs are more likely 
to lead to long term physical, social and occupational disability and premature 
mortality (Zivin et al. 2015). Although evidence exists for effective treatment of 
depression and anxiety (NICE 2004), this seems to have had little impact on the 
prevalence of these disorders. This may be because CMDs are relapsing conditions 
that can recur many years after an earlier episode, because the stressors that cause 
them endure, and because people with CMD do not always adhere to or seek 
treatment (Weich et al. 2007; Cooper et al. 2007). In the case of depression, relapse 
ten years from first presentation frequently occurs (Thornicroft and Sartorius 1993).
Although poverty and unemployment tend to increase the duration of episodes 
of CMD, it is not clear whether or not they cause the onset of an episode. Debt 
and financial strain are certainly associated with depression and anxiety, and 
increasingly the evidence is suggestive of a causal association (Meltzer et al. 2013; 
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Mind 2008). There are a wide range of other known associations, including: being 
female (Weich et al. 1998); work stress (Stansfeld et al. 1999); social isolation 
(Bruce and Hoff 1994); being a member of some ethnic groups (Weich et al. 
2004); poor housing and fuel poverty (Harris et al. 2010; Hills 2012); negative 
life events (such as bullying, violence, bereavement, job loss); childhood adversity 
including emotional neglect, physical and sexual abuse (Fryers and Brugha 2013); 
institutional care, low birth weight (Loret de Mola et al. 2014); poor physical 
health; a family history of depression (Angst et al. 2003); poor interpersonal 
and family relationships, a partner in poor health, being a carer (Stansfeld et al. 
2014); and problems with alcohol and illicit drugs (Salokangas and Poutanen 
1998). Development of effective strategies for prevention of CMD has been 
limited by a lack of evidence on how risk factors act in combination (Clark et al. 
2012). However, multifactorial risk algorithms for predicting major depression and 
anxiety disorders have been published (King et al. 2011a; King et al. 2011b) and 
are already influencing prevention efforts in primary care (Bellón et al. 2016).
Although usually less disabling than major psychiatric disorders such as 
psychotic disorder, the higher prevalence of CMDs mean that their cumulative 
cost to society is great (Zivin et al. 2015). These costs are even higher if CMD 
co-occurs with a personality disorder (Rendu et al. 2002). Mixed anxiety and 
depression (referred to here as ‘CMD not otherwise specified’ (NOS)) has been 
estimated to cause one fifth of days lost from work in Britain (Das-Munshi et 
al. 2008). In the United Kingdom, every year mental illness, largely CMD, costs 
the economy an estimated £70 billion (equivalent to 4.5% of GDP) (OECD 2014). 
Mental illness is the leading cause of UK sickness absence, accounting for 70 million 
sick days in 2013 (ONS 2014). In 2013, 41% of people receiving Employment 
and Support Allowance (ESA) had a ‘mental or behavioural disorder’ coded as 
their primary condition (OECD 2014). See Chapter 3 for use of treatment in 
people with CMD and Chapter 13 for comorbidity with CMD.
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2.2 Definition and assessment
Common mental disorders (CMDs)
CMDs, also known as neurotic disorders, cause marked emotional distress 
and interfere with daily function, although they do not usually affect insight 
or cognition. CMDs comprise different types of depression and anxiety. Symptoms 
of depressive episodes include low mood and a loss of interest and enjoyment in 
ordinary things and experiences. They impair emotional and physical wellbeing 
and behaviour. Anxiety disorders include generalised anxiety disorder (GAD), 
panic disorder, phobias, and obsessive compulsive disorder (OCD). Symptoms 
of depression and anxiety frequently co-exist, with the result that many people 
meet criteria for more than one CMD. OCD is characterised by a combination 
of obsessive thoughts and compulsive behaviours. Obsessions are defined as 
recurrent and persistent thoughts, impulses or images that are experienced 
as intrusive and inappropriate, are resisted, and cause marked anxiety or 
distress. Compulsions are repetitive, purposeful and ritualistic behaviours 
or mental acts, performed in response to obsessive intrusion and to a set 
of rigidly prescribed rules (NICE 2006).
The Clinical Interview Schedule – Revised (CIS-R)
Specific CMDs and symptoms of CMD were assessed in the first phase interview 
using the Clinical Interview Schedule – Revised (CIS-R). The CIS-R is an interviewer 
administered structured interview schedule covering the presence of non-psychotic 
symptoms in the week prior to interview. It can be used to provide prevalence 
estimates for 14 types of CMD symptoms and six types of CMD, together with 
a continuous scale that reflects the overall severity of CMD psychopathology 
(Lewis et al. 1992).
Each section of the CIS-R assesses one type of CMD symptom. These are:
• Somatic symptoms
• Fatigue
• Concentration and forgetfulness
• Sleep problems
• Irritability
• Worry about physical health
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• Depression
• Depressive ideas
• Worry
• Anxiety
• Phobias
• Panic
• Compulsions
• Obsessions
Each section starts with two filter questions to establish the presence of 
the particular symptom in the past month. A positive response leads to further 
questions enabling a more detailed assessment of the symptom in the past week 
including frequency, duration, severity, and time since onset. Answers to these 
questions determine the scores for each symptom. Symptom scores range from 
zero to four, except for depressive ideas, which has a maximum score of five. 
Descriptions of the items that make up the scores for each of the symptoms 
measured by the CIS-R can be found in Appendix B. Data on the symptom scores 
are not presented in this chapter, but are available in the archived dataset.
The scores for each section are summed to produce a total CIS-R score, which is an 
indication of the overall severity of symptoms.
• CIS-R score of 12 or more is the threshold applied to indicate that a level of 
CMD symptoms is present such that primary care recognition is warranted. In 
this chapter, ‘presence of CMD symptoms’ includes all participants with a CIS-R 
score of 12 or more (including those with a score of 18 and above).
• CIS-R score of 18 or more denotes more severe or pervasive symptoms of a level 
very likely to warrant intervention such as medication or psychological therapy. In 
this chapter ‘severe CMD symptoms’ is used to indicate those with a CIS-R score 
of 18 or more.
The participants’ answers to the CIS-R were used to generate 10th International 
Classification of Disease (ICD-10) diagnoses of CMD using the computer algorithms 
described in Appendix B (WHO 1992). These ICD-10 diagnoses were then 
amalgamated to produce the six categories of disorder used in this report:
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• Generalised anxiety disorder (GAD)
• Depression (including mild, moderate and severe)
• Phobias
• Obsessive compulsive disorder (OCD)
• Panic disorder
• CMD not otherwise specified (CMD-NOS, referred to in previous surveys in the 
APMS series as ‘mixed-anxiety and depression’).
It should be noted that ‘CMD-NOS’ was defined as having a CIS-R score of 
12 or more but falling short of the criteria for any specific CMD. By definition, 
participants with this diagnosis therefore could not be classed as having any other 
CMD measured by the CIS-R. For the other five ICD-10 disorders, participants could 
be classed in more than one category (although phobias and panic disorder have 
diagnostic criteria that are mutually exclusive).
The CIS-R was also used to assess CMDs in the 1993, 2000 and 2007 APMS. The 
schedule was administered using computer assisted interviewing in the 2000, 2007 
and 2014 surveys, and by paper in 1993. The approach has otherwise remained 
consistent and the data are comparable across survey years. The comparisons 
between survey years reported in this chapter are limited to participants aged 16–64 
years and living in England (the first two surveys also covered Scotland and Wales). 
This age range was used because the 1993 survey did not sample adults aged 
65 and over. 
Self-diagnosis and professional diagnosis
In the 2014 survey, new questions were added. Participants were presented with a 
show card listing different mental disorders and were asked: a) which they thought 
they had had at some point in their life; b) whether this had also been diagnosed by 
a professional; and c) whether a diagnosed disorder had been present in the past 
12 months. It should be noted that the rates presented are estimates based entirely 
on self-reports, and have not been checked against health records. 
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2.3 Results
Prevalence of CMD symptoms, by age and sex
Around one adult in six (15.7%) were identified with symptoms of CMD 
(as indicated by a CIS-R score of 12 or more). See Table 14.6 for 95% confidence 
intervals around some of these estimates. It is likely that if all adults in the 
population had been assessed using the CIS-R, the proportion scoring 12 or 
more would be between 14.7% and 16.7%. One in twelve (8.1%) had severe 
symptoms of CMD (CIS-R score of 18 or more, 95% CI: 7.4% to 8.9%). 
Women were more likely than men to be affected. One in five (19.1%) women 
had CMD symptoms, compared with one in eight men (12.2%). Women were also 
more likely than men to have severe symptoms of CMD (9.8% of women scored 
18 or more on the CIS-R, compared with 6.4% of men).
CMD symptoms were associated with age. Overall, working-age people 
were around twice as likely to have symptoms of CMD as those aged 65 and 
over. Between 16 and 64, the proportion with CMD symptoms remained around 
17%–18%. But among those aged 65 and over the rate was much lower 
(10.2% of 65 to 74 year olds and 8.1% of those aged 75 and over). A similar 
pattern was observed for severe symptoms of CMD.1
The pattern of association between age and CMD symptoms was different for 
men and women. In women, rates of CMD symptoms peaked in the youngest group 
(26.0% of 16 to 24 year olds). This was three times the rate for 16 to 24 year old 
men (9.1%). In men the rate of CMD symptoms remained quite stable between the 
ages of 25 and 64, while in women a second (less-pronounced) peak was evident 
around midlife (45 to 54 year olds). Both men and women experienced a tailing 
off of CMD symptoms in later life. This pattern was similar, although even more 
pronounced, in rates of severe symptoms (a CIS-R score of 18 or more). Table 2.1
1 Around 8% to 10% of people in age groups in the 16 to 64 range scored 18 or more on the CIS-R, compared with 4.2% of those 
aged 65 to 74 and 3.3% of those aged 75 and over.
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Trends in CMD symptoms, 1993 to 2014
There was an increase in CMD symptoms (CIS-R score of 12 or more) in 16–64 
year olds between 1993 (14.1%) and 2000 (16.3%), but since then there has been 
stability in the proportion with a CIS-R score of 12 or more. In 2014, 17.5% of 
working-age adults had symptoms of CMD.
Figure 2A: CIS-R score of 12 or more, by age and sex
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Figure 2B: CIS-R score of 18 or more, by age and sex
Base: all adults
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While the overall prevalence of symptoms of CMD (CIS-R score 12 or more) 
remained stable between 2000 and 2014, the proportion with severe CMD 
symptoms (CIS-R score of 18 or more) increased (7.9% in 2000; 8.5% in 2007; 
9.3% in 2014). While rates of severe symptoms of CMD did not significantly differ 
between 2007 and 2014, the trend since 1993 has been one of slow but steady 
increase (from 6.9% to 9.3%). No equivalent trend is evident for rates of less severe 
symptoms (CIS-R 12–17), which have remained remarkably stable over time 
(Figure 2C). Table 2.2
Figure 2C: CIS-R score, 1993 to 2014
Base: adults aged 16–64
1993 2000 2007 2014
CIS-R 12–17
CIS-R 18+
CIS-R 12+
Year
0
2
4
6
8
10
12
14
16
18
20%
Figure 2D: CIS-R score of 12 or more and 18 or more by sex, 1993 to 2014
Base: adults aged 16–64
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There is evidence of different patterns of change over time in different age groups 
and in men and women. These trends need to be treated with some caution as the 
base sizes for some age by sex combinations are small. However, it seems that in 
women, increases in rates over time have been steady and evident across different 
age groups, while the trends for men are less clear. Table 2.2
Increases in rates of severe CMD symptoms were most pronounced in women aged 
16 to 24 (from 9.6% in 1993 to 15.1% in 2014) and 55 to 64 (from 5.5% to 9.3%), 
Figure 2E: Severe CMD symptoms (CIS-R 18+) in men, 1993 to 2014
Base: men aged 16–64
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Figure 2F: Severe CMD symptoms (CIS-R 18+) in women, 1993 to 2014
Base: women aged 16–64
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and for men aged 55 to 64 (from 5.7% to 9.1%). Overall, and for men, the recent 
change in rates of severe CMD symptoms between 2007 and 2014 in 55 to 64 
year olds was statistically significant. This increase may relate to people of this age 
being particularly vulnerable at time of economic recession (Frasquilho et al. 2015). 
The apparent increase in rate among young women does not quite meet statistical 
significance at the 95% level, and so should be treated with caution unless 
corroborated by other data sources. 
The gap in rates of CMD symptoms between young men and women has grown. 
In 1993, 16 to 24 year old women (19.2%) were twice as likely as 16 to 24 year 
old men (8.4%) to have symptoms of CMD. By 2014, CMD symptoms were almost 
three times more common in women of that age (26.0%) than men (9.1%). 
Table 2.2
Prevalence of CMDs, by age and sex
One in six (17.0%) people (aged 16 and over) were identified with a CMD in 
the week before interview. The largest category of CMD, as in previous years 
of the survey, was CMD-NOS (7.8%). GAD remained the next most commonly 
identified CMD (5.9%), followed by depression (3.3%), phobias (2.4%), OCD 
(1.3%) and panic disorder (0.6%). All types of CMD were more prevalent in 
women than in men, with differences by sex reaching statistical significance 
for GAD, phobias, panic disorder and CMD-NOS. Table 2.3
Figure 2G: Prevalence of common mental disorders (CMDs), by sex
Base: all adults
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With the exception of panic disorder (which had a low prevalence), each type 
of CMD was more common in people of working age (aged 16 to 64) than in 
those aged 65 and above.
Anxiety disorders were more common among young women aged 16 to 24 
(GAD 9.0%; phobias 5.4%; OCD 2.4%; and panic disorder 2.2%) than in 
other age-sex groups. Table 2.3
Trends in CMDs, 1993 to 2014
GAD, depression, and phobias were more common in people aged 16 to 64 in 
2014 than in previous years of the survey, while rates of OCD, panic disorder and 
CMD-NOS remained more stable. The prevalence of GAD increased from 4.7% in 
2007 (and 4.4% in 1993) to 6.6% in 2014 and depression rose from 2.6% in 2007 
(and 2.2% in 1993) to 3.8% in 2014. Phobias increased from 2.1% in 2007 (and 
1.8% in 1993) to 2.9% in 2014. These increases were apparent in both men and 
women, except in the phobia rate which remained unchanged in men. Table 2.4
Figure 2H: Prevalence of common mental disorders (CMDs), by age
Base: all adults
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CMD, by CIS-R score
Having a high symptom score on the CIS-R does not necessarily mean that the 
criteria for a specific diagnosis are fulfilled. Conversely, some adults who receive 
a diagnosis do not necessarily score 12 or more on the CIS-R. CIS-R scores of 12 
and above are conventionally taken to indicate a CMD. All participants with such 
a score who did not meet the criteria for any of the specific disorders assessed on 
the survey were categorised with CMD-NOS. Participants with a CIS-R score of 11 
or less might nevertheless meet criteria for one of the specific CMDs. Hence all 
of those with a CIS-R score of 12 or above were classed as having a CMD in the 
previous week, compared with only 0.4% of those with a score of 5 or below, and 
6.4% of those with a score of between 6 and 11. Most of those with a specific 
CMD who scored below 12 were classed as having GAD.
Figure 2I: Prevalence of common mental disorders (CMDs), 1993 to 2014
Base: adults aged 16–64
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Around three quarters of people with a CIS-R score of between 12 and 17 (73.3%) 
were identified with CMD-NOS. For adults with a CIS-R score of 18 or above, most 
met the criteria for a specific disorder and only a quarter (27.2%) were classed as 
having CMD-NOS. Nearly half of those with a CIS-R score of 18 or more (46.3%) 
were identified with GAD, a third (35.0%) with depression, and a quarter (24.0%) 
with phobias (it was possible to be identified with more than one CMD). Table 2.5
Self-diagnosed and professional diagnosed CMD, by CMD in past week
Nearly half of adults (43.4%) think that they have had a mental disorder at some 
point, 35.2% of men and 51.2% of women. A fifth of men (19.5%) and a third of 
women (33.7%) have also had diagnoses confirmed by a professional. 13.3% of 
adults reported presence of a diagnosed mental disorder in the past 12 months.
Most participants identified by the CIS-R interview as having CMD already thought 
that they had CMD, and in many cases they had also been so diagnosed by a 
professional. Of those identified with CMD symptoms in the week before interview, 
84.2% reported that they had had a mental disorder at some point, and 63.8% 
had been given this diagnosis by a professional. The corollary of this is that a third 
(36.2%) of people identified by the survey as currently having a disorder had never 
been diagnosed with one. Just under half (47.9%) reported having a diagnosed 
CMD in the last year.
Of those identified with CMD, two thirds (67.2%) reported that they had had 
depression at some point. This included 54.8% who reported being diagnosed 
by a professional. Of those with CMD, 44.6% mentioned having ‘panic attacks’: 
30.2% of whom reported that this had been diagnosed by a professional, 18.0% 
within the last year. Other CMDs were mentioned less frequently. Table 2.6
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Whatever the type of disorder identified by the CIS-R assessment, the most 
common professional diagnosis (as reported by survey participants) was depression, 
ranging from 43.8% of those identified with panic disorder (albeit a very small 
sample) to 83.0% of those with OCD. People identified as having OCD in the 
CIS-R assessment rarely reported being diagnosed as such by a professional (in only 
13.2% of cases). There was an even greater apparent mismatch among those 
identified as having some form of phobia, of whom only 7.2% reported having 
a professional diagnosis of phobia. Table 2.6
Figure 2J: Self-diagnosed CMD, professional diagnosed CMD and 
presence of diagnosed CMD in past year, among adults with CMD 
in the past week 
Base: all adults with a CMD as identified by CIS-R
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Professional diagnosed CMD, by CMD in past week (as identified by CIS-R)
CMD in past week, as identified by CIS-R
Depression Phobias OCD Panic disorder
Ever diagnosed 
with CMD by 
professional 
(self-reported)
% % % %
Depression 70.0 72.1 83.0 43.8
Phobia 5.9 7.2 6.0 –
OCD 7.1 7.9 13.2 –
Panic attacks 42.7 45.5 41.9 22.3
Bases 284 201 103 43a
a Note small base for panic disorder.
Variation in CMDs by other characteristics
Ethnic group
In men, prevalence of CMD did not vary significantly by ethnic group, 
whereas it did in women. Using age-standardised figures, non-British White 
women were less likely than White British women to have a CMD (15.6%, 
compared with 20.9% respectively), while CMDs were more common 
in Black and Black British women (29.3%).
Perhaps because of small sample sizes, differences between ethnic groups in rates 
of specific disorders were not statistically significant. However, depression appeared 
to be more prevalent among Black women, while panic disorder appeared to be 
more prevalent among women in Black, Asian and mixed or other ethnic groups. 
Conclusions about any apparent but non-significant differences in rates should 
not be made without further evidence. Table 2.7
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Household type
Adults aged between 16 and 59 who lived alone were significantly more likely 
to have CMD than people who lived with others. A quarter of men (25.5%) and a 
third of women (35.0%) aged less than 60 who lived alone were assessed as having 
a CMD, compared with 13.2% of all men and 20.7% of all women.
Differences between the sexes in the prevalence of CMD were most noticeable 
in large family households, large adult households, and older couple households. 
The overall prevalence of CMD in women who lived in large family households was 
26.4%, compared with 13.7% of men who lived in such households; in large 
adult households it was 24.6% of women and 13.1% of men; and in older 
couple households it was 15.1% of women and 6.1% of men. Table 2.8
Figure 2K: Prevalence of common mental disorder (CMD), 
by household type and sex
Base: all adults
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Employment status
Employed adults were less likely to have a CMD than those who were economically 
inactive or unemployed. There was no difference in the overall prevalence of CMDs 
between those in full-time and in part-time employment.
Using age-standardised figures, the CMD rate in employed people aged 16 to 64 
was half that of their non-employed counterparts (14.1% of those in full-time 
employment and 16.3% of those in part-time employment, compared with 28.8% 
of unemployed people looking for work, and 33.1% of the economically inactive).
Women in full-time employment were twice as likely to have CMD as full-time 
employed men (age-standardised 19.8%, compared with 10.9% respectively). 
Unemployed women were also more likely to have CMD than unemployed 
men (34.6% of women and 24.5% of men). However, there was no significant 
difference in prevalence between men and women employed part-time (14.7% 
and 16.9% respectively), nor was there a difference between economically 
inactive men and women (33.1% and 33.0% respectively). Table 2.9
Figure 2L: Prevalence of common mental disorder (CMD), by employment 
status (age-standardised) and sex
Base: adults aged 16–64
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Benefit status
There were very large differences in the prevalence of CMD between those in 
receipt of particular benefits and those who were not. This was true for all types of 
CMD. Patterns of prevalence were similar for men and women and are discussed 
below in terms of their age-standardised rates.
Two-thirds of adults aged 16 to 64 in receipt of Employment and Support 
Allowance (ESA, a disability-related out-of-work benefit) had a CMD (66.1%), 
compared with one in six adults not in receipt of this benefit (16.9%). More than 
four in five women in receipt of ESA had a CMD (81.0%), compared with one in 
five (21.1%) of those not in receipt. GAD (41.1%), phobias (31.2%) and depression 
(28.5%) were all particularly prevalent among female ESA recipients, as were GAD 
(24.3%) and depression (25.3%) for men. Table 2.10
Figure 2M: Prevalence of common mental disorders (CMDs), by receipt 
of Employment and Support Allowance (age-standardised)
Base: adults aged 16–64
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Out-of-work benefits include those aimed at people who are unemployed and 
looking for work, such as Jobseeker’s Allowance, as well as those aimed at people 
who are out of work for reasons of illness or disability, such as ESA. Hence figures for 
those in receipt of any out-of-work benefit reflect a combination of those shown in 
Table 2.9 for unemployed adults and those in Table 2.10 for adults in receipt of ESA.
Almost half of adults aged 16 to 64 in receipt of some kind of out-of-work benefit 
were identified as having a CMD (age-standardised 47.4%, compared with 15.8% 
of those not in receipt of such benefits). Differences in prevalence between those in 
receipt and those not in receipt of out-of-work benefits were statistically significant 
for each of the six types of CMD.
Housing benefit is available to certain low-income households to help with rent 
payments. It is not restricted to those of working age. The prevalence of CMD 
among those in receipt of housing benefit was more than twice that among those 
not in receipt of it (age-standardised 35.1%, compared with 14.9% of those not 
in receipt). Table 2.10
Figure 2N: Prevalence of common mental disorder (CMD), by receipt 
of benefits (age-standardised)
Base: adults aged 16–64/all adults
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Region
CMDs were more prevalent in certain regions of England. This was driven partly 
by differences in the prevalence of the less common disorders, OCD and panic 
disorder, as well as by CMD-NOS. Rates of CMD were highest in the South West 
of England (age-standardised 20.9%), North West (19.0%), West Midlands (18.4%) 
and London (18.0%). They were lowest in the South East (13.6%) and East of 
England (14.4%).
The prevalence of panic disorder was 1.3% in the North West, 0.9% in the 
South West, 0.8% in London, and 0.5% or less in other regions (age-standardised 
figures). OCD was particularly prevalent among women in the East Midlands, 
compared with other areas (age-standardised 4.4% in the East Midlands, 2.5% in 
the South West, and 1.6% or less in other regions). CMD-NOS were most common 
in the South West (age-standardised 9.8%) and the West Midlands (9.3%), and 
least common in the South East (5.4%), the East of England (5.6%) and the North 
East (5.9%). Table 2.11
Cigarette smoking status
Smokers were significantly more likely than non-smokers to have a CMD. Among 
smokers, those smoking 15 or more cigarettes a day were more likely to have 
a CMD than those who smoked fewer (age-standardised prevalence: 14.1% of 
those who had never smoked and 15.2% of ex-smokers had a CMD, compared 
with 23.3% of those smoking fewer than 15 cigarettes a day and 31.3% of those 
smoking 15 or more). A similar pattern among smokers and non-smokers was 
present when looking at the prevalence of each type of CMD (although not all 
differences were significant). Table 2.12
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2.4 Discussion
CMDs are among the most prevalent health conditions affecting people in the UK. 
The one week prevalence rates reported in this chapter suggest around one in six 
adults in England has a CMD at any one time. Around half of these have symptoms 
severe enough to warrant active intervention, and the rest would likely benefit at 
least from clinical recognition. The most prevalent of the CMDs was CMD-NOS, 
identified in 7.8% of adults, followed by generalised anxiety disorder (GAD) (5.9%), 
depression (3.3%), phobias (2.4%), obsessive compulsive disorder (OCD) (1.3%) 
and panic disorder (0.6%).
Figure 2O: Prevalence of common mental disorder (CMD), by smoking 
status (age-standardised)
Base: all adults
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As in previous studies, rates of CMD were higher in women than men. Prevalence 
was also higher for both men and women in 2014 than in 1993. However, while 
prevalence remained broadly stable between 2000 and 2014 for men, there has 
been a steady increase among women. 20.4% of women were identified with CMD 
in 2000, 21.5% in 2007, and 23.1% in 2014. This could represent an increased 
likelihood for women to report symptoms compared to men, or an increase in risk 
factors for CMD in women such as exposure to domestic violence (Trevillion et al. 
2012), increased work and home stressors such as caring (Pinquart and Sörensen 
2006), financial problems, unemployment or social isolation (Clark et al. 2012). 
There is evidence that the onset of recession around 2008 in the US and Europe led 
to increasing rates of mental disorder (Riumallo-Herl et al. 2014) and suicide (Chang 
et al. 2013). This is an area which requires further research (Payne and Doyal 2010).
All types of CMD (with the exception of panic disorder, which had a very low 
prevalence) were more common in adults of working age than in those aged 
65 and above. Below the age of 65, overall rates of CMD were fairly constant, 
at around 18% to 19%. Prevalence among those aged 75 and above was half 
this rate (8.8%). Although this was similar to the findings in the 2007 survey, 
it is striking that older people suffer much lower rates of mental disorder than 
their younger counterparts (Streiner et al. 2006), despite the increasing social 
isolation and poorer physical health that ageing may bring (Luanaigh and Lawlor 
2008). Rates of dementia complicate the picture of mental health in this older 
group. Nevertheless, this relatively lower level of CMD is reassuring, given that 
older adults with mental health problems incur greater disability than those 
with physical illness alone (Bartels and Naslund 2013).
Compared with previous years, CMD rates in those aged 55 to 64 have increased 
(Spiers et al. 2011). One interpretation of this may be that the recession, which 
began in 2008, has had more of an impact on the mental health of adults 
approaching retirement than of those who had already reached retirement age. 
Those currently aged less than 65 also face different uncertainties about the future 
in relation to extended working lives. Various chapters show evidence of a cohort 
effect, with those currently aged 55 to 64 reporting levels of disorder potentially 
higher than that of 55 to 64 year olds in previous surveys in the APMS series.
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This chapter also presents data that suggests a recent increase in prevalence 
of CMD among young women, from 22.2% in 2007 to 28.2% in 2014. The 
sample size for this subgroup was small, and the apparent change in rate did not 
quite reach statistical significance, however it is consistent with trends reported 
elsewhere and warrants more detailed investigation (Knudsen 2016; Lessof et al. 
2016). This is the first cohort to come of age in the context of social media. There 
is some limited evidence on links between mental illness and social media exposure 
(Primack et al. 2009) and that excessive use of computers and mobile phones may 
be linked to a higher risk of mental disorder in young women, possibly mediated 
by sleep loss (Thomée et al. 2012). There is also some research on use of the 
Internet and mental distress in women (Derbyshire et al. 2013), but this is an 
area that needs further research.
CMDs were more prevalent in certain groups of the population. These 
included Black women, adults under the age of 60 living alone, women living 
in large households, adults who were not in employment or who were in receipt of 
benefits and those who smoked cigarettes. These associations are in keeping with 
increased social disadvantage and poverty being associated with increased risks 
of CMD (Cooper 2011; Gabbay et al. 2015). There is scope for further research 
and social intervention here (WHO 2014). Although we confirmed the well-known 
association between lack of paid employment and CMD, we found no significant 
association with part-time working. There has been some concern in the UK in 
recent years about part-time and zero hours contracts. However, our evidence 
would suggest that less than full-time working is not necessarily a risk factor for 
poor mental health. This is notable given other UK evidence that poor mental 
health may induce people to work fewer hours (Dawson et al. 2015). What may 
matter even more is working excessive hours (Kleiner et al. 2015).
Most of the participants identified with CMD using the survey assessment 
recognised that they had a CMD. Just under two-thirds also said that they had, at 
some point, been diagnosed with a CMD by a professional. This adds weight to the 
use of diagnostic measures of mental health and suggests that surveys such as this 
are using criteria that accord with participants’ experiences.
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Nevertheless, the symptoms identified by the survey instrument did not always 
match the diagnoses participants reported being given by professionals. Most of 
those reporting some kind of professional CMD diagnosis said that they had been 
diagnosed with depression or panic attacks. It is likely that this reflects the language 
used by people when discussing their mental health with professionals, and reflects 
people’s understanding of their own experiences of mental illness. When doctors 
and patients talk about mental health, it is likely that they use widely understood 
terms and symptoms such as ‘depression’ and ‘panic attacks’. That is to say, any 
differences between disorders identified by the CIS-R and disorders that people 
report having been diagnosed with, does not necessarily mean that people have 
been misdiagnosed.
2.5 Tables
Prevalence and trends
Table 2.1  Severity of symptoms of common mental disorder (CMD), by age 
and sex 
Table 2.2  Severity of CMD symptoms (CIS-R score) in 1993, 2000, 2007 
and 2014, by age and sex 
Table 2.3  CMD in past week, by age and sex 
Table 2.4  CMD in past week in 1993, 2000, 2007 and 2014, by age and sex 
Table 2.5  CMD in past week, by CIS-R score 
Table 2.6  Self-diagnosed CMD, professional diagnosed CMD, and presence 
of professional diagnosed CMD in past 12 months, by CMD in 
past week
Characteristics
Table 2.7  CMD in past week (observed and age-standardised), by ethnic group 
and sex 
Table 2.8  CMD in past week, by household type and sex 
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Table 2.9  CMD in past week (observed and age-standardised), by employment 
status and sex
Table 2.10  CMD in past week (observed and age-standardised), by benefit status 
and sex
Table 2.11  CMD in past week (observed and age-standardised), by region 
and sex 
Table 2.12  CMD in past week (observed and age-standardised), by cigarette 
consumption and sex 
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Summary
• In this chapter reported use of psychotropic medication and psychological 
therapy are examined, as well as the extent of use of health care services 
for a mental health reason (GP, inpatient and outpatient health care) and day 
and community service use. It should be noted that rates presented are based 
on participant self-reports, not health records. Misclassifications of type of 
treatment or service are possible, and which was the providing organisation 
was not established.
• Overall, one adult in eight (12.1%) reported being in receipt of mental health 
treatment (psychotropic medication, psychological therapy or both) at the time 
of interview. Medication was the most commonly used type of treatment.
• This chapter focuses mainly on rates of treatment and service use among people 
with symptoms of common mental disorder (CMD), as measured by the revised 
Clinical Interview Schedule (CIS-R). Treatment rates for other disorders are covered 
in the relevant chapters. Treatment use was strongly associated with severity of 
CMD symptoms; ranging from one person in twenty (5.6%) among those with 
few or no current symptoms (CIS-R score 0 to 5), to nearly half (45.8%) of those 
with severe symptoms (CIS-R score 18+).
• The proportion of people with CMD using mental health treatment has increased. 
Around one person in four aged 16–74 with CMD symptoms (CIS-R score 12+) 
was receiving some kind of mental health treatment in 2000 (23.1%) and 2007 
(24.4%). By 2014, this had increased to more than one in three (37.3%).
• The increase in treatment since 2007 was mainly driven by a steep rise in the 
use of psychotropic medication. However, there has also been an increase in 
the proportion of people with severe CMD symptoms (CIS-R 18+) in receipt 
of psychological therapy.
• The use of primary and community care for a mental health reason has also 
increased over time. People have become more likely to discuss their mental 
health with a GP, and since 2000 there has been a slight – but steady – increase 
in the proportion of adults with CMD using community and day care services. 
Service contact was highest in people with depression, phobia and OCD. 
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• Demographic inequalities in mental health treatment are apparent in the APMS 
data. After controlling for differences in level of CMD symptoms, those most 
likely to report use of treatment were female, White British, and in midlife 
(especially aged between 35 and 54).
• Socioeconomic inequalities in who receives treatment were less evident and more 
mixed. Employed people with CMD were less likely to receive treatment than 
those who were economically inactive. People with CMD living in lower income 
households were more likely to have an unmet treatment request than those 
living in higher income households.
• Overall, one in ten (10.3%) adults with severe CMD symptoms (CIS-R 18+) had 
an unmet treatment request in the previous 12 months. The people who reported 
requesting but not getting a particular treatment were overwhelmingly those with 
symptoms of CMD, suggesting that such requests tended to be made by people 
who might have benefited from treatment. Half of people (53.2%) with an 
unmet treatment request were not receiving any other mental health treatment 
at the time of the interview.
3.1 Introduction
A central objective of the Adult Psychiatric Morbidity Surveys (APMS) since 
1993 has been to describe patterns in the use of treatment and services by 
people with symptoms of common mental disorder (CMD) (Singleton et al. 2001; 
McManus et al. 2009).
A case has been made that over the last two decades beneficial changes in the 
delivery of mental health services have taken place (Torjesen 2016). Examples 
include increased availability of specialist community services, improved transition 
between children’s services and adult mental health services, and more complete 
implementation of clinical guidelines. These have been paralleled by significant 
reductions from 1997 to 2012 in suicide rates in people cared for by mental 
health services (Kapur et al. 2016).
Level of unmet need: The relationship between people and services is described 
by the concepts of demand, need, and utilisation (Brewin et al. 1987). Demand 
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is the subjective perception of the requirement for services and treatments as 
viewed by clients or carers, and is based on personal experience and lay knowledge 
of disorder and treatment. Need has been defined as the requirement for services 
and treatments identified from the professional perspective. It presupposes the 
identification of problems for which there are potentially effective interventions 
(Brewin et al. 1987; Bebbington 1990). It is therefore a technical concept, although 
it often corresponds with the demand perspective. Finally, utilisation is the actual 
take-up of services and adherence to treatments. It is shaped by the availability 
of services, the attitude of people to their health, and their perception of the 
accessibility and utility of services on offer. Inadequate treatment may therefore 
arise because clients and service providers do not recognise needs, and/or because 
of inadequate provision of treatment resources. Over-treatment is also possible, 
defined as utilisation without need.
In APMS, need was not assessed directly. However, it is possible to estimate this 
by assuming that people with a particular level of symptoms of disorder are likely 
to benefit from treatment. The level of ‘unmet need’ in the population is then 
the proportion of people with symptoms who do not receive treatment. Unmet 
needs will be greater if the provision of treatments is insufficient, inappropriate, 
or inaccessible, or where service uptake is poor.
There are limitations to this approach to estimating unmet need. The APMS 
definition of common mental disorder (CMD) is broad: it thus conflates milder, 
potentially self-limiting conditions (i.e. those that will remit in the absence of 
treatment) with conditions that are more likely to persist and need treatment, 
including some that are severe and enduring. The interventions defined as 
treatment include a range of psychological therapies and medications, but exclude 
general support, for example, from a GP or community organisation. The findings 
are also based on cross-sectional data, and therefore include only those individuals 
with symptoms present at the time of assessment. Some of those classified as not 
receiving treatment may have had this in the past, or may have sought help shortly 
after taking part in the survey. Since psychological therapies tend to be of shorter 
duration than pharmacological treatments, this approach may underestimate 
provision and uptake of the former in particular. Furthermore, we cannot evaluate 
the effectiveness of treatment or recovery trajectories using cross-sectional data. 
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Finally, some people without current CMD symptoms may have recovered, perhaps 
as a result of treatments they are still receiving, or were receiving treatment for 
another type of mental disorder. Thus it cannot be assumed that such circumstances 
represent over-treatment.
Despite these limitations, a population-based survey like APMS provides unique 
insight. APMS measures symptoms of mental disorder in people with and without 
diagnosed conditions, independent of any help-seeking or treatment. These surveys 
collect information from people in contact with services, but also from those who 
are not, some of whom may not even be registered with a GP.
Headline findings from APMS 2000 and APMS 2007 were that only one-quarter 
of adults with CMD were receiving psychotropic (mental health) medication or 
psychological therapy. Thus three-quarters of people who might have benefited 
from treatment were not receiving this at the time of interview. ‘One in four’ 
represented the proportion of people assessed by those surveys as having a CMD 
and who reported that they were receiving treatment. These findings are consistent 
with the two-thirds to three-quarters of people identified in other epidemiological 
surveys as meeting criteria for mental disorder and who are not receiving treatment.
Trends in receipt of treatment and services: Analyses of the first three APMS 
surveys (1993, 2000 and 2007) found that the proportion of adults with CMD in 
receipt of any psychotropic medication increased between 1993 and 2000, and 
remained stable between 2000 and 2007 (Spiers et al. 2016; Alonso et al. 2007).
Analyses focused on reported use of hypnotics in the same surveys found a 
similar trend, with prevalence of hypnotic use double in 2000 (0.8%) compared 
to 1993 (0.4%); with no further evidence of an increase between 2000 and 2007 
(Calem et al. 2012). A recent report using national prescribing data found very 
similar trends in relation to antidepressant prescribing, with increases in the 1990s 
and initially stability post-2000 (Spence et al. 2014). This was followed by steep 
increases in antidepressant prescribing from 2008, which the authors attributed 
in part to the effects of the financial crisis in that year and the subsequent 
global recession. This coincided with the introduction of the Improving Access 
to Psychological Therapies (IAPT) programme in 2007/8 (DH 2012). It might 
be expected that the onset of recession would have led to an increase in mental 
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disorder in the population, while recent changes in the development and delivery of 
services would result in a greater proportion of affected people receiving treatment. 
The first of these hypotheses is addressed in Chapter 2 (with some support for this 
position). The second hypothesis is considered in this chapter.
Inequalities in receipt of treatment and services: As well as comparing 
treatment rates over time, APMS data can also be used to examine whether 
particular groups are more (or less) likely to receive treatment after controlling 
for differences in levels of symptoms (Bebbington et al. 2000). Analyses of APMS 
2007 data indicated that white people were the ethnic group most likely to receive 
mental health treatment (Cooper et al. 2013) and that people of working age were 
more likely than older people to get appropriate treatment, especially psychological 
therapy (Cooper et al. 2010). APMS 2014 allowed us to examine whether these 
inequalities have persisted, and (due to the introduction of a new question in 2014) 
whether some groups of people are more likely to have requested mental health 
treatment but not received it than other groups.
This chapter presents findings on:
• The extent of unmet needs (the proportion of the population with a treatable 
disorder who do not receive treatment or services), and how this has changed 
over time.
• Inequalities in treatment use (whether, after taking account of levels of need, 
people from certain demographic or socioeconomic groups are less likely to use 
medications or psychological therapies, or more likely to have their treatment 
requests refused).
These are covered in the following sections:
• 3.2 Definition and assessment
• 3.3 Results: Trends in mental health treatment and service use
• 3.4 Results: Inequalities in mental health treatment and service use
• 3.5 Results: Inequalities in unmet treatment requests
• 3.6 Discussion.
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3.2 Definition and assessment
Measuring mental health treatment
Participants were asked about any treatments they were receiving for a mental 
or emotional problem around the time of the interview. These included different 
types of psychotropic medication and counselling and other psychological therapies.
Trends in treatment presented in this chapter draw on the broadly comparable 
data from APMS 2000, 2007 and 2014; where there have been changes in data 
collection these are described in the sections below. Trends are based on those aged 
16 to 74, as the 2000 survey did not interview people aged 75 and over. In the 
1993 survey, receipt of psychological therapies was only asked of a sub-sample of 
participants. Consequently, no comparable ‘any treatment’ measure was available 
for the whole 1993 sample.
Measuring psychotropic medications
There have been changes between the surveys in how medication data have been 
collected. In 2000, interviewers asked about and coded all prescribed drugs, including 
non-psychotropic medications. In 2007, a show card prompt list of psychotropic 
medications was used instead. People were also asked to show interviewers the 
packaging for each psychotropic medication reported, so that the interviewer could 
check it was correctly coded. The 2000 and 2007 surveys found similar rates of use 
of psychotropic medication, and this stability is consistent with prescribing data as 
well. This suggests that the change in method did not affect comparability.
A show card approach was also used in 2014. However, rather than listing drug 
brand names first, followed by the generic name (the approach taken in 2007), 
the generic name was listed first on the show card prompt. This change was made 
because a) a number of widely prescribed brand medications were approaching the 
end of their license; and b) there had been a shift in practice towards prescribing 
generic medications when available. More medications were asked about on the 
2014 showcards than in 2007. This was due to the increased range of licensed and 
available psychotropic medications in 2014. Furthermore, in 2014, medications 
used in the treatment of bipolar disorder, epilepsy, dementia, and substance misuse 
were also asked about, although only the first of these was included in the ‘any 
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psychotropic medication’ derived variable used for trend analysis. The participants 
in 2014 who reported taking bipolar disorder medications usually also reported 
other psychotropic medication as well, and so their inclusion should not have had 
a significant impact on trends.
See the Glossary for a full list of the medications asked about and how they 
were grouped together. Groupings relate to the main reasons that medications 
are commonly prescribed, but they may have been prescribed to individuals for 
different reasons. Several medications were listed in more than one group.
Measuring psychological therapies
Psychological therapies were asked about in broadly comparable ways in each survey. 
The main analyses of trends in their use are based on endorsement of an initial stem 
question, the wording of which has not changed between surveys: 
‘Are you currently having any counselling or therapy listed on this card for 
a mental, nervous or emotional problem?’ 
Follow-up questions established the types of therapy, and this list has changed 
slightly each survey year, reflecting the nature of current provision and terminology. 
For example, mindfulness therapy was added to the list in 2014, while ‘marital 
therapy’ was replaced with ‘couple and family therapy’.
Survey development piloting work has found that participants are generally unable 
to state reliably which services provided treatments such as psychological therapies. 
Therefore, APMS data cannot be used to describe shifts between primary and 
specialist services in the source of such treatments.
Measuring health service use for a mental health reason
Health service contact records were not examined in the survey. Health service 
use for a mental health reason was recorded if a survey participant reported any 
of the following:
• Having spoken with GP about being anxious, depressed, or about a mental, 
nervous or emotional problem in the past two weeks or past year;
• Being an inpatient for a mental, nervous or emotional reason in the past quarter; or
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• Being an outpatient or day patient for a mental, nervous or emotional reason in 
the past quarter.
Although the reference periods varied between different types of health service, this 
approach was consistent with that used in previous years of the survey and so was 
retained to allow for trend analysis.
Measuring community and day care service use
Survey participants were also asked questions on use of community and day-care 
services in the past year. To ensure comparability with previous surveys in the series, 
changes to items and terminology were minimal. The different types asked about 
are listed in the Glossary.
Measuring unmet treatment requests
In APMS 2014, participants were asked a question that had not been included on 
previous surveys in the series:
‘In the past 12 months, have you asked for any type of counselling or mental 
health related medication, but not received it?’
If the participant answered yes, follow-up questions were asked about what type of 
treatment had been requested and whether or not the participant was on a waiting 
list for it at the time of the interview.
Measuring treatment need
The revised Clinical Interview Schedule (CIS-R) has been used in every wave of 
APMS to measure CMD symptoms and to identify people meeting CMD diagnostic 
criteria. This chapter focuses on differences in treatment rate by CMD. Treatment 
and service use among people with other types of mental disorder is addressed 
in the disorder-specific chapters.
CMD symptoms
The CIS-R score provides an indication of overall non-psychotic symptom severity, 
and is used in the analyses in this chapter to indicate level of mental health 
service required.
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• CIS-R score of 12 or more: is used to indicate the presence of clinically 
significant symptoms of CMD, and identifies people with ‘symptoms of CMD’ 
sufficient to warrant recognition.
• CIS-R score of 18 or more: is also a threshold applied in this chapter and 
is used to indicate the presence of ‘severe symptoms of CMD’, sufficient to 
warrant intervention.
CMDs
An algorithm applied to the responses on the CIS-R can also be used to identify 
likely presence of six different types of CMD. These were depression, generalised 
anxiety disorder (GAD), phobias, obsessive compulsive disorder (OCD), panic 
disorder, and CMD not otherwise specified (CMD-NOS).1 The CIS-R cannot clinically 
diagnose CMD, as that would require detailed assessment by a trained professional. 
In this chapter those identified with ‘any CMD’ are considered, as well as those 
meeting the diagnostic criteria for particular CMDs. Everyone with a CIS-R score of 
12 or more was classified with at least one type of CMD. However, it was possible 
to be identified with certain CMDs without having a score of 12 or more. The CIS-R 
and the individual CMDs are described more fully in Chapter 2 and the Glossary.
Measuring inequalities in use of mental health treatment
APMS data can be used to examine whether particular groups are more (or less) 
likely to receive mental health treatment after controlling for differences in levels 
of symptoms (Bebbington et al. 2000). For example, analyses of APMS 2007 data 
found that white people were the ethnic group most likely to receive mental health 
treatment (Cooper et al. 2013) and that people of working-age were more likely 
than older people to get appropriate treatment, especially psychological therapy 
(Cooper et al. 2010). APMS 2014 allowed us to examine whether these inequalities 
have persisted, and (due to the introduction of a new question in 2014) whether 
some groups of people are more likely than others to have requested mental 
health treatment but not received it.
1 Previously in the APMS series ‘CMD-NOS’ was referred to as ‘mixed anxiety and depression’.
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For this chapter, multiple logistic regression modelling has been carried out to 
examine whether there are inequalities in mental health treatment use.2 Without 
controlling for differences in the level of mental health symptoms, variation in 
treatment rate between groups might simply (and appropriately) reflect differences 
in level of need. In order to determine what characteristics independently predict 
use of mental health treatment after controlling for CMD symptoms, a range of 
variables were included in the final regression modelling. In summary, the multiple 
logistic regression analysis consisted of the following steps:
Step 1: Unadjusted analyses: a wide range of health and social factors were 
tested for association with use of mental health treatment using univariate logistic 
regressions. This step was necessary to estimate the unadjusted odds ratios (ORs) 
of receiving mental health treatment for each subgroup, to allow comparisons with 
the results of the next steps (e.g. after adjusting for presence and severity of CMD).
Step 2: Grouped CIS-R score was added to all the models from step 1 to control for 
differences in the level of mental health symptoms. Grouped CIS-R score was used, 
rather than a continuous score, to allow for comparison with treatment rates.
Step 3: Self-assessed general health was included in models from step 3 to control 
for differences in how people view their health in general.
Step 4: All health and social factors considered in previous steps were included 
as independent variables in the final multiple regression model.3 For the full list 
of variables considered, see Table 3.15.
This final step allowed us to identify the factors independently associated 
with mental health treatment use after controlling for other factors. The final 
results, in the form of adjusted ORs, are compared with unadjusted ORs (from 
step 1) and treatment rates for the groups found to be at elevated risk of not 
getting treatment.
2 Logistic regression, also known as logit regression, is a statistical model used to estimate the probability of an event occurring 
given certain information. The final model presented in this chapter was used to estimate whether people who share a particular 
characteristic (for example, age group) are more or less likely to receive treatment than those in a reference age group, when 
the other characteristics in the model are held constant. If the value is greater than one, the odds of the outcome occurring are 
greater for the given group compared to the reference group. Conversely, a value less than one indicates the odds of the outcome 
occurring are lower for the given group compared with the reference category.
3 The F-adjusted mean residual goodness-of-fit test was applied and suggested no evidence of lack of fit of the model (F-adjusted test 
statistic: 0.656; prob >F= 0.749).
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3.3 Results: Mental health treatment and service use
Mental health treatment use, by CIS-R score
Overall, 12.1% of participants reported receiving mental health treatment 
(psychotropic medication and/or psychological therapy) at the time of the APMS 
2014 interview.4 Reported treatment use was strongly associated with severity of 
mental health symptoms, ranging from one person in twenty (5.6%) among those 
with few or no current symptoms (CIS-R score 0 to 5), to nearly one-half (45.8%) of 
those with severe symptoms (CIS-R score 18+). Treatment use among those without 
CMD symptoms is not necessarily unwarranted, but could indicate, for example, 
recovery or an intermittent condition.
Medication was the most common form of mental health treatment, reported by 
10.4% of people, compared with 3.0% who reported receiving psychological 
therapy. Medication was more common than psychological therapy both in those 
with current symptoms of CMD and in those without current symptoms. A small 
proportion of people (1.3%) reported receiving both medication and psychological 
therapy, and this figure was also higher among those with the most severe symptoms 
(10.7%), and for men (14.5%) compared with women (8.3%). Table 3.1
4 In this chapter rates of treatment and service use for a mental health reason are presented for the whole population, and by severity 
of mental health symptoms (as indicated by CIS-R score) and type of common mental disorder (CMD). Where numbers allow, rates 
are also broken down by sex.
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Mental health treatment use, by type of CMD
About one-third (36.2%) of people meeting the diagnostic criteria for at least one 
CMD (mean CIS-R score 18.9) were receiving treatment at the time of the survey, 
compared with 7.1% of those without CMD (mean CIS-R score 2.5). The true figure 
for the wider population with CMD, the proportion receiving treatment would be 
likely to be between 33.5% and 38.9% (95% confidence interval).
Treatment rates varied by type of CMD, and were highest in those with depression 
(59.4%), OCD (52.1%), phobias (51.6%) and GAD (48.2%). In contrast, a quarter 
(24.7%) of people with CMD-NOS and a fifth (20.9%) of those with panic disorder 
were receiving treatment.5 These CMD classifications, however, averaged lower 
levels of symptom severity: the mean CIS-R score for people with CMD-NOS was 
16.2, compared with 26.8 for those with depression and 28.9 for people with OCD. 
It should also be noted that for disorders other than CMD-NOS, it was possible 
for more than one CMD to be present.
5 Note small base size for those with panic disorder (43 participants) means that analyses by this group should be treated 
with caution.
0 
5 
10 
15 
20 
25 
30 
35 
0 
10 
20 
30 
40 
50 
60 
70 
Type of CMD 
 
Figure 3B: Current use of mental health treatment, by type of CMD
Base: all adults
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Medication was the most commonly reported treatment for people with each 
type of CMD. Its prevalence ranged from around one in two (51.4%) people 
with depression to one in five (21.3%) of those with CMD-NOS and one in 
seven (15.1%) with panic disorder (note that small base numbers mean figures 
for this group should be treated with caution).
Medication combined with psychological therapy was the second most common 
treatment among those with the most severe types of CMD (mean CIS-R score of 
18 or more): reported by 17.1% of those with phobias and 14.9% of those with 
depression. Combined medication and psychological therapy was rare among those 
with panic disorder (1.9%) or CMD-NOS (2.2%) (mean CIS-R scores below 18). 
Tables 3.2, 3.4
Psychotropic medication use, by CIS-R score
The most commonly reported psychotropic medications were those used primarily 
in the treatment of anxiety and depression.6 Each was reported by 8.3% of adults 
6 See the Glossary for a list of how different medications were grouped together. Some medications were in more than one grouping. 
Note that medications can be prescribed for a range of symptoms, and their use does not indicate that particular symptoms are 
present. For example, antipsychotics (medications commonly used in the treatment of psychosis) are commonly used to augment 
antidepressants in the absence of psychotic symptoms.
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Figure 3C: Type of mental health treatment, by type of CMD
Base: all adults
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overall. Medications commonly used in the treatment of psychosis, sleep problems, 
and bipolar disorder were taken by around 1% of the population overall (1.1%, 
1.2% and 1.4% respectively), and in about 6% of those with a CIS-R score of 
18 or more (5.9%, 6.2% and 6.0% respectively).
As well as different types of medication used in the treatment of mental disorders, 
drugs used in the treatment of substance dependence were also asked about. 
Overall, 1.0% of participants reported using substance dependence medication at 
the time of the interview. This was also strongly linked with severity of CMD 
symptoms; 7.1% of people with a CIS-R score of 18 or more were using 
medications used to treat substance dependence. Their use was associated with 
each type of CMD, although the highest rates were among those with depression 
(12.3%) and phobias (12.4%). Tables 3.3, 3.4
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Figure 3D: Type of psychotropic medication used, overall and in adults 
with a CIS-R score of 18 or more
Base: all adults
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Psychological therapy use, by CIS-R score
Overall, 3.0% of adults reported receiving psychological therapy around the 
time of the interview. Again, this was strongly associated with the severity of CMD 
symptoms. About one person in a hundred (0.9%) with few or no CMD symptoms 
(CIS-R score 0–5) reported psychological therapy, compared with one in six (17.6%) 
with the most severe symptoms (CIS-R score 18+).
Cognitive behavioural therapy (CBT) and counselling (including bereavement 
counselling) were the most common types of psychological therapy used, each 
reported by about 6% of people with a CIS-R score of 18 or more. Psychotherapy 
or psychoanalysis was mentioned by 0.7% of people, and by 4.5% of those with 
severe CMD symptoms (CIS-R 18+). Table 3.5
Psychological therapy use, by type of CMD
Overall, 11.8% of people with CMD reported being in receipt of psychological 
therapy. This was reported most commonly by people with a phobia (25.4%), OCD 
(23.4%), and depression (22.9%). Rates were lower in people with CMD-NOS 
(5.6%), panic disorder (7.7%) and GAD (17.9%). Table 3.6
 
Figure 3E: Type of psychological therapy used, overall and in adults 
with a CIS-R score of 18 or more
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Health service use, by CIS-R score
The use of health services for a mental or emotional problem included attending 
hospital in the last quarter, either as an inpatient or outpatient, for a mental health 
reason or speaking with a GP about a mental health problem (in the past year). 
Overall, 12.5% of adults reported discussing their mental health with a GP in the 
past year. All measures of health service use for a mental health reason were more 
common in those with the most severe symptoms. 56.2% of people with a CIS-R 
score of 18 or more had discussed their mental health with a GP in the past year, 
and 15.8% had done so in the last two weeks. 4.0% of people with a CIS-R score 
of 18 or more had been an outpatient, and 1.8% had been an inpatient, in the last 
quarter for a mental health reason. Table 3.7
Health service use, by type of CMD
Nearly a half (44.1%) of people with a CMD reported discussing their mental 
health with a GP in the past year, compared with 6.0% of people without CMD. 
Service contact was most frequent in people with OCD (65.4%), phobia (65.4%), 
depression (66.1%) and GAD (54.8%). The same groups were also the most likely 
to have been hospital patients for mental health reasons. Rates of health service use 
for a mental health reason were lower in people with CMD-NOS (33.2%). Table 3.8
Community and day care services use, by CIS-R score
The reported use of community and day care services ranged from 4.3% of people 
with few or no symptoms (CIS-R score 0–5), up to 27.8% of those with a CIS-R 
score of 18 or more. Among people scoring 18 or more on the CIS-R, usage rates 
were similar for seeing a psychiatrist (6.8%), a community psychiatric nurse (5.4%), 
an outreach/family support worker (5.4%), a social worker (5.2%), and self-help/
support group (4.8%). Table 3.9
Community and day care services use, by type of CMD
Consultation with a psychiatrist was reported most commonly by people with 
OCD (18.5%) or with phobia (14.3%). Other nursing services (not including the 
community psychiatric nurse (CPN) or community learning disability nurse) was 
the community and day care service used most by people without CMD (2.2%). 
Table 3.10
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Trends in treatment in adults with CMD symptoms
Mental health treatment use was defined as reported receipt of psychotropic 
medication or psychological therapy at the time of interview. Trends are based on 
those aged 16–74, as the 2000 survey did not interview people aged 75 or more.
Any treatment: 2000, 2007 and 2014
The overall treatment rate in people aged 16–74 with CMD symptoms (CIS-R 12+) 
was relatively stable at around one in four between 2000 (23.1%) and 2007 
(24.4%), and then increased sharply by 2014 to more than one in three (37.3%).
The same pattern was also evident among those with severe CMD symptoms 
(CIS-R 18+): one in three reported mental health treatment in 2000 (32.8%) and 
2007 (32.4%), increasing to nearly a half in 2014 (46.7%). Both men and women 
were more likely to receive mental health treatment in 2014 than in 2007. Table 3.11
 
Figure 3F: Community and day care services used in past year in people
with and without CMD
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Any psychotropic medication: 2000, 2007 and 2014
Much of this increase in treatment use is accounted for by a steep rise in 
reported use of psychotropic medication. One in five adults aged 16–74 with 
CMD symptoms (CIS-R 12+) reported psychotropic medication use in 2000 (19.3%) 
and 2007 (19.6%), compared with nearly one in three in 2014 (31.6%). While 
methodological changes to the survey cannot be ruled out as explaining some of 
this increase, the trend is also corroborated by trends in prescribing data.7 Higher 
rates of psychotropic prescribing may be linked to the increase also observed in 
people with CMD who discussed their mental health with a GP. The increased 
rate of medication was evident in both men and women, as well as in people 
with severe CMD symptoms (28.5%, 26.5% and 39.4% of 16–74 year olds with 
CIS-R score of 18+ reported psychotropic medication in 2000, 2007 and 2014 
respectively). Table 3.11
7 For example, the increase in prescribing presented here corresponds closely to trends identified in national antidepressant 
prescribing data for 1997 to 2012 (Spence et al. 2014).
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Any psychological therapy: 2000, 2007 and 2014
There were also increases in reported receipt of psychological therapy among 
adults with CMD symptoms. However, rather than the steep increase between 
2007 and 2014 evident for medication, use of psychological therapies has risen 
more steadily since 2000 (12.5%, 15.2% and 18.4% of 16–74 year olds with 
CIS-R score of 18 or more reported use of psychological therapies in 2000, 
2007 and 2014 respectively). Table 3.11
Trends in health service use in adults with CMD symptoms
Among the types of health services used for a mental health reason covered by 
APMS, only use of primary care changed significantly over time. In 2000, 6.3% of 
16–74 year olds with CMD symptoms reported discussing their mental health with 
a GP in the 2 weeks preceding interview. This increased to 10.1% in 2007 and 
stayed at this level in 2014 (10.6%). The proportion who had spoken to their 
Figure 3H: Psychological therapy use in adults with CIS-R score 12+ 
and 18+, 2000, 2007, 2014
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GP about their mental health in the past year increased from 38.2% in 2000 
to 46.4% in 2014 (although in this case the increase occurred between 2007 
and 2014). Table 3.12
Trends in community and day care services use in adults with CMD symptoms
The proportion of 16–74 year olds with CMD symptoms (CIS-R score 12+) using any 
type of community or day care service appeared to increase (from 17.2% in 2000 to 
20.6% in 2014), although this did not reach statistical significance (p=0.08). There 
were no significant differences between men and women. Table 3.13
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Figure 3I: Health services used for a mental health reason in people 
with a CIS-R score of 12 or more, 2000, 2007, 2014
Base: all aged 16–74 with CIS-R score of 12+
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3.4 Results: Inequalities in use of mental health treatment
Summary
In this section, groups in the population who were less likely to be in receipt 
of mental health treatment are identified. Treatment rates for different groups 
are presented first. However, without controlling for mental health symptoms, 
differences in treatment between groups might simply, and appropriately, reflect 
differences in level of need. Logistic regression therefore was also used to examine 
whether some groups were more likely than others to receive mental health 
treatment after controlling for CMD and other factors. For details of the 
methodology used see Section 3.2.
The results are presented in the form of ORs, which here indicate the relative odds 
of receiving mental health treatment for one group compared to another. They are 
compared to treatment rates for a given group, and with ORs coming from logistic 
Figure 3J: Community and day care service use in people with a CIS-R
score of 12 or more, 2000, 2007, 2014
Base: all aged 16–74 with CIS-R score of 12+
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regression analysis that did not take account of other factors (Table 3.14, model 1). 
This helped us identify what factors explain the differences in rates of treatment 
between different groups.
We found that while CIS-R score was the strongest predictor of whether or 
not someone was in receipt of treatment, it did not fully explain the differences in 
treatment rates between groups (Table 3.14, model 2). When all factors were taken 
into account, the following remained significant predictors of treatment receipt 
(Table 3.14, model 4: final model):
• Sex
• Age group
• Ethnic group
• Employment status
• General health
• CIS-R score.
Treatment rates, and the unadjusted and adjusted regression analysis results, are 
discussed for each of these significant factors below.8 The non-significant factors 
were retained in the final model and can be found in Table 3.15. Tables 3.14, 3.15
Variation in receipt of mental health treatment, by sex
In unadjusted analysis, women in the population were more likely to report 
mental health treatment than men. This was true both for medication and for 
psychological therapy. Overall, 15.0% of women and 9.0% of men received 
treatment of some sort. The mean CIS-R score in women was 1.8 points higher 
than that in men. The treatment gap was, however, more evident among those 
with fewer CMD symptoms (CIS-R 12 or more). After controlling for differences 
in CIS-R, women remained significantly more likely to get treatment than men 
8 If the factor is significant (that is, if the overall p-value for a variable less than 0.05) we then looked at the p-values for each of 
the categories within the factor. If the p-value for a category is less than 0.05 then the category is significantly different from the 
reference category.
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(OR 1.58, 95% CI 1.32 to 1.89, compared to unadjusted OR 1.80, 95% CI 1.53 
to 2.12).9 Tables 3.14, 3.15, 3.16, 3.17
Variation in receipt of mental health treatment, by age
In unadjusted analysis, receipt of mental health treatment varied with age. The 
proportion of people using treatment ranged from 5.5% of 16 to 24 year olds to 
16.0% of those aged 55 to 64. The same pattern was evident both for people 
with and without CMD, and for men and women. Tables 3.16, 3.17
9 Confidence intervals (CI) at the 95% level mean that if the same population is sampled on numerous occasions and interval 
estimates are made on each occasion, the resulting intervals would bracket the true population rate in approximately 95% of the 
cases. A CI includes information about the uncertainty associated with an estimate.
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After controlling for CIS-R score, the youngest age group were even less likely 
to receive treatment than other age groups. Those aged 35 to 54 had the highest 
odds of receiving treatment (OR 3.11 for 35 to 44 year olds, OR 3.10 for 45 to 54 
year olds). Except for those aged 75 or more, all age groups had significantly higher 
odds of receiving treatment than the youngest age-group (16 to 24 year olds). 
Table 3.14
In terms of type of treatment, those aged 16–24 were the least likely to use 
psychotropic medication, while those aged 75 or more had the lowest rates of 
psychological therapy. Despite being more at risk due to medication side effects, 
those aged 75 or more were ten times more likely to receive medication than 
psychological therapy. Table 3.16
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Figure 3L: Current use of mental health treatment, by age and CIS-R score
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Variation in receipt of mental health treatment, by ethnic group
Treatment rates varied by ethnic group, despite the fact that mean CIS-R score did 
not vary between ethnic groups. White British people were the ethnic group most 
likely to report receiving treatment; 13.3% reported this compared with around 7% 
of people in minority ethnic groups (including White non-British). Black adults had 
the lowest treatment rate (6.2%). Table 3.18
After further controlling for other factors in the final model, people in the Black/
Black British group had the lowest odds of being in receipt of treatment (OR 0.27, 
compared with the White British group). Analysis by ethnic group should be treated 
with some caution due to small sample sizes, although these findings are consistent 
with results from APMS 2007 (Cooper et al. 2013). Tables 3.14, 3.15
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Variation in receipt of mental health treatment, by employment status
Analysis that did not control for other factors shows that economically inactive 
people have higher rates of treatment: 18.2% compared with 12.6% of 
unemployed people and 8.2% of employed people. This pattern held true 
both for men and women.
After controlling for other factors, including CIS-R score, the difference in likelihood 
of treatment was no longer significant between unemployed and employed people. 
However, those who were economically inactive remained significantly more likely, 
with twice the odds of being in treatment than those who were employed 
(OR 2.04, 95% CI 1.64 to 2.54). Tables 3.14, 3.19, 3.20
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With respect to type of treatment, among economically inactive people aged 16 to 
64 (who were the employment status group with the highest mean CIS-R score 
and were the most likely to report treatment in general) combined medication and 
psychological therapy was not uncommon; 10.5% reported this compared with 
4.9% of unemployed people and 3.5% of people in employment.
Independent predictors of treatment receipt
In summary, as outlined above, after controlling for other factors the following 
were all associated with higher likelihood of mental health treatment use:
• Female (OR 1.58 compared with male, 95% CI 1.32 to 1.89)
• White British ethnicity as opposed to any other ethnic group (particularly Black, 
with OR 0.27 compared with White British, 95% CI 0.14 to 0.49)
• 25 to 74 years old, especially 35 to 44 (OR 3.11 compared with 16–24 year olds, 
95% CI 2.03 to 4.76) and 45–54 (OR 3.10, 95% CI 1.98 to 4.84)
• Economically inactive (OR 2.04 compared to employed, 95% CI 1.64 to 2.54)
• Poor general health (OR 3.28, 95% CI 2.59 to 4.15)
• Poor mental health, especially CIS-R score 18+ (OR 7.66 compared with CIS-R 
score 0–5, 95% CI 5.87 to 9.98). Table 3.15
3.5 Results: Inequalities in unmet treatment requests
Overall, 1.7% of people reported having asked for, but not received, a particular 
mental health treatment in the past 12 months. This was strongly associated with 
CMD symptoms. One in ten (10.3%) adults with severe CMD symptoms (CIS-R 18+) 
had an unmet treatment request in the previous 12 months, compared with just 
0.3% of people with very few or no CMD symptoms (CIS-R score 0–5). The people 
who had asked for but not received treatment were overwhelmingly those with 
symptoms of CMD, suggesting that such requests tended to be made by people 
who might have benefited from treatment. Half of people (53.2%) with an unmet 
treatment request were not receiving any other mental health treatment at the 
time of the interview. Tables 3.22, 3.25
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Unmet treatment requests were most likely to be reported by people aged 16–34 
(2.5%), and were hardly ever reported by those aged 75 and over (0.3%). A similar 
pattern by age was observed in people with CMD. Table 3.23
The proportion of people who reported an unmet treatment request varied by 
household income tertile. 8.8% of people with CMD living in households in the 
lowest income tertile reported requesting but not getting a particular mental health 
treatment in the past 12 months, compared with 4.2% of those with CMD living 
in the highest income households.10 Table 3.24
10 These results should be treated with caution due to the relatively small size of the CMD group and because the reported rates of 
unmet treatment requests are low.
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Figure 3O: Requested but not received treatment in the past 12 months,
by age and CIS-R score
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3.6 Discussion
This chapter presents information on trends and inequalities in treatment and 
service use, drawing on data collected in APMS 2000, 2007 and 2014. The survey 
series relies on self-report data and it should be noted that participants in such 
studies are not always aware themselves precisely what treatments and services 
they are using. Misclassifications, under-reporting, and even over-reporting are all 
possible. The checking of participants’ medication packaging for drug names will 
have helped, but there was little that could be done to verify the classification of 
types of psychological therapy as health records were not checked. The survey series 
has also never sought to establish who provided each type of treatment or service, 
for example whether NHS or private.
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Figure 3P: Requested but not received particular treatment in the past 
12 months, by equivalised income tertiles and CIS-R score
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It is also important to note that while there has been much consistency in 
how the data has been collected, a number of changes might have affected the 
trends presented. Surveys like APMS have to balance the consistent collection of 
information across the series, with ensuring that questions reflect current context 
and terminology. For example, between the 2007 and 2014 surveys several key 
psychotropic medications became available in generic form, while NICE guidelines 
to health professionals encouraged the prescription of generic medications (NICE 
2016a). To reflect these changes in prescribing practice, the 2014 survey prioritised 
the listing of generic medication names, given these may become increasingly 
familiar to the public, and asked about a wider range of medications. More types 
of psychological therapy were also asked about, although the positioning of these 
questions at the start of the relevant section should have safeguarded against 
any impact on trend data.
These methodological limitations are important to highlight, as they may 
account for some of the steep increase in reported treatment rates between 
the 2007 and 2014 surveys. In 2007, one person in four with a CIS-R score of 
12 or more reported receiving treatment. Seven years later this figure has risen 
to more than one in three. The increase is most pronounced for psychotropic 
medication, closely reflecting trends found in recent analyses of antidepressant 
prescribing data (Spence et al. 2014). This trend may indicate a material 
improvement in treatment access, but should also be considered in the context 
of NICE guidelines (2009/2011) not to  offer antidepressants routinely for mild 
depression (NICE 2016b).
The increase in treatment was evident (among those with more severe 
CMD symptoms) for psychological therapies as well. This is also what might have 
been expected given the roll-out of the Improving Access to Psychological Therapy 
(IAPT) programme since the last survey took place. In addition it should be noted 
that lower intensity IAPT therapies such as computerised cognitive behaviour 
therapy and self-directed learning might not always have been captured by the 
survey questions.
While the figure of ‘one-in-three’ adults with CMD symptoms being in receipt of 
mental health treatment represents a major increase since the last survey, it is still 
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the case that a majority of people with symptoms are not receiving treatment. 
However, the threshold taken to indicate presence of CMD symptoms – a CIS-R 
score of 12 or more – might be considered quite low. Among those with more 
severe symptoms – the 8% of the population with a CIS-R score of 18 or more – 
closer to half reported receipt of mental health treatment of some kind.
This chapter has presented crucial evidence on inequalities in treatment access 
that remain after controlling for differences in levels of mental illness between 
groups. Surveys are ideally placed to examine treatment gaps, as data are collected 
both from people in treatment and from those who are not, and assessment tools 
enable undiagnosed conditions to be identified.
While demographic inequalities were sharply evident, socioeconomic inequalities 
were much less so. No significant associations were found between treatment 
rates and area level deprivation after controlling for level of symptoms, nor were 
there associations with several measures of material deprivation. There were 
indications that people with CMD living in lower income households were more 
likely to have unmet need in terms of requesting but not receiving a particular 
psychiatric treatment. But there were also indications that people with CMD who 
were employed, especially men, may struggle to access treatment, a finding with 
particular relevance for policy around the accessibility of services. Overall, there 
was relatively little evidence that treatment use was determined by socioeconomic 
factors. The APMS survey did, however, exclude some of the most vulnerable by 
drawing its participants from those living in private households, excluding, for 
example, people who are homeless.
The most pronounced inequalities in use of treatment related to age, sex and ethnic 
group. People with CMD who were Black, Asian, non-British White, or of mixed or 
other ethnicity were less likely to obtain treatment than those in the white British 
group. In terms of age, those in midlife had three times the odds of treatment use 
compared with the youngest. Younger people with CMD were less likely to get 
psychotropic medication than other age groups and were also the most likely to 
have their treatment requests unmet. Older people with CMD had the lowest rates 
of psychological therapy, but also the lowest rates of unmet treatment requests – 
suggesting that they may not be asking for what they need, or may not even be 
aware of what is available. It may also be the case that men with CMD are less 
 101 | APMS 2014  | Chapter 3: Mental health treatment and service use | Copyright © 2016, Health and Social Care Information Centre
likely than women to be using treatment, in part due to longstanding stigma 
or reluctance to talk about mental health or to seek help from health professionals.
It is very striking how the proportion of people who had discussed their mental 
health with a GP increased since the 2007 survey. Increases over this same time frame 
in psychotropic medication prescribing may in part be explained by this change in the 
nature and extent of GP contact. Alongside this, Chapter 2 highlighted that there has 
been an increase in the prevalence of CMD in the population (specifically in women). 
It is possible that as the population has become more unwell, and as those who are 
unwell become more likely to be treated, much of the additional burden is falling on 
primary rather than secondary care. Resource allocations for primary care may need 
to reflect these changes in demand.
3.7 Tables
Prevalence of and trends in treatment and service use
3.1  Treatment currently received for a mental or emotional problem, by severity 
of common mental disorder (CMD) symptoms
3.2  Treatment currently received for a mental or emotional problem, by CMD 
in past week
3.3  Types of psychotropic medication currently taken, by severity of CMD symptoms
3.4  Types of psychotropic medication currently taken, by CMD in past week
3.5  Current counselling or therapy for a mental or emotional problem, by severity 
of CMD symptoms
3.6  Current counselling or therapy for a mental or emotional problem, by CMD 
in past week
3.7  Health care services used for a mental or emotional problem, by severity 
of CMD symptoms
3.8  Health care services used for a mental or emotional problem, by CMD in 
past week
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3.9  Community and day care services used in past year, by severity of 
CMD symptoms
3.10  Community and day care services used in past year, by CMD in past week
3.11  Treatment for mental or emotional problem in 2000, 2007 and 2014, among 
people with CMD symptoms (CIS-R 12+ and 18+)
3.12  Health care services used for mental or emotional problem in 2000, 2007 
and 2014, among people with CMD symptoms (CIS-R 12+)
3.13  Community and day care services used in 2000, 2007 and 2014, among 
people with CMD symptoms (CIS-R 12+)
Inequalities in use of mental health treatment 
3.14  Logistic regression models identifying factors that predict whether or not 
someone is in receipt of mental health treatment
3.15  Results of final multiple logistic regression model (controlling for all factors) 
predicting receipt of treatment
3.16  Treatment for mental or emotional problem, by age and sex
3.17  Treatment for mental or emotional problem, by age, sex and CMD symptoms
3.18  Treatment for mental or emotional problem, by ethnic group
3.19  Treatment for mental or emotional problem, by employment status, sex 
and severity of mental health
3.20  Treatment for mental or emotional problem, by employment status and age
3.21  Treatment for mental or emotional problem, by equivalised household 
income tertiles and severity of CMD symptoms
Unmet treatment requests 
3.22  Requested but not received a particular mental health treatment in the past 
12 months, by severity of CMD symptoms and sex
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3.23  Requested but not received a particular mental health treatment in the past 
12 months, by age, by severity of CMD symptoms
3.24  Requested but not received a particular mental health treatment in the 
past 12 months, by equivalised household income tertiles and severity 
of CMD symptoms
3.25  Requested but not received a particular mental health treatment in past 
12 months, by current receipt of any mental health treatment and severity 
of CMD symptoms
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Summary
• This chapter presents findings about the extent of trauma and of screening 
positive for posttraumatic stress disorder (PTSD) in the general population.
• Traumatic events were defined as experiences that either put a person – 
or someone close to them – at risk of serious harm or death, like a major 
natural disaster, a serious car accident, being raped, or a loved one dying by 
murder or suicide. About a third (31.4%) of adults in England report having 
experienced at least one traumatic event.
• Individuals who experience such trauma may go on to develop PTSD. PTSD 
is a severe and disabling condition, characterised by flashbacks, nightmares, 
avoidance, numbing and hypervigilance. While effective treatments exist, many 
with the condition delay seeking help or are not identified by health services.
• Participants completed the 17-item PTSD Checklist – Civilian (PCL-C) in the 
self-completion part of the interview. Those with a score of 50 or more and 
meeting Diagnostic Statistical Manual (DSM) criteria for PTSD were identified as 
screening positive for PTSD. A positive screen did not mean that a disorder was 
necessarily present, only that there were sufficient symptoms to warrant further 
investigation.
• Overall, about one participant in twenty (4.4%) screened positive for PTSD in 
the past month, with similar rates for men and women. Among women, the 
likelihood of screening positive for PTSD was particularly high among 16–24 year 
olds (12.6%) and then declined sharply with age. In men, the rate remained quite 
stable between the ages of 16 and 64, only declining in much later life.
• Screening positive for PTSD was higher in households where one person 
aged 60 or under lived alone, among those not in work (either unemployed or 
economically inactive), and among benefit recipients (especially those in receipt 
of an out-of-work benefit related to disability).
• Overall, 3.3% of people believed that they have had PTSD, and 1.9% had also 
been diagnosed by a professional. Of those screening positive for PTSD, one in 
eight (12.8%) had already been diagnosed by a health professional.
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• About half (47.9%) of people screening positive for PTSD were in receipt 
of mental health treatment: 38.9% were taking medication and 24.0% were 
having psychological therapy. People screening positive for PTSD were far more 
likely than the rest of the population to have requested – but not been given – 
particular treatment (16.1% compared with 1.0%).
• People screening positive for PTSD were about six times more likely to have recently 
used health care for a mental or emotional problem, than those who did not screen 
positive (60.5% compared with 10.4%). However, by no means all had done 
so: four in ten adults who screened positive for PTSD in the past month had not 
spoken with a GP about a mental or emotional problem in the last year (39.8%).
4.1 Introduction
During their lifetime many people will experience traumatic events, for example, 
road traffic accidents, assaults or natural disasters. During and immediately after 
such trauma, they will commonly feel distressed, experiencing (for example) 
symptoms of insomnia and anxiety. These symptoms usually dissipate with time. 
Although this is the usual response, symptoms may sometimes persist, and 
some individuals go on to develop posttraumatic stress disorder (PTSD) (RCPscyh 
2013). This can be a severe and disabling condition, characterised by flashbacks, 
nightmares, avoidance, numbing and hypervigilance. PTSD is often comorbid 
with other mental health disorders, including depression (Rytwinski et al. 2013) 
and substance misuse (Debdell et al. 2014).
Effective treatments for PTSD do exist (National Institute for Health and Clinical 
Excellence, NICE 2005). However, due to the stigma associated with help seeking and 
delayed recognition of symptoms, treatment is often delayed for many years,reducing 
its effectiveness. NICE (2005) guidelines indicate the types of treatment suitable for 
those with established difficulties due to PTSD. These guidelines remind us that ‘a 
number of sufferers with PTSD may recover with no or limited interventions. However, 
without effective treatment, many people may develop chronic problems over many 
years.’ Recommended treatments include psychological interventions, whereas there 
is limited evidence for the use of medication.
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PTSD was first included in the third edition of the Diagnostic and Statistical Manual 
for Mental Disorders (DSM) (APA 1980). However, it had been known for some time 
previously that trauma was associated with mental health consequences, and terms 
like shell shock, nervous shock and combat fatigue were in common usage. The 
inclusion of PTSD in DSM-III was mainly because the mental health consequences 
seen in US Vietnam veterans had encouraged a more thorough examination of the 
disorder. PTSD was defined as a stress disorder consequent on many different types 
of stressors occurring in both combat and civilian contexts. This traumatic event 
must be sufficiently severe to make individuals fear for their own – or their loved 
ones’ – lives or safety.
Traumatic events are not randomly distributed among the general population. 
Certain groups or individuals are at higher risk of exposure (Breslau et al. 2008), 
including military personnel, emergency service workers, refugees and those living 
in inner city (or deprived) areas. However, not everyone exposed to trauma develops 
PTSD. A number of risk and protective factors have been reported, such as sex, 
age, ethnicity and income (Brewin et al. 2000). In addition, research has shown 
that subjective appraisal of threat is more important for the development and 
maintenance of PTSD than objective trauma severity (Elhers and Clarke 2000).
The prevalence of PTSD in the general community has been shown to vary 
considerably across (and within) nations (Kessler et al. 2005; Darves-Bornoz et al. 
2008; Van Ameringen et al. 2008; Frissa et al. 2013; Dorrington et al. 2014). Some 
of this variation is likely to be due to the method of data collection (for example, 
face-to-face interviews versus self-reported questionnaire measures), the instrument 
used to measure PTSD (clinician administered tools versus screening questionnaires), 
and underlying cultural differences.
Epidemiological studies of PTSD typically rely on a subjective assessment by the 
participant as to whether a particular event was sufficiently severe to justify being 
a trauma and self-reported assessment of their symptoms – raising the possibility 
of reporting bias (Roemer et al. 1998). In the Adult Psychiatric Morbidity Survey 
(APMS) 2014, questions have been asked of everyone irrespective of whether or not 
they report trauma.
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In this chapter, the prevalence of exposure to trauma and screening positive for 
PTSD are reported, overall and in relation to a variety of socio-demographic factors. 
Levels of service use and treatment for a mental health reason are also presented. 
Comorbidity with PTSD is examined in Chapter 13.
4.2 Definition and assessment
PTSD
Individuals responding to a traumatic event may develop PTSD. This involves 
having experienced, witnessed, or been confronted with an event or events 
involving actual or threatened death or serious injury, or a threat to the physical 
integrity of self or others. Moreover, their response must have involved intense 
fear, helplessness, or horror. Symptoms can develop within weeks but according 
to the 10th Revision of the International Statistical Classification of Diseases and 
Related Health Problems (ICD-10) (WHO 2010) onset is almost always within six 
months. It may take months or even years for individuals to present to services. 
Delayed presentation is common but there is also some evidence that PTSD 
may have a delayed onset (Andrews et al. 2007).
According to DSM-IV (APA 1994) the symptoms are grouped into three clusters1:
• Re-experiencing (including recurrent distressing images, thoughts, dreams 
or perceptions of the event)
• Avoidance and numbing (avoiding thoughts, feelings, activities or conversations 
associated with the trauma; diminished interest or participation in activities, 
feelings of detachment or estrangement from others)
• Hyperarousal (including difficulty falling or staying asleep, irritability or 
outbursts of anger, difficulty concentrating, hypervigilance and an exaggerated 
startle response).
1 DSM5 identifies four symptom clusters to PTSD, the PTSD Checklist draws on the original three clusters (www.dsm5.org/
Documents/PTSD%20Fact%20Sheet.pdf).
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For a diagnosis of PTSD, symptoms must have been evident for more than one 
month and must cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.
PCL-C
The PTSD Checklist (PCL) is a 17-item self-report measure reflecting DSM-IV 
symptoms of PTSD (Blanchard et al. 1996). The PCL has a variety of clinical 
and research purposes, including:
• Testing individuals for possible PTSD
• Aiding in diagnostic assessment of PTSD
• Monitoring change in PTSD symptoms.
The PCL-C (civilian) asks about symptoms in relation to generic “stressful 
experiences” and can be used with any population. This version simplifies 
assessment based on multiple traumas because symptoms are not attributed to 
a specific event.
The response options are: not at all (scored 1), a little bit (2), moderately (3), quite 
a bit (4), and extremely (5). A total symptom severity score (range = 17–85) can be 
obtained by summing the scores from each of the 17 items listed below. There are a 
number of ways of scoring the PCL. For this report, a positive screen was defined as 
a score of 50 or more, together with endorsement of the DSM-IV criteria, identified 
as positive responses to at least one B item (questions 1–5 on re-experiencing 
symptoms), three C items (questions 6–12 on avoidance and numbing), and two 
D items (questions 13–17 on hyperarousal symptoms). Where a participant missed 
two or more items, for example due to responding ‘don’t know’ or refusing to 
answer, no score was derived. This only applied in 15 cases.
The PCL-C is referred to in this chapter as a screen for reasons of convention 
although it is not currently recommended as part of an official screening 
programme in England. A positive screen for PTSD does not mean that someone 
necessarily has the disorder; instead it indicates that someone has sufficient 
symptoms to warrant a clinical assessment.
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The PTSD Checklist Civilian version (PCL-C)
Below is a list of problems and complaints that individuals sometimes have in response to 
stressful life experiences. Please read each one carefully, and indicate how much you have 
been bothered by that problem in the last month:
1. Repeated, disturbing memories, thoughts, or images of a stressful experience 
from the past
2. Repeated, disturbing dreams of a stressful experience from the past
3. Suddenly acting or feeling as if a stressful experience were happening again 
(as if you were reliving it)
4. Feeling very upset when something reminded you of a stressful experience 
from the past
5. Having physical reactions (e.g., heart pounding, trouble breathing, or sweating) 
when something reminded you of a stressful experience from the past
6. Avoid thinking about or talking about a stressful experience from the past or avoid 
having feelings related to it
7. Avoid activities or situations because they remind you of a stressful experience 
from the past
8. Trouble remembering important parts of a stressful experience from the past
9. Loss of interest in things that you used to enjoy
10. Feeling distant or cut off from other people
11. Feeling emotionally numb or being unable to have loving feelings for 
those close to you
12. Feeling as if your future will somehow be cut short
13. Trouble falling or staying asleep
14. Feeling irritable or having angry outbursts
15. Having difficulty concentrating
16. Being “super alert” or watchful on guard
17. Feeling jumpy or easily startled
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Exposure to trauma
Irrespective of how participants scored on the PCL-C, all were asked after 
completing the PCL-C whether a traumatic event or experience had happened 
to them at any time in their life. To clarify the nature and severity of traumatic 
stressor that should be included, the following was stated:
‘The term traumatic event or experience means something like a major nat-
ural disaster, a serious automobile accident, being raped, seeing someone 
killed or seriously injured, having a loved one die by murder or suicide, or 
any other experience that either put you or someone close to you at risk of 
serious harm or death.’
Participants were not asked to specify the nature or number of events experienced.
4.3 Results
Prevalence of trauma, by age and sex
Lifetime experience of trauma
In 2014, all participants were asked whether they had experienced a traumatic 
event. About a third (31.4%) reported having experienced at least one major 
trauma in their lifetime. If all adults in the population had been asked this, it is 
likely (95% confidence interval) that the proportion to report having experienced 
a trauma would be between 30.0% and 32.7%. Rates were very similar for men 
and women (31.5% and 31.2% respectively). However, there was a statistically 
significant interaction between the effects of sex and current age on reporting of 
traumatic experience. While reporting of lifetime experience of trauma did not vary 
with age among women, reporting of lifetime traumatic experience among men 
peaked in midlife (45 to 54 year olds) and was lowest among 16 to 24 year olds. 
Table 4.1
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Figure 4A: Whether experienced trauma, by age and sex
Base: all adults
Screening positive for PTSD in past month, by age and sex
Rates of PTSD were considerably lower than the experience of traumatic events. 
Overall, 4.4% of adults screened positive for PTSD in the last month (95% 
confidence interval: 3.8% to 5.0%).
Screening positive for PTSD did not vary by sex, but did vary with age, with 
younger people more likely to do so than older people (8.0% of 16 to 24 year olds 
screened positive for PTSD in the last month compared with 0.6% of those aged 
75 and over). However, the pattern of association by age was different for men 
and women. Among women, the likelihood of screening positive for PTSD was 
particularly high among 16–24 year olds (12.6%), and then declined sharply with 
age (to 0.8% of women aged 75 and over). In men, the rate remained quite stable 
between the ages of 16 and 64 (between 3.6% and 5.0%), only declining in later 
life (to 1.1% of those aged 65–74 and 0.4% of those aged 75 and over). Table 4.1
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Figure 4B: Screen positive for PTSD, by age and sex
Base: all adults
Experience of PTSD symptoms, by age and sex
All adults were asked whether they had experienced a number of symptoms relating 
to PTSD in the last month. The most common symptom was re-experiencing, 
mentioned by around one in five adults (22.9%). A similar proportion (19.1%) 
had experienced arousal, while fewer mentioned avoidance (11.3%).
Women were more likely than men to report the re-experiencing symptom in 
the last month (25.5% of women, compared with 20.2% of men). There was 
no difference by sex in the presence of the arousal and avoidance symptoms.
The prevalence of individual PTSD symptoms varied significantly by age. For all 
symptoms, prevalence was highest in younger people and decreased with age. 
For example, the re-experiencing symptom was present in 33.3% of 16 to 24 
year olds, and decreased with age to 19.2% of those aged 75 and over. Table 4.1
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Figure 4C: Experience of PTSD symptoms, by age
Base: all adults
Variation in screening positive for PTSD by other characteristics
Ethnic group
The age-standardised rate of trauma in adulthood did not vary significantly 
by ethnic group.
Variation by ethnic group in the rate of screening positive for PTSD, however, 
did approach significance (95% confidence). 8.3% of Black/Black British adults 
screened positive for PTSD (age-standardised) compared with 4.2% of their White 
British counterparts. Table 4.2 
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Figure 4D: Screen positive for PTSD, by ethnic group (age-standardised)
Base: all adults
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Household type
Traumatic experience was associated with living in certain types of household, being 
highest in households containing a lone adult under the age of 60 with no children 
(39.2%). The experience of trauma was lowest in people living in large adult 
households, where 27.0% reported a major traumatic event.
This pattern was similar to the distribution of people screening positive for PTSD, 
with those living in households containing a single adult under the age of 60 being 
the most likely to screen positive for PTSD (10.8%). Analysis by household type 
could not be age-standardised. For this reason, the younger age profile of those 
living in households of one adult under the age of 60 may account for some of 
this association. Table 4.3 
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Figure 4E: Experience of trauma and screen positive for PTSD,
by household type
Base: all adults
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Employment status
Employment status was associated with both experience of trauma and 
likelihood of screening positive for PTSD. Of economically inactive people of 
working age, almost four in ten adults (38.2%) reported a major trauma at some 
point in their lives, compared to three in ten (29.7%) of those in employment. 
Similarly, economically inactive people were more likely to screen positive for 
PTSD (10.5%) than their employed counterparts (2.7%). Table 4.4 
Benefit status
Benefit status was looked at in relation to three groupings: being in receipt of any 
out-of-work benefit (including Jobseeker’s Allowance and Employment and Support 
Allowance (ESA)), receiving an out-of-work benefit specifically related to disability 
(almost always ESA), and living in a household that received housing benefit 
support with rent. These categories are further described in the Glossary.
Screening positive for PTSD was higher in those who received benefits than in those 
who did not. The strength of association was greatest among those receiving ESA 
(the out-of-work benefit related to disability). One in three people in this group 
(25.2% of men and 45.9% of women) screened positive for PTSD, compared with 
%
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Employed Unemployed Economically inactive 
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Figure 4F: Experience of trauma and screen positive for PTSD, 
by employment status (age-standardised)
Base: adults aged 16–64
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one in twenty (3.6% of men and 4.9% of women) not receiving an out-of-work 
disability benefit. Note that some of these bases sizes were small, so the findings 
should be treated with caution. Table 4.5
Region
There were no regional differences in levels of trauma exposure or screening positive 
for PTSD. Variation in trauma exposure, however, did approach significance (95% 
confidence) : with people living in the West Midlands the most likely to report trauma 
(34.3%), and those living in Yorkshire and the Humber least (25.6%). Table 4.6
Self diagnosis and professional diagnosis
Participants were asked whether they thought they had ever had PTSD and, 
if so, whether this had been diagnosed by a professional and if they felt that 
the disorder had been present in the last 12 months.
Overall, 3.3% of adults believed that they have had PTSD at some point and 
1.9% had also had this diagnosed by a professional. Of those who screened 
positive for PTSD on the PCL-C, about one in six (17.4%) believed that they 
had had PTSD, and one in eight (12.8%) had been diagnosed with PTSD by a 
professional. 8.2% of adults who screened positive for PTSD had a diagnosis 
and experienced symptoms of PTSD within the last 12 months. Table 4.7
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Figure 4G: Self-diagnosed, professional diagnosis and recent 
symptoms of PTSD, by PTSD screen
Base: all adults
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Treatment
Around half of those who screened positive for PTSD (47.9%) were currently 
receiving treatment for a mental or emotional problem. The most common form of 
treatment was psychotropic (mental health) medication, either on its own (23.9% 
of those who screened positive for PTSD), or in combination with psychological 
therapy (15.0%). Psychological therapy without medication was the least common 
form of treatment (9.0%). Table 4.8
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Figure 4H: Screen outcome for PTSD, by treatment type
Base: all adults
Four in ten participants who screened positive for PTSD (38.9%) were currently 
taking psychotropic medication. The most common types were those primarily used 
for the treatment of depression (32.9%) or anxiety (31.3%). In addition, 8.7% were 
taking medication used in the treatment of substance misuse disorders. Table 4.9
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Figure 4I: Screen outcome for PTSD, by medication type
Base: all adults
One in four of those who screened positive for PTSD (24.0%) were currently 
having psychological therapy such as counselling. The most common types were 
cognitive behavioural therapy (8.6%), counselling (8.6%) and psychotherapy or 
psychoanalysis (7.6%). Smaller proportions were receiving other types of therapy. 
Table 4.10 
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Figure 4J: Screen outcome for PTSD, by type of therapy currently used
Base: all adults
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Participants were also asked if, in the past 12 months, they had asked 
for any kind of mental health treatment but had not received it. Those 
who screened positive for PTSD were about 16 times more likely than 
those who screened negative to have requested treatment unsuccessfully 
(16.1% compared with 1.0%). Table 4.13
Service use
People screening positive for PTSD were about six times more likely than those 
who screened negative to have used a healthcare service in the last year for a 
mental or emotional problem (60.5% compared with 10.4%). The most common 
was primary care. However, four in ten adults who screened positive for PTSD 
had not spoken with a GP about a mental or emotional problem in the last year 
(39.8%). Table 4.11
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Figure 4K: Screen outcome for PTSD, by type of healthcare used for 
a mental or emotional problem
Base: all adults
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People who screened positive for PTSD were almost five times more likely than 
those who screened negative to have used a community or day care service in 
the last year (30.0% compared with 6.4%). The most commonly used services 
were a psychiatrist (10.5%), community day care centre (9.7%) and a community 
psychiatric nurse (7.8%). Table 4.12
4.4 Discussion
Epidemiological studies on PTSD in the general population are relatively rare, 
as most studies have focussed on groups at high risk of exposure to trauma, notably 
military personnel (Fear et al. 2010), other occupational groups (Bennett et al. 
2004; Carlier et al. 1997; Meyer et al. 2012) or populations exposed to natural 
disasters (Galea et al. 2007) and war (Weine et al. 1995). This chapter presents the 
prevalence of lifetime trauma and screening positive for PTSD based on a general 
population sample of adults living in England, both overall and broken down by 
age, sex, ethnicity, household structure, employment status and region. This is the 
first time the PCL-C has been used in this population, and the use of this measure 
allows direct comparisons with other population groups.
Around a third of all adults experienced a major trauma in their lifetime. Overall, 
there was no difference between men and women, though in the youngest age 
group a lifetime trauma was reported more frequently by women than by men. 
The rates reported here are much lower than those from a community sample 
of individuals living in South East London, which used a similar but not directly 
comparable measure (72.1%) (Frissa et al. 2016). However, less than half of those 
who reported a trauma in that study felt that the trauma had placed themselves or 
others at risk of severe harm, while this was specified in the APMS question.
Overall, 4.4% of adults screened positive for PTSD in the last month, this did 
not vary significantly by sex. Examination of the PTSD symptom clusters showed 
that the most frequently reported were re-experiencing symptoms, rather more 
frequently in women than in men. Screening positive for PTSD did vary by age, 
with the presence of symptoms highest among younger participants.
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The adult prevalence of PTSD was reported for the first time in APMS 2007 
(McManus et al. 2009), with 3.0% of participants screening positive for current 
PTSD using the Trauma Screening Questionnaire, while 42.2% reported at least one 
lifetime trauma. Rates of PTSD using these different measures are not comparable, 
although the proportion of adults reporting a lifetime trauma declined.
Although the highest rates of PTSD were observed in Black/Black British 
participants, the ethnic differences fell short of conventional levels of statistical 
significance. This corresponds with the findings in the 2007 APMS (McManus et 
al. 2009). The prevalence of trauma by ethnicity did not vary significantly, though 
the rates were highest among those of mixed and other ethnic groups, and lowest 
among Asian/Asian British adults.
Examination of the data by household type showed that the highest rates 
of trauma and PTSD occurred in adults living in households containing 
only one adult (aged less than 60) and no children. The social circumstances 
of individuals exposed to trauma may act as a protective factor. Social 
support has been associated with lower PTSD risk in the general population 
(Brewin et al. 2000), military (Iversen et al. 2008) and other occupational 
settings (Carlier et al. 1997). It is likely to help individuals cope with potentially 
traumatic experiences because close-knit social environments promote support, 
advice and feedback (Cohen and Willis 1985).
Employment status was associated with both exposure to trauma and PTSD. 
Economically inactive participants reported higher rates of trauma exposure and 
PTSD than those in employment. Unemployment is known to be associated with 
a range of mental health problems but due to the cross-sectional nature of these 
data it is not possible to determine causality.
NICE guidelines have been developed regarding treatment for people with PTSD 
(NICE 2005). Psychological interventions are the most effective treatment, while 
evidence to support the use of medications is limited. Data presented in this chapter 
show that just over half of those screening positive for PTSD were not receiving 
any treatment. The proportion receiving treatment was substantially higher than 
in the 2007 APMS (28%), however, the results are not directly comparable as the 
previous survey used a different measure of PTSD (McManus et al. 2009). In the 
current study, of those screening positive for PTSD and were receiving treatment, 
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about half were receiving some form of counselling or therapy either on its own 
(the NICE recommended treatment for PTSD) or in combination with medication. 
The rest were generally receiving antidepressants and/or anxiolytics (medication to 
treat anxiety).
We did not collect or link to other sources of information on service utilisation, so 
we are therefore unable to ascertain the validity of the self-report methodology 
used. However, other work has shown this to be a relatively accurate method of 
obtaining service use data (Beebe et al. 2006).
There was a lack of recognition of symptoms among those screening positive for 
PTSD, with 3.3% reporting that they thought they have had PTSD at some point 
in their life and 4.4% screening positive for PTSD in the past month. This may be 
due to an individual’s poor recognition of the disorder, the stigma associated with 
seeking help or lack of awareness of treatment need. However, nearly two-thirds of 
those who screened positive had contacted some form of health service during the 
last year – with the vast majority speaking to their GP. Of concern is that 16.1% of 
those screening positive for PTSD had requested a particular type of mental health 
treatment which had not been provided.
Some of the comparisons reported in this chapter are based on small numbers 
and thus should be interpreted with caution. In addition, due to the cross-sectional 
nature of these data, the direction of cause and effect is unclear.
Although a third of adults living in England reported experiencing at least one 
lifetime trauma, only 4.4% screened positive for PTSD. The link between exposure to 
trauma and the development of symptoms of PTSD is not fully understood, and so 
the factors associated with resilience in the general population require investigation.
4.5 Tables
Prevalence
Table 4.1  Domain, screen positive for PTSD in last month and whether 
experienced trauma, by age and sex
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Characteristics
Table 4.2  Screen positive for probable PTSD in past month and whether 
experienced trauma (observed and age-standardised), by ethnic 
group and sex
Table 4.3  Screen positive for probable PTSD in past month and whether 
experienced trauma, by household type and sex
Table 4.4  Screen positive for probable PTSD in past month and whether 
experienced trauma (age-standardised), by employment status 
and sex
Table 4.5  Screen positive for probable PTSD in past month and whether 
experienced trauma (age-standardised), by benefit status and sex
Table 4.6  Screen positive for probable PTSD in past month and whether 
experienced trauma (observed and age-standardised), by region 
and sex
Treatment and service use
Table 4.7  Self diagnosed PTSD and professional diagnosis of PTSD, by screen 
positive for probable PTSD
Table 4.8  Treatment currently received for a mental or emotional problem, 
among people with and without a positive probable PTSD screen
Table 4.9  Types of psychotropic medication currently taken by people with 
and without a positive probable PTSD screen
Table 4.10  Current counselling or therapy for a mental or emotional problem, 
among people with and without a positive probable PTSD screen
Table 4.11  Health care services used for a mental or emotional problem, 
among people with and without a positive probable PTSD screen
Table 4.12  Community and day care services used in past year, among people 
with and without a positive probable PTSD screen
Table 4.13  Requested but not received a treatment, among people with 
and without a positive probable PTSD screen
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Summary
• Psychotic disorders produce disturbances in thinking and perception that are
severe enough to distort perception of reality. The main types are schizophrenia
and affective psychosis. This chapter presents information on psychotic disorder
in the adult general population. Because psychotic disorder has a low prevalence,
data from APMS 2007 and 2014 have been combined to increase the number
of positive cases for analysis.
• Participants were identified with ‘psychotic disorder in the past year’ only
if they completed a phase two SCAN (Schedule for Clinical Assessment in
Neuropsychiatry) interview and it was positive: weighting was used to adjust
for those who screened positive for psychosis but did not do a SCAN.
• Overall, the prevalence of psychotic disorder in the past year has remained
broadly stable at less than one adult in a hundred (0.4% in 2007, 0.7% in 2014).
There were no significant differences in rate between men and women. Although
the observed rate was highest in those aged 35–44, associations with age were
not statistically significant for psychotic disorder in the last year.
• Psychotic disorder was associated with ethnic group, with rates found to
be higher in black men (3.2%) than men from other ethnic groups. Psychotic
disorder did not vary significantly in rate between ethnic groups among women.
• Socioeconomic factors were strongly linked with psychotic disorder, for example
it was more common in those who are economically inactive and less so among
people in employment. Associations with benefit status were particularly
pronounced: about one in seven (13.4%) claimants of Employment and Support
Allowance tested positive, although the small base size for this group means that
this finding should be treated with caution.
• Psychotic disorder was more common in people who live alone, a finding
consistent with wider evidence on links between mental illness, social
isolation, and the challenges that people with psychotic disorder may face
with maintenance of relationships.
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• Overall, four-fifths of people identified with psychotic disorder were in receipt
of treatment, almost all of whom were on medication; about half of people
identified with psychosis combined medication with psychological therapy at the
time of the interview. Very few were in counselling without medication. There
were indications that the treatment rate for this group increased between 2007
and 2014, although the sample is too small for reliable trends. Among people
with psychotic disorder, more than one in ten had an unmet treatment request.
• Survey identification of disorders can never be as reliable as a full clinical
assessment conducted by a professional over a number of sessions. As with
the data presented for all disorders in this report, figures should be treated as
indicative of the proportion of the population affected by symptoms, and not
a precise point estimate of the prevalence of the disorder.
5.1 Introduction
Psychotic disorders produce disturbances in thinking and perception severe 
enough to distort perception of reality. Symptoms include auditory hallucinations, 
delusional beliefs and disorganised thinking. These may be accompanied by 
unusual or bizarre behaviour and difficulties with social interaction and activities 
of daily living. People with a psychotic illness can make a full recovery, although 
a majority will have repeated psychotic episodes over their lifetime or some degree 
of persistent disability. Psychoses can be serious and debilitating conditions, 
associated with high rates of suicide (University of Manchester 2015) and early 
mortality (Saha et al 2007). 
The Adult Psychiatric Morbidity Surveys (APMS) measured functional psychosis by 
assessing the presence of disorders such as schizophrenia, schizoaffective disorder, 
and affective psychosis (Singleton et al. 2001; McManus et al. 2009). Organic 
psychoses, such as those associated with dementia and Alzheimer’s disease, are 
not discussed in this chapter.1 It can be difficult to compare the community based 
1 APMS 2007 and 2014 included the TICS-M and the Animal Naming measures, which can be used to assess cognitive functioning 
and as proxy indicators of possible dementia. Diagnosed dementia and Alzheimer’s disease can also be recorded at the general 
health section of the interview. These data will be available in the UK Data Service archive.
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prevalence of psychotic disorder from different surveys because of variations in the 
diagnostic categories,2 assessment methods,3 and reference periods used.4 A recent 
systematic review (Kirkbride et al. 2012) found that studies of the prevalence of 
all psychotic disorders showed considerable variation in methodology, quality, and 
results, which made them difficult to pool for meta-analyses. Overall, the studies 
suggested that around four people per 1000 had an active psychotic disorder in the 
past year (annual prevalence). The rate has remained steady over the last 60 years. 
Despite being relatively uncommon, psychotic illness has been found to result in a 
high level of service and societal costs (Knapp 2003; NICE 2014). The World Health 
Organisation (WHO) calculates that the burden and human suffering associated 
with psychosis at the family level is exceeded only by dementia and quadriplegia 
(WHO 2001). People with a psychotic illness who live in the community have low 
rates of employment, and when employed are often in poorly paid and less secure 
jobs (Marwaha et al. 2007). 
Treatment options include antipsychotic medication (also referred to as 
neuroleptics); early intervention, community care, hospitalisation; and cognitive 
behavioural and family therapy for the management of psychotic symptoms 
(Birchwood and Trower 2006; Haddock and Lewis 2005). One of the key priorities 
identified by the Department of Health in relation to psychotic disorder is the early 
delivery of intervention services to people experiencing their first psychotic episode 
(NHS Confederation 2011).
In this chapter we present estimates of the prevalence of past year psychotic 
disorder in the general population. Variation with factors such as age, sex, ethnicity 
and socioeconomic circumstance are discussed, as well as levels of treatment and 
service use. Early surveys in the psychiatric morbidity series covered the offender and 
homeless populations (which are not included in private household surveys like APMS) 
and found rates among these groups to be higher (Gill et al. 1996; Singleton et al. 
1998). Comorbidity with psychotic disorder is described in Chapter 13.
2 Some studies focused on schizophrenia, others included all functional psychoses, and others combined functional and organic 
psychoses. For example, the Psychosis in Finland (PIF) study reported prevalence of all specific psychotic disorders (Perala et al 2007).
3 For example the Composite International Diagnostic Interview (CIDI) is used in the US National Comorbidity Survey Replication 
(Kessler et al. 2004) and the Norwegian Psychiatric Epidemiological Study (Kringlen et al. 2001).
4 APMS reports on psychotic episodes in the past year, some studies refer to current or lifetime experience (for example Perala et al 2007).
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5.2 Definition and assessment
Psychotic disorders 
The disorders discussed in this chapter are based on the WHO International 
Classification of Diseases chapter on Mental and Behavioural Disorders Diagnostic 
Criteria for Research (ICD-10) (WHO 1992). They consist of two main types: 
schizophrenia and affective psychosis. The reference period for psychotic disorder 
was the year prior to interview. 
Case assessment 
To produce estimates of psychotic disorder in adults living in private households 
in England, a two-phase approach was adopted consisting of a phase one screen 
followed by a phase two clinical assessment for a subset of participants.
Phase one screen
Participants with experiences or symptoms indicative of psychosis were identified by 
meeting one or more of the following screening criteria at the phase one interview:
• Currently taking any antipsychotic medication (orally or by injection).  
See the Glossary for a list of antipsychotic medications.
• Reporting an inpatient stay for a mental or emotional problem in the past three 
months, or having been admitted to a hospital or ward specialising in mental 
health problems at any time.
• A positive response to question 5a in the Psychosis Screening Questionnaire (PSQ) 
(Bebbington and Nayani 1995). The PSQ is a series of five probe and five secondary 
questions about mania, thought insertion, paranoia, strange experiences, and 
hallucinations in the past year. Question 5a refers to auditory hallucinations.
• Reporting symptoms suggestive of psychotic disorder (such as mood swings)  
and/or discussing such symptoms with a GP in the past year. 
• A direct question was added to APMS 2014 about whether a participant 
thought that they had ever had any of a list of psychiatric disorders. Self-reported 
identification with psychotic disorder was included as a phase one psychosis 
screening criterion in APMS 2014 only.
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Phase two assessment 
Overall, 6% of participants reported at least one screening criterion indicative 
of psychosis, and so were eligible for a phase two assessment. Not all, however, 
could be assessed at phase two. A fifth (20%) of phase one participants refused to 
be contacted for a phase two interview, and of those issued to phase two with at 
least one psychosis criterion, 27% refused and 6% were non-contacts. In addition, 
the study was designed so that phase two screen-in rates could be monitored 
quarterly: adjustments were made so that in the final quarter of fieldwork 
autism phase two selection criteria were prioritised. Because much was known 
about the characteristics of non-responders to phase two, a complex psychosis 
specific weighting strategy could be developed to address non-response bias. 
See Chapter 14 for discussion of this.
The phase two assessment of psychosis was made using the Schedule for 
Clinical Assessment in Neuropsychiatry (SCAN) version 2.1, a semi-structured 
interview that provides ICD-10 diagnoses of psychotic disorder (WHO 1999). 
Because SCAN involves interviewer judgement of whether symptoms are present 
(as opposed to reliance on self-reports), the interviews were conducted by 
clinically-trained interviewers from the University of Leicester. The presence of non-
organic psychosis in the year before interview was established by applying ICD-10 
diagnostic algorithms to the SCAN generated symptom ratings. Using combinations 
of phase one and phase two data, two differently calculated measures of psychotic 
illness were generated: ‘psychotic disorder in the past year’ and ‘probable 
psychotic disorder’.
Measuring ‘psychotic disorder in the past year’ 
For the identification of psychotic disorder in the past year the following approach 
was used:
• For those who screened positive for psychosis at phase one and had a SCAN 
assessment, the results of the SCAN were used.
• For those who screened negative for psychosis at phase one, it was assumed 
that these were true negatives regardless of whether or not a SCAN assessment 
was completed. 
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• For those who screened positive for psychosis at phase one but did not have a 
SCAN assessment (e.g. due to refusal or non-contact) a weighting strategy was 
applied to take account of non-response. The weighting strategy meant that the 
SCAN results for the participants assessed at phase two were weighted to reflect 
the profile of all participants identified as eligible. 
Measuring ‘probable psychotic disorder’ 
An additional variable has been produced which reduces missing data and 
avoids the need for specific psychosis weights to be used. A difference between 
the ‘psychotic disorder in the past year’ and the ‘probable psychotic disorder’ 
variables is the way in which non-response to phase two is accounted for. A positive 
diagnosis was only possible for ‘psychotic disorder’ if the participant had a positive 
SCAN; while a positive diagnosis of ‘probable disorder’ could also be made on the 
basis of phase one screening questions, where no SCAN interview was undertaken. 
For the measure of probable psychotic disorder the following approach was used:
• For those who screened positive for psychotic disorder at phase one and had 
a SCAN assessment, the results of the SCAN were used.
• For those who screened negative for psychotic disorder at phase one, it was 
assumed that these were true negatives regardless of whether or not a SCAN 
assessment was completed.5
• For those who screened positive for psychotic disorder at phase one but did not 
have a SCAN assessment (e.g. due to refusal or non-contact) those meeting just 
one psychosis screen criterion at phase one were assigned a negative probable 
psychotic disorder outcome, and those meeting two or more psychosis screening 
criteria were assigned a positive outcome.
There have been changes to the psychosis screening criteria used in the 2000, 
2007 and 2014 surveys.6 Firstly, in APMS 2000 participants were asked to name all 
5 As for the ‘psychotic disorder in the past year’ measure, an additional version of this variable has been produced which gives those 
with a positive SCAN assessment but negative phase one screen a positive outcome. Because this identifies more positive cases it is 
useful for subgroup analysis.
6 APMS 1993 used methods for identification of psychosis that were significantly different to those employed on the subsequent 
surveys in the series.
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the medications that they were currently taking, whereas in APMS 2007 and 2014 
prompt cards were used that listed psychotropic medications. This list was extended 
for the 2014 survey to reflect changes in prescribing practice. Secondly, in APMS 
2000 full ICD-10 codings of all health conditions were collected, whereas in APMS 
2007 and 2014 prompt cards were used, listing 22 categories of health condition 
(see the Glossary). Thirdly, an additional screening criterion was included in the 
2014 survey (self-reported diagnosis).
These changes mean that the ‘probable psychotic disorder’ measure is less suitable for 
looking at trends over time than the ‘psychotic disorder in the last year’ measure. 
Whether to use ‘psychotic disorder in the last year’ or ‘probable psychotic disorder’
The ‘psychotic disorder in the past year’ measure has been used as the main 
psychosis outcome in APMS 2007 and 2014. This minimises the risk of false 
positives because identification of disorder is based only on assessment, and not 
on screening criteria. There are concerns about the validity of assigning a positive 
assessment to those meeting two or more phase one screening criteria but not 
having a SCAN interview. For example, some of the psychosis screening criteria 
relate to events that happened long ago (such as having ever been admitted to a 
ward specialising in mental health, even if this was decades ago); to the presence 
of symptoms that could also be linked to different disorders (such as mood swings); 
or to taking particular medication (which while indicated as an antipsychotic, could 
also have been prescribed for other reasons). It is also likely to exclude those at 
an early stage of development (and thus not yet in contact with services). Using 
the probable psychotic disorder measure is likely to overestimate treatment and 
service use among people with psychotic illness in the past year, as several of the 
phase one screening criteria relate to access to services. The probable psychotic 
disorder outcome is likely to include people with a history of psychosis who are 
currently stable on treatment, even where there had been no symptoms in the past 
year. The ‘psychotic disorder in the past year’ variable does have drawbacks. It is 
likely to be an underestimate of the size of the population affected by psychosis, 
as the definition of psychotic disorder in the past year on the basis of the SCAN 
assessment is quite narrow (although appropriate for a study such as this). It 
requires a specific weighting variable and (due to non-response to phase two) the 
number of positive cases identified are small. Because of this, it was decided to 
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prioritise use of the ‘psychotic disorder in the last year’ measure in this chapter, 
but to present prevalence estimates, perform subgroup comparisons, and examine 
treatment rates for psychotic disorder using 2007 and 2014 data combined. 
5.3 Results
Prevalence of psychotic disorder in the past year, in 2007 and 2014
In both 2007 and 2014, less than one adult in a hundred was identified with a 
psychotic disorder in the past year. The estimate for 2007 was 0.4% and for 2014 
it was 0.7%. While statistical tests indicate that this might be a significant increase, 
these figures are also consistent with a continued trend of broad stability in rates of 
psychosis. Any conclusions about trends should be treated with caution considering 
the numbers of confirmed cases were low (23 in 2007; 26 in 2014).
Pooling data from the 2007 and 2014 surveys creates a larger sample. Estimates 
drawing on the combined dataset should be considered the more robust and are 
used in the rest of this chapter. Using the combined dataset, overall prevalence of 
psychotic disorder in the past year was 0.5% of the adult general population. It 
is likely (95% confidence) that if everyone in the household population had been 
tested, the rate would be between 0.4% and 0.7%. Table 5.1
Prevalence of psychotic disorder in the past year (2007 and 2014 combined), 
by age and sex
Using data pooled from the 2007 and 2014 surveys, no difference in rate was found 
between men and women (0.5% of men, 0.6% of women). In none of the survey 
years has a significant difference in rate between men and women been found. 
In both men and women the highest prevalence was observed among those aged 
35 to 44 years (1.0% and 0.9% respectively). This same pattern was also evident 
when using the probable psychosis measure in combined 2007 and 2014 data. 
Age, however, was not found to be significantly associated with psychotic disorder 
in the past year and for this reason, subsequent analyses using this variable are not 
age-standardised. While the presence of organic psychosis is known to increase 
with age, it is not covered in this report. Table 5.2
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Variation in psychotic disorder by other characteristics
Ethnic group
The prevalence of psychotic disorder in the past year (using combined 2007 
and 2014 data) was higher among black men (3.2%) than men from other ethnic 
groups (0.3% of white men, 1.3% in the Asian group, and no cases were observed 
among those in the mixed/other ethnic groups). There was no significant variation 
by ethnic group among women. Table 5.3
 
Figure 5A: Psychotic disorder in the past year (2007 and 2014 combined),
by age and sex
Base: all adults
%
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
16–24 25–34 35–44 45–54 55–64 65–74 75+ 
Age 
 
Men Women
 
Figure 5B: Psychotic disorder in the past year (2007 and 2014 combined),
by ethnic group and sex
Base: all adults
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Household type
Testing positive for psychotic disorder in the past year was strongly linked 
with people’s current living arrangements. Rates were higher in those living alone 
(1.1%), and lower in people living with others (either with children (0.6%), or just 
with other adults (0.4%)). This pattern was evident both for men and women, 
and fits with that observed for the other disorders considered in this report.  
Table 5.4
Region
Cases of psychotic disorder were evident in all English regions, and the rate did not 
vary significantly across the country. Table 5.5
 
Figure 5C: Psychotic disorder in the past year (2007 and 2014 combined),
by household type and sex
Base: all adults
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Employment status
The prevalence of psychotic disorder among those aged 16 to 64 varied by 
employment status. Overall, economically inactive people were more likely to 
have psychotic disorder (2.3%) than those in employment (0.1%). Table 5.6
Benefit status
The prevalence of psychotic disorder varied markedly by whether or not adults 
were in receipt of particular benefits. Due to recent changes that have taken place 
in the benefit system since the last survey, these analyses are based only on the 
2014 sample. The smaller sample size therefore means that these results should 
be treated with some caution. 
Among 16 to 64 year olds in receipt of an out of work benefit such as Jobseeker’s 
Allowance or Employment and Support Allowance (ESA), 7.3% were identified with 
psychotic disorder in the past year, compared with 0.2% of people of this age not 
in receipt of such benefits. 
 
Figure 5D: Psychotic disorder in the past year (2007 and 2014 combined),
by employment status
Base: aged 16–64
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In 16 to 64 year olds specifically in receipt of ESA, one in seven (13.4%) tested 
positive for psychotic disorder in the past year. This pattern was evident both in 
male and female ESA claimants (14.2% and 12.4% respectively). Table 5.7
Treatment and services 
Mental health treatment
Looking at 2007 and 2014 data combined, four-fifths (80.6%) of adults with 
a psychotic disorder in the past year were receiving some form of treatment 
(psychotropic medication and/or psychological therapy) at the time of the interview 
(compared with 9.3% of those without a psychotic disorder). 
There were indications that the treatment rate in adults with psychotic 
disorder might have increased between 2007 and 2014. However, due to the 
very small number of participants identified using the psychotic disorder in the 
last year measure (23 in 2007, 26 in 2014), this finding should be treated with 
great caution. Tables 5.8, 5.9
 Figure 5E: Psychotic disorder in the past year (2014), by benefit status
Base: 16–64 years (out of work benefits); all adults (housing benefit)
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Psychotropic medication 
Almost all people with psychotic disorder who were in receipt of treatment were 
using psychotropic medication. Levels of medication use were about 10 times 
higher in adults with psychotic disorder than in those without psychotic disorder 
(74.6% and 7.9% respectively). 
The types of medication currently taken by people with a psychotic illness included 
antidepressants (48.2%), antipsychotics (including anti-mania medication) (45.7%), 
and drugs used in the treatment of bipolar disorder (50.3%),7 anxiety (35.5%) and 
sleep problems (17.4%). Note that some individual drugs were assigned to more 
than one category (see the Glossary for details).
Medications used in the treatment of substance dependence were also asked 
about in the 2014 survey. These were being used by 14.6% of people identified 
with psychotic disorder in the past year, compared with 0.9% of the rest of the 
adult population. Table 5.10
7 Bipolar disorder medications were additionally covered in the 2014 survey, with substance dependence also asked about (but not 
included in the ‘any medication’ summary variable). 
 
Figure 5F: Current treatment for a mental or emotional problem 
(2007 and 2014 combined), by psychotic disorder in the past year
Base: all adults
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Psychological therapy
Half (54.4%) of adults with a psychotic disorder in the past year were in counselling 
or other psychological therapy at the time of the interview, compared with 2.6% 
without a psychotic disorder. Most of these people combined psychological therapy 
with psychotropic medication. Just 6.0% of people with psychotic disorder were 
using psychological therapy without also using medication as well. Tables 5.9, 5.10
Use of healthcare and community and day care services 
Of adults with psychotic disorder, nearly three quarters (71.3%) had made use 
of health care services for a mental health reason, either having spoken with a 
GP about a mental or emotional problem in the past year, and/or having had 
an inpatient or outpatient visit for a mental health reason in the previous three 
months. Nearly two-thirds (60.4%) had used community care services in the past 
year, and 40.0% had used day care service in the past year. See the Glossary for 
a list of the types of community and day care services covered. Tables 5.9
Unmet treatment request
In the 2014 survey, participants were asked whether they had requested, but 
not received, a particular mental health treatment in the past 12 months. Unmet 
treatment requests were about seven times more likely among people with a 
psychotic disorder than in the rest of the population (12.2% of people with 
psychotic disorder, compared with 1.8% of those without). Table 5.11
Self-diagnosis and professional diagnosis
Participants were asked which of the mental disorders listed on a show card they 
felt that they had ever had. For each one reported, participants were asked whether 
it had been diagnosed by a psychiatrist, doctor, or other health professional; and if 
it had, whether the disorder had been present in the past 12 months. Because these 
questions were new additions to the 2014 survey, these analyses are based on just 
26 participants identified with psychotic disorder in the past year and so the results 
should be treated with caution.
Less than half of the participants identified during the survey with psychotic disorder 
reported that they thought that they have had ‘psychosis or schizophrenia’ at some 
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point in their life.8 Because these questions were asked in the face to face section 
of the interview, it is possible that stigma – which is particularly pronounced for these 
conditions – might have contributed to underreporting (Dean and Phillips 2016). 
All participants who believed that they have had a psychotic illness had also had 
this illness confirmed by a professional, suggesting that awareness of presence 
of this condition tends to come from a professional rather than being something 
people recognise first themselves. Of those who reported ever having had psychosis, 
nearly all reported that it had been present in the past 12 months. The fact that 
few participants reported having had the disorder in the past but not recently may 
indicate that for many with the disorder, the path to recovery is long. Table 5.12
5.4 Discussion
Psychotic illnesses – such as schizophrenia and affective psychosis – affect a very 
small proportion of the population: less than one adult in a hundred and probably 
closer to one in two hundred. APMS 2007 data placed the rate at around 0.4%, 
APMS 2014 found 0.7%. It is worth noting that those stable on treatment or in 
remission are probably not included in this figure and the rate is likely to be an 
underestimate. This approach to their measurement has been comparable over 
time. The figures for 2007 and 2014 are very similar and are consistent with rates 
being stable, but they also do not rule out there having been an increase in the 
proportion of the population affected. APMS data is underpowered to be definitive 
on this either way and needs to be interpreted in the wider context of other data. 
A further population survey of mental health in the future may provide a check on 
whether or not there is long-term stability (as there has been for many decades) 
or an upward trend.
The sample is also too small for robust examination of trends in treatment 
among people with psychotic disorder. While the figures do suggest that a higher 
proportion of people with psychotic illness were using psychotropic medication 
8 Others reported that they thought that they have had “bipolar disorder (or ‘manic depression’)”. This is considered separately in 
Chapter 9.
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and psychological therapy in 2014 than in 2007, these rates are based on the 
experiences of just 26 and 23 participants respectively, and should therefore be 
treated with great caution. 
None of the APMS surveys have found rates of psychotic disorder to vary 
significantly with sex. Other studies, however, have found a higher rate of lifetime 
psychosis in men than women. The APMS series consists of surveys of the general 
population, and is subject to response bias in terms of people’s capacity and 
inclination to participate. One study found that women experiencing a psychotic 
episode tend to be able to maintain higher levels of social functioning than men 
experiencing a psychotic episode (Ochoa et al. 2012). This might suggest that of 
people living in private households, women with current psychosis may be more 
likely than men to take part in a survey or possibly that men may be more likely 
to be in an institutional setting (and therefore out of scope of the survey) while 
experiencing a psychotic episode (Thorup et al. 2007). It is possible that people 
experiencing a psychotic episode may be less likely to take part in a survey, although 
the impact of this is minimised to some extent by reporting on the past year rate 
rather than just current. The relatively rare and complex nature of psychosis makes 
it harder to recruit a representative sample of people with the disorder. Prevalence 
could also be underestimated since studies which have access to case notes as 
well as interview data, have been shown to ascertain more cases of psychotic 
disorder than studies using interview information alone (Kirkbride et al. 2012; 
Isohanni et al. 1997). 
In terms of other characteristics APMS data has shown rates of psychosis across 
the population to be concentrated in particular groups. For example, a significantly 
higher rate of psychotic disorder was found in black men compared with other 
men of other ethnic groups. This is consistent with previous analyses of APMS 
1993, 2000 and 2007 data (Qassem et al. 2015) as well as with findings from 
other surveys (King et al. 2005; Fearon et al. 2006). It suggests a need for increased 
mental health service resources in areas with high proportions of black inhabitants 
(Qassem et al. 2015).
The great majority of the participants identified with psychotic disorder were 
recipients of ESA, which indicates how disabling the condition is. ESA is a benefit 
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intended for people unable to work for reasons of illness or impairment and the 
threshold for eligibility is set high. About one ESA claimant in seven was identified 
with psychosis, compared with a rate of about one in a thousand among people 
in employment. This is consistent with previous analyses of APMS 2007, showing 
associations between psychotic disorder and low equivalised household income. 
Analysis of APMS 2007 showed associations between psychotic disorder and 
marital status (McManus et al 2009). In this chapter, it was established that people 
with psychosis are also less likely to be living with another person at all. This 
indicates that they may lack social support, and help with recognition of the onset 
of symptoms and management of treatment at home. Over half of the participants 
identified with psychosis in the survey did not report that they thought that they 
had it. Nearly everyone who did report thinking they had psychosis had been given 
that diagnosis by a professional. The findings in this chapter provide context for a 
continued focus on improving community services including early intervention and 
support for people with a first episode (NHS Confederation 2011; De Girolamo 
et al. 2012).
5.5 Tables
Prevalence and trends
Table 5.1 Psychotic disorder in past year in 2007 and 2014, by age and sex 
Table 5.2  Psychotic disorder in past year and probable psychotic disorder  
(2007 and 2014 combined), by age and sex
Characteristics 
Table 5.3  Psychotic disorder in past year (2007 and 2014 combined),  
by ethnic group and sex 
Table 5.4  Psychotic disorder in past year (2007 and 2014 combined),  
by household type and sex 
Table 5.5  Psychotic disorder in past year (2007 and 2014 combined),  
by region and sex
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Table 5.6  Psychotic disorder in past year (2007 and 2014 combined),  
by employment status and sex
Table 5.7 Psychotic disorder in past year (2014), by benefit status and sex
Treatment and service use
Table 5.8  Treatment and service use among people with psychotic disorder 
in past year, in 2007 and 2014 
Table 5.9  Treatment and service use (2007 and 2014 combined), by psychotic 
disorder in past year 
Table 5.10  Psychotropic medication currently taken (2007 and 2014 combined), 
by psychotic disorder in past year 
Table 5.11  Requested but not received a particular mental health treatment in 
the past 12 months, by psychotic disorder in past year 
Table 5.12  Psychotic disorder in the past year, by self-diagnosis and professional 
diagnosis of psychotic disorder
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This chapter contains 
Experimental Statistics
Experimental statistics are official statistics which are published in order to involve 
users and stakeholders in their development and as a means to build in quality at an 
early stage. It is important that users understand that limitations may apply to the 
interpretation of this data.
These statistics have been labelled as experimental in order to allow for further 
work to be undertaken to assure users that these statistics meet the overall quality 
standards necessary to be designated as National Statistics. Information on how 
users should interpret these statistics are available throughout this chapter, in the 
Methods chapter of this publication, and in the accompanying Background Data 
Quality Statement.
NHS Digital will gather feedback to these statistics, their construction and 
interpretation from relevant experts, and following this announce details of how 
the assessment of these statistics will progress on the NHS Digital website during 
February 2017.
All official statistics should comply with the UK Statistics Authority’s Code of 
Practice for Official Statistics which promotes the production and dissemination 
of official statistics that inform decision making.
Find out more about the Code of Practice for Official Statistics at: 
www.statisticsauthority.gov.uk/assessment/code-of/practice
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Summary
• Autism spectrum disorders (ASDs), also referred to as autism, are developmental
disorders characterised by impaired social interaction and communication,
severely restricted interests, and highly repetitive behaviours.
• This chapter presents data on the profile of ASD among adults living in the
English household population. This is the second time such data have been
collected in England, after it was covered for the first time in the 2007 Adult
Psychiatric Morbidity Survey (APMS).
• In the phase one interview ASD was screened for using the Autism Quotient
(AQ-20). In the phase two interview, fuller assessments were carried out by
clinically trained interviewers using the Autism Diagnostic Observation Schedule
(ADOS) with a subset of participants with an AQ score of 4 or more. The results
were weighted to generate a prevalence estimate for the population as a
whole. This approach has been extensively validated. It should be recognised
however that psychiatric diagnoses tend to be reached by professionals over
multiple sessions involving probing and clinical judgement. Health surveys
are a population research tool and should not be expected to provide the
equivalent of a professional diagnosis. For further discussion of survey
limitations see Chapter 14.
• The recommended threshold of a score of 10 or more (as well as meeting
subdomain thresholds for ASD) on the phase two ADOS assessment was used
to indicate a case.
• Data from the 2007 and 2014 surveys were combined to generate a larger
sample for analysis. The APMS series has been designed so that samples can
be combined in this way. Estimates based on the combined dataset are more
robust than estimates based on the 2007 or the 2014 samples separately.
31 potential cases were identified in the combined phase two samples, which
is small for subgroup analysis and means caution with interpretation is required.
Had all participants completed a phase two interview (see above), we estimate
that about 120 cases might have been identified in the sample as a whole.
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• Using the combined sample, the prevalence of ASD was estimated to be 
around 0.8%. Survey estimates are always subject to sampling error. Given this, 
we estimate that if all adults in the population had been tested, the proportion 
identified with ASD would probably be between 0.5% and 1.3% (95% 
confidence interval (CI)). The size of this confidence interval is large, but similar 
to that for some other low prevalence disorders considered on APMS.
• Consistent with other research, estimated rates of ASD were higher in men 
(1.5%, 95% CI: 0.8% to 2.6%) than women (0.2%, 95% CI: 0.1% to 0.6%).
• ASD was associated with level of educational qualification, with rates being 
higher among people with no qualifications.
• People with ASD appeared to be no more likely than other adults to make use 
of treatment or services for mental or emotional problems.
6.1 Introduction
Autism spectrum disorders (ASDs) are developmental disorders characterised 
by widespread abnormalities of social interaction and communication, as well as 
severely restricted interests and highly repetitive behaviours (Wing 1997). As with 
other mental and behavioural disorders, they probably exist on a continuum. Presence 
of ASD can have a negative impact on learning and, at the more severe end of the 
spectrum, on the ability to live independently in adulthood (Howlin et al. 2004). 
Adults with the condition often experience isolation and adverse experiences such 
as being bullied and socially excluded (Brugha et al. 2014).
The cost of supporting an individual diagnosed with an ASD without intellectual 
disability is estimated as £0.92 million in the United Kingdom, with residential 
care, supportive living accommodation and individual productivity loss contributing 
the highest costs (Buescher et al. 2014). But quantifying a total cost of ASD is 
problematic because there have been no reliable estimates based on the number 
of adults in England with the condition with and without an autism diagnosis. 
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APMS 2007 was the first general population probability sample survey in any 
country to have assessed ASD in adults (Brugha et al. 2009b), with APMS 2014 
being the second. Rates may be different in specific adult populations, such as 
among people who are homeless or living in prison. Rates were higher in men 
and in those without educational qualifications.
ASD is known to be strongly associated with the presence of learning disabilities 
and it has been estimated that 7.5% of adults with a learning disability may also 
have ASD (Cooper et al. 2004). The 2007 survey was extended to cover people 
with learning impairments, including those living in residential settings, and 
found rates to be higher in this group (Brugha et al. 2012). A secondary analysis 
of the APMS 2007 confirmed earlier indications that autism is associated with an 
increased risk of epilepsy (Rai et al. 2012).
ASD has been assessed among children and young people, and two large-scale 
surveys estimated the prevalence of childhood ASD to be around 1%,1, 2 and higher 
in boys than girls (Baird et al. 2006; Green et al. 2004). ASDs are more apparent and 
easier to study in children, in part because the diagnosis of autism should include 
presence of symptoms in childhood and parent and teacher observations of this are 
more likely to be accurate and available for this group. Because these studies have 
used different methodologies to APMS, the results are not directly comparable. 
The number of reported (diagnosed) cases of autism increased steeply 
throughout the 1990s. It is quite possible that this was due to changes in public 
and professional awareness of the condition, different diagnostic definitions 
and practices, availability of services and referrals, and earlier age at diagnosis 
(Fombonne 2009). Nevertheless, the current evidence available does not rule 
out the possibility that the prevalence of ASD has increased (Rutter 2005).
1 The prevalence of ASDs among children in South Thames was estimated by Baird et al. to be 116.1 per 10,000 (95% CI 90.4–141.8). 
A narrower definition of childhood autism, which combined clinical consensus with instrument criteria for past and current 
presentation, provided a prevalence of 24.8 per 10,000 (17.6–32.0).
2 Green et al. presented confidence intervals for the estimated prevalence of ASD among 5 to 10 year olds in England (1.13, 95% 
CI 0.65–1.39) and for 11 to 16 year olds (0.76, 95% CI 0.47–1.06).
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6.2 Definition and assessment
Autism spectrum disorder (ASD)
The concept of autism gained recognition in the mid-20th Century and is 
still evolving (Frith 1991; Silberman 2015). It remains unclear whether ASDs 
comprise one condition or a range of similar inter-related neuro-developmental 
conditions, with separate subtypes. Experts have achieved a broad consensus 
on what constitutes the category of ASD, and the diagnostic criteria set out 
in the fourth Diagnostic and Statistical Manual (DSM-IV) (APA 1994) and the 
International Classification of Disease (ICD-10) (WHO 1993) are very similar. 
Both systems use the term pervasive developmental disorders (PDD) and require 
information on early childhood development for diagnosis. The fifth revision of 
the DSM (DSM-5) (APA 2013) has removed the requirement to endorse subtypes 
of ASD, such as Asperger’s syndrome. It emphasises instead the importance of 
severity based on social communication impairments and restricted, repetitive 
patterns of behaviour, and whether with or without accompanying intellectual 
impairment. Furthermore, in DSM-5, individuals with a well-established DSM-
IV diagnosis of autistic disorder, Asperger’s syndrome, or PDD not otherwise 
specified should be given the diagnosis of ASD. In this chapter, the terms 
autism and ASD are used interchangeably.
Assessment of ASD
Case assessment of ASD
In surveys of ASD in childhood, information on behaviour and early development 
has been collected from parents and teachers. For adults, the ideal scenario would 
involve assessments of directly observed current behaviour and information on 
both early development and on current day to day functioning over an extended 
period. This is not a practical option for a large general population survey of 
adults. Therefore, the assessment process used on APMS 2007, and replicated on 
APMS 2014, was based on a combination of self-report data collected at the 
phase one interview and a semi-structured assessment carried out by a clinically 
trained research interviewer at the phase two interview (Brugha et al. 2009a). 
This multi-stage case assessment for ASD is similar in structure to that used in the 
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APMS series since 1993 for the assessment of psychotic disorders. The APMS 
2007 process involved a detailed validation assessment (Brugha et al. 2011b). 
It includes the following stages:
A. Phase one AQ-20 self-completion test
B. Selection of cases for phase two assessment
C. Phase two ADOS assessment of a subset of cases
D. Weighting to adjust for selection probabilities and non-response.
This approach has undergone an extensive programme of validation work 
supported by the NHS and Department of Health (Brugha et al. 2009a; 
2011b; 2012; 2016). The validation programme has involved calibration of the 
ADOS with other research instruments for autism assessment; interviews with 
participants’ parents and other family members; comparison with further data 
collected from community, learning impairment, and patient samples; consensus 
ratings of participant vignettes with autism practitioners; and engagement with 
psychiatrists and epidemiologists with expertise in this field. The validation of the 
APMS process for identifying autism has been more extensive than that of other 
conditions covered on the survey. Further work is now planned to address recent 
developments in classification based on DSM-5 and drafting work for ICD-11. 
A. Phase one interview: Autism Quotient
The full Autism Quotient, here referred to as the AQ-50, is one of few fully
structured questionnaires designed to capture signs of ASD in adult participants
(Baron-Cohen et al. 2001). The AQ-50 was reported in clinical populations to have
good correspondence with a full ASD diagnosis (Baron-Cohen et al. 2001). Other
available questionnaires tend to be either longer (Ritvo et al. 2008) or require data
to be collected from a collateral informant, such as a parent (Constantino et al. 2003).
A clinical diagnosis cannot be derived from the AQ-50; it is a test designed to
identify potential underlying autistic traits.
The full AQ consists of 50 items; to minimise participant burden on the already 
long APMS 2007 questionnaire, a shorter 20 item version was derived using 
data collected by two of the AQ authors in the development of the full schedule. 
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Details of the modelling undertaken to select the best subset of items are given 
in a separate technical report (Brugha et al. 2011b). The AQ-50 questionnaire is 
composed of items designed to assess five broad dimensions: social functioning, 
imagination, communication, attention switching and attention to detail. The 20 
adopted items selected by the modelling procedure as the best predictors of a 
positive ASD assessment spread quite evenly across these categories: six were social 
functioning items; four, communication; four, attention to detail; three, attention 
switching; and three, imagination. The AQ-20 was discussed by an expert panel and 
tested in the cognitive piloting conducted as part of the APMS 2007 development 
work. Further modelling took place using a random sample of adults in contact 
with mental health services. This identified the 17 most predictive AQ items used 
in the 2007 survey, these were retained and three (which had performed poorly 
in the 2007 data) were replaced with items with improved prediction selected 
from the original AQ-50 (Tyrer et al. 2013). The revised 20 item version of the 
AQ is reproduced in full in the questionnaire in Appendix D.
A score was generated for each participant based on their responses to the 17 
AQ items included in both the 2007 and 2014 surveys. Each response indicative of ASD 
was given one point, so that a higher score indicated greater likelihood that the person 
may have ASD. The AQ-20 is a self-completion questionnaire, and it was administered 
via a laptop computer in the phase one interview. Because it is a brief test and not a 
diagnostic measure, a clinical assessment was included in the phase two interview.
On APMS, the AQ was used only to exclude cases with an extremely low 
likelihood of having autism (those with an AQ score of between zero and three) 
and to inform the selection probabilities for phase two. It was not used to 
positively identify ASD.
B. Selection of cases for phase two assessment
A subsample of phase one participants was invited to take part in a second
phase interview. Participants’ probabilities of selection for phase two were determined
by their responses to questions at phase one, including their score on the AQ and
whether they were male or female. Those with a higher AQ score had a higher
chance of being selected, as did men. No one with an AQ score of zero to three was
selected for a phase two assessment (unless they endorsed a psychosis criterion,
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as psychotic disorder was also covered in phase two). All men with an AQ score of 
eight or more and all women with an AQ score of 11 or more were selected for 
phase two (except for those interviewed in the final two months of fieldwork, who 
were excluded). For men with an AQ score between four and seven and women 
with a score between four and ten, a subsample of those agreeing to recontact were 
selected for phase two, as outlined in the table below.
Probability of selection to phase two based on phase one AQ score
Sex Phase one AQ score Phase two selection probabilitya
Men 0 to 3 0.000
4 to 7 0.157
8 to 10 1.000
11 or more 1.000
Women 0 to 3 0.000
4 to 7 0.045
8 to 10 0.245
11 or more 1.000
a Of those who agreed to take part in phase two.
It was not feasible for all phase one participants to have a phase two assessment, 
and this approach was designed so that those with the highest likelihood of a 
having autism (or psychosis) had the highest likelihood of being assessed, combined 
with being able to generate estimated rates of ASD for the population as a whole.
C. Phase two assessment: Autism Diagnostic Observation Schedule (ADOS)
The second phase interviews were carried out by clinically trained research 
interviewers from the University of Leicester. The assessment of conditions such 
as ASD required a more flexible interview than was possible at the first phase, 
and the use of judgement in rating clinical criteria for diagnostic classification.
The Autism Diagnostic Observation Schedule (ADOS), Module 4, was completed 
with 628 participants at the APMS 2014 phase two (and 618 at the phase two 
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of APMS 2007). It is a widely recommended ‘gold standard’ clinical research 
assessment instrument for autistic disorders that is used to collect information 
on adult functioning (Lord et al. 2002). The ADOS is a semi-structured clinical 
assessment of whether current behaviour is consistent with a diagnosis of an 
autistic disorder. In 2014, additional questions on restricted, repetitive patterns 
of behaviour and sensory differences were added to the second phase two 
interview. This was done due to their increased emphasis in DSM-5 and because 
the ADOS does not offer an adequate opportunity to measure restricted and 
repetitive behaviours, although such behaviours are coded on the ADOS if they 
occur. This additionally collected data is not reported on in the current chapter, 
but will be analysed in subsequent publications.
The ADOS and its algorithm have been validated in previous clinic based 
testing, but prior to APMS 2007 they had rarely been used with older adults or 
in a general population setting (Gotham et al. 2008). The methods and results 
of a quality assurance and validation study made use of clinician ratings and 
developmental interviews with parents and other informants to inform severity and 
clinical significance thresholds (Brugha et al. 2009a). That study found the ADOS 
performed well, and its results have informed the case threshold used in this report. 
The ADOS consists of a series of tasks that evaluate communication, reciprocal social 
interaction (social functioning), creativity, imagination and stereotyped interests 
and restricted interests. These tasks are rated by the trained interviewer. The ADOS 
ratings that correspond to autism criteria are summed to produce an overall score. 
A score of seven or more is the threshold used to identify an inclusive category of 
ASD that is intended to correspond generally to the conceptualisation that underlies 
the term PDD (Brugha et al 2011b). The recommended threshold of 10 or more is 
applied in this report to indicate a case of autism, validated in the same population.
D. Weighting to adjust for selection probabilities and non-response
For the designation of an ASD outcome the following approach was used:
• For men with a phase one AQ score of four or more and women with a phase
one AQ score of eight or more, and who had an ADOS assessment, the results
of the ADOS were used.
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• Men with a phase one AQ score of three or less and women with a phase two 
ADOS score of seven or less were designated ASD negative, regardless of whether 
or not an ADOS assessment was completed.
• Men with a phase one AQ score of four or more and women with a phase one 
AQ score of eight or more who did not have an ADOS assessment (e.g. due to 
non-selection, refusal or non-contact) were excluded from the analysis, and a 
weighting strategy was applied to take account of their absence and to address 
non-response biases.
For analysis of estimated prevalence of disorders assessed at phase two 
(autism and psychosis), the weighted phase two participants are added to the 
set of phase one participants who were not eligible for phase two, the prevalence 
being assumed to be zero for the not eligible group. Those not eligible are given 
their phase one weights. The sampling and weighting strategy is described in 
more detail in Section 14.7 of the Methods Chapter.
For the analyses presented in this report the 2007 and 2014 samples were 
combined to increase the sample size available for subgroup analysis. The survey 
series has been designed with the intention that samples should be combined, 
especially for analyses of low prevalence disorders or subgroups. This approach 
is also taken in the chapter on psychotic disorder.3
6.3 Results
Prevalence of autism in 2007 and 2014, by age and sex
The estimated prevalence of autism in 2014, using the threshold of a score of 
10 on the ADOS to indicate a positive case, was 0.7% of the adult population 
in England (equivalent to a rate of 7 per thousand). The estimated prevalence of 
autism in the 2007 data (1.0%) was similar to the 2014 estimate; with largely 
overlapping confidence intervals.
3 Several papers published in peer-reviewed medical journals have analysed samples combined from across the survey series. See 
Appendix A for examples of these.
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A total of 12 probable cases were identified in the 2014 sample, because a 
sub-sample of respondents was selected for a phase two interview. This small base 
means that great caution is required in interpreting the population distribution of 
autism. To improve how robust the estimates are, the 2007 and 2014 samples have 
been combined, yielding 31 participants identified with autism. Estimates based 
on the combined sample are more robust than those based on the separate 2007 
and 2014 samples. 
Using the combined sample, the prevalence of ASD was estimated to be 
around 0.8%. Survey estimates are always subject to sampling error. Given this, 
we estimate that if all adults in the population had been tested, the proportion 
identified with ASD would probably be between 0.5% and 1.3%. The size of 
this confidence interval is similar to that of some of the other low prevalence 
disorders considered on APMS.4
Estimated rates of ASD were higher in men (1.5%, 95% CI: 0.8% to 
2.6%) than women (0.2%, 95% CI: 0.1% to 0.6%). Tables 6.1, 6.2
4 For example, the estimated proportion of the population with signs of dependence on drugs other than cannabis is 0.8%, with a 
95% confidence interval of 0.6% to 1.2%.
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Some variation in prevalence of autism was evident with age, although there was 
not a clear pattern. Tables 6.1, 6.2
Variation by other characteristics in combined 2007 and 2014 data
Ethnic group
None of the 31 adults identified with autism in the APMS 2007 and 2014 
samples was a participant from a minority ethnic group. However, due to the 
small number of minority ethnic respondents in the sample as a whole, caution 
is required in interpreting whether or not autism is associated with ethnic group. 
No table is presented for this analysis.
Figure 6B: Autism in 2007, 2014 and combined years, by age
Base: all adults
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Region
There was no significant variation in the prevalence of autism across the four NHS 
England regions. Table 6.3
Education
Presence of autism was associated with the highest educational qualification that 
people had achieved. Overall, the rate was lowest among those with a degree level 
qualification (0.2%) and highest among those with no qualifications (1.5%). 3.2% 
of men without qualifications were identified with autism. Table 6.4
Employment status
Analysis by employment status was run on those aged 16–64, to exclude people 
who are retired constituting most of the economically inactive group. There was no 
significant variation in the proportion of adults identified with autism according to 
whether they were employed, unemployed or economically inactive. Table 6.5
Figure 6C: Autism, by highest educational qualification: 
2007 and 2014 combined
Base: all adults
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Treatment and service use
As mentioned above, even when the 2007 and 2014 APMS samples were 
combined, there were just 31 adults identified with autism. This of necessity 
limits the scope of analysis.
People identified with autism were no more likely than those without autism to 
use any of a range of different types of treatment or services for a mental health 
reason. In fact, in terms of use of health services for a mental health reason, it 
even appears that people with autism were less likely. Healthcare services included 
use of inpatient or outpatient health services within the last three months for 
a mental health reason or discussing a mental or emotional problem with a 
GP within the last year. 3.7% of adults identified with autism reported this, 
compared with 11.6% of those who without autism. Table 6.6
Physical and mental comorbidity with autism is considered in Chapter 13.
Figure 6D: Autism, by employment status: 2007 and 2014 combined
Base: all adults 
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6.4 Discussion
The estimated prevalence of autism in adults in private households in 
England was estimated to be around 0.8% (95% CI: 0.5% to 1.3%) based on 
the combined samples for the 2007 and 2014 APMS. There was no significant 
difference between the rates of autism identified in 2007 and 2014. In these 
surveys adults were interviewed if they were able to participate fully. However, 
adults who would be unable to participate in the APMS because of learning 
disabilities were also represented in a recent extension to the 2007 APMS 
(Brugha et al. 2012). No significant change in the prevalence of autism was 
found when the population of adults with learning disabilities was accounted 
for in the analysis.
There was no clear pattern in the distribution of autism by age. Rates were 
higher in men than women, as found in most research on autism (Brugha 2011a). 
However, it has been suggested that assessments for autism may draw more on 
how the condition manifests in men, and this may lead to under identification 
of autism in women (Trubanova et al. 2014). Autism was much more common 
among people, especially men, without any qualifications, and rates were lower 
in those with a university degree. No one from an ethnic minority group was 
identified with autism in either the 2007 or the 2014 APMS. This is likely to be 
due to the small sample size. 
Among 16 to 64 year olds, employment status was not significantly related to 
whether or not someone was identified with autism. This finding took into account 
the ‘economically inactive’ group, which includes students, and those looking after 
home, long term sick or disabled, or in early retirement. Employment and autism is 
a complex topic that needs more detailed study, including research which considers 
people in whom autism is unrecognised (that is, present but not diagnosed). 
Adults in the survey identified with autism were no more likely than adults 
without autism to use treatment or services for a mental health reason. And in 
fact, adults with autism appeared even less likely than those without to use health 
services for a mental or emotional reason. In contrast, every other mental health 
condition examined in this and previous APMS has been shown to be associated 
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with increased use of treatment and health services. Other work shows that 
adults with mental disorders receive attention from services because mental 
health problems are recognised needs (Spiers et al. 2016). This recognition of 
need does not appear to extend to adults with ASD.
Adults with autism have enduring problems with communication and social 
understanding. There are no effective medical treatments for autism in adulthood. 
However care services for identifying and supporting them are being developed lead 
by local authorities throughout England.5 These services are based on the principle 
that carers and health and social care staff can recognise and accept the presence 
of the condition, and learn how to understand and communicate with those who 
have it. Clinical experience of providing informed social care of this kind to adults 
given a diagnosis of ASD could lead to real improvements in quality of life. 
6.5 Tables
Prevalence
Table 6.1 Autism in 2007 and 2014, by age and sex 
Table 6.2 Autism (2007 and 2014 combined), by age and sex
Characteristics  
Table 6.3 Autism (observed and age-standardised), by region and sex 
Table 6.4  Autism (age-standardised), by highest educational qualification 
and sex
Table 6.5 Autism (age-standardised), by employment status and sex 
Treatment and service use 
Table 6.6 Treatment and service use, by autism
5 www.improvinghealthandlives.org.uk/projects/autsaf2014results 
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Summary
• Personality disorders are longstanding, ingrained distortions of personality that 
interfere with the ability to make and sustain relationships. The self-completion 
Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II) was used 
among 16–64 year old participants in the first phase interview to screen for 
antisocial personality disorder (ASPD) and borderline personality disorder (BPD).
• ASPD is characterised by a pervasive pattern of disregard for and violation of the 
rights of others in people aged at least 18, which has persisted since the age 
of 15. BPD is characterised by high levels of personal and emotional instability 
associated with significant impairment.
• 3.3% of people aged 18–64 screened positive for ASPD. It was more common 
in men (4.9%) than women (1.8%).
• 2.4% of people aged 16–64 screened positive for BPD, differences between 
men and women did not reach statistical significance.
• Personality disorder has also been seen as unitary, characterised by core 
interpersonal dysfunction and the presence of a range of adaptive and 
maladaptive traits. A general personality disorder screen (the SAPAS) was added 
to APMS 2014 to screen adults of all ages for ‘any personality disorder’ (PD).
• 13.7% of people aged 16 and over screened positive for any PD, with similar 
rates in men and women.
• Screening positive on all three measures of PD (ASPD, BPD, and any PD) was more 
common among younger people, and in those living alone, not in employment, 
or in receipt of benefits.
• 6.2% of people screening positive for ASPD and 13.2% of BPD screen 
positives, also believed that they have had a personality disorder. In comparison, 
about 1% of people who did not screen positive for these believed that they 
have had a personality disorder. Most people who believed that they have had 
a personality disorder, also had a diagnosis of this from a professional.
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• Participants screening positively for PD, on any of the measures used, were 
more likely to be in receipt of mental health treatment than those who did not. 
25.8% of people who screened positive for ASPD, 39.1% of screen positives for 
BPD, and 27.1% of screen positives for any PD reported receiving psychotropic 
medication, psychological therapy or both.
• 16.6% of screen positives for BPD, 9.1% of screen positives for ASPD, and 
7.3% of screen positives for any PD had requested some kind of mental health 
treatment which they had not (yet) received, compared with 0.8% of people 
not screening positive for any PD.
7.1 Introduction
Personality disorders are longstanding, ingrained distortions of personality 
that interfere with the ability to make and sustain relationships. Impairment in 
relational functioning is an enduring feature of personality disorder (Skodol et 
al. 2005). Along with substantial social difficulties (Yang et al. 2010), individuals 
with personality disorder also experience poor general health (Fok et al. 2014) 
and reduced life expectancy (Fok et al. 2012). Antisocial personality disorder 
(ASPD) and borderline personality disorder (BPD) are two types with particular 
public and mental health policy relevance (Coid et al. 2006). They are associated 
with substantial burden on affected individuals, their families and wider society 
(Coid et al. 2009). Personality disorders often co-occur with mood and anxiety 
disorders (Grant et al. 2005). Yet prospective, population-based research shows 
that even after accounting for the effects of concurrent mood and anxiety 
disorder, personality disorder is an independent risk factor for poor future mental 
health, as well as serious relational difficulties (Moran et al. 2016). Mapping the 
prevalence and correlates of personality disorder in the general population is 
therefore important as the diagnosis identifies a subsection of the population 
who are at particularly high risk of future health problems.
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Antisocial personality disorder (ASPD)
ASPD is characterised by disregard for and violation of the rights of others. 
People with ASPD have a pattern of aggressive and irresponsible behaviour which 
emerges in childhood or early adolescence (Goldstein et al. 2006). It is associated 
with increased morbidity and mortality, due, among other things, to increased rates 
of assaults, suicidal behaviour, road accidents, and sexually transmitted infections 
(Ellis et al. 1995; Shephard and Farrington 2003). The presence of ASPD may 
complicate treatment of comorbid conditions.
The estimated prevalence of ASPD in the wider general population varies with 
diagnostic classification system, method of assessment and place: for example the 
rate is higher in urban than rural areas (Coid et al. 2006). Despite these differences, 
there is great similarity in the estimates generated by community surveys of 
personality disorder based on full clinical assessment: 0.7% of 18–65 year olds in 
Oslo, Norway (Torgersen et al. 2001), 0.6% in the US (Lenzenweger et al. 2007), 
and 0.3% in England (McManus et al. 2009). ASPD is more prevalent in men 
than women.
People with ASPD have often grown up in families where parenting was 
characterised by conflict and inconsistency, and care sometimes transferred to 
outside agencies (Black et al. 1995). Resultant truancy, delinquent peer groups 
and substance misuse contribute to low educational attainment, unemployment, 
unstable housing and inconsistency in relationships in adulthood (Martin et al. 
1985). While ASPD is distinct from general antisocial behaviour, Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) (APA 1994) criteria do require 
childhood antisocial behaviour (to the level of conduct disorder) for the full 
diagnosis in adulthood. Interventions during childhood have, therefore, been 
identified as a priority by the Home Office in preventing the development of 
full adult ASPD (Moran and Hagell 2001).
Criminality is strongly associated with, but not essential for, the diagnosis of 
ASPD, which includes a broad range of antisocial behaviours and personality 
traits. The 1997 APMS prisoners’ survey identified ASPD in a very high proportion 
of inmates: 63% of male remand prisoners and 49% of male sentenced 
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prisoners (Singleton et al. 1998). People with the disorder account for a 
disproportionately large proportion of crime and violence committed.
The costs and extended harm associated with ASPD include high levels of personal 
injury and financial damage to victims, as well as increased costs of policing, and 
the impact on the criminal justice system and prison services (Welsh et al. 2008). 
Additional costs resulting from ASPD include increased use of healthcare, lost 
employment opportunities, and family breakdown.
Borderline personality disorder (BPD)
BPD is characterised by high levels of personal and emotional instability 
associated with significant impairment. People with BPD have severe difficulties 
in sustaining relationships, and self-harm and suicidal behaviour is common (Paris 
and Zweig-Frank 2001). Most people with the disorder first show symptoms in 
late adolescence or early adult life. The symptoms fluctuate but generally improve 
over time (Newton-Howes et al. 2015). Among those receiving treatment, as many 
as half improve sufficiently not to meet the criteria for BPD 5–10 years after first 
diagnosis (Zanarini et al. 2003).
As with ASPD, the prevalence of BPD identified through community based surveys is 
sensitive to the diagnostic classification system used and the method of assessment. 
The rates identified have, however, been broadly similar across studies: 0.7% in the 
Oslo study (Torgersen et al. 2001), 1.4% in the US (Lenzenweger et al. 2007), and 
0.5% in APMS 2007 (McManus et al. 2009). The rate has been found to be higher 
in women than men; in APMS 2007 it was identified in 0.7% of women and 0.3% 
of men (Skodol et al. 2005). A higher rate among women is consistently observed 
in clinical samples.
A considerable proportion of people with BPD are known to have experienced 
some form of physical, emotional or sexual abuse or neglect in childhood. Its 
association with past trauma and its similarities with posttraumatic stress disorder 
(PTSD) have led some to suggest that BPD should be regarded as a form of 
delayed PTSD (Cloitre et al. 2014). It is rare for a patient to have BPD without 
comorbid conditions (Coid et al. 2009), and because of this considerable overlap 
some have argued that BPD should not be classed as a personality disorder 
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(NCCMH 2009). National Institute for Health and Clinical Excellence (NICE) 
guidelines on the treatment and management of BPD, however, do regard BPD 
as a personality disorder.
Personality disorder
The categorical classification of personality disorder remains controversial. 
Population-based studies have failed to demonstrate a bimodal distribution of 
abnormal personality traits (Livesley et al. 1992). Furthermore, the diagnostic criteria 
for individual personality disorder subtypes considerably overlap. There is therefore 
substantial artefactual comorbidity among personality disorder subtypes. Given 
these limitations, it has been proposed that personality disorder should be classified 
as a unitary disorder, characterised by core interpersonal dysfunction (of varying 
degrees of severity), accompanied by the presence of a range of adaptive and 
maladaptive traits (Tyrer et al. 2015; Ellis et al. 1995). In light of these recent 
proposals, in APMS 2014 a general personality disorder screen was added 
to the assessment battery.
In this chapter, screen positive rates for ASPD, BPD and also for ‘any personality 
disorder’ for the household population in England are presented. Associations with 
age, sex, ethnicity, household structure, employment and benefit status, and region 
are examined, as well as levels of mental health service use and treatment among 
people screening positive. Comorbidity with personality disorder is covered in 
Chapter 13.
7.2 Definition and assessment
Antisocial, borderline and any personality disorders
When this survey was in development DSM-IV was in place and the measures 
used relate to DSM-IV criteria. DSM-5 has since been released, and implications 
for the classification of PD are addressed in the discussion section of this chapter 
(see Section 7.4).
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Personality disorder
DSM-IV defines a personality disorder as ‘an enduring pattern of inner 
experience and behaviour that deviates markedly from the expectations of the 
individual’s culture, is pervasive and inflexible, has an onset in adolescence or early 
adulthood, is stable over time, and leads to distress or impairment’.1
Personality disorders were made a separate diagnostic axis under the DSM-III 
classification of mental disorders (APA 1980). DSM-IV identifies ten types of 
personality disorder grouped into three clusters (APA 1994):
• Cluster A includes the ‘odd or eccentric’ types
• Cluster B disorders are the ‘dramatic, emotional or erratic’ types, and
• Cluster C is the anxious-fearful group (Coid et al. 2006).
• ASPD and BPD are both cluster B disorders: the other ‘dramatic, emotional or 
erratic’ types (narcissistic and histrionic) yielded no positive cases when assessed 
in APMS 2000 and were not included in the 2007 or 2014 surveys.2
ASPD
DSM-IV characterises ASPD as a pervasive pattern of disregard for and violation of 
the rights of others that has persisted in the individual since the age of 15 or earlier, 
as indicated by three (or more) of seven criteria:
• Failure to conform to social norms
• Irresponsibility
• Deceitfulness
• Indifference to the welfare of others
• Recklessness
• Failure to plan ahead
• Irritability and aggressiveness (Millon and Davis 1993).
1 NICE guidelines recommend the use of the DSM-IV diagnostic system for both antisocial and borderline personality disorder.
2 Coid et al. examine reasons for the absence of histrionic and narcissistic personality disorder in the APMS 2000 sample: some 
studies have identified a higher rate of histrionic in particular, e.g. Torgersen et al. (2001) 2.0% histrionic, 0.8% narcissistic; 
and Samuels et al. (2002) 0.2% histrionic; 0.03% narcissistic.
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A feature of ASPD in the DSM-IV is that it requires the individual to meet 
diagnostic criteria in childhood (presence of conduct disorder before age 15) as 
well as adulthood. Because particular behaviours must have persisted beyond the 
age of 18, people younger than this cannot be given the diagnosis. For this reason, 
participants aged 16 or 17 were excluded from the base for the ASPD analysis.
BPD
According to the DSM-IV diagnostic criteria for BPD, the key features are instability 
of interpersonal relationships, self-image and mood, combined with marked 
impulsivity, beginning in early adulthood.3 It is indicated by five (or more) of the 
following criteria:
• Frantic efforts to avoid real or imagined abandonment
• Pattern of unstable and intense personal relationships
• Unstable self image
• Impulsivity in more than one way that is self-damaging (e.g. spending, sex, 
substance abuse, binge eating, reckless driving)
• Suicidal or self-harming behaviour
• Affective instability
• Chronic feelings of emptiness
• Anger
• Paranoid thoughts or severe dissociative symptoms (quasi-psychotic).
Unlike ASPD, a DSM-IV diagnosis of BPD is possible before the age of 18, and the 
BPD analysis therefore included all APMS participants aged 16 and over.4
3 The tenth International Classification of Disease (ICD-10, WHO 1992) does not have a directly equivalent category although 
‘emotionally unstable personality disorder, borderline type’ (F60.31) shares some features.
4 Although some psychiatrists argue that a diagnosis of BPD should not be made before 18, as personality is still forming.
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Assessment
Three methodologically rigorous surveys have covered all ten types of personality 
disorder,5 including APMS 2000 which used the Structured Clinical Interview for 
DSM-IV Personality Disorders (SCID-II) (First et al. 1997; Singleton et al. 2002). 
There are issues with all the available screening tools,6 and no ‘gold standard’ has 
emerged (Zimmerman 1994; Guy et al. 2008). One common disadvantage is the 
large number of questions required to assess the full range of disordered personality 
types. In order to release capacity for new topics, the 2007 survey only measured 
ASPD and BPD. This was made possible by the modular structure of the SCID-II, 
which covers each personality disorder type separately.
In the current survey, personality disorders were not assessed in two phases 
(as they had been in previous surveys in the series). Instead APMS 2014 screened for 
personality disorders based only on phase one self-report data. The rates presented 
in this chapter, therefore, are not comparable with the two-phase rates in the 2007 
report. A positive screen for personality disorder only indicates that someone may 
have sufficient traits to warrant further and fuller investigation. Screen positive rates 
tend to be higher than actual rates of disorder. It should also be noted that the 
term ‘screen’ is used as a convention, and does not indicate that that the screening 
tests used in the survey are used as part of any national screening programme 
in England.
Screening positive for ASPD or BPD on the SCID-II
SCID-II is available as both a self-completion screen and as a semi-structured 
clinician administered face to face interview. In APMS 2014, the modules of the 
self-completion SCID-II covering BPD and ASPD were included in the Computer 
Assisted Self Interview (CASI) at phase one. They were asked of participants aged 
between 16 and 64 (in 2007, the SCID-II was asked of everyone).
The ASPD module covered childhood conduct disorder and adult antisocial 
personality, as a diagnosis of ASPD requires both to be present. The questions 
5 DSM-III listed 12 types of personality disorder, but passive-aggressive and self-defeating were not included in DSM-IV. ICD-10 lists 
nine categories of personality disorder.
6 These include relying on respondent self-report in response to a structured interview, the way in which other disorders can mimic 
symptoms of borderline personality disorder, and the absence of an informant account of a patient’s personality. (Zimmerman 1994).
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used to assess these disorders are listed in the questionnaire in Appendix D. Each 
question asked the participant to indicate whether or not they had a particular 
personality characteristic, for example: ‘Are you the kind of person who…’. All 
questions had three response categories: yes, no, and ‘don’t know/does not apply’. 
A score of one was given for each item endorsed.
Screening positive for any personality disorder on the SAPAS
In APMS 2014, the Standardised Assessment of Personality: Abbreviated 
Scale (SAPAS) (Moran et al. 2003) was added to measure the likelihood that 
an individual has a personality disorder in a more general sense, as opposed 
to screening for specific types of personality disorder (Hesse and Moran 2010). 
The SAPAS was chosen on the grounds that it is currently the best performing 
rapid screen for personality disorder (Germans et al. 2012). Each of the eight 
questions on the SAPAS asked participants to indicate whether or not they had a 
particular personality characteristic, for example “Are you normally an impulsive 
sort of person?” Participants could answer either ‘yes’ or ‘no’. A score of one 
was given for each item endorsed, generating a score of 0–8. Those scoring four 
or more were defined as screening positive for possible personality disorder. This 
cut-point was chosen as it provides the best balance between sensitivity and 
specificity in a general population sample (Lenzenweger et al. 2007; Fok et al. 
2015). Participants with more than two SAPAS items missing were not given a 
SAPAS score.
In summary, in this chapter:
• Screen positive for ASPD and BPD always draws on the SCID-II
• Screen positive for ‘any PD’ always draws on the SAPAS.
7.3 Results
Screening positive for ASPD, BPD and any PD by age and sex
Overall, 3.3% of participants aged 18 to 64 screened positive for ASPD 
on the SCID-II. If everyone in the population had been screened, it is likely 
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(95% probability) that between 2.8% and 4.0% of 18 to 64 year olds would 
screen positive. The ASPD rate was higher in men (4.9%, 95% confidence interval 
(CI): 3.9% to 6.0%) than women (1.8%, 95% CI: 1.4% to 2.4%). Screening 
positive for ASPD was associated with age. Positive screens for ASPD were more 
common in men aged 18–24 (6.4%) and 25–34 (6.6%) than in men in older 
age groups (4.1% of men aged 55–64). A similar pattern was observed among 
women: 3.3% of women aged 18–24 screened positive for ASPD, compared 
with 0.4% of women aged 55–64.
2.4% of adults aged 16 to 64 screened positive for BPD on the SCID-II, it is likely 
that the rate in the wider population of 16 to 64 year olds is between 2.0% and 
2.9%. An apparent difference in rate by sex did not achieve statistical significance, 
with 1.9% (95% CI 1.3% to 2.7%) of men screening positive and 2.9% (95% 
CI 2.3% to 3.7%) of women. Younger people were more likely to screen positive 
for BPD than older people, this pattern was more evident in women than men. 
Table 7.1
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Figure 7A: Screen positive for antisocial and borderline personality disorder 
in past year (SCID-II)
Base: 18–64 (ASPD); aged 16–64 (BPD)
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Using the SAPAS, 13.7% of adults screened positive for any PD, at a cut-point of 4. 
The proportion of the population as a whole is likely to be between 12.7% and 
14.6%. The prevalence among men (13.2%, CI 95% 11.9% to 14.7%) and women 
(14.0%, CI 95% 12.8% to 15.4%) was very similar. There was a strong, linear 
association between age and screening positive for any PD: 22.4% of 16–24 year 
olds screened positive compared with 8.0% of adults aged 75 and over. Table 7.2
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Figure 7B: Screen positive for any personality disorder (SAPAS), 
by age and sex
Base: all adults
ASPD and BPD screens by any PD screen
The SAPAS identifies about one person in eight aged 16 or over as screen 
positive for ‘any PD’ (covering all ten types of PD), while the SCID-II screen detects 
specifically ASPD in about one person in thirty (aged 18–64) and BPD in one in forty 
(aged 16–64). As expected therefore, while most participants identified with ASPD or 
BPD also screened positive on the SAPAS, most SAPAS screen positives did not also 
screen positive on the SCID-II. Table 7.3
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Self-diagnosis and professional diagnosis of PD
Participants were asked whether or not they thought that they had ever had any of 
a list of mental disorders, including ‘a personality disorder’. Those who responded 
positively to this were also asked whether a professional had confirmed that diagnosis.
6.2% of people screening positive for ASPD and 13.2% of BPD screen positives, 
also believed that they have had a personality disorder. In comparison, less than 1% 
of people who did not screen positive on the SCID-II believed that they have had 
a personality disorder. Most people who thought that they have had a personality 
disorder, also had a diagnosis of this from a professional.
3.4% of people who screened positive for any PD also believed that they have 
had a personality disorder. Again, most of these people had been diagnosed by 
a professional. Table 7.4
Screening positive for PD by other characteristics
Ethnic group
There was no significant association between any measure of PD and ethnic 
group. This was the case both when the analysis was age-standardised and when 
the analysis was run without adjusting for the different age-profiles of the ethnic 
groups.7 It should be noted that the APMS sample is underpowered for looking 
at variation by ethnic group. Tables 7.5, 7.6
Household type
Participants aged less than 60 and living in lone person households had higher rates 
of PD than those living in other types of household, for all measures of PD.  
Tables 7.7, 7.8
Employment status
Employment status was associated with all measures of PD. Screen positive rates 
were highest among the unemployed for ASPD and any PD, and in people who 
were economically inactive for BPD. Tables 7.9, 7.10
7 Age-standardisation allows for comparisons to be made between groups after adjusting for the effects of any differences in 
age distribution. Observed results refer to those which have not been age-standardised.
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Figure 7C: Screen positive for antisocial, borderline personality disorder 
and any personality disorder, by employment status
Base: 18–64 (ASPD); aged 16–64 (BPD); all adults (PD)
Benefit status
Benefit status was looked at in relation to three groupings: being in receipt of any 
out-of-work benefit (including Jobseeker’s Allowance and Employment and Support 
Allowance (ESA)), receiving an out-of-work benefit specifically related to disability 
(ESA), and living in a household that received housing benefit support with rent. 
These categories are further described in the Glossary.
Screening positive for PD – across all three PD indicators – was higher among 
those who received benefits than among those who did not. The strength of 
association was greatest for those receiving ESA. About half of the people in 
this group (40.0% of men and 57.3% of women) screened positive for any PD, 
compared with one in eight (12.3% of men and 12.9% of women) not receiving 
an out-of-work disability benefit. Tables 7.11, 7.12
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Figure 7D: Screen positive for antisocial, borderline personality disorder and 
any personality disorder, by type of benefit received 
Base: 18–64 (ASPD); aged 16–64 (BPD); all adults (PD)
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Screening positive for PD did not vary by region, using any of the PD measures. 
Tables 7.13, 7.14
Treatment and service use
Participants screening positively for PD, on any of the measures used, were more 
likely to be in receipt of mental health treatment than those who did not. 25.8% 
of 18 to 64 year olds who screened positive for ASPD, 39.1% of screen positives 
for BPD, and 27.1% of screen positives for any PD reported receiving psychotropic 
(mental health) medication, psychological therapy or both. Tables 7.15, 7.16
People screening positive were more likely to be in receipt of medication than 
counselling. Psychotropic medication was being taken by about a quarter of 
individuals screening positive for ASPD (23.0%) and any PD (23.0%), and a third of 
those screening positive for BPD (31.5%). As in the general population, drugs used in 
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the treatment of anxiety or depression were the most commonly prescribed to people 
screening positive for PD, although a notably high proportion of BPD cases were 
taking antipsychotics (6.8%) or medication indicated for bipolar disorder (8.8%).
As well as psychotropic medication, substance dependence medication was being 
taken by 8.0% of ASPD and 8.0% of BPD screen positives, and 4.0% of screen 
positives for any PD. Table 7.17, 7.18
Counselling or other psychological therapy was currently being received by one 
in five (20.2%) people screening positive for BPD (aged 16 to 64), one in seven 
(13.6%) with ASPD (aged 18 to 64), and one in ten (9.7%) screen positive for any 
PD. For ASPD, the most common form was alcohol or drug therapy (6.2%), and 
for BPD it was psychotherapy or psychoanalysis (7.5%) and cognitive behavioural 
therapy (6.9%). Table 7.19, 7.20
Along with the finding that people screening positive for PD are more likely to 
be in receipt of mental health treatment, it was also the case that they were more 
likely to have requested a particular treatment which they then did not receive. 
16.6% of screen positives for BPD, 9.1% of screen positives for ASPD, and 7.3% of 
screen positives for any PD had requested some kind of mental health treatment in 
the past 12 months which they had not (yet) received, compared with 0.8% of 
people not screening positive for any PD. Table 7.21
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Figure 7E: Requested but did not receive a particular mental health 
treatment, by personality disorder screens
Base: 18–64 (ASPD); aged 16–64 (BPD); all adults (PD)
Figure 7D: Screen positive for antisocial, borderline personality disorder and 
any personality disorder, by type of benefit received 
Base: 18–64 (ASPD); aged 16–64 (BPD); all adults (PD)
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7.4 Discussion
The epidemiological data generated from this survey has limitations, chiefly in 
terms of the reliance on self-reported cross-sectional data. Although the numbers of 
people who screened positive for ASPD and BPD were relatively small (164 and 121 
respectively), a number of clear patterns are evident.
People at high risk of personality disorder are more likely to live alone and 
not be in employment compared with those who do not screen positively for 
personality disorder. ASPD is more common in men than women. All the measures 
of personality disorder included in the survey showed strong associations with 
age: with rates higher in younger age groups than older.
Since this study was carried out there have been significant changes in the 
classification of personality disorder. The DSM-5 approach was rejected by the 
American Psychiatric Association (detailed reasons can be found in Zachar et al. (2016)) 
and so the classification has reverted to the DSM-IV criteria, at least for the next few 
years. This former classification includes the definitions of antisocial and borderline 
personality disorder described in this chapter.
The ICD classification has changed radically in that all categorical diagnoses of 
personality disorder have been abandoned (Tyrer et al. 2015). In its place a single 
dimensional classification has been proposed, which extends from no personality 
dysfunction through to severe personality disorder, with personality difficulty, and mild 
and moderate personality disorder as intermediate levels. A recent population-based 
longitudinal study has provided some empirical support for this new severity-based 
classification scheme (Moran et al. 2016). There are five trait domains that qualify 
the level of severity but are not diagnoses in their own right. These are dissocial, 
anankastic, detached, negative affective and disinhibited domains that relate directly 
to normal personality variation. People with personality disorder can have disturbance 
in more than one domain, and in recent research using the ICD-11 criteria those 
currently diagnosed as borderline tend to cluster together across the negative 
affective and dissocial domains (Mulder et al. 2016).
The ICD-11 revision group was also impressed with the evidence that personality 
disorder is not stable over time (Seivewright et al. 2002; Zanarini et al. 2003), 
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a finding which is also tentatively supported by the age distribution associated 
with personality disorder found in this study. For this reason it has included two 
additional diagnoses; late-onset personality disorder and personality disorder in 
development, that allow personality disorder to be diagnosed at different ages 
(Tyrer et al. 2015).
Stability is a defining feature of both the ICD-10 (WHO 1992) and DSM 
definitions of personality disorder (NICE 2003). The cross-sectional association 
with age is therefore interesting as it raises a prospective research question 
about whether the condition truly persists across the life course. Certainly there 
is evidence of fluctuation over time in the presence of criteria within individuals 
(Livesley et al. 1992), and the course of the disorder also seems to be susceptible 
to treatment (NCCMH 2013; Marcus et al. 2006). Moreover, clinical trials have 
shown that some talking therapies can be effective in the treatment of a number 
of personality disorders, although the results of pharmacological trials have been 
less conclusive (Paris 2008).
Most people screening positive for personality disorder in the APMS sample were 
not receiving treatment although it is noteworthy that the prevalence of reported 
therapy was higher among those with personality disorder, compared to those 
without any personality disorder. Of those that were receiving treatment, more 
cited medication than psychological therapies. It is also noteworthy that screening 
positive for personality disorder was also associated with requesting but not 
receiving specific treatment.
As noted previously, the sample size and cross-sectional nature of these data 
requires us to treat these findings with some caution. Nevertheless, they also 
suggest that further improvements in treatment provision may be required in 
order to achieve satisfactory levels of therapeutic help for people with personality 
disorder as recommended by NICE. For example, NICE quality standards for 
people with BPD include being offered a choice of psychological therapy.
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7.5 Tables
Prevalence and trends
Table 7.1  Screen positive for antisocial and borderline personality disorder, by 
age and sex
Table 7.2  Standardised Assessment of Personality – Abbreviated Scale (SAPAS) 
personality disorder screen, by age and sex
Table 7.3  Antisocial and borderline personality disorder (SCID-II) screen by 
screen for any personality disorder (SAPAS)
Table 7.4  Self-diagnosis and professional diagnosis of personality disorder, by 
screen positive for personality disorder
Characteristics
Table 7.5  Screen positive for antisocial and borderline personality disorder 
(observed and age-standardised), by ethnic group and sex
Table 7.6  Screen positive for any personality disorder (observed and age-
standardised), by ethnic group and sex
Table 7.7  Screen positive for antisocial and borderline personality disorder, 
by household type and sex
Table 7.8  Screen positive for any personality disorder, by household type 
and sex
Table 7.9  Screen positive for antisocial and borderline personality disorder, 
by employment status and sex
Table 7.10  Screen positive for any personality disorder, by employment status 
and sex
Table 7.11  Screen positive for antisocial and borderline personality disorder, 
by benefit status and sex
Table 7.12  Screen positive for any personality disorder, by benefit status and sex
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Table 7.13  Screen positive for antisocial and borderline personality disorder 
(observed and age-standardised), by region and sex
Table 7.14  Screen positive for any personality disorder (observed and age-
standardised), by region and sex
Treatment and service use
Table 7.15  Treatment currently received for a mental or emotional problem, 
by screen positive for antisocial or borderline personality disorder
Table 7.16  Treatment currently received for a mental or emotional problem, 
by screen positive for any personality disorder
Table 7.17  Psychotropic medication currently taken, by screen positive for 
antisocial or borderline personality disorder
Table 7.18  Psychotropic medication currently taken, by screen positive for any 
personality disorder in past year
Table 7.19  Current counselling or therapy for a mental or emotional problem, 
by screen positive for antisocial and borderline personality disorder
Table 7.20  Current counselling or therapy for a mental or emotional problem, 
by screen positive for any personality disorder
Table 7.21  Requested but not received a particular mental health treatment in 
the past 12 months, by personality disorder screens
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Summary 
• Attention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental 
disorder which starts in childhood and often persists into adulthood. Adult ADHD 
is often unrecognised or misdiagnosed by professionals. It is associated with 
significant impairment and adverse outcomes, including premature mortality.
• APMS provides the only general population data on ADHD in adults in 
England. The 2007 and 2014 surveys both included the six-item Adult ADHD 
Self-Report Scale (ASRS). The screen assesses ADHD characteristics of inattention, 
hyperactivity and impulsivity during the six months prior to interview. A score of 
4 or more constitutes a positive screen for ADHD. 
• Screening positive for ADHD indicates that someone warrants a fuller assessment. 
While the actual prevalence of ADHD will be lower, APMS provides key information 
on the distribution of ADHD characteristics in the general adult population.
• One in ten (9.7%) adults screened positive for ADHD, with similar rates for men 
and women. This rate was slightly higher than that found in 2007 using the same 
measure (8.2%).
• Screening for ADHD was more common among: younger adults; those living 
alone; people without educational qualifications; the unemployed and those who 
are economically inactive, especially those in receipt of disability-related out-of-
work benefits.
• Very few adults screening positive for ADHD believed that they had the 
disorder (3.7%) or had been diagnosed with ADHD by a professional (2.3%). 
0.5% of adults screening positive for ADHD were currently taking medications 
specifically indicated for ADHD.
• However, adults screening positive for ADHD were three times more likely to be 
in receipt of psychotropic medication or psychological therapy than those who 
did not (32.2% compared with 9.9%). They were also more likely to make use 
of health or community care services, and to have requested particular treatment 
which they did not subsequently get.
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• These findings suggest that ADHD characteristics are widespread in the adult 
population in England. While no definitive assessments of ADHD are reported 
on here, the findings are consistent with the view that ADHD may often go 
unrecognised, misdiagnosed and undertreated.
8.1 Introduction
Attention-deficit/hyperactivity disorder (ADHD) is widely recognised as a 
complex neurodevelopmental disorder in childhood. Prevalence estimates for 
childhood ADHD range between 3% and 9%, depending on the diagnostic 
criteria applied (NICE 2008). The persistence of ADHD into adulthood is also well 
established, but has only gained significant recognition – and become a focus for 
research and clinical management – over the past decade (Nutt et al. 2007).
The National Institute for Health and Clinical Excellence (NICE) reviewed the 
diagnostic construct of ADHD across the lifespan and concluded that when ADHD 
persists into adulthood it is often associated with significant impairment (2008). 
It remains uncertain what level of ADHD symptoms and impairment in adults 
should be considered grounds for intervention. 
Worldwide prevalence estimates for ADHD in adults from survey studies range 
from 2.5% to 3.4% (Simon et al. 2009; Fayyad et al. 2007). Survey estimates of 
reporting both childhood ADHD and persistence into adulthood vary widely within 
and between countries, with US general population surveys suggesting a prevalence 
of between 3% and 5% (Fayyad et al. 2007; Faraone and Biederman 2005; Kessler 
et al. 2006). Analysis of multiple follow-up studies of children diagnosed with 
ADHD has indicated that about 15% of children diagnosed with ADHD retained the 
diagnosis at age 25. A further 50% of children with ADHD were in partial remission 
by age 25, meaning they still experienced some impairing symptoms (Nutt et al. 
2007). More recent follow-up studies in the UK and the Netherlands of children 
with ADHD attending child mental health services found far higher persistence 
rates into adulthood (in the order of 80%) (Van Lieshout et al. 2016; Cheung et al. 
2015). This may reflect the severity of the cases in these studies.
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APMS 2007 provided the first epidemiological data on the prevalence of 
ADHD characteristics in the adult population in England. Findings from that survey 
indicated that prevalence was higher among particular population subgroups: most 
notably unemployed people, those with substance misuse disorders, and previously 
married individuals (McManus et al. 2009). APMS 2014 has the same screening 
tool as that used in 2007, and presents the first opportunity to look at trends in 
ADHD characteristics.
ADHD in adults may go unrecognised or be misdiagnosed by mental health 
professionals (Asherson 2005). A recent survey using diagnostic interview 
assessments with non-psychotic patients attending adult mental health services in 
European countries found an ADHD rate of 15.8% (DSM-IV) (APA 1994) to 17.4% 
(DSM-5) (APA 2013). Their ADHD was often undiagnosed and untreated (Deberdt 
et al. 2015). One difficulty with diagnosis is that some of the characteristic features 
of ADHD may also be seen in other psychiatric conditions. These include personality 
disorders (particularly those characterised by emotional instability such as antisocial 
personality disorder and borderline personality disorder), while poor attention and 
distractibility are also common in depression, anxiety and bipolar disorder. ADHD 
symptoms also overlap or co-occur with other neurodevelopmental disorders such 
as autism and intellectual disability, and specific learning difficulties. This may result 
in additional or alternative diagnoses (Nutt et al. 2007). Furthermore, behavioural 
problems such as substance misuse disorders and antisocial behaviour occur at 
increased rates in adults with ADHD. If ADHD in adulthood is unrecognised as 
a result of comorbidity, service provision and treatment may be ineffective. 
Untreated, the presence of ADHD may lead to educational and occupational 
disadvantage, and significant social impairments. Adults with ADHD tend 
to have fewer academic qualifications, probably because of difficulties with 
distractibility and restlessness, as well as problems with organising time, prioritising 
tasks and meeting deadlines (Nutt et al. 2007). ADHD is found in 26% of 
prisoners (Young et al. 2014; Ginsberg et al. 2010) and 12% of treatment-seeking 
patients with substance abuse disorders (van de Glind et al. 2014). It is associated 
with increased rates of criminal convictions (Lichtenstein et al. 2012), transport 
accidents (Chang et al. 2014) and mortality (Dalsgaard et al. 2015). Additional 
costs to society are incurred through absenteeism, reduced productivity and 
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poor work performance (Kessler et al. 2005b). The social consequences of the 
adult form of ADHD are equally marked, with dysfunctional patterns of behaviour 
leading to poor interpersonal relationships and marital failure (Nutt et al. 2007). 
Service provision and treatment for ADHD in childhood is now well established, 
but is much less available for adults diagnosed with the condition. Many ADHD 
medications considered effective for children and adolescents are not licensed 
for use in adults (Nutt et al. 2007), although this is changing with licensed 
indications for the first time in the UK for use of atomoxetine and lisdexamfetamine 
in adults with ADHD. Mental health services for adults with ADHD remain 
relatively uncommon or greatly under-resourced in the UK and across much of 
Europe, resulting in high levels of untreated disorder even when it is identified 
(Van Lieshout et al. 2016). 
Information about the prevalence of ADHD and the use of mental health 
services by adults presenting with the characteristic features of ADHD in the 
English population is essential for planning improvements in diagnosis and 
service provision. This chapter describes the general population distribution 
of characteristic behavioural symptoms associated with ADHD, examines 
their association with age, sex, and certain sociodemographic characteristics, 
and profiles the use of mental health treatment and services. Comorbidity 
involving ADHD is addressed in Chapter 13.
8.2 Definition and assessment
Attention-deficit/hyperactivity disorder (ADHD)
ADHD is a neurodevelopmental disorder defined by the core dimensions 
of inattention, hyperactivity and impulsiveness. Characteristic symptoms and 
behaviours include significant and enduring difficulties with organisation and 
planning, distractibility, forgetfulness, over-activity, restlessness and impulsiveness, 
to an extent that causes significant distress or significantly interferes with everyday 
functioning (Weiss et al. 2002). The role of ancillary characteristics has been 
highlighted in recent years; these include emotional dysregulation, sleep onset 
insomnia and problems with the self-regulation of behaviour (Asherson et al. 2016). 
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While these are not used to define ADHD, they are commonly seen in the condition 
and often lead to impairment. They are also seen in other mental disorders.
Two official sets of diagnostic criteria are in current use; the International Classification 
of Diseases 10th Revision (ICD-10) (WHO 1992) and the Diagnostic and Statistical 
Manual of Mental Disorders fifth edition (DSM-5) (APA 2013). The ICD-10 uses 
a more restricted set of criteria, whereby ADHD symptoms are classified as 
hyperkinetic disorder when all three characteristics of inattention, hyperactivity and 
impulsivity are present and lead to impairment. This stricter classification excludes 
cases comorbid with conditions such as anxiety, personality disorder and pervasive 
developmental disorder, although such comorbidity is common. The narrowness 
of this definition can be seen as a limitation, as it will not identify people with all 
the features of adult ADHD if the criteria for other conditions are also met, and will 
only detect the most severe cases. On the other hand, given the severity of ICD-
10 hyperkinetic disorder, people meeting these criteria represent a clear priority. 
DSM-5 in contrast sets out a broader definition of the disorder and allows the 
presence both of comorbid disorders and of impairing symptoms in the inattentive 
or hyperactive-impulsive domains. This approach might therefore be seen as over-
identifying ADHD in individuals who are primarily suffering from other disorders 
(Nutt et al. 2007). 
Adult ADHD Self-Report Scale-v1.1 (ASRS)
The Adult ADHD Self-Report Scale (ASRS), developed in collaboration with the 
World Health Organisation (WHO), was used in both the 2007 and 2014 APMS 
to estimate the prevalence of possible ADHD (WHO 2003). The scale is referred 
to in this chapter as a screening test for reasons of convention, although it is not 
currently recommended as part of an official screening programme in England. 
The six-item ASRS is a shortened version of the 18-item Symptom Checklist scale, 
which measures the frequency of recent symptoms of adult ADHD listed in the 
DSM-IV.1 This short screen appears to out-perform the full 18-question ASRS in 
terms of sensitivity (68.7% versus 56.3%), specificity (99.5% versus 98.3%), 
1 DSM-IV Criterion A symptoms are categorised as a clinical diagnosis of adult ADHD requiring a respondent to have at least six 
symptoms of either inattention or hyperactivity-impulsivity during the six months before the interview. 
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and total classification accuracy (97.9% versus 96.2%) (Kessler et al. 2007). Its use 
and validity have been established predominantly in community samples, although 
it has been suggested that the scale could also prove to be a useful complement to 
more accurate clinical diagnostic assessments (Kessler 2005a). However, it may lack 
sufficient predictive validity in some populations, such as those with substance use 
disorders (van de Glind et al. 2013). 
The ASRS screen was administered face-to-face to all participants. The six 
questions assess the ADHD characteristics of inattention, hyperactivity and 
impulsivity during the six months prior to interview. Participants were asked to 
rate the frequency of these characteristics using a five-point response scale: ‘never’, 
‘rarely’, ‘sometimes’, ‘often’ and ‘very often’. In this chapter we report 1) the 
proportion of adults reporting four or more characteristics at or above the specified 
frequency threshold, and 2) the proportion reporting all six characteristics. The four-
item threshold is that recommended for indicating the need for a clinical assessment 
for ADHD (Fayyad et al. 2007). However, the developers of the scale also emphasise 
that the higher the score the more likely it is that ADHD is present, and for this 
reason we also show the proportion of the sample meeting the threshold frequency 
for all six items. This reveals subgroups with the greatest likelihood of a positive 
diagnosis at clinical assessment. 
While it has been established that the ASRS identifies a group with a greater 
chance of meeting the full criteria, the rate will not be accurate because some 
participants may lack significant impairment or another defining characteristic of 
ADHD symptoms. To address this problem, additional work using a short clinical 
assessment format was introduced to phase two during the 2014 fieldwork and 
will be described and reported on separately.2 In the meantime, the validity of 
self-evaluation of ADHD characteristics described in the present report should 
be regarded with some caution.
The questions in the ASRS scale used to screen for possible adult ADHD and the 
threshold frequencies are displayed below. 
2 The phase two data on ADHD will be analysed in subsequent publications.
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Adult Self-Report Scale-v1.1 (ASRS-V1.1) Screen 
Thinking about now and the past six months… Responses indicating 
symptom is significant
… how often do you have trouble wrapping up the fine  
details of a project, once the challenging parts have been done? 
Sometimes, often,  
very often 
… how often do you have difficulty getting things in order  
when you have to do a task that requires organisation?
Sometimes, often,  
very often
… how often do you have problems remembering  
appointments or things you have agreed to do?
Sometimes, often,  
very often
… when you have a task that requires a lot of thought,  
how often do you avoid or delay getting started?
Often, very often 
… how often do you fidget or squirm with your hands  
or your feet when you have to sit down for a long time?
Often, very often
… how often do you feel overly active and compelled to 
do things, like you were driven by a motor?
Often, very often
Although the ASRS screen shows strong concordance with clinical diagnosis in 
US population surveys, caution is required in interpreting ASRS-based findings. 
First, self-reported information is always subject to some social desirability biases 
(Greenfield et al. 2001). Second, adults may under-report their ADHD symptoms 
in comparison to informant observations (Cheung et al. 2015; Moffitt et al. 2015). 
Third, the childhood age of onset, the level of impairment resulting from the 
symptoms of hyperactivity and inattention, and the degree of pervasiveness across 
situations such as home and work are key criteria for the diagnosis of ADHD, and 
the ASRS does not include an overall assessment of these requirements. 
It is important to note that for the purposes of this chapter, scoring four or more 
on the ASRS is counted as a ‘positive screen for ADHD’. Occasionally a rate is also 
presented for those who endorsed all six items on the ASRS. Screening positive 
for ADHD (with a score of 4 or more) indicates that an individual has sufficient 
symptoms to warrant a further and more detailed ADHD assessment. The actual 
ADHD rate is likely to be lower than the rate screening positive for ADHD. 
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8.3 Results 
Screening positive for ADHD in 2007 and 2014, by age and sex 
One in ten (9.7%) adults scored four or more (the threshold at which clinical 
assessment for ADHD may be warranted) on the ASRS. If all adults in the household 
population had been screened it is likely (95% confidence) that the proportion who 
screened positive would be between 8.9% and 10.6%. The proportion endorsing 
all six characteristics on the ASRS screen was much lower (0.7%). 
Overall, men and women were equally likely to screen positive (at either threshold); 
10.0% of men and 9.5% of women scored four or more on the ASRS, and 0.7% of 
men and 0.6% of women scored six. The lack of association with sex is consistent 
with findings from APMS 2007. However, some studies have found ADHD to be two 
to four times more prevalent in men than women (Faraone and Biederman 2005). 
The proportion of adults screening positive for ADHD broadly decreased with age. 
This pattern was observed in both women and men. The proportion with scores 
of four or more was highest in adults aged 16–24 (14.6%), and lowest in adults 
aged 75 and over (3.4%). Table 8.1
16–24 25–34 35–44 45–54 55–64 65–74 75+
Age
%
0
2
4
6
8
10
12
14
16
Men Women
Figure 8A: Screen positive for ADHD (score of 4 or more on the ASRS), 
by age and sex
Base: all adults
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The proportion of adults screening positive for ADHD was somewhat higher in 
2014 (9.7%) than in 2007 (8.2%). This upward trend was evident in both men 
(8.8% in 2007; 10.0% in 2014) and women (7.7% in 2007; 9.5% in 2014). 
Table 8.2
%
4
2
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8
6
10
12
2007 2014
Men Women All
Figure 8B: Screen positive for ADHD in 2007 and 2014, by sex
Base: all adults
Self diagnosis and professional diagnosis of ADHD
Table 8.3 presents ASRS scores in relation to whether or not people considered 
themselves to have had ADHD, and whether or not a professional had diagnosed 
them with ADHD. 
There was some concordance between the survey test for ADHD and people’s own 
perceptions. People who screened positive on the ASRS were also more likely to 
think that they had ADHD than those who did not screen positive. Even so, a small 
minority of those who screened positive for ADHD believed that they had ADHD 
(3.7% of those endorsing four or more ADHD characteristics, and 7.7% who 
endorsed all six). 
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Men were more likely than women to think that they had had ADHD. 5.4% of 
men reporting four or more ADHD characteristics thought that they had had the 
disorder, compared with 1.9% of women. 
People who screened positive on the ASRS were also more likely than 
those who did not to have had the disorder diagnosed by a professional. 
2.3% of people with four or more ADHD characteristics reported having had 
a diagnosis. Men screening positive for ADHD were more likely than screen-
positive women to have been diagnosed. Of those with a score of four or more, 
3.9% of men had been diagnosed with ADHD at some point, compared with 
0.7% of women. Table 8.3
Variation in screening positive for ADHD by other characteristics 
Ethnic group
No significant association was found between ethnic group and screening 
positive for ADHD. While this is consistent with findings from the 2007 survey, 
the small number of minority ethnic participants in the sample should be noted. 
Table 8.4
Household type
People screening positive for ADHD were more likely to live in some types of 
household than in others. In particular, people living in households with one adult 
aged under 60 had the highest prevalence of ADHD characteristics (17.7%), while 
the prevalence was lowest (4.4%) in those living in households consisting of two 
older adults (aged 60 or over). It should be noted that analysis by household type 
could not be age-standardised, and it is likely that the association is partly explained 
by the younger age profile of people screening positive. Table 8.5
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Figure 8C: Screen positive for ADHD, by household type
Base: all adults
Region
The prevalence of ADHD characteristics did not vary with region. Table 8.6
Educational qualifications 
Screening positive for ADHD varied somewhat by highest educational qualification 
achieved, although this was less pronounced than the association with 
employment status. People without qualifications were the most likely to score 
four or more on the ASRS (14.5%). This compares with 11.0% of people whose 
highest qualifications were GCSE (or equivalent), and 7.7% of those with a degree. 
A similar pattern was also observed in the 2007 survey data. Table 8.7
Employment status 
Employment status was strongly associated with screening positive for ADHD. 
Unemployed people (14.6% of unemployed men and 14.5% of unemployed 
women) were about twice as likely as those in employment (7.3% of men and 6.7% 
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of women) to screen positive for ADHD. The employment status associated with 
the highest rates however, particularly among men, was the ‘economically inactive’ 
group. This heterogeneous category included students, people looking after the 
home, those who were long-term sick or disabled, and those taking early retirement 
(the analysis was run on adults aged 16–64). One in four economically inactive men 
(23.8%) and one in seven economically inactive women (15.0%) screened positive 
for ADHD. (See the Glossary for a definition of economic inactivity). Table 8.8
%
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Figure 8D: Screen positive for ADHD, by employment status and sex 
(age-standardised)
Base: all adults aged 16–64
Benefit status 
Benefit status was looked at in relation to three groupings: being in receipt of any 
out-of-work benefit (including Jobseeker’s Allowance and Employment and Support 
Allowance (ESA)), receiving an out-of-work benefit specifically related to disability 
(specifically ESA), and living in a household that received housing benefit support 
with rent. Analysis by out-of-work benefits were based on those aged 16 to 64 
years. These categories are further described in the Glossary.
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Screening positive for ADHD was higher in each of these groups than in people 
not in receipt of the benefits. The strength of association was greatest among 
those receiving ESA. One in three people in this group (35.1% of men and 35.5% 
of women) screened positive for ADHD, compared with one in eleven (9.0% 
of men and 8.6% of women) not receiving an out-of-work disability benefit. 
Table 8.9
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Figure 8E: Screen positive for ADHD, by receipt of Employment and 
Support Allowance and sex
Base: all adults aged 16–64
Treatment and service use
Participants were asked about a range of types of treatment and services. 
These included current use of psychotropic medication or psychological therapy 
for a mental or emotional problem, together with the use of a range of health, 
community and day care services over the last year. Two of the most commonly 
prescribed ADHD medications were asked about: methylphenidate (e.g. Ritalin, 
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Concerta, Equasym) and atomoxetine (Strattera). The treatment and service use 
variables are described in more detail, including variation in their reference periods, 
in the Glossary.
One in three adults (32.2%) screening positive for ADHD was currently in 
receipt of medication, counselling or therapy for a mental or emotional problem. 
This compares with 9.9% of those with ASRS scores of less than four. Adults 
screening positive for ADHD were five times more likely than those below the 
threshold to be having counselling or other psychological therapy (10.1%, 
compared with 2.2%), and three times more likely to be on medication 
(29.0% of those with a score of four or more were taking psychotropic 
medication, compared with 8.5% of those scoring less). 
More than one in three adults who screened positive (37.4%) reported using health 
care services for a mental or emotional reason, compared with one in ten of those 
below the threshold (10.0%). There was a similar pattern in the use of community 
care and day care services. Table 8.10
Among those screening positive, the types of psychotropic medication most likely 
to be taken were drugs for treating anxiety (23.8%) and depression (22.9%). Only 
0.5% of adults who screened positive for ADHD were currently taking medication 
specifically indicated for ADHD (methylphenidate or atomoxetine). However, it is 
possible that some participants may have been taking an ADHD preparation not 
asked about, may have taken an ADHD medication preparation in the past, or could 
be currently taking methylphenidate or atomoxetine and not reported it (either 
because they chose to withhold this information or because they were unaware). 
Adults who scored four or more on the ASRS were more likely to have used every 
type of service asked about than those who screened negative. Table 8.11
7.8% of people screening positive for ADHD reported that they had requested 
a particular mental health treatment in the past 12 months (not necessarily for 
ADHD), but had not received the requested treatment. In comparison, 1.0% of 
people without a positive ADHD screen had requested, but not got, a particular 
mental health treatment. Table 8.12
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8.4 Discussion
There is a lack of survey data describing the presence of possible ADHD in the 
general adult population in England. The circumstances of adults with ADHD are 
also poorly understood. This chapter presents data on the prevalence of possible 
ADHD as measured by the six-item ASRS screen previously used in the 2007 survey. 
In 2014, 9.7% of the population were identified as having sufficient ADHD 
characteristics in the last six months to warrant clinical assessment for ADHD. This 
was slightly higher than the rate found (8.2%) when the survey was last carried 
out, in 2007. Comparable data have been collected in the US using the same 
screening tool, with similar population patterns found. Studies that include a fuller 
assessment of ADHD tend to find a lower prevalence of ADHD (Fayyad et al. 2007; 
Faraone and Biederman 2005; Kessler et al. 2006), as these studies often factor in 
reporting of childhood ADHD and adult persistence (Kessler et al. 2006). ADHD-
like symptoms in some participants screening positive on the ASRS may have first 
occurred in adulthood, and perhaps are related to a different adult-onset condition 
(Faraone and Biederman 2016). They may also reflect adult onset forms of ADHD, 
perhaps secondary to acquired factors. While these have been identified in recent 
studies, they have not yet been validated (Moffit et al. 2015). The ASRS does not 
take account of whether symptoms persist across different aspects of a person’s life, 
nor how impairing symptoms are. Despite these limitations, the APMS findings are 
valuable in identifying the population distribution of characteristics associated with 
possible ADHD that warrant recognition and assessment. 
Previous research has identified variations in rates of ADHD by particular socio-
demographic factors. Only some of these factors were consistent with the APMS 
2014 data (Faraone and Biederman 2005). For example, although no significant 
variation by sex and ethnic origin was observed, positive screens for the disorder 
were found to be concentrated in younger age groups, among the unemployed and 
in those in receipt of benefits. The APMS 2007 survey also highlighted associations 
with educational attainment and marital status.
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The great majority of people screening positive for ADHD did not access 
treatment for ADHD. However, they were more likely than those screening 
negative to seek – and not get – treatment and services for mental or emotional 
reasons. They were also more likely than those screening negative to get other 
types of mental health treatment. This may reflect the fact that adults screening 
positive for ADHD often have comorbid diagnoses of other psychiatric conditions 
(such as depression, anxiety and personality disorders). Alternatively, their ADHD 
characteristics may be misdiagnosed by doctors not trained to recognise and 
treat adult ADHD. This interpretation is supported by the very low levels of ADHD 
medication currently being taken by participants screening positive for ADHD, 
together with their high levels of anxiolytic and antidepressant use. It is worth 
noting, however, that the APMS cannot be used to estimate how many adults 
would be likely to benefit from treatment.
Progress is being made with the development of best practice advice and 
guidelines on care for adults with ADHD, which identifies key priorities for 
treatment and management of the disorder (Nutt et al 2007). These APMS findings 
have clearly identified the need for further work in improving the diagnosis and 
treatment of adult ADHD, both at the population level where precise screening 
tools need to be developed in relation to clinical assessments of the general 
population, and in clinical practice. Further analyses of the APMS 2014 data 
are underway in this area.
8.5 Tables
Prevalence and trends
Table 8.1  Number of ADHD characteristics present in the past six months, 
by age and sex
Table 8.2  Screen positive for ADHD in past six months in 2007 and 2014, 
by age and sex
Table 8.3  Screen positive for ADHD in past six months, by self-diagnosis and 
professional diagnosis of ADHD
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Characteristics
Table 8.4  Screen positive for ADHD in the past six months (observed and age-
standardised), by ethnic group and sex
Table 8.5  Screen positive for ADHD in the past six months, by household type 
and sex 
Table 8.6  Screen positive for ADHD in the past six months (observed and age-
standardised), by region and sex 
Table 8.7  Screen positive for ADHD in the past six months (age-standardised), 
by highest educational qualification and sex
Table 8.8  Screen positive for ADHD in the past six months (age-standardised), 
by employment status and sex 
Table 8.9  Screen positive for ADHD in the past six months (age-standardised), 
by benefit status and sex 
Treatment and service use
Table 8.10 Treatment and service use, by ASRS score 
Table 8.11 Psychotropic medication currently taken, by ASRS score
Table 8.12  Requested but not received a particular mental health treatment 
in the past 12 months, by ASRS score
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Summary 
• Bipolar disorder, previously known as manic depression, is a common, lifelong, 
mental health condition characterised by recurring episodes of depression and 
mania. It is associated with significant impairment.
• Before APMS 2014, bipolar disorder had not been assessed in the UK general 
population. The World Mental Health Survey initiative incorporated screening 
for bipolar disorder, identifying a rate of 2.4% across 11 other countries.
• The 15-item Mood Disorder Questionnaire was added to the 2014 survey. 
A positive screen required endorsement of at least 7 lifetime manic/hypomanic 
symptoms, as well as several co-occurring symptoms, together with moderate 
or serious functional impairment. A positive screen indicated the likely presence 
of bipolar disorder and that fuller assessment would be warranted.
• Overall, 2.0% of the population screened positive for bipolar disorder. 
Rates were similar in men and women.
• Positive screening for bipolar disorder was more common in younger age-groups. 
3.4% of 16–24 year olds screened positive compared with 0.4% of those aged 
65–74. None of the participants aged 75 and over screened positive for bipolar 
disorder. It did not vary by region or ethnic group.
• Rates of positive screening for bipolar disorder were higher in non-employed 
people, in those receiving particular benefits, and in people living alone.
• Most people screening positive for bipolar disorder were not in receipt of 
psychotropic medication or psychological therapy at the time of the interview. 
Furthermore, one in eight had unsuccessfully requested a particular mental 
health treatment in the past 12 months.
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9.1 Introduction
Bipolar disorder, previously known as manic depression, is a common, lifelong, 
mental health condition. It is characterised by recurring episodes of depression 
(feelings of low mood and lethargy) and of mania (feelings of elation and 
overactivity) or hypomania (a milder form of mania) (RCPsych 2016). While at 
one level it is considered to lie on a spectrum, several subtypes can be identified, 
diagnoses of which are based on the frequency and pattern of episodes of (hypo)
mania and depression. Worldwide prevalence rates of bipolar disorder are estimated 
to be between 1.0% and 5.0% (Bebbington and Ramana 1995). These figures 
vary depending on the part of the bipolar spectrum researchers assess and the 
instruments used. The World Mental Health Surveys identified a rate of 2.4% across 
11 countries (Akiskal et al. 2000; Merikangas et al. 2011), and in the National 
Comorbidity Survey Replication, a US nationally representative study, prevalence 
rates for bipolar spectrum disorders were found to be 4.4% (Merikangas et al. 
2007). Prevalence rates have been found to be comparable in men and women, 
with an inverse relationship with age (Merikangas et al. 2011; Pini et al. 2005). 
At present, there is a lack of epidemiological data on the prevalence of bipolar 
disorder in the UK (Gupta and Guest 2002). One of the reasons that bipolar 
disorder has not been measured previously on APMS is that it requires information 
about lifetime symptoms, while APMS tends to focus on more recent time frames. 
This chapter, newly introduced in APMS 2014, therefore provides crucial data 
on the prevalence and socio-demographic profile of bipolar disorders in England. 
The World Health Organisation (WHO) identified bipolar disorder as the 6th 
leading cause of disability in the world (Murray and Lopez 1996). It leads to 
significant psychosocial impairment, such as fewer employment prospects and 
lower annual income (Coryell et al. 1993; Judd et al. 2005; Marwaha et al. 2013), 
as well as placing a great burden on health care services (Pini et al. 2005). The 
annual economic costs for bipolar disorder in England were estimated, in 2007, 
to be £5.2 billion, two thirds of which was attributable to loss of employment. 
This estimation is projected to rise to £8.21 billion by 2026 (McCrone et al. 2008). 
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Bipolar disorder is comorbid with a number of other disorders such as 
substance misuse, anxiety disorders, personality disorders and attention-deficit/
hyperactivity disorder (ADHD) (NICE 2014b). Furthermore, the risk of suicide among 
those with bipolar disorder is approximately 20–30 times greater than that in the 
general population (Pompili et al. 2013). It has a peak age of onset between 15–19 
years, though it is recognised that there is often considerable delay between onset 
and treatment, with those seeking help not receiving a correct diagnosis for around 
six years from the onset of symptoms and very often longer (NICE 2015). Diagnosis 
of bipolar disorder is challenging, in that it cannot be confidently differentiated 
from unipolar depression until an episode of hypomania is identified. Further, the 
prevalence of depressive symptoms in people with bipolar is greater than that of 
elated mood (Philips and Kupfer 2013).
Treatment options, as based on the guidelines of the National Institute for 
Health and Care Excellence (NICE), vary depending on whether the individual is 
experiencing a depressive or manic (hypomanic) episode. For manic or hypomanic 
episodes, treatment will usually involve some form of mood stabilising medication, 
which can take the form of anti-psychotic drugs. For depressive episodes NICE 
currently recommends psychological therapies such as cognitive behavioural therapy 
(CBT), and/or medication. Long term treatment with mood stabilising medication 
such as lithium is also recommended as maintenance treatment to reduce the risk 
of relapse (NICE 2014a). NICE estimates that 25% of adults with bipolar disorder 
never seek help or treatment (2014b).
9.2 Definition and assessment
Bipolar disorder
There are a number of subtypes of bipolar disorder recognised in the new edition 
of the US-based Diagnostic and Statistical Manual of Mental Disorders (DSM-5) with 
the major groupings being: bipolar I; bipolar II and cyclothymia (APA 2013). In the 
WHO’s International Classification of Diseases version 10 (ICD-10), no distinction is 
made between type I and II.
 224 | APMS 2014  | Chapter 9: Bipolar disorder | Copyright © 2016, Health and Social Care Information Centre
Bipolar I disorder is characterised by at least one lifetime episode of mania; 
a period of elevated mood and increased levels of energy including such 
symptoms as increased talkativeness, inflated self-esteem, feelings of grandiosity, 
and a decreased need for sleep, that lasts at least one week and causes significant 
impairment in social or occupational functioning. Whilst in DSM-5 a manic 
episode is sufficient to make the diagnosis of bipolar I, in ICD-10 the experience 
of a depressive episode is required for the bipolar disorder diagnosis to be made. 
The vast majority of people experiencing a manic episode will however go on 
to develop a depressive episode in their lifetime (Phillips and Kupfer 2013). 
Diagnosis for bipolar II disorder requires at least one episode of hypomania, similar 
to a manic episode though not severe enough to cause impairment in social or 
occupational functioning, and at least one episode of major depression. 
For a diagnosis of cyclothymia, the individual must experience hypomanic and 
depressive symptoms that fall short of the criteria for a manic, hypomanic or major 
depressive episode. DSM-5 also identifies ‘other specified bipolar and related 
disorders’ (previously referred to as ‘bipolar not otherwise specified (NOS)’ by DSM-IV) 
for instances in which there is significant distress or impairment but not meeting the 
full diagnostic criteria for previously defined bipolar disorder subtypes (APA 2000). 
Mood Disorder Questionnaire (MDQ)
Bipolar disorder was assessed in the APMS 2014 self-completion using the 
Mood Disorder Questionnaire (MDQ), a self-report 15-item scale based on DSM-IV 
criteria (the diagnostic classification system current at the time the survey was in 
development). It was designed to screen for bipolar spectrum disorders, i.e. bipolar I, 
bipolar II, cyclothymia and bipolar NOS. This assesses lifetime experience of manic 
or hypomanic symptoms by way of 13 yes/no items. It also establishes whether 
several of the symptoms have been experienced at the same time, and whether 
they have caused moderate to serious problems (Hirschfield et al. 2000).
A positive screen for bipolar disorder requires endorsement of at least 7 lifetime 
manic/hypomanic symptoms, as well as several co-occurring symptoms, and 
moderate or serious associated functional impairment. 
The MDQ has been used in a number of large scale epidemiological studies in 
the US. It was developed and validated using a psychiatric outpatient population, 
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and was found to correctly identify seven out of 10 people with bipolar disorder, 
and successfully screen out nine out of 10 people that did not have bipolar disorder 
(APA 2013). A general population study showed similarly specificity rates, though 
limitations were noted since the sensitivity (the ability to identify those with 
bipolar disorder successfully) was low (0.28) (Hirschfield et al. 2003). 
All participants in APMS 2014 were asked the first 13 items on the MDQ. Those 
who answered ‘yes’ to at least seven of these items were asked whether they had 
experienced several symptoms at the same time, and if so, how much of a problem 
this caused in terms of being unable to work; having family, money or legal 
troubles; or getting into arguments or fights.
Mood Disorder Questionnaire
Has there ever been a period of time when you were not your usual self and…  Yes/No
… you felt so good or so hyper that other people thought you were not your 
normal self or you were so hyper that you got into trouble?
… you were so irritable that you shouted at people or started fights or arguments? 
… you felt much more self-confident than usual? 
… you got much less sleep than usual and found you didn’t really miss it?
… you were much more talkative or spoke much faster than usual?
… thoughts raced through your head or you couldn’t slow your mind down? 
… you were so easily distracted by things around you that you had trouble 
concentrating or staying on track?
… you had much more energy than usual? 
… you were much more interested in sex than usual? 
… you were much more active or did many more things than usual? 
… you were much more social or outgoing than usual, for example, you 
telephoned friends in the middle of the night?
… you did things that were unusual for you or that other people might have 
thought were excessive, foolish, or risky?
… spending money got you or your family into trouble?
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Note that the term ‘screening’ is used here to refer to identifying people with 
a high likelihood of having a disorder. A definitive diagnosis of bipolar disorder 
would require a comprehensive clinical assessment which was not carried out in 
this survey. The MDQ is not used as part of any National Screening Programme 
in England. 
9.3 Results 
Screening positive for bipolar disorder, by age and sex 
Overall, 2.0% of participants screened positive for bipolar disorder, with the rate in 
the wider population likely to be (with 95% confidence) between 1.6% and 2.4%. 
There was no significant difference in the rates for men and women (2.1% for men 
and 1.8% for women). However, the proportion screening positive for bipolar 
disorder did vary by age, being more common in younger age-groups: 3.4% of 
16–24 year-olds screened positive compared with 0.4% of those aged 65–74. None 
of the participants aged 75 and over screened positive for bipolar disorder. Table 9.1
Figure 9A: Positive bipolar disorder screen, by age and sex  
Base: all adults
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Variation in screening positive for bipolar disorder by other characteristics 
Ethnic group
Screening positive for bipolar disorder did not vary by ethnic group. This was the 
case whether or not the analysis was age-standardised. Table 9.2
Household type
Bipolar disorder screen positive rates varied with the type of household people 
lived in. Among people aged less than 60, 5.5% living in a household as a lone 
occupant screened positive for bipolar disorder, compared with 1.9% who lived 
with one other person. Rates for other types of household ranged between 
0.4% and 2.6%. Table 9.3
Figure 9B: Positive bipolar disorder screen, by household type and sex
Base: all adults
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Region
The proportion screening positive for bipolar disorder did not differ by region. 
Table 9.4
Employment status 
The likelihood of screening positive for bipolar disorder varied with employment 
status. 16 to 64 year olds who were either unemployed or economically inactive 
were more likely to screen positive (3.9% and 4.3% respectively, age-standardised), 
while their counterparts in employment (1.9%) were less likely to. In men, the 
highest rates were observed in the economically inactive and in women the highest 
rates were observed in the unemployed, although this variation was not significant. 
Table 9.5
Figure 9C: Positive bipolar disorder screen, by employment status and sex
Base: all adults aged 16–64
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Benefit status 
Benefit status was looked at in relation to three groupings: being in receipt of any 
out-of-work benefit (including Jobseeker’s Allowance and Employment and Support 
Allowance (ESA)), receiving an out-of-work benefit specifically related to disability 
(ESA), and living in a household that received housing benefit support with rent. 
These categories are further described in the Glossary.
Screening positive for bipolar disorder was significantly more likely in people who 
received any form of benefit than in those who did not. The strongest association 
was observed for those who received an out-of-work benefit related to disability 
(ESA); 12.4% screened positive compared with 2.0% who did not receive the 
benefit. Moreover, among those receiving this type of benefit, women were almost 
four times more likely to screen positive for bipolar disorder (21.4%) than men 
(5.7%). Table 9.6
Figure 9D: Positive bipolar disorder screen, by receipt of Employment 
and Support Allowance and sex
Base: all adults aged 16–64
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Self-diagnosis and professional diagnosis of bipolar disorder
Participants were asked whether they themselves thought they had ever 
experienced bipolar disorder. If they did, they were asked whether this had been 
diagnosed by a professional, and if they thought that the disorder had been present 
in the last 12 months. 
80 people in the APMS survey sample (1.0%) reported thinking they had had 
‘bipolar disorder or manic depression’ at some point. Most of these participants 
(62) had this diagnosis confirmed by a professional, and for more than half 
(48 participants) the condition was felt to be present in the last 12 months. 
Of people who had had bipolar disorder diagnosed by a professional and for whom 
this had been present in the past 12 months, 38.3% screened positive on the MDQ. 
No differences were found between men and women. Table 9.7
Treatment and service use
Participants were asked about a range of types of mental health treatment and 
service use. These included current medication or psychological therapy for a mental 
or emotional problem, together with the use of a range of health, community and 
day care services over the last year. 
Of those who screened positive for bipolar disorder, 6 out of 10 were not in receipt 
of any current medication or treatment (59.9%). Those who screened positive were, 
nonetheless, considerably more likely to report receiving some form of psychotropic 
medication (37.8%) or psychological therapy (16.4%) than those who screened 
negative (9.6% and 2.6% respectively). 
Those who screened positive were also more likely to report using the other 
types of service asked about. For example, half of those screening positive for 
bipolar disorder reported having used a health care service in the past year (50.0%), 
compared with a tenth of those who screened negative (11.8%). Table 9.8
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Regarding the type of medication received by people screening positive for bipolar 
disorder, the most common medications were those used to treat anxiety (30.0%) 
or depression (29.6%), followed by 14.5% who took medication specifically for 
bipolar disorder. For all types of psychotropic medication, with the exception of 
medication used to treat ADHD, those screening positive were more likely to be 
taking it than those screening negative. Table 9.9
Participants were asked if they had requested a particular treatment in the past 
12 months but had not received it. One in eight people who screened positive 
for bipolar disorder reported requesting but not receiving some form of mental 
health treatment (12.7%), this compared with 1.4% of bipolar screen negatives. 
Table 9.10
Figure 9E: Current treatment for a mental or emotional problem, 
by bipolar disorder screen
Base: all adults
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9.4 Discussion
This chapter presents findings on bipolar disorder, a newly-introduced module 
within APMS 2014, to provide much-needed information on prevalence and 
sociodemographic profile of people with bipolar disorder in England. The overall 
prevalence of likely bipolar disorder in the APMS 2014 was 2.0%, closely consistent 
with findings from epidemiological studies in other countries (Merikangas et al. 
2011; Merikangas et al. 2007). Rates were similar for men and women and higher 
in younger than older people. 
Prior to these findings, no lifetime prevalence rates from a UK general 
population survey were available for bipolar disorder (Pini et al. 2005). Based on 
studies conducted in other countries, however, prevalence rates worldwide have 
been conservatively estimated at between 1–1.5% (Bebbington and Ramana 
1995), and as high as 5% (Akiskal et al. 2000) in relation to the full spectrum of 
bipolar disorder. The World Mental Health Survey Initiative reported that the lifetime 
aggregate prevalence from 11 countries (not UK) was 2.4% for bipolar disorders 
(BP-I, BP-II, and subthreshold BP) (Merikangas et al. 2011). The APMS 2014 data 
are consistent with this range. 
It is important to note however, that the instrument used for screening for 
bipolar disorder while designed to screen for the full bipolar spectrum disorders 
does have limitations. The MDQ is less sensitive at identifying bipolar II disorders 
than the longer Hypomania Checklist, another widely used instrument (Meyer et 
al. 2011). There are also limitations on its use in general population studies (APA 
2000). Whilst showing excellent specificity (suggesting a positive result is useful for 
ruling in bipolar disorder) the instrument has been shown to have limited sensitivity 
(the proportion of people with a condition who have a positive result); thus these 
survey prevalence rates may be underestimates.1 Overall the MDQ, albeit limited by 
these considerations, appears to have performed reasonably well in the APMS 2014. 
Bipolar disorder is known to cause considerable disability, together with 
impairments in work and social life (Sanchez-Moreno et al. 2009), and this 
1 For discussion of specificity and sensitivity see: Centre for Evidence-based Medicine: www.cebm.net/sppin-and-snnout/
 233 | APMS 2014  | Chapter 9: Bipolar disorder | Copyright © 2016, Health and Social Care Information Centre
is reflected in the findings presented in this chapter. There was a revealing 
relationship with household type. People living alone were more likely to screen 
positive than those living with other people, consistent with evidence suggesting 
links between bipolar disorder, social isolation and difficulty with relationships. 
Individuals who were unemployed or economically inactive were also more likely to 
screen positive for bipolar disorder. This parallels the increased proportion of people 
screening positive for bipolar disorders among those receiving some form of out of 
work benefit, or housing benefit. Examination of the data by ethnicity and region 
showed no associations, although the sample size is small for such comparisons.
The age distribution replicated US data for bipolar disorder and indeed was similar 
to the distribution for several other mental disorders (Kessler et al. 2005). However, 
as bipolar disorder is a lifelong condition, we would have expected the prevalence 
to gradually increase with age. The survey findings may represent a problem of 
recall. The increased mortality associated with the disorder may also be part of 
the explanation.
NICE estimate a possible delay of 6 years between the onset of symptoms and 
treatment, while around 25% of affected adults never seek treatment for bipolar 
disorder (NICE 2014b). The APMS data presented here shows that around a third 
of people screening positive for bipolar disorder believed that they have had the 
disorder, and of those, a third had been diagnosed by a professional. 
The majority of people screening positive for bipolar disorder were not currently 
receiving any form of treatment, either psychological therapy or psychotropic 
(mental health) medication. Furthermore, one in eight who screened positive for 
bipolar disorder had asked for, but not received, some particular form of mental 
health treatment in the last 12 months. 
Almost 40% of adults screening positive for bipolar disorder were currently 
taking some form of psychotropic medication, with 14% prescribed this in 
combination with some form of psychological therapy. Only a small percentage 
was receiving psychological therapy only. Recommendations for treatment vary, 
depending on whether the individual is experiencing a manic (hypomanic) episode 
or a depressive episode. Manic episodes are usually treated pharmacologically 
with antipsychotics, whereas depressive episodes are treated either psychologically 
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or with medication (NICE 2015b). Almost a third of people screening positive for 
bipolar disorder reported taking medications indicated for anxiety, consistent with 
the high prevalence of comorbid anxiety disorder in bipolar disorder reported in 
previous studies. The second most prevalent medication was that primarily indicated 
for depression, and again this is consistent with the prevalence of depressive 
symptoms being higher in people with bipolar disorder than manic or hypomanic 
symptoms (Pompili et al. 2013). 
Some of the comparisons reported in this chapter are based on small numbers and 
must be interpreted with caution. In addition, due to the cross-sectional nature of 
these data, the direction of cause and effect is unclear. 
The findings discussed in this chapter were consistent with prevalence studies 
internationally, despite the limitations of the survey assessment method. They 
offer much needed information on the characteristics, difficulties and health 
service contact of people with bipolar disorder living in the community. Future 
study is warranted to establish the prevalence of bipolar subtypes, why people 
do not seek or obtain help, and how health services might adapt to better 
meet the needs of the whole population of people with bipolar disorder. 
9.5 Tables
Prevalence and trends 
Table 9.1  Number of bipolar disorder characteristics reported (lifetime), 
by age and sex 
Characteristics  
Table 9.2  Screen positive for bipolar disorder (observed and age-standardised), 
by ethnic group and sex 
Table 9.3  Screen positive for bipolar disorder, by household type and sex 
Table 9.4  Screen positive for bipolar disorder (observed and age-standardised), 
by region and sex 
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Table 9.5  Screen positive for bipolar disorder (age-standardised), 
by employment status and sex 
Table 9.6  Screen positive for bipolar disorder (age-standardised), 
by benefit status and sex
Treatment and service use 
Table 9.7  Screen positive for bipolar disorder, self-diagnosis and professional 
diagnosis of bipolar disorder
Table 9.8  Treatment and service use, by bipolar disorder screen 
Table 9.9  Psychotropic medication taken, by bipolar disorder screen
Table 9.10  Requested but not received a particular mental health treatment 
in the past 12 months, by bipolar disorder screen
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Summary
• According to the Alcohol Use Disorders Identification Test (AUDIT), 16.6% of 
adults drank at hazardous levels (AUDIT scores of 8 to 15), 1.9% were harmful 
or mildly dependent drinkers (AUDIT scores of 16 to 19) and 1.2% were probably 
dependent drinkers (AUDIT scores of 20 or more). As in previous years, men were 
more likely than women to drink at hazardous levels and above. Most adults 
drank at lower risk levels (57.5%) or did not drink at all (22.8%).
• Of men aged 16 to 64, between a quarter and a third drank at hazardous 
levels or above. Such drinking was less common in men aged 65 and older. In 
women, drinking at hazardous levels or above was most common in 16 to 24 
year olds (25.6%). In the 25 to 64 year age-groups, between 13% and 15% 
drank at these levels, while rates in older women were lower.
• Harmful, mildly dependent, and probably dependent drinking was most common 
in men aged 25 to 34 (6.6%). The proportions drinking at this level were lower 
in older age-groups. In women, drinking at this level was most frequent in those 
aged 16 to 24.
• Levels of hazardous drinking have declined in men over the past fifteen years 
(36.8% in 2000 among 16 to 74 year olds; 32.4% in 2007; 27.9% in 2014), 
and remained stable in women.
• Overall, levels of harmful and dependent drinking have remained stable. However, 
this masks trends divergent between age groups. AUDIT scores of 16 or above 
have become less common in 16 to 24 year olds (6.2% in 2007, 4.2% in 2014), 
but more common in 55 to 64 year olds (1.4% in 2007, 2.8% in 2014).
• Self-diagnosis and diagnosis by professionals of alcohol or drug dependence 
was most frequent among people whose AUDIT scores indicated probable 
dependence: but even then such diagnoses were reported only by a minority. 
Of those with probable dependence, 42.2% reported that they had at some 
time experienced alcohol or drug dependence, and 34.2% reported that they 
had received such a diagnosis from a professional.
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• White British men and women were more likely to drink at hazardous, harmful 
or dependent levels than their counterparts in other ethnic groups.
• Adults aged less than 60 and living in households with no children were more 
likely to be drink at hazardous levels or above than those who lived with children. 
In particular, men aged under 60 living alone were almost twice as likely to drink 
at harmful or mildly dependent levels or above than men in any other type of 
household. In contrast, adults aged over 60 living alone or with another adult 
were the least likely to drink at hazardous levels or above.
• Men and women in receipt of Employment and Support Allowance (ESA) were 
more likely than those who did not receive this benefit to be harmful or mildly 
dependent drinkers or above. 10.8% of men and 9.4% of women on ESA drank 
at these levels, compared with 4.9% of men and 2.1% of women who did not 
receive ESA. There was a similar pattern for other benefits.
• A quarter of adults with probable alcohol dependence (AUDIT 20+) were 
receiving treatment and services for a mental or emotional problem. They 
were also more likely than others to use health and community care services. 
Furthermore, 6.1% of this group were in receipt of medication intended to 
treat substance misuse and 6.3% were in substance misuse counselling. 
10.1 Introduction
The impact of alcohol consumption
In England, alcoholic drinks are widely available and widely consumed by the 
majority of the adult population. Most people who drink do so without adverse 
consequences. However, alcohol is responsible for a considerable degree of health 
and social harm.
Alcohol-related harms exist on a continuum, and include acute and chronic 
health and social consequences, as well as harm to people other than the drinker. 
According to the World Health Organisation (WHO), alcohol is wholly or partly 
responsible for over 200 different disease conditions. Alcohol is identified as 
a Grade 1 carcinogen (the most carcinogenic type) and is responsible for 4% 
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of all cancers worldwide (WHO 1988; Rehm et al. 2009). Excessive alcohol 
consumption is a leading cause of disability in the UK and Europe (WHO 2010).
Acute harms from alcohol include accidents, injuries, collapse, self-harm and in severe 
cases, acute alcohol poisoning. Alcohol misuse does not only harm those who drink. 
It is implicated in 53% of violent incidents in England and Wales (ONS 2015a). Results 
from the Crime Survey for England and Wales 2015 indicated that one in ten adults 
had witnessed drinking-related antisocial behaviour in their local area (ONS 2015b). 
In 2013, 4% of all road traffic accidents and 14% of all deaths reported in road traffic 
accidents involved at least one driver over the drink-driving limit (Department of 
Transport 2015). Alcohol misuse is associated with violence and marital breakdown, 
and children of problem drinkers are more likely to suffer emotional and behavioural 
problems, and to perform poorly at school (Cuijpers et al. 2006).
There is evidence that heavy drinkers have poorer levels of mental health. 
Alcohol misuse often co-exists with common mental disorders, such as depression 
and anxiety, as well as with misuse of other substances (Grant et al. 2004; Weich 
et al. 2011; McManus 2009). High levels of hazardous and dependent drinking 
have been recorded in people being treated for serious mental health problems. 
Alcohol dependence and other problems associated with alcohol misuse are also 
frequent in homeless people and prisoners, again often in combination with 
poor mental health (Drummond et al. 2008; Light et al. 2013).
Alcohol-related hospital admissions continue to increase in England and 
exceed one million per annum (HSCIC 2015). Between 2003/04 and 2013/14 
hospital admissions due wholly or partly to alcohol consumption more than 
doubled (HSCIC 2015). In 2013/14 the commonest wholly attributable cause of 
alcohol admissions was mental and behavioural disorders due to use of alcohol, 
including alcohol dependence and related conditions (204,450), followed 
by alcoholic liver disease (53,310), and toxic effects of alcohol (35,620). The 
most common partly alcohol-attributable causes of hospital admission were 
cardiovascular disease (511,260) followed by cancer (86,650), unintentional 
injuries (50,720) and intentional injuries including self-harm and assault (9,350). 
These are likely to be an underestimate of the true burden of alcohol on NHS 
hospital services due to the well-recognised under-diagnosis of alcohol use 
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disorders in hospital settings. Wholly attributable alcohol deaths have also 
increased by 23% from 2001 (5,479 deaths) to 2013 (6,592 deaths) (HSCIC 2015).
In 2012, it was estimated that the cost of alcohol misuse in England was around 
£21 billion a year; as well as costs to the health service, this included the costs of 
crime and anti-social behaviour and the impact on productivity in the workplace 
(Home Office 2012).
Policy and guidance
In recent years the government has made alcohol misuse a strategic priority. 
The 2012 Government’s Alcohol Strategy identified ways to reduce the harm 
caused by alcohol: by increasing the price of alcohol, banning multi-buy promotions, 
improving the early identification and treatment of those with alcohol problems, 
and addressing alcohol-related crime and disorder.
The implementation of the ambitions set out in the Government’s strategy has 
included some of the key proposed strategies, such as setting a minimum unit price 
for alcohol and banning multi-buy promotions, not being carried forward. In 2007, 
a Public Service Agreement (PSA) target was set to ‘reduce the harm caused by 
alcohol and drugs’. One indicator of success was defined as reducing the number 
of alcohol-related hospital admissions, to be achieved in part by improving at every 
level the services available to those who wanted to drink less. The target to reduce 
alcohol related hospital admissions has been reiterated in the most recent Public 
Health Outcomes Framework (DH 2013).
In 2016, the UK Chief Medical Officer published new guidelines on alcohol, 
based on the recommendation of an expert review of the association between 
alcohol consumption and health harms (DH 2016). This review identified a lower 
than previously thought beneficial effect of alcohol and evidence of a stronger 
association with certain types of cancer and other health harms than was previously 
identified. Based on this evidence, the guidelines advised that for both men and 
women, it is safest not drink more than 14 UK units of alcohol per week (112g 
of pure ethanol), and within that to avoid alcohol binges by spreading drinking 
over 3 or more days per week. The revised advice in pregnancy is that the safest 
approach is to abstain.
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Patterns of consumption
In 2014, Health Survey for England data showed that 85% of men and 79% of 
women consumed some alcohol in the last year (Craig et al. 2015). The proportion 
of adults who do not drink at all has increased over the past decade from 11% of 
men and 16% of women in 2006 to 15% of men and 21% of women in 2014. In 
particular, the proportion of non-drinkers among young people aged 16 to 24 has 
increased from 17% of young men and 16% of young women in 2006 to 22% of 
young men and 23% of young women in 2014 (DH 2016; Craig and Mindel 2007).
Among adults who had drunk alcohol in the last year, the median weekly 
consumption was 9.2 units by men and 3.8 units by women. Overall, 63% of 
men reported average weekly consumption of no more than 21 units (until the 
publication of new guidelines, the recommended lower risk limit for men), and 
62% of women drank no more than 14 units a week. A further 17% of men 
and 12% of women drank at increasing risk levels (22 to 50 units a week for men, 
15 to 35 units for women). 5% of men and 4% of women drank more than these 
amounts (considered higher risk consumption according to NHS guidance at the 
time) in an average week.
In England in 2014, 59% of men and 43% of women reported drinking alcohol 
every week. 17% of men and 9% of women had drunk alcohol on five or more 
days in the last week. The proportion of men drinking alcohol in the last week 
increased with age, and was highest for those aged 55 to 64 years. A similar trend 
was evident among women – the proportion of women who drank in the last 
week increased up to the 45 to 54 age group, and declined thereafter.
The Adult Psychiatric Morbidity Survey (APMS) focuses on the prevalence of 
hazardous, harmful and dependent drinking, collectively classified by the tenth 
International Classification of Disorders (ICD-10) as alcohol use disorders (National 
Institute of Alcohol Abuse and Alcoholism 2013). It has been estimated that 
a minority of the population consumes the majority of all alcohol consumed in 
England: 70% of the alcohol is consumed by the 20% of the population whose 
drinking is classed as hazardous, harmful or extreme (Sheron and Gilmore 2016).
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10.2 Definition and assessment
‘Alcohol use disorders’ encompass a range of conditions defined in the ICD10. In 
this chapter we consider ‘harmful alcohol use’ (an established pattern of drinking 
causing damage to health) and ‘alcohol dependence’ as defined by ICD10 (including 
signs of addiction to alcohol). We also consider hazardous drinking (an established 
pattern of drinking increasing the risk of health harm). Initial questions about alcohol 
consumption were asked by the interviewer face to face. All participants who drank 
alcohol, even if just occasionally, were then routed to the remaining alcohol use 
questions. These were administered using computer-assisted self-completion interview 
(CASI), consistent with the approach used on the 2000 and 2007 surveys.
The primary measure presented in this chapter is the Alcohol Use Disorders 
Identification Test (AUDIT) (Saunders et al. 1993). The AUDIT takes the year 
before the interview as a reference period, consists of 10 items and covers 
the following areas:
• Alcohol consumption (frequency of drinking, typical quantity, frequency 
of heavy drinking)
• Alcohol-related harm (feeling of guilt or remorse after drinking, blackouts, 
alcohol-related injury, other concern about alcohol consumption)
• Symptoms of alcohol dependence (impaired control over drinking, increased 
salience of drinking, morning drinking).
Answers to all questions are scored from zero to four, and summed to give 
a total score ranging from 0 to 40. A score of:
• Non-drinker or low risk drinking (scores up to 7)
• Hazardous drinking (scores from 8 to 15)
• Harmful drinking and/or mild dependence (scores from 16 to 19)
• Probable dependence (scores 20 or more).
A rationale for using these AUDIT score thresholds is presented in Room et al. 
2005. Alcohol dependence was further assessed using the Severity of Alcohol 
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Dependence Questionnaire (SADQ) (Stockwell et al. 1979) to provide an 
alternative estimate of the prevalence of alcohol dependence. This measure was 
also used in the 2000 and 2007 surveys. The SADQ consists of 20 items, covering 
a range of dependence symptoms, with the six months before the interview as 
the reference period. Answers to all questions are scored from zero to three, and 
summed to give a total score ranging from zero to 60. The thresholds indicate 
different levels of alcohol dependence:
• None or mild dependence (scores up to 14)
• Moderate dependence (scores from 15 to 30)
• Severe dependence (scores from 31 to 60) (NICE 2011).
Because of the focus of the SADQ on symptoms of dependence, for example 
symptoms following a period of heavy drinking, it was asked only of participants 
with an AUDIT score of 10 and above. Note that an error in the AUDIT scoring 
syntax used in 2007 has been identified. The 2007 data has been revised so that it 
is correct and is consistent with the 2000 and 2014 analyses. Further details of how 
the AUDIT and SADQ questionnaires were scored are provided in Appendix B.
10.3 Results
Prevalence of hazardous, harmful or dependent drinking, by age and sex
In 2014, the majority (57.5%) of adults drank alcohol, but at low risk levels. 
22.8% of adults did not drink.
The remaining 19.7% – around one in five adults – drank at hazardous levels 
or above, as indicated by an AUDIT score of 8 or more. Most of these (16.6% 
of all adults) were hazardous drinkers, with an AUDIT score between 8 and 15. 
A further 1.9% of adults were harmful or mildly dependent drinkers (AUDIT score 
16 to 19), and 1.2% were probably dependent drinkers (AUDIT score 20 or more). 
This indicates that 3.1% of the population drank at a level considered to be 
harmful or probably dependent. If all adults in the population had been assessed, 
it is likely (95% confidence interval (CI)) that the proportion drinking at harmful 
or probably dependent levels would be between 2.6% and 3.6%.
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As in previous years, men were more likely than women to drink at hazardous 
levels or above. 26.3% of men and 13.4% of women had an AUDIT score of 
8 or more, including 4.4% of men (95% CI: 3.6% to 5.4%) and 1.8% (95% CI: 
1.4% to 2.4%) of women with an AUDIT score of 16 or more.
Among men, drinking at hazardous levels or above was most prevalent among 
those aged 16 to 64, varying between a quarter and a third across the age range 
with no clear pattern. Adults aged over 64 were less likely to drink at this level; 
18.1% of men aged 65 to 74 and 8.1% of those aged 75 and over.
Among women, 25.6% of those aged between 16 and 24 drank at hazardous 
levels or above. Between the ages of 25 and 64, this proportion was lower and 
fairly constant, around one in seven. As with men, older women were much less 
likely to drink at hazardous levels or above; 6.3% of 65 to 74 year olds and 2.3% 
of those aged 75 and over. Table 10.1
Figure 10A: Drinking at hazardous levels or above in the past year 
(AUDIT score of 8 or more), by age and sex
Base: all adults
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Almost one in ten men aged 25 to 34 (6.6%) had an AUDIT score of 16+, 
indicative  of harmful drinking, mild dependence or probable dependence. This 
proportion declined thereafter with age to 0.6% of those aged 75 and over. Among 
women, drinking at these levels was highest in the youngest age group (3.2%), was 
around 2% for women aged between 25 and 65, and declined to 0.7% of women 
aged 65 to 74. No female participants aged 75 or over were in this group.
AUDIT scores indicating probable dependence (20+) were evident in 1.9% of men 
and 0.6% of women. This was most prevalent among men aged between 35 and 
44 (3.1%) and women aged between 16 and 24 (1.1%). Table 10.1
Trends in hazardous and dependent drinking: 2000 to 2014
Comparisons of 2014 findings with previous survey years (2000 and 2007) are 
based on adults aged between 16 and 74, as the 2000 survey did not interview 
those aged 75 or more.
Figure 10B: Harmful drinking/mild or probable dependence 
(AUDIT score of 16 or more), by age and sex
Base: all adults
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The proportion of men who were hazardous drinkers or above (AUDIT scores of 
8 or more) was less in 2014 than in previous years: 27.9%, compared with 36.8% 
in 2000 and 34.4% in 2007. The proportion of women drinking at this level did 
not change over the same period.
Overall, the proportion of men and of women who were harmful or mildly 
dependent drinkers or probably dependent (AUDIT scores of 16 or more) did 
not change over time. However, there were indications of changes in the proportion 
drinking at this level within particular age groups. Young adults aged 16 to 24 
were less likely to have an AUDIT score of 16 or more than in previous years: 4.2% 
drank at this level in 2014, compared with 6.8% in 2000 and 6.2% in 2007. Men 
and women aged between 55 and 64 were more likely to have AUDIT scores of 16 
or more than in previous years: 2.8% in 2014, compared with 1.3% in 2000 and 
1.4% in 2007. These results are consistent with there being differences between 
generations over time. Other differences over time within age groups were not 
statistically significant. Table 10.2
Figure 10C: Hazardous, harmful and dependent drinking in the past year 
by sex: 2000, 2007 and 2014
Base: adults aged 16–74
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Self-diagnosis and professional diagnosis of alcohol or drug dependence
All participants were asked whether they had ever been alcohol or drug dependent, 
and whether they had been given this diagnosis by a doctor, psychiatrist or other 
professional. This analysis compares responses according to the level of risk indicated 
by AUDIT scores, based on reported behaviour over the last year. It should be noted 
that there were relatively small numbers of women with scores indicating mild or 
probable dependence on alcohol (AUDIT 16+).
Overall, 2.8% of adults said that they felt they had been alcohol or drug dependent 
at some point in their life. Men were more likely than women to report this, both 
overall (4.3%, compared with 1.5%) and within each level of drinking risk. Among 
men, the proportion increased from 2.6% of those with an AUDIT score of 7 or less, 
to 44.8% of those with an AUDIT score of 20+ (indicating probable dependence). 
Among women, the corresponding range was from 1.0% of those whose recent 
drinking was at low risk levels to 34.2% of those with probable dependence. 
Table 10.3
Figure 10D: Self-identified as having ever experienced alcohol or drug 
dependence, by AUDIT category and sex
Base: all adults 
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Those participants who said that they had been drug or alcohol dependent were 
asked whether they had ever been diagnosed with alcohol or drug dependence 
by a doctor, psychiatrist or other professional. Overall, 1.6% of adults reported this; 
again, this was more common in men than women. The proportion of men who 
had been diagnosed increased from 1.3% in the low risk group, to 4.3% of those 
whose drinking was classed as harmful or mildly dependent (AUDIT score of 16 
to 19) and 35.3% of those with a score of 20+, indicating probable dependence. 
In women, levels of reported diagnosis were increased from 0.7% of those with 
AUDIT scores of 0–7 to 6.7% of those with AUDIT scores of 16 to 19.The group 
with a score of 20+ had a much higher likelihood of diagnosis; 30.8% reported 
that  they had been diagnosed with alcohol or drug dependence at some time.
Very few participants, 0.6%, reported that they had been diagnosed with alcohol 
or drug dependence in the last year. This included 13.7% of men and 24.4% of 
women with an AUDIT score of 20+. Table 10.3
Figure 10E: Ever diagnosed by a professional with alcohol or drug 
dependence, by AUDIT category and sex
Base: all adults 
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The Severity of Alcohol Dependence Questionnaire (SADQ)
Surveys in the APMS series also measured alcohol dependence using the SADQ, 
described in Section 10.2 above. This was asked of participants scoring 10 or more 
on the AUDIT, and among this group the SADQ score showed strong concordance 
with the AUDIT score. Table 10.4
Characteristics of hazardous and dependent drinkers
Ethnic group
Comparisons between ethnic groups are based on age-standardised estimates 
to account for differences in the age profile of different groups.
White British adults were more likely to drink at hazardous levels or above 
than other groups. 30.8% of White British men had an AUDIT score of 8 or more, 
compared with 18.4% of non-British White men, 6.6% of Black men, 4.7% of 
Asian men, and 12.9% of men from other or mixed ethnic groups. Similarly, 14.8% 
of White British women had AUDIT scores of 8 or more, compared with 11.6% of 
other White women, 7.4% of Black women, 2.6% of Asian women, and 7.2% of 
women from other ethnic groups.
The pattern for AUDIT scores indicating harmful drinking, mild dependence or 
probable dependence was slightly different, although prevalence was still highest 
among White British adults. 5.2% of White British men had AUDIT scores of 16 or 
more, compared with 0.2% of Asian men and 2% to 4% of men in other groups. 
2.0% of White British women drank at this level, compared with 1.6% of non-
British White women and 1.4% of Black women. No Asian women or women 
from other ethnic groups were identified as drinking at this level of risk. Table 10.5
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Region
Comparisons between regions are based on age-standardised estimates to account 
for differences in the age profile between regions.
The overall proportion with hazardous, harmful or dependent drinking varied across 
regions. It was highest in the North West (25.2%) and lowest the East of England 
(15.5%).
The variation between regions for the proportions with AUDIT scores indicating 
likely dependence was not statistically significant.1 Table 10.6
1 Note that the ‘London effect’ – the high proportion of non-drinkers in London when compared with other English regions – does 
not persist through to differences in the proportions of adults in higher categories of consumption, whether measured by quantities 
consumed or the AUDIT’s broader criteria (Craig et al 2014).
Figure 10F: Harmful drinking/mild or probable dependence 
(AUDIT score of 16 or more), by ethnic group and sex (age-standardised)
Base: all adults 
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Household type
There were strong relationships between the type of household people lived in 
and their AUDIT score. Broadly, drinking at hazardous levels or above (an AUDIT 
score of 8 or more) was most common in households entirely composed of adults 
aged under 60, particularly in people aged under 60 who lived alone (35.6% of 
men, 18.6% of women). Adults who lived in households with children (small or 
large families) were less likely to drink at this level. Households comprising one 
or two adults over 60 were least likely to drink at hazardous levels or above (for 
example, 18.0% of men and 6.4% of women aged over 60 who lived alone). 
There was a similar pattern in the prevalence of AUDIT scores indicating 
harmful drinking, mild dependence or probable dependence. Table 10.7
Figure 10G: Harmful drinking/mild or probable dependence 
(AUDIT score of 16 or more), by household composition and sex
Base: all adults 
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Employment status
Comparisons between groups are based on age-standardised estimates to account 
for differences in the age profile between individuals within different employment 
categories. This analysis is limited to adults aged between 16 and 64.
Among both men and women, drinking at hazardous levels (an AUDIT score of 
8 or above) was highest among those in employment (31.4% of men, 17.4% of 
women) and lowest among those classed as economically inactive (22.9% of men, 
12.1% of women).Variation by employment status for AUDIT scores of 16+ were 
not statistically significant. Table 10.8
Benefit status
Comparisons between groups are based on age-standardised estimates to account 
for differences in the age profile between individuals in receipt of different types 
of benefit. For Employment and Support Allowance (ESA) and any out-of-work 
benefits (JSA and ESA), the analysis is limited to adults aged between 16 and 64.
The proportions of adults with AUDIT scores of 8 or more were not significantly 
different according to whether or not they were in receipt of ESA. However, both 
men and women in receipt of ESA were more likely than those who were not to 
have AUDIT scores of 16 or more (indicating that their drinking was harmful or 
dependent). 10.8% of men and 9.4% of women in receipt of ESA had AUDIT 
scores of 16 or more; unusually the proportions were similar for men and women. 
The equivalent proportions among those who were not in receipt of ESA were 
4.9% of men and 2.1% of women.
A similar pattern was seen for adults in receipt of any kind of out-of-work benefits 
(although the difference was less pronounced among women). The proportion with 
AUDIT scores of 8 or more were similar, regardless of benefit status. But men and 
women in receipt of out-of-work benefits were more likely to be harmful or mildly 
dependent drinkers or probably dependent than those who were not. 11.7% of 
men and 4.0% of women in receipt of these benefits had AUDIT scores of 16 or 
above, compared with 4.6% of men and 2.0% of women who were not in receipt 
of these benefits.
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Adults living in households in receipt of housing benefit were less likely to drink 
at hazardous levels or above (AUDIT score of 8 or more) than those who were not. 
This difference was more pronounced among men (18.2% compared with 26.7% 
respectively) than among women (12.2% and 13.2% respectively). Conversely, 
the proportions whose drinking was harmful, mildly dependent or probably 
dependent were higher in people in receipt of housing benefit. 7.2% of such men 
and 3.1% of such women had AUDIT scores of 16 or more, compared with 4.1% 
of men and 1.6% of women who were not receiving this benefit. Table 10.9
Treatment for a mental or emotional problem
The following analysis compares current treatment for a mental or emotional 
problem by AUDIT scores. It should be noted that there were relatively small 
numbers of women identified with mild or probable dependence on alcohol (16+), 
and also that treatment refers to any psychotropic medication or psychological 
therapy, and was not necessarily for an alcohol-related disorder.
Figure 10H: Harmful drinking/mild or probable dependence 
(AUDIT score of 16 or more), by benefit status and sex (age-standardised)
16–64 (out of work benefits); all adults (Housing benefit) 
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The proportion receiving treatment for a mental or emotional problem 
was higher among those whose AUDIT score indicated likely dependence 
on alcohol. 8.5% of men who were at low risk of alcohol-related harm 
were currently receiving treatment, compared with 7.5% of men who were 
hazardous drinkers and 9.2% of men classified as harmful or mildly dependent. 
The proportion of men with probable dependence receiving treatment for a mental 
or emotional problem was more than twice as high – 26.9%. Among women, 
14.2% in the low risk category and 16.7% of hazardous drinkers were receiving 
treatment. This proportion increased to 38.0% of harmful or mildly dependent 
drinkers, and 47.3% of women who were probably dependent on alcohol.
The majority of those receiving treatment were on medication only, with a 
minority receiving psychological therapy or a combination of therapy and medication. 
For example, among men with an AUDIT score indicating probable dependence, 
16.1% were on medication only, 5.3% received psychological therapy only, and 5.5% 
received a combination of both. The corresponding proportions among women with 
probable dependence were 25.9%, 10.6% and 10.7% respectively. Table 10.10
Figure 10I: Currently receiving treatment for a mental or emotional 
problem, by AUDIT category and sex
Base: all adults 
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Psychotropic medication
Of adults with an AUDIT score below 20, including those whose drinking 
was harmful or mildly dependent, around one in ten reported taking some kind 
of psychotropic medication. This proportion was more than doubled in adults 
with an AUDIT score of 20 or more. This pattern was similar for most types of 
psychotropic medication, particularly medication for anxiety (taken by between 
7% and 11% of those with an AUDIT score of less than 20, compared with 
19.7% of those with an AUDIT score of 20+); and antidepressants (taken by 
between 7% and 11% of those with AUDIT scores below 20, compared with 
20.2% of those with AUDIT scores of 20+). Furthermore, 6.1% of people with 
probable dependence (AUDIT 20+) were in receipt of medications used to 
treat substance misuse. Table 10.11
Psychological therapy
The proportions of adults receiving psychological therapy ranged from 2.5% in the 
low risk category to 13.2% of those whose AUDIT score of 20 or more indicated 
probable dependence. Adults with an AUDIT score of 20 or more were most likely 
to be receiving alcohol or drug counselling (6.3%), followed by psychotherapy 
or psychoanalysis (3.6%) and other forms of counselling (3.3%). Table 10.12
Service use
Adults with an AUDIT score of 20 or more, indicating probable dependence, 
were much more likely to have used health services for a mental or emotional 
problem than those with a lower AUDIT score. 36.9% reported speaking to a 
GP about a mental or emotional problem in the last year, including 18.8% who 
had spoken to a GP in the last two weeks. This was much higher than for adults 
in lower risk AUDIT categories.
Adults with probable dependence on alcohol were also more likely than others to 
have attended hospital in the last three months because of a mental or emotional 
problem, either as an inpatient (2.2%) or an outpatient (2.7%). Table 10.13
Community and day care service use was also higher in probably dependent 
adults than in those whose risk of alcohol-related harm was lower. 18.6% of this 
group reported using one or more services, compared with between 6% and 
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11% of those with lower AUDIT scores. This included 9.0% who had attended 
a community day care centre, 6.5% who had attended a self-help or support 
group, and 5.6% who had seen a community psychiatric nurse (CPN). Table 10.14
Unmet treatment requests
Although relatively few participants said that they had requested a particular 
treatment in the past 12 months but did not get it, this was more likely in those with 
higher AUDIT scores. 1.5% of those with an AUDIT score of 7 or less reported this, 
compared with 1.9% of those with a score between 8 and 15, 5.1% of those with a 
score between 16 and 19, and 5.1% of those with a score of 20 or more. Table 10.15
10.4 Discussion
The prevalence of hazardous drinking, as measured in APMS 2014, is similar 
to that in the 2014 Health Survey for England (HSE), which found 22% of men 
and 16% of women were drinking at levels of increased or higher risk (DH 2016). 
The prevalence of drinking at harmful or dependent levels was highest among 
young adults, men aged 25–34 and women aged 16–24, declining gradually 
with increasing age. This is a similar pattern to that seen in previous APMS 
surveys as well as the HSE in recent years, suggesting a gradual ‘maturing out’ 
of heavy drinking.
Although levels of hazardous drinking and above have remained broadly stable 
since 2000, there are indications of a decline in harmful or mildly dependent 
drinking among the youngest adults (aged 16 to 24) and an increase among 
those aged 55–64.
As in previous APMS surveys, men had a higher prevalence than women 
across the whole spectrum of alcohol use disorders, while participants from 
ethnic minority groups had lower prevalence rates than their white British 
counterparts. Regional variations in hazardous drinking seen in previous surveys 
were less apparent in 2014. Hazardous drinking and above was highest among 
people in employment compared to those who were economically inactive. 
However adults receiving Employment and Support Allowance and out-of-work 
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benefits were more likely to be harmful or dependent drinkers than those not 
receiving benefits, although there were no significant differences in hazardous 
drinking between these economic groups.
It should be noted that, as with less common conditions such as psychotic 
disorders, a survey of the household population may under-represent alcohol 
dependent adults, who are more likely to be homeless or in an institutional setting 
and therefore not included in the survey. Moreover, problematic drinkers living in 
private households may, like other problematic substance users, be relatively less 
likely to respond to surveys, as they may be somewhat less available, able or willing 
to answer survey questions. There is also an issue in interpreting and extrapolating 
prevalence rates of more severe alcohol use disorders of relatively low prevalence 
to the wider population of England, due to relatively small numbers with moderate 
and severe dependence identified by this survey.
Only around a third of men and women with probable alcohol dependence 
recalled having ever been diagnosed by a doctor or professional as having 
alcohol or drug dependence. A quarter of men and half of women with probable 
dependence were currently receiving treatment for a mental or emotional problem, 
mostly medication only, and were more likely to use health services, including 
inpatient, community and primary care, than those with less severe alcohol use 
disorders or low risk drinkers. However, in those of both sexes with probable 
dependence only a small proportion (6.1%) were being prescribed medication for 
substance dependence. Dependent drinkers were also more likely than other groups 
to have requested, but not received, treatment. Overall these findings suggest that 
alcohol dependence remains both under-diagnosed and under-treated in England 
(Cheeta et al. 2008; Brown et al. 2016).
10.5 Tables
Prevalence and trends
Table 10.1  Harmful and dependent drinking in the past year, by age and sex
Table 10.2  Trends in harmful and dependent drinking in the past year, by age 
and sex: 2000 to 2014
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Table 10.3  Self-diagnosis and professional diagnosis of alcohol or drug 
dependence, by AUDIT score and sex
Table 10.4  Severity of Alcohol Dependence Questionnaire (SADQ) score, 
by AUDIT score and sex
Characteristics
Table 10.5  Harmful and dependent drinking in the past year (observed and 
age-standardised), by ethnic group and sex
Table 10.6  Harmful and dependent drinking in the past year (observed and 
age-standardised), by region and sex
Table 10.7  Harmful and dependent drinking in the past year, by household 
type and sex
Table 10.8  Harmful and dependent drinking in the past year (observed and 
age-standardised), by employment status and sex
Table 10.9  Harmful and dependent drinking in the past year (observed and 
age-standardised), by benefit status and sex
Treatment and service use
Table 10.10  Treatment currently received for a mental or emotional problem, 
by AUDIT score and sex
Table 10.11  Types of psychotropic medication currently taken, by AUDIT score
Table 10.12  Current counselling or therapy for a mental or emotional problem, 
by AUDIT score
Table 10.13  Health care services used for a mental or emotional problem, 
by AUDIT score
Table 10.14  Community and day care services used in past year, by AUDIT score
Table 10.15  Requested but not received a particular mental health treatment 
in the past 12 months, by AUDIT score 
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Summary 
• Drug misuse is defined by the World Health Organisation (WHO) as the use of 
a substance for a purpose not consistent with legal or medical guidelines, for 
example the non-medical use of prescription medications or the recreational use 
of illegal drugs.
• This chapter draws on self-completion data to profile the prevalence and trends 
in drug misuse and in signs of dependence in the adult population of England.
• Overall, 35.4% of men and 22.6% of women had taken an illicit drug at least 
once in their life. For both men and women, those aged between 25 and 34 
were most likely to have ever used illicit drugs (52.9% and 35.0% respectively), 
declining to 3.3% of men and 2.8% of women aged 75 or over. 
• Cannabis was the most commonly used drug in the past year (9.4% of men 
and 5.1% of women). Among 16–24 year olds, 23.7% of men and 16.2% of 
women had used it in the past year, followed by ecstasy, cocaine, ketamine 
and mephedrone. Ketamine and mephedrone were rarely reported by people in 
older age-groups.
• People who reported usage of particular drugs were asked about signs of 
dependence on that drug. The signs, or markers, asked about were: daily use 
for 2 weeks or more; having a sense of need or dependence; inability to abstain; 
increased tolerance, and withdrawal symptoms. 
• Overall, 3.1% of adults showed signs of dependence on drugs, including 2.3% 
who showed signs of dependence on cannabis only and 0.8% with signs of 
dependence on other drugs (with or without cannabis dependence as well). 
After increases in the 1990s, the overall rate has remained stable since 2000.
• Rates varied with age and sex, and were greatest in men and in the youngest age 
group; 4.3% of all men showed signs of dependence on illicit drugs (compared 
with 1.9% of women), including 11.8% of men aged 16 to 24 and 6.6% of men 
aged 25 to 34.
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• Signs of drug dependence varied with ethnic group, and were highest among 
black men. This, however, was explained by higher rates of cannabis use in this 
group. It should be noted that daily use of cannabis over a two-week period has 
been questioned as a reliable marker of dependence.
• People in receipt of Employment and Support Allowance (ESA) were more 
likely to report signs of drug dependence than people who did not receive this 
benefit. Some of these people will have been eligible for ESA due to their drug 
dependence and associated physical and mental poor health. 
• Half (50.1%) of people with signs of dependence on drugs other than cannabis 
were in receipt of mental health treatment at the time of the interview. In 
contrast, those with signs of dependence on cannabis only (12.6%) had similar 
mental health treatment rates to the rest of the population (11.2%).
• Over a third of adults with current signs of dependence on drugs other than 
cannabis (36.2%) had received treatment, help or advice specifically because 
of their drug use at some point, 28.8% had received this in the past six months. 
This was twice the rate of those with signs only of cannabis-dependence; among 
whom 14.6% had ever received treatment, help or support specifically because 
of their drug use, and 5.5% had received this in the past six months.
• A range of new psychoactive substances (NPS) have entered the drugs 
market but were not assessed in this survey. Uncertainty over their content and 
rapid changes in what is available makes measuring the use of these substances 
in surveys extremely challenging and knowledge of the prevalence of their use 
is limited.
11.1 Introduction
The United Kingdom has quite high levels of drug use compared to many 
comparable countries, although overall levels of use have been declining over recent 
years (UKDPC 2012). In 2014/15, it was estimated that more than eleven million 
adults aged between 16 and 59 in England and Wales had taken illegal drugs in 
their lifetime, including nearly three million who had taken an illicit drug in the 
past year (Lader 2015). 
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Many drug users have taken cannabis only a few times in their lives and no 
other drugs (UKDPC 2012). For a minority, drug use becomes regular and 
prolonged, and is associated with a high degree of harm to themselves and others 
(Home Office 2010). Recently there has been a rapid expansion in the number 
of new drugs available on the drug market. These new synthetic substances, 
sometimes called designer drugs or legal highs, generally mimic the effects of more 
traditional drugs and came to prominence during a period when the ecstasy and 
cocaine on the market was generally of very poor quality. The new psychoactive 
substances (NPS) were appealing to users as they were legal, better quality and 
readily available. Since then action has been taken to control many of these 
substances, but slightly modified ones are then produced most of which are only 
transiently on the market. The actual content of the substances marketed under 
different brand names changes constantly and some are highly potent and pose 
serious risks to users. This uncertainty over content increases the risk but also, 
alongside the rapid changes in what is available, also makes measuring the use 
of these substances in surveys extremely challenging so our knowledge of the 
prevalence of their use is limited.
Drug misuse is not necessarily problematic, though it can never be considered 
risk-free (ACMD 2008). More people take cannabis than any other drug, but 
problematic drug use, particularly dependence, is most frequently associated with 
opiates (NCCMH 2008). For example, Public Heath England report that opiates, 
(mainly heroin) were the main problem substance for 52% of the 295,224 people 
aged 18 or over in contact with drug and alcohol treatment services in 2014/15 
(PHE 2015). However, the number of young people with heroin problems entering 
treatment has been declining in recent years and the proportion of those in 
treatment for other substances has been increasing. 
A number of adverse health outcomes have been associated with drug misuse. 
Injecting drug users are vulnerable to thrombosis, abscesses, blood-borne diseases 
(particularly hepatitis B and C and HIV), and respiratory problems (Coulthard 
et al. 2002). Frequent cannabis use has also been associated with respiratory 
problems (PHE 2015). 
Problematic use of one drug often co-occurs with misuse of or dependence on 
other drugs and alcohol (Farrell et al. 2002). Alcohol dependence and tobacco also 
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cause major health and wider problems and are dependence-producing, alcohol 
is considered further in Chapter 10. Drug misuse and drug dependence are more 
prevalent in adults with various psychiatric problems, from common mental disorders 
to personality disorders and severe psychotic illness (Coulthard et al. 2002; CMH et al. 
2011). For example, cannabis use has been linked to the development of acute and 
long-term psychotic symptoms, though the causal pathways for the latter remain 
unclear (Moore et al. 2007). In prisoners in England and Wales, severe dependence 
on cannabis or stimulants, such as amphetamines or cocaine, was associated with an 
increased risk of psychosis (Farrell et al. 2002). Significant proportions of those being 
treated as inpatients or in the community for severe mental illness have substance 
misuse problems, and this has treatment implications that are not always satisfactorily 
addressed (Menezes et al. 1996; Phillips and Johnson 2003; Weaver et al. 2003). 
The 2002 Comorbidity of Substance Misuse and Mental Illness Collaborative study 
concluded that 75% of users of drug services and 85% of users of alcohol services 
were experiencing mental health problems (Weaver et al 2003). Comorbidity, 
including with drug dependence, is considered in Chapter 13 of this report.
The number of admissions to NHS hospitals with a primary diagnosis of drug-related 
mental health or behavioural disorder has risen since 2012/13 but is still lower than 
ten years ago; in 2013/14 there were 7,104 (HSCIC 2014). This is an 8.5% (555) 
increase from 2012/13 when there were 6,549 such admissions. Overall, however, 
between 2003/04 and 2013/14 admissions have decreased by 11%. 
In 2014, there were 2,248 drug misuse deaths involving illegal drugs registered 
in England and Wales. This was a marked increase from 2013 and equates to a 
mortality rate of 39.9 deaths per million population, the highest ever recorded 
(ONS 2015). From 2003 to 2007 drug misuse deaths in England increased but this 
was followed by a period of stabilisation and decline between 2008 and 2012, 
before the recent steep rise. Opiates are the drugs most commonly associated with 
drug misuse deaths, followed by benzodiazepines and alcohol is quite often found 
in combination with illicit drugs (PHE 2016). 
Though the health impacts of drug dependence are significant, the harm to 
society of drug-related crime is also great (MacDonald et al. 2005). It has been 
estimated that between a third and a quarter of acquisitive crime – including 
burglary, theft, fraud and the sale of sex – is drug-related (Home Office 2010). 
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Surveys of offenders have shown high rates of recent heroin and cocaine use, 
and made explicit the link between criminal behaviour and the need to get money 
to buy drugs (Boreham et al. 2006). Other types of crime are less strongly linked 
to drug use, although drug dealing may be linked to high levels of community 
violence (UKDPC 2012; Lupton et al. 2002). 
The risk factors for drug use are similar to those for a number of unhealthy as well 
as criminal behaviours, and include social and economic deprivation, inequality and 
family breakdown (UKDPC 2012). In young people, truancy, exclusion from school, 
serious or frequent offending and homelessness are linked to an increased risk of 
frequent drug use and the use of Class A drugs (Becker and Roe 2005; Fuller et al. 
2015). The harm caused by problematic drug use also extends to the families of 
drug users and to the communities in which they live. The children of problematic 
drug users have been described as being at risk from conception to adulthood, from 
multiple and cumulative harms to their mental and physical health, and to their 
social, emotional and educational development (ACMD 2003). Already-deprived 
communities are most at risk of drug-related harm, through the direct effect on 
users, as well as increased rates of crime and antisocial behaviour (Home Office 
2010). The annual social and economic cost of Class A drug use has been estimated 
at £15.4 billion a year; 99% of this is accounted for by problem drug use (Home 
Office 2010). 
The major source of data on the prevalence of drug use by adults aged 16 and 
over in England is the annual Crime Survey for England and Wales (CSEW), funded 
by the Home Office and previously called the British Crime Survey. The 2014/15 
CSEW estimated that 8.6% of adults aged between 16 and 59 in England had 
taken drugs in the past year. Cannabis was the most commonly used drug; 6.8% 
of adults had taken cannabis in the past year while 3.2% had taken a Class A 
drug in the same time period (Lader 2015). 
This chapter presents the prevalence of reported drug misuse and signs of 
dependence in the English adult general population and examines some associations, 
including those with use of treatment and services. It is important to note that using 
a household survey to measure drug use and dependence will underestimate several 
key groups whose patterns and levels of drug use may be atypical. These include 
students in halls of residence, the homeless, and those living in institutional settings, 
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including hospitals and prisons (Singleton et al. 1998). Additionally, problematic 
drug users living in private households may be less likely to participate in surveys, 
given that they may lead chaotic lives which make them less available, able or willing 
to answer survey questions (Lader 2015). Hence household surveys are likely to 
underestimate the number of dependent drug users (UKDPC 2012). 
11.2 Definitions and assessment
Drug misuse 
Drug misuse is defined by the WHO as the use of a substance for a purpose not 
consistent with legal or medical guidelines, for example the non-medical use of 
prescription medications or the recreational use of illegal drugs (ACMD, 2008). 
It may lead to problematic drug use, including dependence.
Dependence syndrome is defined in the International Classification of Diseases, 
10th edition (ICD-10) as ‘a cluster of behavioural, cognitive, and physiological 
phenomena that develop after repeated substance use and that typically include 
a strong desire to take the drug, difficulties in controlling its use, persistence in its 
use despite harmful consequences, a higher priority given to drug use than to other 
activities and obligations, increased tolerance, and sometimes a physical withdrawal 
state’ (WHO 1992). Diagnostic criteria for dependent drug use are covered by the 
substance dependency codes F10 to F19 of the ICD-10, and are very similar to the 
criteria specified in the fourth Diagnostic Statistical Manual (DSM-IV; APA 1994). 
A threshold of three or more of the following occurring in the past 12 months is 
required for a diagnosis:
• Preoccupation with substance use
• Sense of need or dependence
• Impaired capacity to control substance-taking behaviour 
• Increased tolerance
• Withdrawal symptoms, and
• Persistent substance use despite evidence of harm. 
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DSM-5 was launched after APMS 2014 was in development. The drug dependence 
questions used in the survey series were designed to DSM-IV criteria. 
Measuring drug use and dependence
Questions about drug use were asked using a computer-assisted self-completion 
interview (CASI), as in the 2000 and 2007 surveys. They covered lifetime experience 
of 15 types of named drug, together with use in the past year. The drugs asked 
about are those considered to be mostly widely used and about match those included 
on the CSEW, with the additional inclusion of volatile substances. For the reasons 
outlined in the introduction, new psychoactive substances (NPS) were not included.
For each of eight drug types (cannabis, amphetamines, crack, cocaine, ecstasy, 
tranquillisers, opiates and volatile substances), reported use in the past year 
was followed by five questions based on the Diagnostic Interview Schedule and 
designed to assess symptoms of drug dependence (Malgady et al. 1992). These 
questions asked about the past month and year, and covered:
• Daily use for 2 weeks or more
• Sense of need or dependence 
• Inability to abstain 
• Increased tolerance, and
• Withdrawal symptoms. 
A positive response to any of the items was used as an indicator of possible drug 
dependence. This is a lower threshold than that recommended by ICD-10 and DSM-
IV, and the set of questions does not include the diagnostic criteria of preoccupation 
and persistent use despite evidence of harm. However, the same approach and 
wording was used in the 1993, 2000 and 2007 surveys and comparability has been 
maintained. Because people can be dependent on more than one type of drug, and 
because the nature of cannabis use is widely considered to be different from the other 
drugs asked about,1 dependence was grouped into three categories, those:
1 In particular it has been argued that daily use of cannabis for a two week period does not sufficiently differentiate between 
recreational use and dependency (see Singleton et al., 1998).
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• With no dependence
• Who were dependent on cannabis only, and 
• Who were dependent on another drug (including those who were also 
dependent on cannabis).
11.3 Results
Prevalence of illicit drug use, by age and sex
Lifetime experience of illicit drug use was strongly related to age and sex. Overall, 
35.4% of men and 22.6% of women had taken an illicit drug at least once in their 
life. For both men and women, those aged between 25 and 34 were most likely to 
have ever used illicit drugs (52.9% and 35.0% respectively), declining to 3.3% of 
men and 2.8% of women aged 75 or over.
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Men and women in most age groups were more likely to have tried cannabis than 
other drugs. Overall, 31.6% of men had used cannabis, compared with 11.0% 
who had used cocaine, 8.3% amphetamines and 8.1% ecstasy (the next most 
commonly used drugs). Among women, 20.6% had used cannabis. The next most 
commonly used drug, cocaine, had been taken by 5.0% of women. 
The age profile of users varied with type of drug. Ketamine and mephedrone were 
the fourth and fifth most cited drugs taken by 16–24 year olds, their reported 
lifetime use then declined steeply with age. 
Lifetime use of many other drugs (such as ecstasy, amphetamines, magic 
mushrooms, LSD, and amyl nitrite) was highest among 35–44 year olds. These 
figures relate to a complex mix of period, generational and age group associations. 
Recall could be a factor in the very low levels of reported lifetime use among those 
in the oldest age groups. Table 11.1
Figure 11B: Ever taken ketamine or mephedrone, by age and sex
Base: all adults
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11.3% of men and 6.0% of women had used at least one illicit drug in the past year. 
Illicit drug use in the past year was most common in young people (26.4% of men 
and 17.1% of women aged 16 to 24) and declined sharply with age to 0.5% of men 
aged 75 or over. It was not reported by any female participants in this age-group. 
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Figure 11C: Six most common drugs ever taken (excluding cannabis), 
by age
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Cannabis was the most commonly used drug in the past year; 9.4% of men and 
5.1% of women had used it in the past year, including 23.7% of men and 16.2% 
of women aged 16 to 24. The use of other drugs in the past year was relatively 
uncommon, except in young adults where cocaine and ecstasy were the next most 
likely to be mentioned. Ketamine was included in the survey for the first time in 
2014, and among young adults aged 16 to 24, particularly men, it was the next 
most commonly reported drug used in the past year. Table 11.2
Illicit drug use in the past year, by ethnic group and region
The analysis by ethnicity was standardised to account for the different age profiles 
of the ethnic groups, and the age-standardised rates are referred to here. Black/Black 
British adults were the most likely to have taken drugs in the past year (14.3% of 
men; 9.7% of women), and Asian/Asian British adults were the least likely to have 
done so (5.9% of men; 0.4% of women). The higher rate of drug use among Black 
men was explained by higher rates of cannabis use in this group. Table 11.3
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The proportion of adults who had taken illicit drugs in the past year did not vary 
significantly across English regions. Table 11.4
Prevalence of drug dependence, by age and sex
The prevalence of signs of drug dependence was measured for each of eight types 
of drug: cannabis, amphetamines, cocaine, crack, ecstasy, opiates (heroin and 
methadone), tranquillisers and volatile substances (glue, gas, aerosols or solvents). 
For each drug, sign of dependence was defined as endorsing at least one of five 
questions about use of the drug (see Section 11.2). Dependent users were grouped 
into those who were dependent on cannabis only and those who were dependent 
on other drugs (including those who were also dependent on cannabis). 
Overall, 3.1% of participants showed signs of dependence on illicit drugs, with the 
true rate in the wider population likely to be between 2.6% and 3.6% (95% 
confidence interval (CI)). This includes 2.3% who showed signs of dependence on 
cannabis only (95% CI: 1.9% to 2.8%) and 0.8% with signs of dependence on 
other drugs (with or without cannabis dependence as well) (95% CI: 0.6% to 
1.2%). Rates varied with age and sex, and were greatest in men and in the 
youngest age group; 4.3% of all men showed signs of dependence on illicit drugs 
(compared with 1.9% of women), including 11.8% of men aged 16 to 24 and 
6.6% of men aged 25 to 34. Table 11.5
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Of the five signs of drug dependence asked about, the most commonly reported 
was two weeks of daily use (1.7%, data not shown). The table below shows that, 
overall, 1.1% of people reported just one sign of dependence, 0.7% reported two, 
and 1.2% reported three or more (1.6% of men and 0.9% of women). The latter 
is closer to the threshold for drug dependence according to ICD-10. This chapter 
focuses on all those reporting at least one sign, an approach consistent with 
previous surveys in the series.
Number of signs of drug dependence reported
Men Women All
% % %
0 95.7 98.1 96.9
1 1.6 0.6 1.1
2 1.1 0.4 0.7
3–5 1.6 0.9 1.2
The highest rates of dependence were on cannabis; 3.7% of men and 1.6% of 
women. Rates of dependence in the survey sample were 0.5% or lower for other 
drugs. The prevalence of dependence on heroin/methadone was almost the same 
as the prevalence of use in the last year, suggesting that almost all users showed 
signs of dependence. No participants reported signs of dependence on volatile 
substances. For most age groups, dependence was most likely to be on cannabis 
only. Dependence on other drugs was largely restricted to younger men. There was 
almost no overlap in women between signs of dependence on cannabis and on 
other drugs.
Trends in signs of drug dependence, 1993 to 2014
The prevalence of drug dependence in 1993, 2000, 2007 and 2014 can be assessed 
for adults aged 16 to 64 (the upper age limit of the 1993 survey). Between 1993 
and 2000 there was an increase in the proportions of adults reporting signs of 
dependence on drugs other than cannabis, as well as signs of dependence on 
cannabis but not other drugs. Between 2000 and 2014 the overall level of signs 
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of dependence has remained stable. This was true both for signs of dependence 
on cannabis only, and for signs of dependence on other drugs (with or without 
cannabis as well). Table 11.6
This pattern of overall stability in rates of drug dependence is interesting given the 
wider context of declining rates in drug use. There are also indications of possible 
different trends within age-groups. Although not statistically significant, it appears 
that rates of drug dependence in 16–34 year olds may have started to fall, while 
rates in 35–54 year olds are sustained, suggesting a possible generational effect. This 
is consistent with patterns observed in the alcohol chapter (Chapter 10). Table 11.6
Figure 11G: Signs of dependence on any drug, on cannabis only, 
and on other drugs in the past year, 1993 to 2014
Base: 16–64 year olds, living in England
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Drug dependence by other characteristics
Ethnic group
Like the pattern observed for drug use, the prevalence of reported signs of drug 
dependence also varied between ethnic groups. Using age-standardised data, the 
proportion showing signs of dependence was highest (at 7.5%) among adults 
in the Black/Black British group. This may be explained by their higher rates of 
cannabis use, and could reflect reporting of daily use. Table 11.7
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Household type
Household type was also associated with drug dependence. Signs of drug 
dependence were highest in those aged less than 60 who lived alone (6.7%). 
Table 11.8
Employment status
Among people aged 16–64, the prevalence of drug dependence varied with 
employment status. In men, signs of drug dependence were most common in those 
classed as economically inactive (9.6%). For women, the highest prevalence was 
found in the unemployed (4.4%). Prevalence was lowest in both men and women 
who were in employment (4.5% of employed men, 2.1% of employed women). 
This is a different pattern to that found for drinking alcohol at hazardous levels, 
where rates are highest among those in employment (see Chapter 10). Table 11.9
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Figure 11I: Signs of drug dependence in the past year (age-standardised), 
by ethnic group and sex
Base: all adults
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Benefit status
Recipients of benefits were more likely to show signs of dependence than those 
not receiving benefits, and the differences were most pronounced for Employment 
and Support Allowance (ESA). People with drug dependence may be in receipt 
of ESA as a result of their dependence and associated comorbid physical and 
mental health problems. For ESA, there was a significant interaction between 
sex and receipt of this type of benefit. The difference between the levels of drug 
dependence for those in receipt of ESA and those not was larger for women than 
men, around eight times for women compared with around double for men. Due 
to small base sizes these figures should be viewed with caution. Table 11.10
 
Figure 11J: Signs of drug dependence in the past year (age-standardised), 
by employment status and sex
Base: adults aged 16–64
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Region
Levels of drug dependence in different English regions did not vary significantly. 
Table 11.11
Treatment and service use, by type of drug dependence
Estimates in this section should be treated with caution: the sample of drug-
dependent adults was very small, in particular for those showing signs of 
dependence on drugs other than cannabis (44 people). Furthermore, the treatment 
tables in this chapter were not age-standardised, despite drug dependence being 
strongly associated with age.
 
Figure 11K: Signs of drug dependence in the past year (age-standardised), 
by receipt of Employment and Support Allowance (ESA) and sex
Base: adults aged 16–64
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Psychoactive medication and psychological therapy
Adults who reported signs of dependence on drugs other than cannabis were 
more likely than other adults to be receiving treatment for a mental or emotional 
problem, although this treatment was not necessarily for a drug problem. Half 
(50.1%) of people with signs of dependence on drugs other than cannabis were in 
receipt of mental health treatment at the time of the interview. In contrast, those 
with signs of dependence on cannabis only (12.6%) had similar mental health 
treatment rates to the rest of the population (11.2%). Table 11.12
Compared with other adults, those with signs of dependence on drugs other than 
cannabis were more likely to be taking psychoactive medication; 38.8% compared 
with 9.6% of those dependent on cannabis and 9.7% of those who reported no 
signs of drug dependence. Adults with signs of drug dependence were also more 
likely to use psychological therapy; 5.5% of those dependent on cannabis and 
30.7% of those dependent on other drugs, compared with 2.6% of other adults. 
Tables 11.13, 11.14
Figure 11L: Treatment currently received for a mental or emotional 
problem, by level of drug dependence in past year
Base: all adults
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Health care 
People with signs of drug dependence were also more likely than others to access 
health care services for a mental or emotional problem. 21.7% of adults with signs 
of cannabis dependence only and 54.4% of those with signs of dependence on 
other drugs had spoken with a GP for this reason in the past year, compared with 
11.7% of other adults. 4.6% of cannabis-dependent adults and 19.8% of ‘other’ 
drug-dependent adults had spoken with a GP about a mental or emotional problem 
in the past two weeks, compared with 2.0% of other adults. Table 11.15
Community and day care 
Levels of community and day care service use in the past year were the same for 
adults who reported no signs of drug dependence and adults who reported signs of 
cannabis dependence only (6.4%), while 28.9% of adults with signs of dependence 
on other drugs had used at least one of the community or day care services asked 
about in the past year. Adults with signs of dependence on other drugs had distinct 
patterns of service use; in particular, they were more likely than others to access 
psychologists (10.6%), community psychiatric nurses (8.0%) and psychiatrists 
(7.7%). Table 11.16
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Figure 11M: Spoken with GP about mental or emotional problem in past 
two weeks, by level of drug dependence in past year
Base: all adults
%
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Treatment, help or advice due to drug use
All participants were also asked whether they had ever received treatment, help or 
advice due to drug use. Over a third of adults with current signs of dependence on 
‘other’ drugs (36.2%) had received treatment, help or advice specifically because of 
their drug use at some point, 28.8% had received this in the past six months. This 
was twice the rate of those with signs only of cannabis-dependence; among whom 
14.6% had ever received treatment, help or support specifically because of their 
drug use, and 5.5% had received this in the past six months. Table 11.17
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Figure 11N: Community or day care service use in past year, 
by level of drug dependence in past year
Base: all adults
%
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Unmet treatment requests
Adults showing signs of drug dependence were more likely to have requested 
but not received a particular mental health treatment in the past 12 months than 
other adults; 5.0% of those with signs of cannabis-dependence and 4.5% of those 
with signs of dependence on other drugs, compared with 1.5% of other adults. 
Table 11.18
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Figure 11O: Received treatment, help or advice in the past six months
because of use of drugs, by level of drug dependence in past year
Base: all adults
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11.4 Discussion
The pattern of drug use reported here is similar to that reported in the Crime 
Survey for England and Wales (CSEW). 
Men were more likely than women to take drugs, and the prevalence of drug use 
was highest in early adulthood and declined thereafter. By far the most commonly 
used drug was cannabis. Both surveys are limited by their lack of data on new 
psychoactive substances (NPS).
Drug use and signs of drug dependence increased between 1993 and 2000, 
and have remained steady since. This also reflects trends in drug use reported 
elsewhere (Lader 2015). When drug use and drug dependence data are examined 
together, it appears that most drug users do not become dependent. There is 
evidence of ‘maturing out’, that is, youthful drug use does not necessarily develop 
into a lifetime habit. As with drug taking in general, symptoms of dependence 
were more common in men than in women, and most common in young adults. 
The prevalence of signs of drug dependence measured here varies with ethnicity, 
employment status, household structure, and receipt of benefits. These variations 
warrant further investigation. 
The majority of drug users in this sample who could be described as dependent 
tended to be dependent only on cannabis. However, while there were very few 
heroin/methadone users in the sample, almost all of them reported at least one 
sign of dependence.
Drug dependent individuals were more likely to use services for a mental or 
emotional problem, particularly if showing symptoms of dependence on drugs 
other than cannabis. However, at least half of these adults, whatever the nature 
of their dependence, were not in contact with such services. 
Although this indicates a link between drug dependence and recognised mental 
health problems, the characteristics of the dependent individuals in the sample 
suggest they were mostly on the edge of dependence. Ultimately, a survey of 
this kind cannot provide a fully representative picture of drug dependent adults 
in England. 
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11.5 Tables 
Prevalence, trends and characteristics
Table 11.1 Lifetime experience of illicit drug use, by age and sex 
Table 11.2 Illicit drug use in the past year, by age and sex 
Table 11.3  Illicit drug use in the past year (age-standardised), by ethnic group 
and sex 
Table 11.4 Illicit drug use in the past year (age-standardised), by region and sex 
Table 11.5 Drug dependence in the past year, by age and sex 
Table 11.6  Drug dependence in the past year (1993, 2000, 2007, 2014), 
by age and sex 
Table 11.7  Drug dependence in the past year (age-standardised), by ethnic group 
and sex 
Table 11.8  Drug dependence in the past year, by household type and sex 
Table 11.9  Drug dependence in the past year (age-standardised), by employment 
status and sex
Table 11.10  Drug dependence in the past year (age-standardised), by benefit 
status and sex
Table 11.11  Drug dependence in the past year (age-standardised), by region 
and sex
Treatment and service use
Table 11.12  Treatment currently received for a mental or emotional problem, 
by drug dependence
Table 11.13  Types of psychotropic medication currently taken, by drug 
dependence
Table 11.14  Current counselling or therapy for a mental or emotional problem, 
by drug dependence
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Table 11.15  Health care services used for a mental or emotional problem, 
by drug dependence 
Table 11.16  Community and day care services used in past year, 
by drug dependence
Table 11.17  Treatment, help or advice because of using drugs, by drug 
dependence 
Table 11.18  Requested but not received a particular mental health treatment 
in the past 12 months, by drug dependence.
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Summary
• Suicide prevention is a major goal for local authorities and central government. 
Between 2007 and 2013, suicide registration data showed a broadly upward 
trend among men and stability among women, although in 2014 and 2015 the 
male rate declined and the female rate increased.
• Self-reported suicidal thoughts, suicide attempts and self-harming (without 
suicidal intent) are associated with great distress for the people who engage in 
them, as well as for the people around them. They are strongly associated with 
mental illness, and help to identify people at increased risk of taking their own 
life in the future.
• The Adult Psychiatric Morbidity Survey (APMS) included questions on these in 
both the face to face and the self-completion parts of the interview. For reasons 
of comparability, trends over time draw on face to face reports, which tend to be 
lower. A variable combining face to face and self-completion data was used for 
examining differences in rates between groups.
• The proportion of the population who reported having self-harmed increased 
from 2.4% and 3.8% of 16 to 74 year olds in 2000 and 2007, to 6.4% in 2014. 
This increase is evident in both men and women and across age-groups. Greater 
awareness of self-harming is probably a factor in the increased reporting.
• One in four 16 to 24 year old women (25.7%) reported having self-harmed at 
some point; about twice the rate for men in this age group (9.7%) and women 
aged 25 to 34 (13.2%). The gap between young men and young women has 
grown over time.
• Self-harm in young women mostly took the form of self-cutting. The majority 
reported that they did not seek professional help afterwards.
• In 2014, 5.4% of 16 to 74 year olds reported suicidal thoughts in the past 
year, a significant increase on the 3.8% reporting this in 2000. For women, the 
increase occurred between 2000 and 2007; for men it took place later, between 
2007 and 2014.
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• Since 2000 there has been a slight increase in the reporting of suicide attempts, 
but only among women (0.5% in 2000, 1.0% in 2007).
• Particular subgroups have experienced more pronounced increases over time. For 
example, people aged 55 to 64 suicidal thoughts (2.1% in 2000; 4.9% in 2014) 
and suicide attempts (0.1% in 2000; 0.6% in 2014) at least doubled in rate 
since 2000. This was evident both in men and women.
• Some groups in the population were more likely than others to report these 
thoughts and behaviours, such as those who lived alone or were out of work 
(either unemployed or economically inactive). Benefit status identified people at 
particularly high risk: two-thirds of Employment and Support Allowance (ESA) 
recipients had suicidal thoughts (66.4%) and approaching half (43.2%) had 
made a suicide attempt at some point.
• Overall, half of people who attempted suicide sought help after their most 
recent attempt (50.1%). About a quarter sought help from a GP, a quarter went 
to a hospital or specialist medical or psychiatric service, and a fifth tried to get 
help from friends or family.
• Men and women were equally likely to seek help after a suicide attempt. 
Older people were more likely to seek help from a hospital or specialist medical 
or psychiatric service than younger people; the latter were more likely to turn to 
family and friends. Using GPs as a source of support following a suicide attempt 
was equally common across age-groups.
12.1 Introduction
In 2015, England’s Department of Health (DH) published its second annual 
report on the cross-government outcomes strategy to save lives: Preventing suicide 
in England: Two years on (DH 2015). Between 1990 and 2007 the suicide rate in 
England fell, and in 2007 reached its lowest recorded level in men (at 13.9 per 
100,000). The male suicide rate then saw an upward trend, reaching 16.1 per 
100,000 in 2013 (a return to about the level it was in 2001) before falling in 2014 
and 2015. In 2015 it was highest in men aged 40 to 59 (ONS 2016). Economic 
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and employment context has been identified as a factor in trends in male suicide; 
those areas of England worst affected by recent unemployment experienced greater 
increases in suicide (Barr et al. 2012). Rates in women are lower and have stayed 
relatively constant since 2007, although increasing from 4.3 to 5.0 deaths per 
100,000 between 2013 and 2015 (ONS 2016).
Among its key objectives, the English National Suicide Prevention Strategy 
includes the development of epidemiological evidence concerning suicide and 
self-harm (DH 2015). Such knowledge is needed to plan services and target 
interventions at the most relevant groups. A prior attempt is a key risk factor for 
suicide (WHO 2014), and so measuring suicide attempts and self-harm can help 
profile people at increased risk of suicide. However, it is important to note that the 
relationship between suicidal ideas, self-harm and suicide is not straightforward. 
The profile of people reporting suicidal thoughts, attempts and self-harm is very 
different, in terms of age and sex, from that of people who take their own life, 
and the great majority of people who engage in these thoughts and behaviours 
do not go on to die by suicide. 
Suicidal thoughts and suicidal behaviours are, in their own right, associated with 
high levels of distress, both for the people engaging in them and in those around 
them. They frequently co-occur, but are distinct. While much research on self-harm 
has combined suicide attempts with non-suicidal self-harming, Adult Psychiatric 
Morbidity Survey (APMS) data can be used to examine these behaviours separately 
as it includes some indication of self-reported intention.
Among those who engaged in non-fatal self-harming (with suicidal intent 
or not) many do not consult health services and, if they do, they may not be 
identified as being suicidal. Data collected routinely for administrative health 
datasets provides a unique understanding of patterns of service use but provides 
a different understanding to community prevalence studies. Studies of people 
attending health services will be affected by the factors associated with clinic and 
hospital attendance (Geulayov et al. 2016). Official statistics on recorded suicides 
(official suicides and undetermined deaths) provide a profile of people who have 
taken their own life, but not systematically coded detail about their life and 
socioeconomic circumstances. While this can be obtained from surveys, survey 
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samples exclude those people, mostly male, who take their own life at the first 
attempt (Isometsä and Lönnqvist 1998). There is therefore a need to look across a 
range of data sources, and at suicidal thoughts and self-harm as well as attempts.
This chapter provides nationally representative estimates of the prevalence of suicidal 
thoughts, suicide attempts and self-harm, and trends in these since 2000. Their 
relationship to age, sex and other characteristics is described alongside findings 
on the methods and reasons reported for self-harming. Finally, results are presented 
on the help-seeking behaviour of people who have made a suicide attempt, and 
on the types of professional help received by those who have self-harmed.
12.2 Definition and assessment
Suicidal thoughts, suicide attempts and self-harm
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(APA 2013) includes two types of self-harming behaviour as conditions for further 
study: non-suicidal self-injury (NSSI) and suicidal behaviour disorder (SBD). While 
intentionality can be difficult to establish (Kapur et al. 2013), this is broadly the 
approach that has also been adopted in the APMS series, with a separate focus on 
thinking about suicide; making a suicide attempt with the intention of taking one’s 
own life; and harming oneself without the intent to die.
Measuring suicidal thoughts, suicide attempts and self-harm
Face to face questions
As in APMS 2000 and 2007, all participants were asked in the face to face 
section of the interview a number of questions about suicidal thoughts, suicide 
attempts, and self-harm without suicidal intent.1 These questions form part of 
the revised Clinical Interview Schedule (CIS-R). For the purposes of the analysis in 
this chapter, suicidal thoughts, attempts and self-harm were assessed using the 
following questions:
1 These questions were also asked in the 1993 APMS survey, but only of a subgroup of respondents (those who had been depressed 
in the previous week). Therefore trends are only presented for 2000, 2007 and 2014.
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• Have you ever thought of taking your life, even though you would not actually 
do it?
• Have you ever made an attempt to take your life, by taking an overdose of 
tablets or in some other way?
• Have you ever deliberately harmed yourself in any way but not with the intention 
of killing yourself?
A positive response to each was followed up with a question on whether this last 
occurred in the past week, the past year, or longer ago.
Self completion questions
While questions about suicidal thoughts, attempts and self-harm were asked 
face to face in order to retain comparability with the previous APMS surveys, it was 
recognised that some participants might choose not to report them if asked face 
to face. For this reason, in the 2007 and 2014 surveys, some questions were also 
asked of all respondents a second time, later in the interview, using laptop self-
completion. In 2007 this consisted of the three lifetime prevalence questions listed 
above (a subset of the full section administered face to face). In 2014, most of the 
questions on suicidal thoughts, attempts and self-harm were administered in the 
self-completion section, with some retained in the face to face section for trends 
and for use in scoring the CIS-R.
Questions used for results in this chapter
In 2014, a new question was added on when the participant had last self-
harmed. In previous surveys in the series, participants were asked if they had ever 
self-harmed, but not when this had last happened. Trends in self-harm, therefore, 
are based only on reports of lifetime experience. Also to retain comparability of 
method with the 2000 and 2007 surveys, only data collected in the face to face 
interviews were used to assess change over time. The other analyses of suicidal 
thoughts, attempts and self-harm in this chapter draw on derived variables 
that combine positive responses in the face to face interview with positive 
responses in the self-completion section, as we believe this approach to be 
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the most accurate. Generally, reporting in the self-completion was higher than 
reporting face to face, but not all participants did the self-completion.
Measuring methods of self-harming
In the self-completion section of the interview, participants who reported that they 
had self-harmed at some point were asked which of a list of methods (cutting, 
burning, swallowing something, or some other way) they had used. It was possible 
to give more than one response.
Did you… (You may give more than one response)
1. Cut yourself
2. Or burn yourself
3. Or swallow anything
4. Or harm yourself some other way
Measuring reasons for self-harming
Participants who reported in the self-completion that they had self-harmed were 
also asked two questions about their motivation. It was possible to endorse neither, 
one, or both of these reasons:
• Did you do any of these things to draw attention to your situation or to change 
your situation?
• Did you do any of these things because it relieved unpleasant feelings of anger, 
tension, anxiety or depression?
The issue of intent is very complex; these questions are reductive and the reasons 
given by participants for self-harming may reflect subsequent rationalisations 
(Kapur et al. 2013). The data presented on this should be treated as only indicative. 
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12.3 Results
Suicidal thoughts, suicide attempts and self-harm by age and sex
Prevalence of suicidal thoughts
A fifth of adults (20.6%) reported that they had thought of taking their own life 
at some point. If all adults in the wider population had been asked about this it is 
likely that the proportion agreeing would be between 19.5% and 21.7% (95% 
confidence interval (CI)). This was more common in women (22.4%) than men 
(18.7%), and in people of working-age than those aged 65 or more.
The survey questions related to suicidal thoughts across the lifetime. The 
higher reporting in people aged less than 65 might be explained by generational 
differences, with young people now being more likely to have suicidal thoughts 
than their counterparts in the past. However, age group variations in recall, 
perception and willingness to report, together with healthy-survivor effects,2 
may explain some of this association with age.
 
Figure 12A: Suicidal thoughts ever, by age and sex
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2 ‘Healthy survivor effect’ is a type of selection bias. People who face adversities on average die younger than those who do not. This 
means that those who survive into late old-age will not be representative of their birth-cohort in terms of level of exposure to adversity.
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Prevalence of suicide attempts
One person in fifteen had made a suicide attempt at some point (6.7%, CI 95%: 
6.1% to 7.4%). Despite men being more likely than women to take their own 
life (ONS 2015), women were more likely to report an attempt (5.4% of men, 
compared with 8.0% of women). As for suicidal thoughts, lifetime suicide attempts 
were more likely in working-age adults than in those who were older. While the 
overall pattern by age was not significantly different in men and women, the rate 
of suicide attempts reported by young women (aged 16 to 24) was notably high. 
This fits with their particularly high levels of suicidal thoughts, self-harm, and wider 
psychiatric morbidity, as captured in other chapters of this report.
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%
Figure 12B: Suicide attempts ever, by age and sex 
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Prevalence of self-harm without suicidal intent
The overall rate of self-harm in the adult population (7.3%, CI 95%: 6.7% to 
8.0%) was comparable to that for suicide attempt (6.7%), with rates higher in 
women (8.9%) than in men (5.7%). However, the age gradient for self-harm was 
more pronounced, and this was particularly evident in women. One in four women 
aged 16 to 24 (25.7%) report having self-harmed, compared with one in a hundred 
women aged 75 or over (0.6%).
Young women were also much more likely than young men to self-harm: 
25.7% of women aged 16 to 24 reported this, compared with 9.7% of men in 
the same age group. Such variation by sex was not evident in older age groups. 
Table 12.1
Figure 12C: Self-harm without suicidal intent ever, by age and sex
Base: all adults
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Suicidal thoughts, attempts and self-harm; 2000, 2007 and 2014
Note that the trend data in this chapter are based only on face to face reports. In 
2007 and 2014 self-completion data on this topic was also collected, this tends to 
elicit higher reporting.
Trends in suicidal thoughts
In 2014, 5.4% of 16 to 74 year olds reported suicidal thoughts in the past year 
when asked in the face to face part of the interview, a significant increase on 
the 3.8% reporting this face to face in 2000. For women, the increase occurred 
between 2000 and 2007; for men it took place later, between 2007 and 2014.
Figure 12D: Suicidal thoughts in the past year (reported face to face)
by sex; 2000, 2007 and 2014
Base: adults aged 16–74 and living in England 
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Trends in suicide attempts
Between 2007 and 2014, reporting of a suicide attempt in the past year remained 
stable at 0.7% of 16 to 74 year olds. Since 2000 there has been a slight increase, 
but only among women (0.5% in 2000, 1.0% in 2007).
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Figure 12E: Suicidal thoughts, suicide attempts and self-harm 
(reported face to face); 2000, 2007, 2014  
Base: adults aged 16–74 and living in England
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Trends in self-harm
Reporting of lifetime self-harm in the face to face part of the interview has seen 
sustained increases over time, from 2.4% in 2000, 3.8% in 2007, to 6.4% in 2014. 
This increase is evident across age-groups, in all of which rates have more than 
doubled since 2000. In some age-groups (25 to 34 year olds, and those aged 55 to 
74) reporting of lifetime self-harm has doubled since 2007.
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Figure 12F: Self-harm ever (reported face to face) 
by age; 2000, 2007 and 2014
Base: adults aged 16–74 and living in England
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Among women aged 16 to 24 years in 2000, one in fifteen reported having ever 
self-harmed (6.5%); this increased to one in nine in 2007 (11.7%) and to one in five 
in 2014 (19.7%). In 2000, rates of self-harm were similar in young men and women. 
By 2014, young women were more than twice as likely to report it as their male 
counterparts (19.7%, compared with 7.9% of 16 to 24 year old men). Table 12.2
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Variation in suicidal thoughts, attempts and self-harm 
by other characteristics
Ethnic group
Lifetime suicidal thoughts, attempts and self-harm were evident across all ethnic 
groups. Rates did not differ significantly by ethnic group after age-standardising 
the data. It should be noted however, that due to sample size limitations the ethnic 
group categories are both small and heterogeneous. It is possible that this might 
mask real differences. Table 12.3
Figure 12G: Self-harm ever by sex among 16-24 year olds;
2000, 2007 and 2014   
Base: adults aged 16–24 and living in England 
% Women
Men
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
20 
2000 2007 2014 
Year 
 308 | APMS 2014  | Chapter 12: Suicidal thoughts, suicide attempts, and self-harm | © 2016, Health and Social Care Information Centre
Household type
People under 60 who lived on their own were more likely to have suicidal 
thoughts than those of the same age living with others. This was also true of 
having made a suicide attempt and of having self-harmed. Of people living in such 
circumstances, 40.2% had suicidal thoughts, compared with 24.8% of people who 
lived with another adult. This pattern was also evident in people aged 60 and over: 
those living alone were more than twice as likely to have made a suicide attempt 
as those living with another person (6.4%, compared with 2.5%). Table 12.4
Figure 12H: Suicidal thoughts ever, by household type and sex 
Base: all adults
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Employment status
Employment status was associated with suicidal thoughts, attempts and self-harm 
in the working-age population (16 to 64 year olds). Among men, the associations 
were strong, with rates of each lowest among the employed and highest in the 
economically inactive. In women the differences were less marked, with similar rates 
in the unemployed and those who were economically inactive. Table 12.5
Benefit status
Age-standardised associations of suicidal thoughts and attempts, and self-harm 
with the receipt of out-of-work benefits were examined for people aged 16 to 64. 
Links with housing benefits are reported for the whole population.
Two thirds of people in receipt of Employment and Support Allowance (ESA) 
(66.4%) had thought about taking their life, approaching half had made a suicide 
attempt (43.2%), and a third reported self-harming (33.5%); indicating that this is 
a population in great need of support. People in receipt of other benefits also had 
Figure 12I: Suicide attempt ever, by employment status (age-standardised) 
Base: aged 16–64
%
Men Women
0 
5 
10 
15 
20 
25 
Employed  Unemployed Economically inactive 
Employment status 
 310 | APMS 2014  | Chapter 12: Suicidal thoughts, suicide attempts, and self-harm | © 2016, Health and Social Care Information Centre
higher rates of suicidal thoughts, suicide attempts and self-harm than those who 
did not receive these benefits. Table 12.6
Region
Suicidal thoughts, suicide attempts, and self-harm occur in all regions of England, 
without significant variation in rate. This remained the case when the data were 
age-standardised to adjust for age-differences in the population of different regions. 
Table 12.7
Mental health
As described in Chapter 2, symptoms of common mental disorder (CMD) in the 
past week were assessed using the CIS-R. The total CIS-R symptom score was 
strongly associated with lifetime suicidal thoughts, suicide attempts, and self-harm. 
%
 
Figure 12J: Suicidal thoughts, suicide attempts, and self-harm ever 
by receipt of Employment and Support Allowance (age-standardised)  
Base: adults aged 16–64
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Two-thirds of people with severe symptoms of CMD (CIS-R score 18+) (65.9%) had 
thought about taking their own life, compared with a tenth of those with no or few 
symptoms (10.7%). The association was stronger for men than for women. 
Table 12.8
Methods of self-harming
Overall, three-quarters of people who self-harmed had cut themselves (73.1%); 
around one in ten had burned themselves (10.2%); a similar proportion swallowed 
something (13.8%); and nearly a third had used some other method (29.1%). 
While women were more likely than men to report cutting (77.0%, compared 
with 66.2% of men), men were more likely than women to have burned 
themselves (16.8%, compared with 6.5% of women).
%
Figure 12K: Suicidal thoughts, suicide attempts, and self-harm ever
by severity of symptoms of CMD in the past week (CIS-R score)  
Base: all adults
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Methods of self-harming also varied with age (although caution in interpretation 
is required; there were only 55 people in the sample aged 55 and over who 
reported self-harm). Young people (16 to 34 years) were more likely than their older 
counterparts to report cutting or burning themselves, whereas older people were 
more likely to report swallowing something or some other method. It was also more 
common for 18 to 34 year olds to report more than one method, compared with 
those aged 35 or more. Tables 12.9 and 12.10
Figure 12L: Method of self-harming, by age 
Base: adults who had ever self-harmed
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Reported reasons for self-harming
Three-quarters of people who had self-harmed cited relieving unpleasant 
feelings of anger, tension, anxiety or depression as a reason for doing so (76.7%), 
while a third reported self-harming in order to draw attention to or to change their 
situation (31.0%). Women were more likely than men to agree with at least one of 
these reasons.
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There was an association between reasons for self-harming and age. Younger 
people were more likely than older people to report that they self-harm in order to 
relieve unpleasant feelings, while older people were more likely than younger 
people to report self-harming in order to draw attention. Tables 12.9 and 12.10
Help-seeking behaviour
Help-seeking following a suicide attempt
Participants who reported in the self-completion section of the interview that 
they had made a suicide attempt were asked whether they had sought help 
following the most recent attempt. Overall, half reported that they had done so 
(50.1%). About a quarter of people sought help from a GP (26.4%), a quarter went 
to a hospital or specialist medical or psychiatric service (25.5%), and a fifth tried to 
get help from friends or family (21.7%). Very few mentioned other sources (1.8%).
%
Figure 12M: Reasons for self-harming, by age 
Base: adults who had ever self-harmed 
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Men and women were equally likely to seek help from each of these sources. 
However, there were differences by age-group. Older people were more likely to 
seek help from a hospital or specialist medical or psychiatric service than younger 
people; the latter were more likely to turn to family and friends. Using GPs as a 
source of support was equally common across age-groups. Tables 12.11 and 12.12
%
Figure 12N: Help seeking after most recent suicide attempt, by age 
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Medical and psychological help for self-harming
37.7% of people who self-harmed received medical or psychological help 
afterwards. A third of people who self-harmed reported psychological help (33.1%) 
and a quarter received medical attention (24.6%). 62.3% received neither.
Women were more likely than men to receive medical attention (29.2%, 
compared with 16.2% of men) or psychological help (38.1%, compared with 
24.0% of men). There was also an age-gradient: half those aged 55 and over who 
had self-harmed obtained medical or psychological help at some point (52.9%), 
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compared with a third of those aged 16 to 34 (33.1%). It should be noted that this 
relates to self-harming and help received at any point; some younger people may 
go on to receive support in the future. Tables 12.13, 12.14
12.4 Discussion
Two major implications for policy and practice emerge in the findings presented 
in this chapter. The first relates to self-harming, particularly self-cutting, in young 
women and the second relates to suicide risk among men in midlife.
Young women and self-harm
Over the last fifteen years reporting of self-harm has more than doubled in the 
population as a whole; the steep increase is evident in both men and women and 
%
Figure 12O: Received medical or psychological help 
after self-harming, by age 
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across ages. In 2000, one in fifteen 16 to 24 year old women reported in the face 
to face part of the interview that she had self-harmed (6.5%); this increased to 
one in nine in 2007 (11.7%) and one in five in 2014 (19.7%). When asked in the 
self-completion part of the interview one in four (25.7%) young women reported 
having self-harmed, twice the rate in men of the same age (9.7%) and of women 
aged 25 to 34 (13.2%). The great majority of the self-harm reported by young 
women involved self-cutting.
It is likely that this increase in reporting is due (at least in part) to changes in reporting 
behaviour, that minor self-injury which people had not included as self-harm in 
previous surveys has started to be labelled as such. It is also likely that people now 
feel more able to disclose self-harm. This might happen if self-harming has become 
more normalised and less stigmatised. Improvements in rapport between interviewers 
and participants could also elicit higher – and probably more accurate – reporting. 
Finally, it is possible that increased reporting of self-harm reflects a real increase in the 
behaviour. It is likely that a combination of these factors may be at play.
Evidence from other sources supports the view that there has been some real 
increase in self-harming behaviour. The Multicentre Study of Self-harm in England 
found an increase in self-injury since 2008 among men and girls presenting 
for medical care (Geulayov et al. 2016). Analyses of Hospital Episode Statistics 
(HES) have also shown increases in people presenting with self-harm, although 
data quality concerns have been raised (Clements 2016). Registration statistics 
show that the suicide the rate in 15–19 year olds has risen since 2013 for three 
consecutive years, although they still have the lowest rate of any age group (ONS 
2016). A growing gap in self-harm rates between young women and young men 
is consistent with trends in CMD described in Chapter 2, as well as findings from 
the Scottish Health Survey (Knudsen 2016) and other research (Hawton and Harriss 
2008). Furthermore, a growing gender gap in mental illness and low wellbeing is 
consistent with the increases in rates of mental illness found in girls but not boys 
(The Children’s Society 2016; Lessof et al. 2016).
While it cannot be confirmed that the increase in self-harm is real, it may be 
appropriate for policy and practice to respond now. This matters because individuals 
who start to self-harm when young might adopt the behaviour as a long-term 
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strategy for coping; there is a risk that the behaviour will spread to others; and also 
that it may lead in time to a higher suicide rate. There is also a need for responsible 
reporting of these figures: the way that this issue is discussed may influence future 
suicidal behaviour and risk in young people.3 
If there is an upward trend in self-harming, with a particularly high rate in young 
women, there needs to be greater understanding of what is driving this. Some cite 
bullying on social media as one influence (Daine et al 2013), other sources highlight 
low self-esteem and anxiety (The Children’s Society 2016). APMS data indicates 
that young people who self-harmed were more likely than older people who did 
so to report relieving feelings of anger, tension, anxiety or depression as a reason. 
It is important that alternative coping strategies are supported and that the right 
help is promoted, made available and accessible, including school-based mental 
health promotion programmes. Two-thirds of 16 to 34 year olds who self-harmed 
said that they got no medical or psychological support as a result (compared with 
around a half of older people). Younger people who made a suicide attempt 
described turning to family and friends or their GP. Recognition may be required 
of the additional burden that an increase in self-harm may mean for primary care, 
so that GPs are able to continue to provide this level of support.
Midlife men and suicide risk
The proportion of men aged 55 to 64 who thought about suicide in the past 
year nearly tripled from 1.9% in 2007 to 5.3% in 2014. Other chapters in this 
report have identified deterioration in the mental health of this group, including 
Chapter 2 on trends in CMD. There was a steep rise in registered suicides among 
men in midlife between 2007 and 2014, and they have been highlighted as a 
priority in England’s National Suicide Prevention Strategy. The data presented here 
supports existing evidence on links between male suicidal behaviour and indicators 
of recession (Coope et al. 2014), in particular, being unemployed, economically 
inactive, or receiving out-of-work disability benefits. Two-thirds of Employment 
and Support Allowance (ESA) recipients reported suicidal thoughts, four in ten 
had made a suicide attempt, and three in ten had self-harmed.
3 For advice on the responsible reporting of suicide, see these guidelines produced by the Samaritans: www.samaritans.org/media-
centre/media-guidelines-reporting-suicide
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Data presented here is also consistent with evidence showing that both mental 
illness and social context remain powerful risk factors for suicidal behaviour and 
self-harm. Two-thirds of people with severe CMD (CIS-R score of 18 or more) had 
thought about suicide, and people living alone are more likely to have suicidal 
thoughts, make a suicide attempt, and to self-harm than those who live with 
others. As lone-person households become more prevalent, the mental health 
associations with this secular change warrant investigation with longitudinal data.
12.5 Tables
Prevalence and trends   
Table 12.1  Prevalence and recency of suicidal thoughts, suicide attempts and   
self-harm, by age and sex 
Table 12.2  Suicidal thoughts and suicide attempts in the past year and self-harm 
ever in 2000, 2007 and 2014 (face to face only), by age and sex 
Characteristics
Table 12.3  Lifetime suicidal thoughts, suicide attempts and self-harm  
(observed and age-standardised), by ethnic group and sex 
Table 12.4  Lifetime suicidal thoughts, suicide attempts and self-harm,  
by household type and sex 
Table 12.5  Lifetime suicidal thoughts, suicide attempts and self-harm  
(age-standardised), by employment status and sex 
Table 12.6  Lifetime suicidal thoughts, suicide attempts and self-harm  
(age-standardised), by benefit status and sex 
Table 12.7  Lifetime suicidal thoughts, suicide attempts and self-harm  
(observed and age-standardised), by region and sex 
Table 12.8  Lifetime suicidal thoughts, suicide attempts and self-harm, by  
severity of current symptoms of common mental disorder and sex 
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Methods and reasons
Table 12.9 Methods and reasons for self-harming, by sex 
Table 12.10 Methods and reasons for self-harming, by age 
Treatment, service use and help seeking   
Table 12.11 Sources sought help from following last suicide attempt, by sex 
Table 12.12 Sources sought help from following last suicide attempt, by age 
Table 12.13  Whether received medical and/or psychological help after self-harm, 
by sex 
Table 12.14  Whether received medical and/or psychological help after self-harm, 
by age
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Summary
• Comorbidity refers to the presence of two or more conditions at the same time. 
In the 2007 report in this series, comorbidity between mental disorders was 
examined. In this chapter comorbidity across mental disorders, chronic physical 
conditions, psychological wellbeing and intellectual impairment is profiled.
• Physical health conditions were measured by showing participants a list of health 
conditions and asking whether a health professional had diagnosed them. Five 
chronic conditions were considered. Mental wellbeing was assessed using the 
Warwick Edinburgh Mental Wellbeing Scale (WEMWBS), where a higher score 
indicates greater psychological wellbeing. Intellectual impairment was also 
included, assessed using the Natonal Adult Reading Test (NART).
• Overall, just over a quarter of adults (27.7%) reported having at least one of the 
five chronic physical conditions considered in this chapter diagnosed, and present 
in the last 12 months. High blood pressure was the most common, followed by 
asthma, diabetes, and cancer. A relatively small number of participants (52; 0.7% 
of adults) reported epilepsy; analysis by this group should therefore be treated 
with caution.
• There was an association between common mental disorder (CMD) and chronic 
physical conditions. In people with severe CMD symptoms (revised Clinical 
Interview Schedule (CIS-R) score 18 or more) over a third (37.6%) reported a 
chronic physical condition, compared with a quarter (25.3%) of those with no or 
few symptoms of CMD (CIS-R score 0 to 5).
• This pattern held for each of the chronic conditions examined. For example, 
people with severe symptoms of CMD (CIS-R score 18+) were twice as likely 
to have asthma as people with no or few symptoms (CIS-R score 0–5): 14.5% 
compared with 7.2%.
• Having a chronic physical condition was associated with lower levels of mental 
wellbeing. Overall, the mean WEMWBS score was 51.0 in people with at least 
one of the five chronic conditions considered, compared with 53.2 in people 
without a chronic physical condition.
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• Both the presence of self-reported diagnosed asthma and high blood pressure 
were associated with a wide range of different mental disorders, including 
depression, anxiety disorders (such as generalised anxiety disorder (GAD) and 
phobias), CMD Not Otherwise Specified (NOS), and posttraumatic stress disorder 
(PTSD). Asthma and high blood pressure were the most common chronic physical 
conditions examined; the larger sample of people with these conditions meant 
that statistically significant differences were more likely to be detectable.
• Cancer and diabetes were also strongly associated with CMD-NOS, but higher 
rates of most other mental disorders were not statistically significant for these 
chronic physical conditions.
• Adults with low wellbeing (with the lowest 15% of WEMWBS scores) experienced 
extremely high levels of psychiatric morbidity, including 21.0% screening positive 
for PTSD, 25.9% for attention-deficit/hyperactivity disorder (ADHD) and 6.0% 
for drug dependence. 20.6% of this group had made a suicide attempt. These 
rates were between 8 and 30 times higher than those for people with the highest 
mental wellbeing scores.
• People with lower intellectual ability were more likely to have poorer mental 
health than those with average or above average intellectual functioning.
• The results indicate that people with one condition tend to be more likely to 
have another, and that even subthreshold symptoms of common mental disorder 
are associated with having a chronic physical condition. These findings provide 
evidence to support the bringing of physical and mental health care provision 
closer together.
13.1 Introduction
Comorbidity relates to the simultaneous presence of more than one disorder. In the 
2007 Adult Psychiatric Morbidity Survey (APMS) report, psychiatric comorbidity was 
examined, looking at the links between different mental disorders. The focus of this 
chapter is on the links between mental and physical conditions.
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The government’s mental health outcomes strategy No Health without 
Mental Health places great emphasis on the links between mental and physical 
health (DH 2011). The strategy gave new responsibility to Improving Access to 
Psychological Therapy (IAPT) services for supporting the psychological needs of 
people with long-term conditions or medically unexplained physical symptoms 
(Naylor et al. 2012). There has been a particular emphasis on achieving ‘parity of 
esteem’ (Social Care, Local Government and Care Partnership Directorate 2014), 
which involves valuing mental health equally with physical health.1
The complex and dynamic relationship between physical and mental illness was 
highlighted in the Chief Medical Officer’s 2013 annual report, which focused 
on public mental health priorities (Davies 2014). It highlighted that people with 
mental illness tend to experience worse physical health than those without mental 
illness. They also have higher than expected mortality, beyond what is explained by 
suicide (Chang et al. 2011). Much of this excess mortality is potentially avoidable 
(Hoang et al. 2013). People with chronic physical conditions also have a higher 
prevalence of depression, anxiety and other mental disorders than people without, 
and comorbidity between physical and mental illness is associated with a range 
of particularly adverse outcomes and increased costs (Egede 2007). By interacting 
with and exacerbating physical illness, comorbid mental health problems raise 
total health care costs by at least 45% for each person with a long-term condition 
and comorbid mental health problem (Naylor et al. 2012). People with long-
term conditions and comorbid mental health problems disproportionately live in 
deprived areas and have access to fewer resources of all kinds. The Kings Fund has 
argued that the interaction between comorbidities and deprivation makes a large 
contribution to generating and maintaining inequalities (Hoang et al. 2013).
About 15 million people in England have a long-term condition (DH 2012). Chronic 
conditions are generally those which are managed long-term with drugs or other 
treatment. The chronic physical conditions focused on in this chapter – asthma, 
cancer, epilepsy, high blood pressure, and cardiovascular disease (CVD) – were 
identified by the Department of Health as priorities for this study.
1 www.england.nhs.uk/mentalhealth/parity/
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As highlighted in Chapter 2, about one person in six has a common mental disorder 
(CMD) such as anxiety or depression. Psychiatric comorbidity – or meeting the 
criteria for two or more mental disorders – is associated with increased severity 
of symptoms, longer duration, greater functional disability and increased use of 
health services (ESEMeD 2004; Andrews et al. 2002; Kessler et al. 2005). This was 
examined in the APMS 2007 report and is not the focus of this chapter.2 Substance 
misuse, addressed in Chapters 10 and 11, affects many and the dual diagnosis of 
substance misuse and various mental disorders is well documented (World Health 
Organisation 2001; Abdulrahim 2001). When disorders are classified as either 
present or absent, many people are identified with two or more conditions (Kessler 
et al. 1996; Kessler et al. 2005), and the likelihood of two or more conditions 
co-existing is greater than can be attributed to chance (Slade and Watson 2006; 
Krueger and Markon 2006). For the purposes of the present analysis, we have 
included the most common mental disorders (namely anxiety and depressive 
disorders) as well as: psychotic disorder; antisocial, borderline and any personality 
disorders; posttraumatic stress disorder (PTSD); attention-deficit/hyperactivity 
disorder (ADHD); bipolar disorder; alcohol and drug dependence; and problem 
behaviours such as suicide attempts and self-harm. These are defined according 
to different classification criteria and refer to a variety of different reference periods 
(see Section 13.2).
There has been a cross-government focus on wellbeing, including on mental 
wellbeing.3 It is known that people with chronic physical conditions or poor 
mental health have lower average mental wellbeing (Chanfreau et al. 2012). The 
nature of this relationship however remains contested, with some arguing that 
mental wellbeing is at the other end of a spectrum from mental illness, and others 
that there is a dual continuum, with mental illness and wellbeing being strongly 
correlated but independent (Doll 2008; Weich et al. 2011). The research in this 
area has tended to look at mental wellbeing among people with general measures 
of psychological distress. This chapter presents fresh analysis of the level of mental 
wellbeing among people identified with specific mental disorders.
2 The analysis of comorbidity reported on in the APMS 2007 report attempted to interpret the complicated relationships between 
mental disorders through the application of more advanced statistical methods – particularly latent class analysis (Davies 2014). 
Latent class analysis was applied to the APMS 2007 data in an attempt to identify underlying patterns of association between 
people according to the patterns of diagnostic criteria they met.
3 www.ons.gov.uk/peoplepopulationandcommunity/wellbeing/bulletins/measuringnationalwellbeing/2015-09-23
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Making sense of comorbidity is made difficult by the sheer number of possible 
combinations (Grant et al. 2005; Lenzenweger et al. 2006; Compton et al. 2007). 
An understanding of the prevalence of comorbid conditions, factoring in a range of 
different physical conditions, mental disorders, and wellbeing in the English general 
population is, therefore, not well developed.
13.2 Definition and assessment
The APMS 2014 interview covered a range of different aspects of physical health 
and mental health and wellbeing, allowing for the relationships between these to 
be explored.
Measuring mental disorders
Detail on the methods used to identify people with mental disorders can be found 
in the relevant chapters of this report. In summary, the mental health conditions 
assessed in APMS 2014 were all included in the analyses of comorbidity between 
mental and physical health. Many of these took the form of psychiatric disorders as 
defined by the tenth revision of the International Classification of Diseases (ICD-10) 
chapter on Mental and Behavioural Disorders Diagnostic Criteria for Research: 
either to individual diagnostic categories (such as obsessive and compulsive 
disorder (OCD)) or as groups of ICD-10 diagnoses (such as psychotic disorders) 
(World Health Organisation 1992). Some conditions were defined according to 
the fourth Diagnostic Statistical Manual (DSM-IV) criteria (for example, personality 
disorder) (American Psychiatric Association 1994).4 In particular, it should be 
noted that other conditions (specifically; ADHD, PTSD and bipolar disorder) were 
assessed using a screening tool that did not apply specific diagnostic criteria. In the 
relevant condition-specific chapters these are not described as present or not, but 
as screen positive or negative. Other categories of mental health problem used in 
the comorbidity analysis represent behaviours (self-harm and attempted suicide) 
that are considered problematic and indicative of major mental distress. Because 
of these differences in how categories of mental illness are covered, they are not 
4 While DSM-5 has since been issued, DSM-IV was current when the survey was in development.
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combined into a single group. The reference period also varied between conditions: 
for example CMDs, such as generalised anxiety disorder, referred to symptoms in 
the past week, while psychotic disorder referred to an episode in the past year. 
The methods of assessment for each of the conditions are described in detail in 
the disorder specific chapters of this report, and are summarised in the table below.
Screening and assessment of mental disorders on APMS 2014
Condition Diagnostic status Classification 
system
Assessment  
tool
Reference 
period
Generalised anxiety 
disorder (GAD)
Present to 
diagnostic criteria
ICD-10 CIS-R (Lewis et al. 
1992)
Past week
CMD Not Otherwise 
Specified (NOS)
Present to 
diagnostic criteria
ICD-10 CIS-R Past week
Obsessive and 
compulsive disorder 
(OCD)
Present to 
diagnostic criteria
ICD-10 CIS-R Past week
Depressive episode Present to 
diagnostic criteria
ICD-10 CIS-R Past week
Panic disorder Present to 
diagnostic criteria
ICD-10 CIS-R Past week
Phobias Present to 
diagnostic criteria
ICD-10 CIS-R Past week
Bipolar disorder Screen positive DSM-IV Mood Disorder 
Questionnaire 
(Hirschfield et al. 
2000)
Lifetime
Problem drinking Screen positive — AUDIT (Saunders  
et al. 1993)
Past six 
months
Drug dependence Screen positive DSM-IV Based on the 
Diagnostic 
Interview Schedule 
(Malgady et al. 
1992)
Past year
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Continued
Condition Diagnostic status Classification 
system
Assessment  
tool
Reference 
period
Psychotic disorder Present to 
diagnostic criteria
ICD-10 SCAN (World 
Health 
Organisation 
1999)
Past year
Borderline 
personality disorder 
(BPD)
Present to 
diagnostic criteria
DSM-IV Self-report SCID-II 
(First et al. 1997)
Past year
Antisocial 
personality disorder 
(ASPD)
Present to 
diagnostic criteria
DSM-IV Self-report SCID-II Past year
Any personality 
disorder
Screen positive DSM-IV Standardised 
Assessment of 
Personality (Hesse 
and Moran 2010)
Lifetime
Post-traumatic stress 
disorder (PTSD)
Screen positive: 
endorsed six out of 
ten items.
DSM-IV PTSD Checklist – 
civilian version 
(Blanchard et al. 
1996)
Past week
Attention deficit 
hyperactivity 
disorder (ADHD)
Screen positive: 
endorsed all six 
items
DSM-IV Adult Self-Report 
Scale-v1.1 (WHO 
2003)
Past six 
months
Attempted suicide Occurrence of 
behaviour
— Self-completion Past year
Measuring chronic physical conditions
Participants were presented with a list of 22 physical conditions (or categories of 
physical illness) and were asked which they had ever had; which they had had in 
the past year; whether the condition had been diagnosed by a health professional; 
and if they received any medication or other treatment for it. The chronic conditions 
reported on in this chapter were self-reported by participants as having been 
diagnosed by a health professional and present in the past 12 months, irrespective 
of whether or not they were currently treated.
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The key chronic physical health conditions focussed on here included:
• Asthma
• Cancer
• Diabetes
• Epilepsy
• High blood pressure.
It should be noted that self-report data on diagnosed conditions are subject to 
participants being unaware of or not recalling a diagnosis that has been made, 
which could lead to under-identification. On the other hand, it is possible some 
participants may have reported having these conditions without having received a 
diagnosis. Some conditions were more prevalent than others, for those with a larger 
sample size (such as asthma and high blood pressure) it may have been easier for a 
difference to be statistically significant.
Measuring mental wellbeing
Mental wellbeing was assessed using the Warwick Edinburgh Mental Well-Being 
Scale (WEMWBS). The scale was developed to enable the monitoring of mental 
wellbeing in the general population, as well as for the evaluation of projects, 
programmes and policies which aim to improve mental wellbeing (Stewart-Brown 
et al. 2011). WEMWBS is a 14-item scale with five response categories, summed 
to provide a single score ranging from 14–70. The items are all worded positively 
and cover both feeling and functioning aspects of mental wellbeing. A higher score 
indicates a higher level of mental wellbeing. In this chapter a mean WEMWBS score 
is presented. In addition, predictors for being in the top 15% and bottom 15% in 
the WEMWBS score distribution are examined.5
5 These thresholds have been applied in previous analyses of WEMWBS (Chanfreau et al. 2012).
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Measuring predicted verbal IQ
A predicted verbal IQ (V-IQ) was derived using participants’ scores on the National 
Adult Reading Test (NART), conducted at phase one. This score was converted to 
a prediction of verbal IQ by applying an algorithm. Participants with a V-IQ score 
of below 80 were grouped together for this analysis and could be considered to 
be of ‘borderline intelligence’ with a level of cognitive functioning associated with 
functional impairments and difficulties living independently without the assistance 
of support services.
13.3 Results
Chronic physical conditions
Overall, around a quarter of participants (27.7%) reported having a diagnosis of at 
least one of the five chronic physical conditions considered in this chapter present 
in the last 12 months. High blood pressure (16.9%) was the most commonly cited, 
followed by asthma (8.7%), diabetes (6.0%), and cancer (1.6%). 52 participants 
(0.7%) reported epilepsy; due to the small numbers, analysis by this group should 
therefore be treated with caution. A similar distribution in chronic conditions was 
found for men and women. Table 13.1
Chronic physical conditions among people with mental illness
There was an association between presence of at least one chronic physical 
condition in the past 12 months and having symptoms of CMD in the past week. 
While a quarter (25.3%) of people with no or few symptoms of CMD (CIS-R score 
0 to 5) had a chronic physical condition, in people with severe CMD symptoms 
(CIS-R 18 or more) over a third (37.6%) had a chronic physical condition as well. 
This pattern was similar for men and women. Table 13.1
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This broad pattern was also evident for each of the chronic conditions when 
looked at individually. For example, people with severe symptoms of CMD  
(CIS-R score 18+) were twice as likely to have asthma as people with no or 
few symptoms (CIS-R score 0–5); 14.5% compared with 7.2%.
 
Figure 13A: Prevalence of any of five chronic physical conditions, 
by CMD symptom severity (CIS-R score)  
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Figure 13B: Prevalence of chronic physical conditions, 
by CMD symptom severity (CIS-R score)  
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Chronic physical conditions among people with low mental wellbeing
Having a chronic physical condition was also associated with having a lower level of 
mental wellbeing. Overall, the mean WEMWBS score was 51.03 in people with at 
least one of the five chronic conditions considered, compared with 53.15 in people 
without a chronic physical condition. This pattern of association was evident among 
both men (51.80 compared with 53.29) and women (50.32 compared with 53.02).6
Over a third (39.7%) of adults with the lowest WEMWBS scores had at least one of 
the five chronic physical conditions, compared with around a quarter of people with 
a higher WEMWBS score. No variation in rate was evident between those with a 
mid-range WEMWBS score and those with a score in the highest 15% of the score 
distribution. This was true both for men and women. Table 13.2
6 For asthma only, a reduced wellbeing score was not evident among men with the condition and there was a statistically significant 
interaction with sex for this condition.
Figure 13C: Prevalence of any of five chronic physical conditions,
by level of mental wellbeing (WEMWBS score) and sex
Base: all adults
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A low level of wellbeing (defined as being in the lowest 15% of the WEMWBS 
score distribution) was associated with each of the individual chronic physical 
conditions. For example, 11.0% of people with low wellbeing had diabetes, 
compared with 5.1% of people with moderate mental wellbeing and 4.9% of 
people with high mental wellbeing.
Mental disorders among people with chronic physical conditions
Generally, people with a chronic physical condition were more likely than those 
without to have at least one type of CMD. Table 13.3
Cancer
Among people with cancer, rates of several mental disorders appeared to be 
higher than in those without cancer. However, the only disorder that this was 
statistically significant for was CMD Not Otherwise Specified (CMD-NOS). CMD-
NOS is a category for those with a CIS-R score of at least 12 but who do not meet 
the specific criteria for the other disorders assessed. On average, people classified 
with CMD-NOS have a lower mean CIS-R score than people classified with the 
other specific CMDs (see Chapter 3: Treatment). This suggests that the presence 
of diagnosed cancer in the past year may be associated with increased levels of 
general psychiatric distress, but there was less evidence for an association with 
specific diagnostic categories of mental disorder.
Diabetes
As for cancer, rates of CMD-NOS were higher in people who reported a diabetes 
diagnosis than in those who did not. People with diabetes were also more likely 
to have depression than people without diabetes.
Asthma and high blood pressure
Both asthma and high blood pressure were associated with a wide range of 
different mental disorders, including CMD-NOS, depression, anxiety disorders  
(such as GAD and phobias) and PTSD. Because asthma and high blood pressure 
were the most common chronic physical conditions examined, their larger sample 
size means that the sample was also better powered to pick up on statistically 
significant differences. Due to particularly strong associations with age, the 
high blood pressure analyses were age-standardised.
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Epilepsy
The small base size for the epilepsy group (52 participants) means that findings 
should be treated with caution.7 The strength of association with mental disorder 
appeared to be greater for epilepsy than for the other chronic physical conditions; 
however the rates were only statistically significantly higher for GAD and PTSD.
Harmful use of alcohol in the past year (as indicated by an AUDIT score of 16 or 
more) and signs of drug dependence were not associated with presence of any 
of the chronic physical conditions examined. While rates of harmful alcohol use 
appeared to be low in those with cancer and high in those with epilepsy, these 
were not statistically significant.
7 This pattern has been found in analyses of APMS 2007 data previously (see Rai et al. 2012).
Figure 13D: Prevalence of CMD-NOS, among people with and without
each chronic physical health condition  
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Mental disorders among people with low mental wellbeing
The association between mental disorder and low wellbeing was very strong, 
and statistically significant for every type of mental disorder examined. Adults 
with low wellbeing were defined as those in the bottom 15% of the WEMWBS 
score distribution.
CMD
Among people with low mental wellbeing (lowest 15% in the population 
distribution) more than one in two met the criteria for at least one CMD (57.3%), 
compared with one in a hundred (1.1%) among people in the highest 15% of the 
wellbeing distribution. Men (42.3) and women (43.5) with CMD had a lower level 
of mental wellbeing, as indicated by mean WEMWBS score, than the population 
as a whole (52.6, data not shown). Table 13.4
Figure 13E: Prevalence of harmful alcohol use (AUDIT score 16 or more), 
among people with and without each chronic physical condition 
Base: all adults
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Other mental health conditions and behaviours
Adults with low mental wellbeing had very high levels of psychiatric morbidity 
across all the disorders assessed, with rates between four and 50 times higher than 
those for people with the highest mental wellbeing scores. Over a third (37.6%) 
screened positive for personality disorder (compared with 3.6% of people with 
wellbeing in the top 15% of the distribution). A quarter screened positive for 
ADHD (25.9% compared with 2.0% with high wellbeing), a fifth screened positive 
for PTSD (21.0% compared with 0.8%); and 4.8% were identified with probable 
psychotic disorder (compared with 0.1%). The variation was also evident for signs 
of drug dependence and alcohol dependence. A fifth of people with low wellbeing 
(20.6%) reported having made a suicide attempt at some point. Table 13.4
Figure 13F: Prevalence of any CMD, by level of mental wellbeing 
(WEMWBS score) and sex
Base: all adults
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Mental disorders by predicted verbal IQ score
People with a predicted verbal IQ score of less than 80 (in this analysis used to 
indicate intellectual impairment) had a greater level of psychiatric morbidity than 
those with higher verbal IQ scores. For example, while a quarter (25.0%) of people 
scoring at the lowest end of the verbal IQ range had at least one CMD, this was the 
case for 17.2% of those scoring between 90 and 109 and 13.4% of those scoring 
over 110. The variation by predicted verbal IQ score was particularly pronounced for 
rates of probable psychotic disorder. Table 13.5
Figure 13G: Prevalence of signs of drug dependence, 
by level of mental wellbeing (WEMWBS score) and sex 
Base: all adults
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13.4 Discussion
While the strong associations between general physical and mental health are 
well established, this chapter presents data on the links between different types 
of mental disorders by different types of chronic physical conditions. This is key 
for understanding how pervasive the links between physical and mental illnesses 
are, and for which specific mental and physical conditions the associations are 
strongest. Previous analyses have tended to examine comorbidity between physical 
conditions and a measure of general ‘psychological distress’ (using, for example, 
the General Health Questionnaire), or have focused on psychiatric comorbidity with 
just one type of physical condition, for example, diabetes (Das-Munshi et al. 2007; 
Balhara 2011) or epilepsy (Rai et al. 2012).
Figure 13H: Prevalence of probable psychotic disorder, 
by predicted verbal IQ score (based on the NART) and sex  
Base: all adults
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Having a chronic physical condition is common. Over a quarter of participants 
reported the diagnosed presence of at least one of the five chronic conditions 
examined, in the last 12 months. As reported in Chapter 2, around one person in 
six has a depressive or an anxiety disorder, with a wide range of other less common 
disorders present to varying degrees. People with CMD were much more likely than 
those who did not to have a chronic physical condition. For example, those with 
severe symptoms of CMD (as represented by a CIS-R score of 18 or more) were 
twice as likely to have asthma as those with no or few symptoms (CIS-R score 0–5); 
14.5% compared with 7.2%. This pattern was true for each of the chronic physical 
conditions considered, and was evident both for women and men.
Both asthma and high blood pressure were associated with a wide range of 
different mental disorders, including depression, anxiety disorders (such as GAD and 
phobias), CMD Not Otherwise Specified (NOS), and PTSD. Asthma and high blood 
pressure were the most common chronic physical conditions examined; the larger 
sample size for these conditions meant that statistically significant differences were 
more likely to be detectable. Cancer and diabetes were also strongly associated 
with CMD-NOS, but the higher rates of most other mental disorders tended not to 
be statistically significant for these physical conditions. On average, people classified 
with CMD-NOS have a lower mean CIS-R score than people classified with the 
other specific CMDs (see Chapter 3: Treatment).
It may feel counterintuitive that problematic use of alcohol in the past year and 
signs of drug dependence were not associated with presence of a chronic physical 
condition, given that, for example, sustained misuse of alcohol is a known 
physiological risk factor for the onset of chronic conditions such as certain cancers 
(Danaei et al. 2005) and type 2 diabetes (Baliunas et al. 2009). However, it has 
been noted that onset of poor physical health can prompt subsequent reductions 
in alcohol intake (Fillmore et al. 2007). APMS tends to collect data on current or 
recent health, rather than collecting data on health across the life-course. While 
a strength of the APMS series is its coverage of a range of types of physical and 
mental conditions, limitations include its relatively small sample for the examination 
of comorbidity between low prevalence conditions, as well as the fact that the 
data are not longitudinal. Cross-sectional data is not suitable for examining 
causal relationships.
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The survey data confirm the established relationship between lower IQ and 
common and severe mental illness. This is an important finding that points towards 
the need for further diagnostic and treatment support for this population group, 
who more often than not do not fit within rigid service eligibility criteria.
APMS 2014 was the first time in the survey series that a validated measure of 
mental wellbeing, the WEMWBS, was included. The findings presented in this 
chapter show the very strong associations there are between low mental wellbeing 
and having a chronic physical condition, as well as between low mental wellbeing 
and every different type of mental disorder examined. The data in this chapter lend 
strong support for calls for greater integration of treatment and services for mental 
and physical conditions, given the increased likelihood that patients for one type 
of condition may also be likely to benefit from treatment for another.
13.5 Tables
Table 13.1 Chronic physical health conditions, by CIS-R score and sex 
Table 13.2 Chronic physical health conditions, by mental wellbeing and sex
Table 13.3  Common and severe mental disorders, by chronic physical health 
conditions
Table 13.4 Common and severe mental disorders, by mental wellbeing and sex
Table 13.5 Common and severe mental disorders, by predicted verbal IQ and sex
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Summary
Survey design summary
The Adult Psychiatric Morbidity Survey (APMS) 2014 is the fourth in a series of 
national mental health surveys. Each survey involved interviewing a large stratified 
probability sample of the general population, covering people living in private 
households. The full adult age range was covered, with the youngest participants 
aged 16 and the oldest over 100. The two-phase survey design involved an initial 
interview with the whole sample, followed up with a structured assessment 
carried out by clinically trained interviewers with a subset of participants. People 
were assessed or screened for a range of different types of mental disorder, 
from common conditions like depression and anxiety disorder through to rarer 
neurological and mental conditions such as psychotic disorder, attention-deficit/
hyperactivity disorder (ADHD), and autism spectrum disorder (ASD). The long 
questionnaire also covered many aspects of people’s lives that are linked to 
mental health, and this information can be used to profile the circumstances 
and inequalities experienced by people with mental disorders.
Aims and rationale for the survey
• To estimate the prevalence of a range of types of common and rare mental 
disorders in the population.
• Measure the gap between presence of each disorder and receipt of treatment.
• Produce trends in disorder and treatment through comparisons with previous 
surveys in the series.
• Enable the circumstances of people with different mental disorders to be 
compared with those of people without disorder.
Design strengths
• By sampling from the general population rather than from lists of 
patients, APMS data can be used to examine the ‘treatment gap’. That 
is, the survey data can be used to explore what proportion of people with 
a condition are not in contact with services or in receipt of any treatment, 
or who are in receipt of inappropriate treatment.
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• The use of validated mental disorder screens and assessments allows 
for identification of people with sub-threshold symptoms and those with an 
undiagnosed disorder.
• Consistent methodology and coverage over time allows for trends in 
a number of conditions to be monitored.
• An advantage surveys like APMS have over routinely collected health 
data is that for each participant a large amount of data on a range of topics 
is collected and relationships can be examined. In particular, the questionnaire 
covers detailed and current information about people’s social and economic 
circumstances, information which does not tend to be collected in a consistent 
or comprehensive way in administrative datasets.
• The use of a computer assisted self-completion module to cover the most 
sensitive topics – such as suicide attempts, illegal behaviours, and experience 
of abuse and violence – means that the survey includes information that some 
participants may have never disclosed before.
• At the end of the survey a question is asked about permission for 
follow-up. The study therefore presents an opportunity for longitudinal data 
collection and a sampling frame that allows a random sample of people with 
very specific experiences, who may not otherwise have been identifiable, 
to be invited for further research.
• The APMS dataset is being deposited at the UK Data Service and is 
designed to be suitable for extensive further analysis. There is only scope for 
a small part of the data collected to be covered in this report.
Design limitations
• The sampling frame covers only those living in private households, and 
therefore those who were living in institutional settings such as large residential 
care homes, offender institutions, prisons, in temporary housing (such as hostels 
or bed and breakfasts) or sleeping rough, would not have had a chance to be 
selected. People living in such settings are likely to have worse mental health than 
those living in private households (Gill et al. 1996). However, the proportion of 
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the overall population not living in private households is so small that this would 
have little (or no significant) impact on the prevalence estimates for the disorders 
examined on APMS.
• Some people selected for the survey were not able to take part in a 
long interview. These include those with serious physical health conditions, 
who may feel unwell or be staying in hospital during the fieldwork period, and 
those whose mental capability may be impaired, for example due to cognitive 
decline as a result of dementia or injury, or because of a learning impairment. 
Where a selected participant could not take part due to a physical or mental 
health condition, some information about this was recorded by the interviewer 
on the doorstep. This information may be biased due to it having been 
collected often from another household member.
• Some people selected for the survey could not be contacted or refused 
to take part. The achieved response rate (57%) is in line with that of similar 
surveys (Barnes et al. 2010). A problem for all such studies is how to take account 
of those who do not take part, either because contact could not be established 
with the selected household or individual or because they refused to take part. 
The weighting (outlined in Section 14.7) addresses this to some extent.
• The mental health assessments used are not as reliable as a clinical 
interview. In a clinical interview, a trained psychologist or psychiatrist may take 
many sessions and much explorative questioning and clinical judgement to reach 
a diagnosis. In the context of a questionnaire administered by a lay interviewer, 
this is not possible. However, the assessments used have been validated and 
are among the best available for the purpose in hand.
• Socially undesirable or stigmatised feelings and behaviours may be 
underreported. While this is a risk for any study based on self-report data, 
the study goes some way to minimising this by collecting particularly sensitive 
information in a self-completion format.
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• As for all surveys, it should be acknowledged that prevalence rates are 
only estimates. If everyone in the population had been assessed the rate found 
may be higher or lower than the survey estimate. Confidence intervals are given 
for key estimates in the methods chapter (Chapter 14). For low prevalence 
disorders, relatively few positive cases were identified. Particular attention should 
be given to uncertainty around these estimates and to any subgroup analysis 
based on these small samples. All comparisons made in the text have been 
tested and only statistically significant differences are described.
14.1 Introduction
The Adult Psychiatric Morbidity Survey (APMS) series began in 1993, and 
surveys have been conducted every seven years since. APMS 2014 is the fourth 
general population survey of adult mental health in the series. The first two were 
carried out by ONS in 1993 and 2000, and covered England, Scotland and Wales. 
The 2007 and 2014 surveys were carried out by NatCen Social Research, covered 
England only, and had no upper age limit to participation (which was 64 in 1993 
and 74 in 2000). Like the preceding surveys, APMS 2014 consisted of two phases, 
with the second phase interview being conducted with a sub-sample of phase 
one participants by clinically trained interviewers coordinated by the University 
of Leicester.
The APMS series is part of a wider programme of surveys currently commissioned 
by NHS Digital, and funded by the Department of Health. Core topics are covered in 
every survey in the series, such as anxiety and depression, psychosis and substance 
use disorders. New topics in 2014 included screening for bipolar disorder and 
experience of childhood neglect.
This chapter provides a description of the survey methodology used on APMS 2014, 
including an outline of the:
• Sample design for the phase one and phase two interviews
• Topic coverage
• Piloting and questionnaire development
 353 | APMS 2014  | Chapter 14: Methods  | Copyright © 2016, Health and Social Care Information Centre
• Fieldwork procedures
• Survey response
• Weighting strategies
• Data analysis approach used in this report
• Quality assurance.
Further methodological detail is provided in the following appendices:
 A  Publications using data from the psychiatric morbidity survey series
B  Assessment of psychiatric disorders
C  Derived variables used in the main report
D  Phase one questionnaire and phase two contents
E  Fieldwork documents
14.2 Sample design
Overview of the sample design
The sample for APMS 2014 was designed to be representative of the population 
living in private households (that is, people not living in communal establishments 
or sleeping rough) in England. People living in communal or institutional 
establishments tend to be either aged 16 to 24 years (and living in higher education 
halls of residence) or aged 65 years or over (and living in a nursing or care home 
setting) (ONS 2015). Older people living in communal settings are likely to have 
worse mental health than older people living in private housing, and this should 
be borne in mind when considering the survey’s account of the older population’s 
mental health. Between the 2001 and 2011 censuses the proportion of young 
people recorded as living in communal establishments increased slightly and the 
proportion of older people in such settings decreased. However, overall, communal 
establishment residents represented less than 2% of all usual residents in England.
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The survey adopted a multi-stage stratified probability sampling design. The 
sampling frame was the small user Postcode Address File (PAF) because this has 
excellent coverage of private households in England. The small user PAF consists 
of those Royal Mail delivery points which receive fewer than 50 items of mail each 
day. Therefore, most large institutions and businesses are excluded from the sample 
but some small businesses and institutions may receive fewer than 50 items each 
day and so be included. Once the interviewer had verified that an address does 
not contain a private household, such addresses were recorded as ineligible. The 
small proportion of households living at addresses not on the PAF (less than 3%) 
were not covered by the sample frame (ONS 2014).1
The stratified multi-stage random probability sample used for the phase one interview 
involved two stages of sample selection: the sampling of the primary sampling units 
(PSUs) followed by the sampling of addresses within the selected PSUs.
Wakefield local boost sample
In addition to the national sample, a sample for an additional local area boost 
was also drawn. The fieldwork involved the full phase one interview, but did not 
include a phase two assessment. The boost took place in Wakefield and was funded 
by a collaboration of the Wakefield Local Authority, NHS Wakefield CCG and South 
West Yorkshire Partnership NHS Foundation Trust. The Wakefield dataset will be 
deposited with the UK Data Service, with additional weighting variables that will 
allow for the datasets to be combined and analysed together as well as separately. 
This report focuses entirely on the national sample, which includes Wakefield 
only in proportion to its population.
Selection of primary sampling units (PSUs)
The PSUs were individual or groups of postcode sectors. A postal sector contains 
on average 2,550 delivery points. Small postal sectors were grouped with 
contiguous sectors so that each group contained at least 500 delivery points.
1 Addresses selected for all NatCen surveys in the last three years were excluded from the sampling frame. However, because they 
had been selected at random in the first place, this did not introduce selection bias. The benefit of this procedure is to reduce the 
burden of surveys on the public, which, it is hoped, will help to maintain response in the long term.
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Before selection, the list of PSUs in the population was ordered (stratified) by a 
number of strata and a systematic random sample was selected from the ordered 
list. This ensures the different strata in the population are correctly represented 
and increases the precision of survey estimates.2
APMS 2014 used a sampling methodology that was consistent with previous 
surveys in the series, and very similar to that used in 2007. First, all PSUs in 
England were stratified by the 10 Strategic Health Authorities (SHA) as shown 
in Table 14.1. Within each SHA, PSUs were listed in increasing order of the 
proportion of people in non-manual occupations (according to the 2011 Census)3 
and cut-off points were drawn approximately one third and two thirds down 
the ordered list to create three roughly equal-sized groups. Within each of the 
30 strata created (10x3), PSUs were listed in order of Census estimates of the 
percentage of households without a car and cut-off points were drawn to create 
three roughly equal-sized groups. Within each of the 90 strata created (30x3), 
PSUs were listed in order of the percentage of households owner-occupied. 
682 PSUs were then systematically selected from the ordered list with probability 
proportional to the delivery point count of each PSU. Using the same stratification 
methodology, an additional sample of 16 PSUs was selected at a later stage to 
boost the size of the available achieved sample, thus bringing the total number 
of selected PSUs to 698. As stated above, this approach was comparable with 
that used for the other surveys in the series and is designed to produce a sample 
representative of the wider population, with biases in sample selection addressed 
through weighting. Table 14.1
Sampling addresses and households
In the second stage of sampling 22 delivery points were randomly selected 
within each of the selected PSUs. About half-way through fieldwork, progress 
was reviewed and it was decided that the sample should be reduced by removing 
2 An estimate from a survey is precise if similar results are obtained with repeated surveys. One measure of precision is the standard 
error around an estimate.
3 The NS-SEC (National Statistics Socio-economic Classification) measure relating to household reference persons (the person in 
whose name the accommodation is owned or rented) does not easily lend itself to a manual/non-manual breakdown. Hence 
the social grade measure available for all people aged 16 and over in households was used, where non-manual was defined by 
social classes AB (higher and intermediate managerial/administrative/professional) and C1 (supervisory, clerical, junior managerial/
administrative/professional).
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a random selection of 636 addresses from the remaining two fieldwork quarters. 
Finally, three of the sampled addresses were not issued to interviewers due to 
problems with the addresses. Therefore the total sample of issued addresses 
was 14,717.4
Interviewers visited the addresses to identify private households with at least 
one resident aged 16 or over. When visited by an interviewer, 1,398 of the selected 
addresses were found not to contain private households. These addresses were thus 
ineligible, and were excluded from the survey sample. At eligible addresses found 
to contain more than one dwelling/household, interviewers used multi-dwelling/
household selection grids to select one dwelling/household at random.
In summary, out of the 14,717 addresses in the original sample, 13,122 (89%) were 
found to contain at least one private household, 1,398 (9%) were non-residential 
addresses, and 197 (1%) were addresses of unknown eligibility.
Sampling one adult per household
One adult aged 16 years or over was randomly selected for interview in each eligible 
household. This was done in preference to interviewing all eligible adults because:
• It helped interviewers to conduct the interview in privacy and thereby obtain 
more reliable information.
• Individuals within households tend to be similar to each other and, where 
households differ markedly from each other, the resultant clustering can lead to 
an increase in standard errors around survey estimates. By selecting one person 
in each household this clustering effect was overcome.
• Given the length of the interview process, interviewing one household member 
helped to reduce the burden placed on each household.
4 Consisting of 698 PSUs each with 22 addresses, minus 636 deselected and 3 not issued.
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Sampling for the phase two 
The approach taken for selecting which phase one participants would be invited 
for a phase two assessment was based on that used in the 2007 survey, but 
amended to select on the basis of two disorders (psychosis and autism) not four 
(borderline and antisocial personality disorder were also covered at phase two in 
2007). Further refinements to the sampling fractions, including introducing different 
sampling fractions for men and women, were possible due to the availability of 
data from the 2007 survey on the performance of the ASD screening items.
For each phase one participant, the probability of selection for a phase two 
assessment was calculated as the higher of two disorder-specific probabilities: 
psychosis probability and ASD probability. The probabilities were generated based 
on participants’ responses to screening questions in the phase one questionnaire 
and whether they were male or female. These disorder-specific probabilities 
of selection to phase two were then corrected for in disorder specific weights, 
described in Section 14.7.
14.3  Topic coverage
APMS 2014 phase one interview
The table below summarises the topic coverage of the phase one interviews. 
The interview structure consisted of initial modules of questions administered by 
the interviewer, a self-completion section, and further interviewer administered 
modules. A few sections were asked only of particular age-groups, for example 
questions on cognitive decline were restricted to those aged over sixty years. This 
was done in part to minimise respondent burden. The full phase one questionnaire 
is reproduced in Appendix D and the documentation lodged with the UK Data 
Service describes each of the survey items.
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APMS 2014 phase one interview content
Age of participant
CAPI interview: face to face interview [1] 16–59 60–69 70+
Details of household members and relationships • • •
General health and activities of daily living • • •
Caring responsibilities • • •
Mental wellbeing (WEMWBS)a • • •
Physical health conditions • • •
Sensory impairmenta • • •
Learning impairmenta • • •
Mental illness diagnosesa • • •
Treatment and service use • • •
Common mental disorders • • •
Suicidal behaviour and self-harm • • •
Psychosis screening questionnaire • • •
Attention-deficit/hyperactivity disorder • • •
Work related stress • • –
Tobacco • • •
Alcohol – any drinking • • •
CASI interview: self completion 
Alcohol (AUDIT, SADQ) • • •
Drug use and dependence • • •
Personality disorder • • •
Social functioning (SRQ) • • •
Bipolar disordera • • •
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continued Age of participant
CASI interview: self completion 16–59 60–69 70+
ASD • • •
Posttraumatic stress disorder • • •
Military experience • • •
Domestic violence and abuse • • •
Child neglecta • • •
Suicidal behaviour and self-harm • • •
Discrimination • • •
Sexual identity and behavioura • • –
Menopausea • – –
CAPI interview: face to face interview [2]
Cognitive and intellectual functioning:
TICS-M – • •
National Adult Reading Test (NART) • • •
Animal naming test – • •
Stressful life events (LTE) • • •
Parenting • • •
Social support networks (IMSR) • • •
Religion • • •
Social capital and participation • • •
Socio-demographics • • •
Consents (for data linkage and phase two contact) • • •
a These are new modules included in APMS for the first time in the 2014 survey.
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Mental disorders covered on APMS 2014
A summary of the measures used to assess or screen for each of the mental 
disorders included in APMS 2014 is listed below, with further technical detail in 
Appendix B.
Measures used to assess and screen for mental disorder
Condition Diagnostic 
status
Classification 
system
Assessment tool Survey 
phase
Reference 
period
Generalised 
anxiety 
disorder (GAD)
Present to 
diagnostic criteria
ICD-10 CIS-R 
(Lewis et al. 1992)
One Past week
CMD not 
otherwise 
specified (NOS)
Present to 
diagnostic criteria
ICD-10 CIS-R One Past week
Obsessive and 
compulsive 
disorder (OCD)
Present to 
diagnostic criteria
ICD-10 CIS-R One Past week
Depressive 
episode
Present to 
diagnostic criteria
ICD-10 CIS-R One Past week
Panic disorder Present to 
diagnostic criteria
ICD-10 CIS-R One Past week
Phobia Present to 
diagnostic criteria
ICD-10 CIS-R One Past week
Alcohol use 
disorders
Screen positive ICD-10 AUDIT (Saunders 
et al. 1993); SADQ 
(Stockwell et al. 
1994)
One Past six 
months
Drug 
dependence
Screen positive DSM-IV Based on Diagnostic 
Interview Schedule 
(Malgady et al. 
1992)
One Past year
Psychotic 
disorder
Present to 
diagnostic criteria
ICD-10 SCAN 
(WHO 1999)
One/ 
two
Past year
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continued
Condition Diagnostic 
status
Classification 
system
Assessment tool Survey 
phase
Reference 
period
Any personality 
disorder
Screen positive – SAPAS (Moran  
et al. 2003)
One Lifetime
Borderline 
personality 
disorder (BPD)
Present to 
diagnostic  
criteria
DSM-IV Self-report SCID-II 
(First et al. 1997)
One Lifetime
Antisocial 
personality 
disorder (ASPD)
Present to 
diagnostic  
criteria
DSM-IV Self-report SCID-II One Lifetime
Posttraumatic 
stress disorder 
(PTSD)
Screen positive DSM-IV PTSD-Check List 
(Blanchard et al. 
1996)
One Past week
Attention-
deficit/hyper-
activity disorder 
(ADHD)
Screen positive DSM-IV Adult Self-Report 
Scale-v1.1 
(WHO 2003)
One/ 
two
Past six 
months
Bipolar 
Disorder (BD)
Screen positive DSM-IV Mood Disorder 
Questionnaire 
(Hirschfeld et al. 
2000)
One Lifetime
Attempted 
suicide
Occurrence of 
behaviour
– Self completion One Past year
Autism Present to 
diagnostic  
criteria
DSM-IV Autism Diagnostic 
Observation 
Schedule (ADOS: 
Lord et al. 2003)
One/ 
two
Lifetime
The phase two interview assessed psychotic disorder and autism. In addition, a 
further assessment of ADHD was introduced to the phase two interview in 2014. 
The approach taken to the phase two assessment of psychosis is described in 
Chapter 5, the phase two assessment of autism is described in Chapter 6. The 
phase two assessment of ADHD is not covered in this report but will be covered 
in subsequent publications.
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Coverage of the 1993, 2000, 2007 and 2014 APMS interviews
The following table summarises the topic coverage of the 1993, 2000, 2007 and 
2014 APMS phase one questionnaires. In 1993 the survey was administered by 
paper and pen, from 2000 a consistent computer assisted interviewing approach 
was used. The aim has been to have consistent core coverage, with additional 
modules covered in different years.
Summary of APMS coverage in 1993, 2000, 2007 and 2014
Face to face interview 1993 2000 2007 2014
General health – • • •
Activities of daily living – – • •
Caring responsibilities – – • •
Service use and medication •a • • •
Self-perceived height and weight – – • –
Common mental disorders • • • •
Suicidal behaviour and self-harm •b • • •
Psychosis screening questionnaire • • • •
Attention-deficit/hyperactivity disorder – – • •
Work related stress – – • •
Smoking • • • •
Drinking • • • •
Self completion
Problem drinking •c • • •
Drug use • • • •
Personality disorder – • • •
Social functioning – – • •
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continued
Self completion
Problem gambling – – • –
ASD – – • •
Posttraumatic stress disorder – – • •
Military experience – – • •
Bipolar disorder – – – •
Domestic violence, abuse and neglect – – • •
Suicidal behaviour and self-harm (repeated) – – • •
Eating disorder – – • –
Discrimination – – • •
Face to face interview
Intellectual functioning:
TICS-M – • • •
National Adult Reading Test (NART) – • • •
Animal naming test – • • •
Key life events • • • •
Social support networks • • • •
Religion – – • •
Social capital and participation – – • •
Socio-demographics • • • •
a In APMS 1993 only participants who screened positive for CMD were asked about use 
of services and receipt of treatment.
b In APMS 1993 only participants with depression in the past week were asked about 
suicidal behaviour.
c APMS 1993 data on problem drinking is not compatible with that collected in 2000,  
2007 and 2014.
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Key variations across the survey series
A primary purpose of the survey series is to assess change in the population 
prevalence of disorders over time. For this reason comparability with previous 
surveys was a priority and so both the questionnaire and the approach taken to its 
administration were largely the same. However, there have been some changes in 
coverage and method over time, and these are summarised below. They were made 
as a result of consultation with data users and potential data users.
Area
The 1993 and 2000 surveys covered England, Scotland and Wales, while the 2007 
and 2014 surveys covered England only.
Age range
APMS 2007 and 2014 sampled adults aged 16 and over without an upper age 
limit. APMS 2000 included adults aged 16–74 and APMS 1993 covered adults 
aged 16–64.
New topics added
The following topics were included for the first time in the 2014 survey:
• Sensory impairment
• Previous diagnosis of mental illness and learning impairment
• Bipolar disorder
• Child neglect
• Menopause
• Sexual behaviour
Summary of amendments to existing modules
The full questionnaire was reviewed prior to launch in 2014. A detailed list of all 
questionnaire changes are included with the archived dataset, including information 
on the rationale for changes. In summary, amendments made to modules that were 
in the 2007 questionnaire include:
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• Mental wellbeing: single item measures were replaced with the validated 14 item 
Warwick Edinburgh Mental Well-Being Scale (WEMWBS) (Tennant et al. 2007).
• General health: the SF125 was replaced with detailed questions about specific 
chronic conditions.
• Caring responsibilities: additional questions were asked about the nature of the 
relationship between the participant and the person they provide care for.
• Medications and service use: an extended list of medications and services were 
asked about, to reflect changes in prescribing practice and services available; 
new questions were added on requesting treatment.
• Common mental disorder: questions on social phobia were added (the mini 
Social Phobia Inventory, Weeks et al. 2007).
• Work-related stress: the module was extensively revised, including adding 
additional questions on bullying in the workplace.
• Tobacco: new questions were added on smoking cessation and e-cigarettes.
• Personality disorder: the addition of a screen for any personality 
disorder (SAPAS).
• Suicidal behaviour and self-harm: while some questions were retained 
in the face to face section of the interview, most were moved into the 
self-completion section.
• Drug use: new questions were added on use of ketamine and mephedrone.
• PTSD: the screening tool changed to the PTSD-Check List (PCL) for better 
comparability with other surveys.
• Military experience: additional questions on deployment were added.
• Interpersonal violence and abuse: additional questions about the assailant 
were added.
5 The 12-item Short-Form Survey (SF12) www.rand.org/health/surveys_tools/mos/12-item-short-form.html. This change was made 
partly due to steep increases in the license costs for use of this tool.
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• Key life events: changes were made to the questions about key life events to 
make it clearer when the events had taken place.
• Religion: questions on spirituality were replaced with questions on belief.
• Poverty: questions were added on material deprivation.
Phase two sample selection
For the 2014 survey, data from the 2007 survey were available on which to model 
sampling fractions for autism. This allowed for the development of more precise 
and discriminating probabilities. The 2014 approach is outlined in Section 14.2.
14.4 Piloting and questionnaire development
Guidance and consultation
The APMS series is long-established, and the 2014 survey design is based on that 
used in previous surveys in the series. The survey development that did take place, 
to ensure that the survey meets current needs, drew on the expertise of a wide 
range of advisors and data users. These included:
• Project oversight and management from key managers at NHS Digital.
• A Steering Group comprised of representatives from the Department of Health, 
Public Health England, NHS England, Royal College of Psychiatrists, Improving 
Access to Psychological Therapies, and academic leads in psychiatric epidemiology 
(Professor Paul Bebbington) and economics (Lord Professor Richard Layard). 
This group was co-ordinated by NHS Digital.
• An APMS Academic Group, co-ordinated by the research team, and drawing on the 
expertise of leading academics from a range of universities and medical schools.
• A convened group of senior NatCen interviewers with practical experience of 
survey delivery in field.
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Cognitive testing
Two waves of cognitive testing were carried out in 2013 and 2014.6 Because 
one of the main questionnaire modules being developed addressed psychiatric 
diagnoses, participants with personal experience of mental illness were oversampled. 
The purpose of this stage of development work was to test the questions new 
to the 2014 survey and some questions from 2007 that were identified by data 
users and others as in need of revision. In addition, the cognitive testing explored 
alternative survey names and visual branding, and lead to the development of a 
study logo. Participants’ interpretations of questions were explored, as well as their 
views on acceptability, language and terminology. Reports on the findings of the 
cognitive testing were submitted to NHS Digital.
Dress rehearsal
Following the cognitive testing, the questionnaire was refined in preparation 
for a full dress rehearsal. The dress rehearsal enabled testing of the flow, content 
and timings of the interview as a whole, and of individual modules, together with 
the operation of fieldwork procedures. The dress rehearsal included phase two 
interviews conducted by clinically trained interviewers co-ordinated by the University 
of Leicester. The phase two pilot sample included people both men and women of a 
range of ages. Again, a report on the dress rehearsal was submitted to NHS Digital.
14.5 Fieldwork procedures
Training and supervision of interviewers
Phase one interviewers
The NatCen interviewers selected to work on the first phase of the survey tended 
to be particularly experienced, and most had worked previously on other health-
related surveys. They were fully briefed on the administration of the survey. Topics 
covered on the one-day survey-specific training included introducing the survey, 
questionnaire content, confidentiality and responding to participant distress.
6 For more details on cognitive testing see Collins D (2003) Pretesting survey instruments: An overview of cognitive methods in 
Quality of Life Research 12. Kluwer Academic Publishers.
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Written instructions were provided for interviewers. As the fieldwork took place 
over the course of a year, refresher sessions were available for interviewers who 
took a break from the survey. Less experienced interviewers were accompanied 
by a project supervisor during the early stages of their fieldwork to ensure 
that the interviews were administered correctly. Routine supervision of 10% 
of interviewer work was subsequently carried out.
Phase two interviewers
The phase two interviewers were recruited and co-ordinated by the University 
of Leicester. They were all experienced in psychological research interviewing, 
and most had worked on APMS 2007. Phase two interviewers received an extensive, 
month-long induction and training programme, run by a senior research psychologist 
and a psychiatrist. They also received training sessions from NatCen on using 
computer assisted interviewing. Whilst in the field these interviewers received 
regular supervision sessions and technical support.
Advance letters
An advance letter was sent to each sampled address. This introduced the survey 
and stated that an interviewer would be calling to seek permission to interview. 
A sample advance letter is provided in Appendix E.
Making contact
At initial contact, the interviewer established the number of households at the 
address, and made any selection necessary (see Section 14.2). The interviewer 
randomly selected one adult per household, and then attempted to interview 
that person. As in previous waves in the series, the survey title used in the field 
was the ‘National Study of Health and Wellbeing’. This was felt to be more 
readily understandable than ‘psychiatric morbidity’, an observation confirmed in 
the cognitive testing (see Section 14.4). Interviewers had various materials they 
could use on the doorstep and leave with participants, including a survey leaflet 
that introduced the study and provided details of a number that people could 
call (see Appendix E).
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Collecting the data
The phase one and the phase two interviews each took about an hour and a 
half to complete on average, although some were shorter and others took as long 
as three hours. The phase one and phase two interviews both involved computer 
assisted interviewing (CAPI). In phase one, some information was collected by 
self-completion, also using the laptop. Despite the self-completion section being 
very long, 75% of participants completed this entirely alone. In 16% of cases the 
interviewer read out the self-completion and entered the participant’s responses, 
and for 3% of cases the interviewer read out the questions but the participant 
entered their own responses. 6% of participants did not complete the self-
completion section of the interview at all, this was mainly older participants.
At the end of the phase one interview, permission was sought for the participant’s 
survey responses to be linked with other health datasets, including the NHS Central 
Register and Hospital Episode Statistics. 77% gave permission for data linkage. 
The documentation for this is included in Appendix E. Verbal permission was also 
sought for a University of Leicester interviewer to contact the participant again in 
order to explain the phase two interview, should they be selected: 78% agreed.
If the selected participant was not capable of undertaking the interview alone, 
for reasons of mental or physical incapacity, the option was available for additional 
information to be collected from another member of the family or a carer on their 
reasons for not being able to take part. In 2007 this took the form of a proxy 
interview, with data collected in the laptop. In 2014, information was collected 
on the doorstep.
Token of appreciation and helpline information
A high street voucher was given to all those who took part in a phase one 
interview as an appreciation for their time. In addition, those who were selected 
and took part in the phase two interview were given an additional high street 
voucher. All participants were also offered a list of helpline numbers that they could 
call. These included the numbers for organisations providing information about the 
various disorders covered in the survey as well as for those providing support to 
people in crisis. The helplines leaflet also emphasised contacting a GP for support 
and advice as a first step (see Appendix E).
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14.6 Survey response
Response at phase one
Of the 14,717 addresses in the original sample, 13,122 (89%) were found to include 
at least one private household, 1,398 (9%) were non-residential addresses, and 203 
(1%) were addresses of unknown eligibility. This left 13,313 cases in the sample 
set. Of these 3872 (29%) were refusals in field and 300 refusals direct to the office. 
782 were coded as non-contacts and 813 were unproductive for another reason. 
7,546 productive interviews were achieved, representing a 57% response rate. This 
included 18 partial interviews where the participant completed the treatment, service 
use and CIS-R modules, but did not reach the end of the interview.
Response rates of adults at phase one
Number Percentage
Potentially eligible households 13,313
Field refusals 3,872 29%
Office refusals 300 2%
Non-contacts 782 6%
Other unable/unproductive 813 6%
Productive adults 7,546 57%
Full interviews 7,528
Partial interviews 18
Response at phase two
7,528 participants provided a full phase one interview. A probability of selection 
was calculated for each participant based on their answers to the phase one 
screening questions on psychosis and ASD as outlined in Section 14.2. Overall 78% 
of phase one participants agreed to be contacted about the phase two interview. 
After the application of the highest of the two disorder specific sampling fractions, 
875 participants were issued for a phase two interview. Phase two interviews 
were conducted with 630 of these (72%), and there were 204 refusals and 
41 non-contacts.
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14.7 Weighting the data
Weighting the phase one data
The survey data were weighted to take account of selection probabilities and non-
response, so that the results were representative of the household population aged 
16 years and over. Weighting occurred in four steps.
First, address selection weights (wt1) were applied to take account of 
the differential selection probabilities of addresses (after the removal of 636 
addresses from the originally drawn sample, see Section 14.2). For each of the 
698 sampled PSUs, the weight was calculated as follows: wt1 = total addresses 
on PAF / (698 x number of sampled addresses per PSU). All addresses in the 
same PSU were assigned the same weight.
Second, to reduce household non-response bias, a household level weight was 
calculated from a logistic regression model using interviewer observation and 
area-level variables (collected from Census 2011 data) available for responding and 
non-responding households. The dependent variable was whether the household 
responded or not. The independent variables considered for inclusion in the model 
were the presence of any physical barriers for entry to the property (e.g. a locked 
common entrance or the presence of security staff), Government Office Region 
(GOR), Index of Multiple Deprivation 2010 (IMD 2010) quintiles,7 population density 
(number of persons per hectare), percentage of households owner-occupied, 
and the percentage of adults in a non-manual occupation.
Not all the variables were retained for the final model: variables not significantly 
related to the propensity of households to respond were dropped from the 
analysis. The variables significantly associated with response were: GOR, whether 
there were entry barriers to the selected address, the percentage of households 
owner-occupied and population density. The model shows that the propensity for 
a household to respond was lower in Yorkshire and Humberside, East of England, 
and in inner and outer London (relative to the North East), higher for households 
7 IMD 2010 is a measure of multiple deprivation at the small area level. www.gov.uk/government/statistics/english-indices-of-
deprivation-2010
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with no physical barriers for entry to the property, higher in areas where a relatively 
high percentage of households were owner-occupied and lower in areas with a 
relatively high population density.
The non-response weight (wt2) for each eligible household was calculated as the 
inverse of the probability of response estimated from the final model. The full 
model is given in Table 14.2. Table 14.2
Third, selection weights (wt3) were applied to take account of the different 
probabilities of selecting participants in different sized households.8 The weight 
was equal to the number of adults (16+) in the household, the inverse of the 
probability of selection.9
The composite weight for selection and participation was calculated as the product 
of the weights from the previous stages: wt4 = wt1 x wt2 x wt3.
The final stage of the weighting was to adjust the composite weight (wt4) 
using calibration weighting.10 Calibration takes an initial weight (in this case 
wt4) and adjusts (or calibrates) it to given control totals. The process generates a 
weight which produces survey estimates that exactly match the population for the 
specific characteristics (control totals) used in the adjustment. Calibration reduces 
any residual non-response bias and any impact of sampling and coverage error 
for the measures used in the adjustment. The population control totals used were 
the ONS 2014 mid-year population estimates for age-by-sex and region, shown in 
Tables 14.3 and 14.4. After calibration, the APMS 2014 weighted data matches 
the estimated population in terms of age-by sex and region as shown in 
Table 14.5. Tables 14.3 to 14.5
An additional weight was calculated for the combined APMS 2007 and 2014 
datasets by re-calibrating the combined data to the ONS 2014 mid-year population 
8 The selection of multiple dwellings and/or households was done as a paper exercise and was not collected in the CAPI. As a result, 
there was no information on selection at addresses with multiple dwelling units or at dwelling units with multiple households, so it 
was not possible to adjust for this in the weighting. Evidence from other large scale English-only household surveys (e.g. the Health 
Survey for England) show that only a very small percentage of addresses in England (under 1%) turn out to include multiple dwellings/
households. Therefore, any bias from not adjusting for multiple dwellings/households should be negligible.
9 The selection weight wt3 was trimmed at 4 to avoid a small number of very high weights which would inflate the standard errors, 
reduce the precision of the survey estimates and cause the weighted sample to be less efficient.
10 The calibration weighting was carried out in STATA (StataCorp. 2013).
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estimates for age-by sex and region. The combined weight is being used solely 
for analysis of the combined 2-year dataset.
Weighting the phase two data
Two weighting variables have been developed specifically for use when analysing 
outcomes derived from phase two data: presence of psychosis and presence of 
autism. These weights were designed to generate condition-specific datasets that 
are representative of the general population, and based on all the participants with 
relevant information.
The phase two participants have a set of survey weights different from those 
generated for phase one, with one set of weights being applicable for psychosis 
and a second set being applicable for autism. Participants get a phase two weight if 
they were eligible for phase two, were selected, and then responded.
For analysis of prevalence of disorders assessed at phase two (autism and psychosis), 
the weighted phase two participants are added to the set of phase one participants 
who were not eligible for phase two, the prevalence being assumed to be zero for 
the not eligible group. Those not eligible are given their phase one weights.
The phase two weights account for two factors:
1. Not all those eligible for phase two were selected with equal probability: 
all those screened in with a positive psychosis score were selected (although 
those selected in the final two months of fieldwork were subsequently 
excluded), as were all men with an Autism-Spectrum Quotient (AQ) score 
of eight or more and all women with an AQ score of 11 or more. But for 
men with an AQ score of between 4 and 7, and women with an AQ score 
of between 4 and 10, sub-sampling was used.
2. Some of the eligible phase one participants did not agree to be contacted for 
phase two during their phase one interview so were automatically excluded 
from the phase two selection. Others were selected for phase two but then 
declined to take part. These refusals introduce the possibility of phase two non-
response bias. The phase two weights incorporate a non-response adjustment 
to ensure that those responding have a similar weighted profile to those eligible.
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The phase two weights were calculated by modelling, via logistic regression, the 
probability of being selected and responding to phase two, conditional on being 
eligible for selection. The weight per phase two participant was then calculated 
as the inverse of the predicted probability from the model, multiplied by their 
phase one weight. The predicted probabilities simultaneously account for selection 
probabilities and for observable non-response biases.
The variables included in the model were: phase one psychosis and AQ scores; 
gender; marital status, ethnic group (four categories (Moran et al. 2003)); and age 
group. Other variables, such as employment status, qualification, and the index 
of multiple deprivation quintile group, were tested in the regression model but 
excluded because not significant (the implication being that there is no statistical 
evidence of non-response bias on these variables).
14.8 Data analysis and reporting
Introduction
APMS 2014 is a cross-sectional survey of the general population. While it allows for 
associations between mental disorder and personal characteristics and behaviour to 
be explored, it is important to emphasise that such associations cannot be assumed 
to imply causality. A list of the variables used in the analysis in this report is provided 
in Appendix C: all will be included in the archived dataset.
Weighted analysis and unweighted bases
As outlined in Section 14.7 above, all the data presented in the substantive 
chapters of this report are weighted to account for likelihood of selection and non-
response. Bases are presented as unweighted to show the number of participants 
included, should weighted bases be required these can be generated from the 
archived dataset.
Testing for seasonal variation
The fieldwork for the psychiatric morbidity surveys conducted in 1993 and 2000 
was conducted around March to August of their respective calendar years. 
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Fieldwork for APMS 2007 and 2014 was spread across a whole year, so that 
any seasonal variation in rates could be explored. This raised the issue of whether 
month of interview would need to be controlled for when examining trends in 
disorders assessed on the basis of symptoms in a recent reference period. To check 
on this, we looked at the rate of any common mental disorder and the rate of 
depression in terms of the month in which the interview took place. Adjusting 
for month of interview did not significantly affect rates of disorder and so is 
not included this report.
Age-standardisation
Rates of disorder in some analyses have been age-standardised in this report to allow 
for comparisons between groups after adjusting for the effects of any differences 
in their age distributions. When sub-groups are compared in respect of a variable 
on which age has an important influence, differences in age distributions between 
sub-groups are likely to affect the observed differences in the proportions of interest.
Most analyses in this report (sample size permitting) are presented separately 
for men and women, as well as for the total population. Age-standardisation was 
undertaken separately within each sex, expressing male data to the overall male 
population and female data to the overall female population. When comparing 
data for the two sexes, it should be noted that no age-standardisation has 
been undertaken to remove the effects of the sexes’ different age distributions. 
It should also be noted that where data for all adults combined is presented 
as age-standardised, this has been produced in the way outlined above, with 
male data expressed to the age profile of the male population and female 
data expressed to the profile of the female population.
Age-standardisation was carried out using the direct standardisation method. The 
reference population was the Office for National Statistics’ Census based mid-year 
2014 population estimates for England.
Age-standardisation was not conducted for some analyses. These include analysis 
by household type. Our age-standardisation approach requires cases to be present 
in each ‘cell’. Because some household type groups (e.g. ‘one or more adults aged 
65+’) did not have cases in some age/sex combinations (e.g. men aged 16–24), 
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there was no rate in the cell to weight up to the population prevalence. Moreover, 
where there are very few cases in a cell, this tends to cause instability in the age-
standardised rate generated. This is one of the reasons why observed rates are 
often presented alongside rates that have been age-standardised.
Standard analysis breaks
Most of the disorders covered in this report are analysed by a core set of breaks: 
age, sex, ethnic group, household type, employment status, benefit status, and 
region, described briefly below and are defined in more detail in the Glossary.
Ethnic group
Participants identified their ethnicity according to one of fifteen groups presented on 
a show card, including ‘other – please state’. These groups are based on those used 
in the latest Census and are drawn from the ONS harmonised ethnic group questions 
for use on national surveys. The groups were subsumed under four headings: White; 
Black/Black British; Asian/Asian British; and those who reported their ethnic group 
as mixed, multiple or other. For some analyses by ethnic group the White group was 
further divided into ‘White British’ (which included those giving their ethnic group 
as White and English, Scottish, Welsh or from Northern Ireland) and White other. 
About 15% of the sample (1,131 participants) identified with an ethnic group other 
than White British. This is in line with the combined prevalence of these groups in 
the adult population resident in England. It should be noted that these small groups 
are highly heterogeneous, for example the ‘Black’ group could include both recent 
migrants from Somalia and Black people born in Britain to British parents. The results 
of analysis by ethnic group should therefore be treated with caution.
Household type
In APMS, basic information (age, sex and relationship status) was collected from 
the participant about all members of the household in which they lived. This 
enabled a variable to be derived that summarised the structure of the household 
in which people lived, particularly in relation to the number and ages of the other 
people lived with. This enables the circumstances of people living alone to be 
compared with those of people living with others, as well as identifying participants 
living with children. A ‘small family’ was defined as one or two adults living with 
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one or two children, and a ‘large family’ was defined as at least one adult living 
with three or more children. 
Employment status
Detailed information was collected from participants on the nature of their 
employment status in the previous week. Participants were classified as either 
employed (including working in a family business); unemployed (and therefore 
looking and available for work); or economically inactive (including those who are 
unable to work due to disability or illness, students, retired, or looking after the 
home). The standard International Labour Organisation11 definition was used, and 
is described more fully in the Glossary. Where this analysis break has been used, 
generally the base has been restricted to participants aged between 16 and 64.
Benefit status
Participants were asked, using a series of showcards, whether or not they were in 
receipt of each of a range of benefits. For the purposes of the analyses presented in 
this report, three variables were derived. One allows participants reporting current 
receipt of Employment and Support Allowance (ESA) to be compared with those 
who do not receive this benefit. ESA is a benefit available to people of working 
age but who are unable to work due to disability or impairment. While Incapacity 
Benefit (IB) was not actually available at the time of the interview, a few participants 
(11) reported receiving this, and they were included in the ESA group. ‘Any out of 
work benefit’ included those reporting ESA or IB, combined with those in receipt 
of Jobseeker’s Allowance (JSA). Analyses using these two variables were restricted 
to participants aged 16–64. A third benefit group was used in the analysis in this 
report: those living in a household in receipt of Housing Benefit. This is a household 
level benefit and relates to support provided to help with rent costs.
Region
The former GORs were used for the analysis by region. The APMS sample is too 
small for analysis by geographical groupings below region.
11 www.ilo.org/global/about-the-ilo/lang--en/index.htm
 378 | APMS 2014  | Chapter 14: Methods  | Copyright © 2016, Health and Social Care Information Centre
Treatment and service use
When looking at treatment and service use, participants screening positive 
for each disorder were compared with those who did not. Because of the 
relatively low prevalence of many of the disorders assessed in APMS 2014, this 
generally meant that the base size for the group with the disorder was usually 
small. Age-standardising a small group can be problematic, for the reasons 
outlined in Section 14.8, and so the treatment and service use tables were 
not age-standardised in most of the chapters.
Sampling errors and design factors
The percentages quoted in the main report are estimates for the population based 
on the information from the sample of people who took part in this survey. All 
such survey estimates are subject to some degree of error. The confidence interval 
(CI) is calculated from the sampling error, which is a measure of how such a survey 
estimate would vary if it were calculated for many different samples. If the survey 
was repeated many times, such a 95% CI would contain the true value 95% of the 
time. For this survey, a multi-phase stratified design was used, rather than a simple 
random sample, and the sampling errors need to reflect this.
The effect of a complex sample design on estimates is quantified by the design 
factor (deft). It is the ratio of the standard error for a complex design to the standard 
error which would have resulted from a simple random sample. A deft of two, for 
example, indicates that the standard errors are twice as large as they would have 
been had the sample design been a simple random sample. The sampling errors, 
design effects and CI for key prevalence variables can be found in Tables 14.6 to 
14.15. The calculations were carried out using the statistical package SPSS v21 
(IBM Corp. 2012). Tables 14.6 to 14.16
Quality assurance
Quality assurance has been defined as any method or procedure for collecting, 
processing or analysing survey data that is aimed at maintaining or enhancing 
reliability or validity (Statistics Canada 1998). It was an ongoing process throughout 
APMS, from preparation and sampling through data collection and data analysis to 
report writing, as detailed in this chapter. NatCen has a quality management system 
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with sets of procedures that were followed throughout. The purpose of establishing 
standard procedures, as highlighted by the WHO in relation to its World Health 
Surveys, is to help ensure that (Üstun et al. 2005):
• Data collection is relevant and meaningful
• Data can be compared across surveys and between subgroups
• Practical implementation of the survey adheres to proper practice
• Errors in data collection are minimised
• Data-collection capability is improved over time.
Examples of quality control measures built into, or to check afterwards, the survey 
process included:
• The computer programme used by interviewers had in-built soft checks (which 
can be suppressed) and hard checks (which cannot be suppressed); these included 
querying uncommon or unlikely answers, and answers out of the acceptable range.
• For phase one interviewers, telephone checks were carried out with participants 
at 10% of productive households to ensure that the interview had been 
conducted in a proper manner.
• The phase two interview was less structured, and required clinical skill and 
assessment by a graduate psychologist. The work of these research psychologists 
was supervised by a senior research psychologist. The experienced trainer also 
accompanied all of the interviewers on at least one of their participant visits 3 
months into fieldwork, to ensure that they were conducting the interview as per 
protocol and to validate the coding. If a further supervised visit was felt necessary, 
this was also carried out. 
• An ADOS (ASD assessment) reliability day was carried out, where all phase two 
interviewers returned to Leicester for their ADOS interviewing to be validated. 
Furthermore, if a phase two interviewer was unsure about any rating during 
fieldwork, they made extensive notes and then contacted the field research 
manager to discuss.
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14.9 Tables
Sampling
Table 14.1 Regional stratifier used and number of PSUs selected
Table 14.2 Final response model
Table 14.3  2014 mid-year household population estimates for adults in England, 
by age and sex
Table 14.4  2014 mid-year household population estimates for adults in England, 
by Government Office Region
Table 14.5  Weighted and unweighted sample distribution, by Government Office 
Region, age and sex
Standard errors and confidence intervals for key estimates
Table 14.6  True standard errors and 95% confidence intervals for CIS-R score 
and prevalence of common mental disorders (CMDs)
Table 14.7  True standard errors and 95% confidence intervals for treatment rate 
among people with a CMD
Table 14.8  True standard errors and 95% confidence intervals for major trauma 
and screen positive for posttraumatic stress disorder (PTSD)
Table 14.9  True standard errors and 95% confidence intervals for prevalence 
of psychotic disorder in past year
Table 14.10 True standard errors and 95% confidence intervals for autism
Table 14.11  True standard errors and 95% confidence intervals for screening 
positive for personality disorder
Table 14.12  True standard errors and 95% confidence intervals for number of 
attention-deficit/hyperactivity disorder characteristics present in the 
past six months
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Table 14.13  True standard errors and 95% confidence intervals for prevalence 
of bipolar disorder
Table 14.14  True standard errors and 95% confidence intervals for prevalence 
of hazardous and harmful drinking in the past year
Table 14.15  True standard errors and 95% confidence intervals for prevalence 
of drug dependence
Table 14.16  True standard errors and 95% confidence intervals for prevalence 
and recency of suicidal thoughts, suicide attempts and self-harm
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 Abbreviations
ADHD Attention-deficit/hyperactivity disorder
ADL Activities of Daily Living
APMS Adult Psychiatric Morbidity Survey
AQ20 20 item Autism Quotient
ASPD Antisocial personality disorder
ASRS Adult ADHD Self-Report Scale
AUDIT Alcohol Use Disorders Identification Test
BPD Borderline personality disorder
CAPI Computer Assisted Personal Interviewing
CASI Computer Assisted Self-completion Interviewing
CI Confidence interval
CIS-R Clinical Interview Schedule-Revised
CMD Common mental disorder
DH Department of Health
DSM Diagnostic Statistical Manual
GAD Generalised anxiety disorder
HSE Health Survey for England
HSCIC Health and Social Care Information Centre, now NHS Digital
ICD-10 International Classification of Disease – version 10
IMD Index of Multiple Deprivation
JSA Jobseeker’s Allowance
MDQ Mood Disorder Questionnaire
MHCYP Mental Health of Children and Young People Survey
NART National Adult Reading Test
OCD Obsessive compulsive disorder
ONS Office of National Statistics
PHE Public Health England
PSQ Psychosis Screening Questionnaire
PTSD Posttraumatic stress disorder
PTSD-CL Posttraumatic stress disorder – checklist screening tool
SADQ Severity of Alcohol Dependence Questionnaire
SAPAS Standardised Assessment of Personality – Abbreviated Scale
SCAN Schedules for Clinical Assessment in Neuropsychiatry
SCID-II Structured Clinical Interviews for DSM Disorders
TICS-M Modified Telephone Interview for Cognitive Status
WEMWBS Warwick Edinburgh Mental Well-Being Scale
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 Glossary
ADHD/ADD Attention-deficit/hyperactivity disorder (ADHD) is a life-long condition 
characterised by sustained and excessive problems with organisation, 
sustaining attention in activities that require cognitive involvement, 
hyperactivity, restlessness and impulsiveness to the extent that it 
significantly interferes with everyday life. 
Also see ASRS (Adult ADHD Self-Report Scale – v1.1). 
Adults Adults were defined as people aged 16 and over.
Age-standardisation Age-standardisation has been applied to some analyses to enable different 
groups to be compared after adjusting for the effects of any differences in 
their age distributions. When different sub-groups are compared in respect 
of a variable on which age has an important influence, any differences in 
age distributions between these sub-groups are likely to affect the observed 
differences in the proportions of interest. 
Age-standardisation was carried out using the direct standardisation 
method. The standard population to which the age distribution of sub-groups 
was adjusted was the Office for National Statistics 2014 mid-year household 
population estimates for England. Age-standardisation was carried out using 
the following age groups: 16–24, 25–34, 35–44, 45–54, 55–64, 65–74 and 
75 and over. When age-standardisation was applied to analysis by ethnic age, 
sometimes the 65–74 and 75 and over age groups were combined due to 
small sample sizes.
Age-standardisation was not applied where a variable did not have participants 
for every cell in every age band. For example, because there could be no 
people aged 16–24 living in households where everyone was aged 65 or 
over, age-standardisation was not applied to analysis by household type. 
All age-standardised tables are labelled as such in the title. 
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Alcohol dependence The National Institute of Health and Clinical Excellence defines alcohol 
dependence as a cluster of behavioural, cognitive and physiological factors 
that typically include a strong desire to drink alcohol and difficulties in 
controlling its use. Someone who is alcohol-dependent may persist in drinking 
despite harmful consequences. They will also give alcohol a higher priority 
than other activities and obligations.
Alcohol dependence was measured using two instruments. The primary 
measure, the Alcohol Use Disorders Identification Test (AUDIT), was used to 
divide the population into groups: non-drinker or low risk drinking; hazardous 
drinking; harmful drinking and/or mild dependence; and probable dependence.
Those who scored 10 or above on the AUDIT were also asked the Severity 
of Alcohol Dependence Questionnaire – Community (SADQ-C). 
Also see harmful drinking and hazardous alcohol use. 
Anxiety disorders Anxiety disorders include generalised anxiety disorder (GAD), panic disorder, 
phobias and obsessive compulsive disorder (OCD). 
Also see common mental disorders. 
ASPD (antisocial 
personality disorder) 
DSM-IV characterises antisocial personality disorder as a pervasive pattern of 
disregard for and violation of the rights of others that has been occurring in 
the individual since the age of 15 years, as indicated by three (or more) of 
seven criteria: 
• A failure to conform to social norms
• Irresponsibility
• Deceitfulness
• Indifference to the welfare of others
• Recklessness
• A failure to plan ahead, and
• Irritability and aggressiveness. 
Also see personality disorder. 
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ASRS (Adult 
ADHD Self-Report 
Scale-V1.1) 
The Adult ADHD Self-Report Scale-V1.1 (ASRS) was used in the 2007 and 2014 
APMS to estimate the prevalence of possible ADHD. The six item ASRS screen 
is a shortened version of the 18 item Symptom Checklist scale measuring the 
frequency of recent DSM-IV Criterion A symptoms of adult ADHD. 
Also see ADHD (attention-deficit/hyperactivity disorder). 
Benefits Participants were asked whether or not they, or their household, were in 
receipt of a range of different types of state benefit. Three groupings of 
benefits were examined in this report:
• Employment Support Allowance (ESA, plus those who reported still being 
in receipt of ‘Incapacity Benefit’ (IB))
• All out-of-work benefits (ESA, IB plus Jobseeker’s Allowance)
• Housing benefit.
Bipolar disorder Bipolar disorder is defined in ICD-10 as a condition that is characterised by 
repeated episodes in which someone’s mood and activity levels are significantly 
disturbed, with some occasions of an elevation of mood and increased energy 
and activity (mania or hypomania), and on others of a lowering of mood and 
decreased energy and activity (depression). It was screened for on the APMS 
series for the first time in 2014, using the Mood Disorder Questionnaire (MDQ).
BPD (borderline 
personality disorder) 
According to the DSM-IV diagnostic criteria for borderline personality disorder 
(BPD), the key features are instability of interpersonal relationships, self-image 
and mood, combined with marked impulsivity, beginning in early adulthood. 
It is indicated by five (or more) of the following criteria: 
• Frantic efforts to avoid real or imagined abandonment
• Pattern of unstable and intense personal relationships
• Unstable self-image
• Impulsivity in more than one way that is self-damaging (e.g. spending, sex, 
substance abuse, binge eating, reckless driving)
• Suicidal or self-harming behaviour
• Affective instability 
• Chronic feelings of emptiness
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BPD (borderline 
personality disorder) 
continued
• Anger, and 
• Paranoid thoughts or severe dissociative symptoms. 
Also see personality disorder. 
Chronic physical 
health conditions
A chronic – or long term – physical health condition is a health problem that 
requires ongoing management over a period of years or decades.
It generally is one that cannot currently be cured but can be controlled with 
the use of medication and/or other therapies.
Chronic physical health conditions focused on in this report include: 
• Asthma
• Cancer 
• Diabetes 
• Epilepsy 
• High blood pressure
CIS-R (Clinical 
Interview Schedule – 
Revised) 
The CIS-R is a questionnaire designed to measure common mental symptoms 
and disorders, such as anxiety and depression. It comprises of 14 sections 
each covering a particular type of common mental disorder (CMD) symptom. 
Scores are obtained for each symptom based on frequency, duration and 
severity in the last week. Individual symptoms scores can be summed to 
provide an overall score for the level of symptoms of CMD. A score of 12 
or more indicates the presence of significant symptoms of CMD warranting 
clinical recognition, while a score of 18 or more indicates symptoms of a level 
likely to require intervention. Diagnoses of six specific CMD were obtained by 
looking at answers to the various sections of the CIS-R and applying algorithms 
based on the ICD-10 diagnostic criteria for research. 
The six categories of CMD are: 
• Generalised anxiety disorder (GAD)
• Depressive episode (mild, moderate or severe)
• Phobias
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CIS-R (Clinical 
Interview Schedule – 
Revised) 
continued
• Obsessive-compulsive disorder
• Panic disorder
• CMD-NOS
Also see common mental disorders and CMD symptoms. 
Common mental 
disorders (CMDs) 
These are characterised by a variety of symptoms such as fatigue and sleep 
problems, forgetfulness and concentration difficulties, irritability, worry, panic, 
hopelessness, and obsessions and compulsions, which present to such a degree 
that they cause problems with daily activities and distress. The prevalence 
of CMD symptoms in the week prior to interview was assessed using the 
revised version of the Clinical Interview Schedule (CIS-R). A score of 12 or 
more indicates the presence of significant symptoms of CMD while a score 
of 18 or more indicates symptoms of a level likely to require treatment. 
Also see CMD symptoms and CIS-R (Clinical Interview Schedule – Revised). 
Common mental 
disorders (CMDs) 
symptoms
The CIS-R comprises 14 sections, each covering a particular symptom of CMD 
as follows: 
• Somatic symptoms are characterised by a physical ache or pain/discomfort 
that cannot be attributed to a medical condition or to the use of drugs. 
Somatic symptoms often interfere significantly with a person’s ability to 
perform important activities. 
• Fatigue the emphasis is on feelings of bodily or physical weakness 
and exhaustion after only minimal effort, accompanied by a feeling 
of muscular aches and pains and inability to relax. A variety of other 
unpleasant physical feelings are common, such as dizziness, tension 
headaches, and feelings of general instability. 
• Concentration and forgetfulness this includes the inability to concentrate 
without the mind wandering and forgetting something important to the 
extent that it interferes with a person’s ability to perform daily activities. 
• Sleep problems are characterised by a disturbance in the person’s 
amount of sleep, quality or timing of sleep, or in behaviours or 
physiological conditions associated with sleep. 
• Irritability is associated with feeling short tempered and angry to the 
extent that it results in arguments or quarrels. 
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Common mental 
disorders (CMDs) 
symptoms
continued
• Worry about physical health this is defined by feelings of worry about 
a physical/serious physical illness to the extent that an individual is unable 
to take their mind off their health worries. 
• Depression is characterised by a lowering of mood, reduction of 
energy, and decrease in activity. Capacity for enjoyment, interest, and 
concentration is reduced, and marked tiredness after even minimum 
effort is common. 
• Depressive ideas are characterised by loss of self-esteem and ideas of 
worthlessness or guilt. Suicidal thoughts are common. 
• Worry is associated with a persistent feeling of worry about things 
(other than physical health). 
• Anxiety is defined as generalised and persistent but not restricted 
to, or even strongly predominating in, any particular environmental 
circumstances. The dominant symptoms are variable but include 
complaints of persistent nervousness, trembling, muscular tensions, 
sweating, light-headedness, palpitations, dizziness, and discomfort. 
• Phobias are a group of disorders in which anxiety is evoked only, or 
predominantly, in certain well-defined situations that are not currently 
dangerous. As a result, these situations are characteristically avoided or 
endured with dread. Individual symptoms include palpitations or feeling 
faint and are often associated with secondary fears of dying, losing 
control, or going mad. 
• Panic the essential feature is recurrent attacks of severe anxiety (panic), 
which are not restricted to any particular situation or set of circumstances 
and are therefore unpredictable. The dominant symptoms include sudden 
onset of palpitations, chest pain, choking sensations, dizziness, and 
feelings of unreality. 
• Compulsions are repetitive, purposeful and ritualistic behaviours or 
mental acts, performed in response to obsessive intrusion and to a set 
of rigidly prescribed rules. 
• Obsessions are defined as recurrent and persistent thoughts, impulses or 
images that are intrusive and inappropriate and cause anxiety or distress. 
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Common mental 
disorders (CMDs) 
symptoms
continued
Symptoms of CMD are not reported on separately in the APMS 2014 report, 
but are included in the archived dataset. 
Also see common mental disorders and CIS-R (Clinical Interview 
Schedule – Revised). 
Community care 
services 
Community care services included use of the following in the past year: a 
psychiatrist, psychologist, community psychiatric nurse, community learning 
difficulty nurse, other nursing services, social worker, self-help/support group, 
home help/homecare worker or outreach worker.
Comorbidity The co-occurrence of two (or more) different conditions. Comorbidity is 
associated with increased severity and longer duration of disorders, greater 
functional disability and increased use of health services. In this report this 
refers to psychiatric comorbidity only.
Current treatment 
for mental or 
emotional problem 
Current treatment for a mental or emotional problem included currently 
receiving any psychoactive medication, counselling or talking therapy, for 
a mental, nervous or emotional problem.
Day care services Day care service use included use of a community mental health centre, day 
activity centre, sheltered workshop and other nursing services in the past year.
Depot injection When antipsychotic medication is given by injections on a monthly basis, 
these are sometimes termed depot injections.
Depressive 
symptoms
Depressive symptoms include low mood and loss of interest and enjoyment 
in ordinary things and experiences.
Drug dependence Dependence syndrome is defined in ICD-10 as ‘a cluster of behavioural, cognitive, 
and physiological phenomena that develop after repeated substance use and that 
typically include a strong desire to take the drug, difficulties in controlling its use, 
persisting in its use despite harmful consequences, a higher priority given to drug 
use than to other activities and obligations, increased tolerance, and sometimes 
a physical withdrawal state’. A threshold of three or more of the following 
occurring in the past 12 months is required for a formal diagnosis: 
• Preoccupation with substance use
• A sense of need or dependence
• Impaired capacity to control substance-taking behaviour
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Drug dependence
continued
• Increased tolerance
• Withdrawal symptoms, and
• Persistent substance use despite evidence of harm.
DSM (Diagnostic and 
Statistical Manual of 
Mental Disorders)
The Diagnostic and Statistical Manual of Mental Disorders is a manual 
produced by the American Psychiatric Association that categorises currently 
recognised mental health disorders. While DSM-5 has since been released, 
DSM-IV was in place when APMS 2014 was in development, and where survey 
measures operational DSM criteria, they tend to draw on DSM-IV. 
Economic activity/ 
employment status 
Economically active people are those over the minimum school-leaving age 
who were working or unemployed in the week before the week of the 
interview. These people constitute the labour force. 
Employed 
This category includes people aged 16 and over who, in the week before 
the week of the interview, worked for wages, salary or other form of cash 
payment such as commission or tips, for any number of hours. It covers 
people absent from work in the reference week because of holiday, sickness, 
strike or temporary lay-off, provided they had a job to return to with the same 
employer. It also includes people attending an educational establishment 
during the specified week if they were paid by their employer while attending 
it, people who worked in Government training schemes and unpaid family 
workers. People are excluded if they have worked in a voluntary capacity 
for expenses only, or only for payment in kind, unless they worked for a 
business, firm or professional practice owned by a relative. Full-time students 
are classified as ‘working’, ‘unemployed’ or ‘inactive’ according to their 
own reports of what they were doing during the reference week. 
Unemployed people 
This survey used the International Labour Organisation (ILO) definition of 
unemployment. This classifies anyone as unemployed if he or she was out of 
work in the four weeks before interview, or would have been but for temporary 
sickness or injury, and was available to start work in the two weeks after the 
interview. Otherwise, anyone out of work is classified as economically inactive. 
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Economic activity/ 
employment status
continued
Economically inactive 
The ‘economically inactive’ group includes students, and those looking after 
the home, long term sick or disabled, or retired. 
Most of the analyses based on employment status in the report are based 
on those aged 16 to 64.
Equivalised 
household income
Making precise estimates of household income, as is done for example in 
the Family Resources Survey, requires far more interview time than available 
to this survey. Household income was thus established by means of a show 
card on which banded incomes were presented. Information was obtained 
from the selected participant, although they were encouraged to seek further 
information from the household reference person when this was someone 
else in the household. 
Initially the participant was asked to state their own aggregate gross income, 
and was then asked to estimate the total household income including that 
of any other people in the household. Household income can be used as an 
analysis variable, but there has been interest in using measures of equivalised 
income that adjust income level to take account of the number of people 
in the household. Methods of doing this vary in detail: the starting point is 
usually an exact estimate of net income, rather than the banded estimate of 
gross income obtained in APMS 2014. The method used in the present report 
uses the McClements scoring system, described below. 
1. A score was allocated to each household member, and these were added 
together to produce an overall household McClements score. Household 
members were given scores as follows: 
First adult 0.61
Spouse/partner 0.39
Other second adult 0.46
Third adult 0.42
Subsequent adults 0.36
Dependant aged 0–1 0.09
Dependant aged 2–4 0.18
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Equivalised 
household income 
continued
Dependant aged 5–7 0.21 
Dependant aged 8–10 0.23 
Dependant aged 11–12 0.25
Dependant aged 13–15 0.27
Dependant aged 16+ 0.36 
2. The equivalised income was derived as the annual household gross income 
divided by the McClements score. Where information on annual household 
gross income was not available, this was replaced with annual individual 
gross income. 
3. This equivalised annual income was attributed to all members of the 
household, including children. 
4. Households were ranked by equivalised income, and quintiles q1–q5 were 
identified. Because incomes were obtained in banded form, there were 
clumps of households with the same income spanning the quintiles. It was 
decided not to split clumps but to define the quintiles as ‘households with 
income up to q1’, ‘over q1 up to q2’ etc. Equivalised household income 
quintiles and corresponding income groups: 
• Lowest quintile <£12,999
• 2nd quintile >=£12,999 <£20,279
• 3rd quintile >=£20,279 < £31,666
• 4th quintile >=£31,666 <£52,499
• Highest quintile >=£52,499.
5. All individuals in each household were allocated to the equivalised 
household income quintile to which their household had been allocated. 
Insofar as the mean number of people per household may vary between 
quintiles, the numbers in the quintiles will be equal. Inequalities in 
numbers are also introduced by the clumping referred to above, and by 
the fact that in any sub-group analysed the proportionate distribution 
across quintiles will differ from that of the total sample. 
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Ethnicity Ethnic group was classified according to the latest ONS’s harmonised format:
White
English/Welsh/Scottish/Northern Irish/British 
Irish 
Gypsy or Irish Traveller 
Any other White background, please describe 
Mixed/Multiple ethnic groups
White and Black Caribbean 
White and Black African 
White and Asian 
Any other Mixed/Multiple ethnic background
Asian/Asian British
Indian
Pakistani
Bangladeshi
Chinese
Any other Asian background
Black/African/Caribbean/Black British
African
Caribbean
Any other Black/African/Caribbean background
Other ethnic group
Arab
Any other ethnic group, please describe 
For analyses in this report the mixed and multiple ethnicities group was 
combined with ‘other’. For some analyses, the White group was further divided 
into ‘White British’ and ‘White other’.
Harmful alcohol use A pattern of alcohol consumption that causes mental or physical damage.
Also see alcohol dependence and hazardous alcohol use. 
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Hazardous alcohol 
use 
A pattern of alcohol consumption that increases someone’s risk of harm. 
Some would limit this definition to the physical or mental health consequences 
(as in harmful use). Others include social consequences. The term is currently 
used by the World Health Organisation (WHO) to describe this pattern of 
alcohol consumption. It is not a diagnostic term.
The prevalence in the previous year was assessed using the Alcohol Use 
Disorders Identification Test (AUDIT) at the initial interview. An AUDIT score 
of eight or above indicates hazardous alcohol use. 
Also see alcohol dependence and harmful alcohol use. 
Healthcare services The ‘health care services used’ variable included an inpatient stay or outpatient 
visit in the past quarter, or spoken with a GP in the past year, for a mental or 
emotional reason. The time frame varied and so it is important to note that 
this variable does not represent all health care services used for a mental or 
emotional problem in the past year. 
Health conditions The 2007 and 2014 surveys adopted a show card approach to measuring 
self-reported general health and long standing illness. Participants were asked 
to identify which (if any) of the conditions listed below they had had since 
the age of 16. 
• Cancer 
• Diabetes 
• Epilepsy/fits 
• Migraine or frequent headaches 
• Dementia or Alzheimer’s disease 
• Anxiety, depression or other mental health issue 
• Cataracts/eyesight problems
• Ear/hearing problems 
• Stroke 
• Heart attack/angina 
• High blood pressure 
• Bronchitis/emphysema 
• Asthma 
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Health conditions
continued
• Allergies 
• Stomach ulcer or other digestive problems 
• Liver problems 
• Bowel/colon problems 
• Bladder problems/incontinence 
• Arthritis 
• Bone, back, joint or muscle problems 
• Infectious disease 
• Skin problems 
• Other
Household structure Information is collected from participants about who else is living in the 
household with them. This is used to derive a classification of household type. 
The following groupings are used in the report: 
• 1 adult 16–59, no child 
• 2 adults 16–59, no child 
• Small family (1 or 2 adults and 1 or 2 children) 
• Large family (1 or more adults and 3 or more children) 
• Large adult household (3 or more adults) 
• 2 adults one or both 60+, no child 
• 1 adult 60+, no child
ICD-10 The International Classification of Diseases and Related Health Problems 10th 
Revision (ICD-10) is a classification system for diseases and signs, symptoms, 
abnormal findings, complaints, social circumstances and external causes of 
injury or diseases, as classified by the World Health Organisation (WHO). 
Medications Current use of specific psychotropic medications was asked about using 
a series of showcards. These included all the most commonly prescribed 
preparations used in the treatment of mental health problems. Both generic 
and brand names were shown. Depot injections used in the treatment of 
psychosis were also included. Individual medications were grouped into 
categories reflecting what they are used to treat. One type of medication 
could be in more than one category. 
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Medications
continued
Medications used in the treatment of: 
Anxiety
• Amitriptyline
• Buspirone
• Citalopram
• Clomipramine
• Diazepam
• Escitalopram
• Fluoxetine
• Flupentixol
• Gabapentin
• Levemepromazine
• Lorazepam
• Oxazepam
• Paroxetine
• Pregabalin
• Promazine
• Sertraline
• Venlafaxine
Bipolar disorder
• Aripiprazole
• Carbamazepine
• Haloperidol
• Lamotrigine
• Lithium
• Olanzapine
• Paliperidone
• Quetiapine
• Risperidone
• Valproate
• Zuclopentixol
Depression
• Agomelatine
• Amitriptyline
• Citalopram
• Clomipramine
• Dosulepin
• Duloxetine
• Escitalopram
• Fluoxetine
• Flupentixol
• Fluvoxamine
• Imipramine
• Lamotrigine
• Lithium
• Lofepramine
• Mianserin
• Mirtazapine
• Moclobemide
• Nortriptyline
• Paroxetine
• Phenelzine
• Reboxetine
• Sertraline
• Tranylcypromine
• Trazodone
• Trimipramine
• Tryptophan
• Venlafaxine
ADHD
• Atomoxetine
• Methylphenidate
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Medications
continued
Sleep problems
• Melatonin
• Nitrazepam
• Oxazepam
• Zaleplon
• Zolpidem
• Zopiclone 
• Temazepam
Psychosis
• Amisulpride
• Aripiprazole
• Chlorpromazine
• Clopixol (Zuclopentixol decanoate)
• Clozapine
• Depixol (Flupentixol decanoate)
• Flupentixol 
• Haldol (Haloperidol decanoate)
• Haloperidol
• Levemepromazine
• Modecate (Fluphenazine 
decanoate)
• Olanzapine
• Paliperidone
• Promazine
• Quetiapine
• Risperdal Consta (Risperidone 
long-acting injection)
• Risperidone
• Sulpiride
• Trifluoperazine
• Zuclopentixol
In addition, medications used to treat the following conditions were also 
asked about:
Substance dependence
• Acamprosate
• Buprenorphine
• Chlordiazepoxide
• Diazepam
• Methadone
• Naltrexone
Epilepsy
• Carbamazepine
• Lamotrigine
• Levetiracetam
• Pregabalin
• Valproate 
Dementia
• Donepezil
• Galantamine
• Rivastigmine
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Mood Disorders 
Questionnaire  
(MDQ)
Bipolar spectrum disorders are under-diagnosed in primary care and psychiatric 
patient populations. The Mood Disorders Questionnaire (MDQ) is a 13-item 
self-report questionnaire designed to screen for bipolar spectrum disorders 
(BD type I, II, cyclothymia and BD not otherwise specified). In a yes/no format, 
the scale screens for lifetime history of DSM-IV mania/hypomania. 
Hirschfeld RMA. et al. Development and validation of a screening instrument 
for bipolar spectrum disorder: The Mood Disorder Questionnaire, Am J of 
Psychiatry, 2000; 157: 1873–5. 
Percentile The value of a distribution which partitions the cases into groups of a specified 
size. For example, the 20th percentile is the value of the distribution where 20 
per cent of the cases have values below the 20th percentile and 80 percent 
have values above it. The 50th percentile is the median. 
Personality disorder Personality disorder is ‘an enduring pattern of inner experience and 
behaviour that deviates markedly from the expectation of the individual’s 
culture, is pervasive and inflexible, has an onset in adolescence or early 
childhood, is stable over time, and leads to distress or impairment’ 
(American Psychiatric Association, 1994). Two types of personality disorder 
were investigated: antisocial personality disorder (ASPD) and borderline 
personality disorder (BPD). 
Also see antisocial (ASPD) and borderline personality disorder (BPD). 
Psychiatric morbidity The expression ‘psychiatric morbidity’ refers to the degree or extent of the 
prevalence of mental health problems within a defined area. 
Psychotic disorder These are disorders that produce disturbances in thinking and perception 
that are severe enough to distort the person’s perception of the world and their 
relationship to events within it. Psychoses are normally divided into two groups: 
organic psychoses, such as dementia and Alzheimer’s disease, and functional 
psychoses, which mainly cover schizophrenia and affective psychosis. The 
disorders discussed in Chapter 5 are based on the World Health Organisation’s 
International Classification of Diseases chapter on Mental and Behavioural 
Disorders (ICD-10) Diagnostic Criteria for Research (DCR) and consist mainly 
of two types: Schizophrenia and affective psychosis. 
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Psychotic disorder
continued
Two measures of psychosis are presented in the chapter: ‘probable psychotic 
disorder’ (consistent with the approach used in the 2000 and 2007 surveys) 
and ‘psychotic disorder’. These are defined in Section 5.2 in Chapter 5. 
Posttraumatic stress 
disorder 
Posttraumatic stress disorder (PTSD) is distinct from other psychiatric illnesses 
in that its diagnosis requires exposure to a traumatic stressor (being actually 
involved in, witnessing or confronted with life endangerment, death, serious 
injury or threat to self or others) which is accompanied by feelings of intense 
fear, horror, or helplessness. 
Also see PTSD-CL and Trauma. 
PTSD-CL The PTSD Checklist (PCL) is a 17-item self-report measure reflecting 
DSM-IV symptoms of PTSD. The PCL has a variety of clinical and research 
purposes, including: 
• Testing individuals for possible PTSD 
• Aiding in diagnostic assessment of PTSD 
• Monitoring change in PTSD symptoms
The PCL-C (civilian) asks about symptoms in relation to generic “stressful 
experiences” and can be used with any population. This version simplifies 
assessment based on multiple traumas because symptom endorsements 
are not attributed to a specific event.
The measure is described more fully in Chapter 4. 
P value A p value is the probability of the observed result occurring due to 
chance alone. A p value of less than 5% is conventionally taken to indicate 
a statistically significant result (p<0.05). It should be noted that the p value 
is dependent on the sample size, so that the sample differences or associations 
which are very small may still be statistically significant. Results should therefore 
be assessed for their importance on the magnitude of the differences or 
associations as well as the p value itself. 
Quintile Quintiles are percentiles which divide a distribution into fifths, i.e. the 20th, 
40th, 60th and 80th percentiles.
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Region Tables within chapters provide data for regional analysis based on former 
Government Office Regions. Few disorders in this report varied significantly 
by region, and generally region is not referred to in the text of the chapters. 
A table presenting the breakdown of each disorder by region is included in 
each chapter as this information may be useful for users of the data involved 
in regional service planning and provision.
SAPAS (Standardised 
Assessment of 
Personality – 
Abbreviated Scale)
The Standardised Assessment of Personality – Abbreviated Scale (SAPAS) is a 
screening questionnaire consisting of eight dichotomously rated items designed 
to screen for personality disorder.
SCAN (Schedule for 
Clinical Assessment 
in Neuropsychiatry) 
Schedule for Clinical Assessment in Neuropsychiatry version 2.1 (SCAN), a 
semi-structured interview that provides ICD-10 diagnoses of psychotic disorder. 
SCID-II (Structured 
Clinical Interview for 
DSM-IV) 
APMS adopts the DSM-IV classification of personality disorder and uses the 
Structured Clinical Interview for DSM-IV (SCID-II). The SCID-II is available as 
both a self-completion screen and as a semi-structured clinician administered 
face to face interview. Only the self-completion screen was included in APMS 
2014. This was used alongside the SAPAS.
Screening For the purposes of this report, ‘screening’ involves identifying people who 
have signs or traits that indicate the likely presence of a disorder. The term 
is not used here to refer to national screening programmes such as those 
recommended by the UK National Screening Committee (UK NSC).
Self-harm The definition of self-harm used on APMS refers to self-harming without 
suicidal intention and includes acts such as cutting, burning, swallowing, 
and other self-inflicted injuries.
Standardisation In this report, standardisation refers to standardisation (or ‘adjustment’) 
by age (see age-standardisation). 
Suicidal behaviour Suicidal behaviour includes suicidal thoughts and attempts. Suicidal thoughts 
refer to thinking about taking one’s own life; it does not incorporate feelings 
about ‘life not being worth living’ or ‘wishing to be dead’. ‘Suicidal attempts’ 
is a term used to describe an attempt to take one’s life.
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Trauma According to DSM-IV, traumatic stressors are events in which an individual 
experiences, witnesses, or is confronted with life endangerment, death, 
or serious injury or threat to self or others. Traumatic stressors are distinct 
from and more severe than generally stressful life events, such as divorce 
or expected bereavement. 
Also see PTSD (posttraumatic stress disorder) and PTSD-CL (Post-traumatic 
Stress Disorder – Check List Questionnaire). 
Treatment See current treatment for a mental or emotional problem. 
Wellbeing Subjective wellbeing is generally regarded as consisting of at least two factors. 
Broadly, these are ‘hedonic’ wellbeing (happiness, pleasure, enjoyment) and 
‘eudemonic’ wellbeing (purpose, meaning, fulfilment). 
WEMWBS (Warwick-
Edinburgh Mental 
Well-being Scale)
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) was developed 
to enable the monitoring of mental wellbeing in the general population. 
WEMWBS is a 14-item scale with 5 response categories, summed to provide 
a single score ranging from 14–70. The items are all worded positively and 
cover both feeling and functioning aspects of mental wellbeing.
This report presents findings of a survey of mental illness and wellbeing among 
people aged 16 and over living in private households in England. The survey was 
commissioned by NHS Digital and funded by the Department of Health, and is 
the fourth in a series of surveys of adult mental health.
NHS Digital
NHS Digital is the national provider of information, data and IT systems for 
commissioners, analysts and clinicians in health and social care. Acting as a ‘hub’ 
for high quality, national, comparative data, it delivers information for local decision 
makers, to improve the quality and efficiency of care. NHS Digital is an executive 
non-departmental public body, sponsored by the Department of Health
NatCen Social Research
NatCen Social Research is an independent institute specialising in social survey 
and qualitative research for the development of public policy. Research is in areas 
such as health, housing, employment, crime, education and political and social 
attitudes. Projects include ad hoc, continuous and longitudinal surveys, using 
face to face, telephone, postal and web methods.
Department of Health Sciences, University of Leicester
The Department of Health Sciences at the University of Leicester is a research-led 
department with established strengths across epidemiology, medical statistics, 
public health, primary care, health services research, and psychiatry. Structured 
to support innovative multidisciplinary and multi-method solutions to research 
questions, it conducts high quality scientific research that can inform policies 
and practices aimed at securing people’s health and wellbeing.
